{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Pepsico, in 2022 Q1, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  | \n\u2612 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \n\u2610 | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  | \nPepsiCo, Inc.  |  |  |  |  |  |  |  | \n |  | \nNorth Carolina |  | 13-1584302\n(State or Other Jurisdiction ofIncorporation or Organization) |  | (I.R.S. EmployerIdentification No.)\n | \n |  | \n |  |   |  | \n(Address of principal executive offices and Zip Code)  |  | \nRegistrant's telephone number, including area code  |  | \n(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTitle of each class |  | Trading Symbols |  | Name of each exchange on which registered\nCommon Stock, par value 1-2/3 cents per share |  | PEP |  | The Nasdaq Stock Market LLC\n2.500% Senior Notes Due 2022 |  | PEP22a |  | The Nasdaq Stock Market LLC\n0.250% Senior Notes Due 2024 |  | PEP24 |  | The Nasdaq Stock Market LLC\n2.625% Senior Notes Due 2026 |  | PEP26 |  | The Nasdaq Stock Market LLC\n0.750% Senior Notes Due 2027 |  | PEP27 |  | The Nasdaq Stock Market LLC\n0.875% Senior Notes Due 2028 |  | PEP28 |  | The Nasdaq Stock Market LLC\n0.500% Senior Notes Due 2028 |  | PEP28a |  | The Nasdaq Stock Market LLC\n1.125% Senior Notes Due 2031 |  | PEP31 |  | The Nasdaq Stock Market LLC\n0.400% Senior Notes Due 2032 |  | PEP32 |  | The Nasdaq Stock Market LLC\n0.750% Senior Notes Due 2033 |  | PEP33 |  | The Nasdaq Stock Market LLC\n0.875% Senior Notes Due 2039 |  | PEP39 |  | The Nasdaq Stock Market LLC\n1.050% Senior Notes Due 2050 |  | PEP50 |  | The Nasdaq Stock Market LLC  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 | Accelerated filer | \u2610\nNon-accelerated filer | \u2610 | Smaller reporting company | \u2610\n |  | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \n |  | Page\u00a0No.\nPart I        Financial Information | \nItem 1. | Condensed Consolidated Financial Statements | 3\n | Condensed Consolidated Statement of Income \u201312 Weeks Ended March 19, 2022 and March 20, 2021 | 3\n | Condensed Consolidated Statement of Comprehensive Income \u201312 Weeks Ended March 19, 2022 and March 20, 2021 | 4\n | Condensed Consolidated Statement of Cash Flows \u201312 Weeks Ended March 19, 2022 and March 20, 2021 | 5\n | Condensed Consolidated Balance Sheet \u2013March 19, 2022 and December 25, 2021 | 7\n | Condensed Consolidated Statement of Equity \u201312 Weeks Ended March 19, 2022 and March 20, 2021 | 8\n | Notes to the Condensed Consolidated Financial Statements | 9\nItem\u00a02. | Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations | 24\nReport of Independent Registered Public Accounting Firm | 43\nItem 3. | Quantitative and Qualitative Disclosures About Market Risk | 44\nItem 4. | Controls and Procedures | 44\nPart II      Other Information | \nItem 1. | Legal Proceedings | 45\nItem 1A. | Risk Factors | 45\nItem 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 46\nItem 6. | Exhibits | 46  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended\n |  |  |  |  | 3/19/2022 |  | 3/20/2021\nNet Revenue |  |  |  |  | $ | 16,200 |  |  | $ | 14,820 | \nCost of sales |  |  |  |  | 7,433 |  |  | 6,671 | \nGross profit |  |  |  |  | 8,767 |  |  | 8,149 | \nSelling, general and administrative expenses |  |  |  |  | 6,822 |  |  | 5,837 | \nGain associated with the Juice Transaction(a) |  |  |  |  | (3,322) |  |  | \u2014 | \nOperating Profit |  |  |  |  | 5,267 |  |  | 2,312 | \nOther pension and retiree medical benefits income |  |  |  |  | 134 |  |  | 120 | \nNet interest expense and other |  |  |  |  | (240) |  |  | (258) | \nIncome before income taxes |  |  |  |  | 5,161 |  |  | 2,174 | \nProvision for income taxes |  |  |  |  | 888 |  |  | 451 | \nNet income |  |  |  |  | 4,273 |  |  | 1,723 | \nLess: Net income attributable to noncontrolling interests |  |  |  |  | 12 |  |  | 9 | \nNet Income Attributable to PepsiCo |  |  |  |  | $ | 4,261 |  |  | $ | 1,714 | \nNet Income Attributable to PepsiCo per Common Share |  |  |  |  |  |  | \nBasic |  |  |  |  | $ | 3.08 |  |  | $ | 1.24 | \nDiluted |  |  |  |  | $ | 3.06 |  |  | $ | 1.24 | \nWeighted-average common shares outstanding |  |  |  |  |  |  | \nBasic |  |  |  |  | 1,383 |  |  | 1,380 | \nDiluted |  |  |  |  | 1,391 |  |  | 1,387 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended\n |  |  |  |  | 3/19/2022 |  | 3/20/2021\nNet income |  |  |  |  | $ | 4,273 |  |  | $ | 1,723 | \nOther comprehensive (loss)/income, net of taxes: |  |  |  |  |  |  | \nNet currency translation adjustment |  |  |  |  | (560) |  |  | 131 | \nNet change on cash flow hedges |  |  |  |  | 106 |  |  | 72 | \nNet pension and retiree medical adjustments |  |  |  |  | 13 |  |  | 27 | \nOther |  |  |  |  | (4) |  |  | \u2014 | \n |  |  |  |  | (445) |  |  | 230 | \nComprehensive income |  |  |  |  | 3,828 |  |  | 1,953 | \nLess: Comprehensive income attributable tononcontrolling interests |  |  |  |  | 12 |  |  | 9 | \nComprehensive Income Attributable to PepsiCo |  |  |  |  | $ | 3,816 |  |  | $ | 1,944 |   |  | \n  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 3/19/2022 |  | 3/20/2021\nOperating Activities |  |  | \nNet income | $ | 4,273 |  |  | $ | 1,723 | \nDepreciation and amortization | 555 |  |  | 560 | \nGain associated with the Juice Transaction | (3,322) |  |  | \u2014 | \nBrand portfolio impairment charges | 241 |  |  | \u2014 | \nRussia-Ukraine conflict charges | 241 |  |  | \u2014 | \nOperating lease right-of-use asset amortization | 103 |  |  | 99 | \nShare-based compensation expense | 81 |  |  | 79 | \nRestructuring and impairment charges | 27 |  |  | 43 | \nCash payments for restructuring charges | (32) |  |  | (49) | \nAcquisition and divestiture-related charges | 56 |  |  | (10) | \nCash payments for acquisition and divestiture-related charges | (17) |  |  | (7) | \nPension and retiree medical plan (income)/expense | (1) |  |  | 21 | \nPension and retiree medical plan contributions | (178) |  |  | (413) | \nDeferred income taxes and other tax charges and credits | 257 |  |  | 108 | \n |  |  | \n |  |  | \nChange in assets and liabilities: |  |  | \nAccounts and notes receivable | (837) |  |  | (455) | \nInventories | (549) |  |  | (397) | \nPrepaid expenses and other current assets | (190) |  |  | (210) | \nAccounts payable and other current liabilities | (1,238) |  |  | (1,906) | \nIncome taxes payable | 489 |  |  | 227 | \nOther, net | (133) |  |  | (132) | \nNet Cash Used for Operating Activities | (174) |  |  | (719) | \n |  |  | \nInvesting Activities |  |  | \nCapital spending | (522) |  |  | (471) | \nSales of property, plant and equipment | 3 |  |  | 5 | \nAcquisitions, net of cash acquired, and investments in noncontrolled affiliates | (13) |  |  | (13) | \nProceeds associated with the Juice Transaction | 3,456 |  |  | \u2014 | \nOther divestitures and sales of investments in noncontrolled affiliates | 5 |  |  | 35 | \nShort-term investments, by original maturity: |  |  | \n |  |  | \nMore than three months - maturities | \u2014 |  |  | 535 | \n |  |  | \nThree months or less, net | 22 |  |  | 3 | \nOther investing, net | 4 |  |  | \u2014 | \nNet Cash Provided by Investing Activities | 2,955 |  |  | 94 |   |  | \n  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 3/19/2022 |  | 3/20/2021\nFinancing Activities |  |  | \n |  |  | \nPayments of long-term debt | (1,251) |  |  | (1) | \n |  |  | \nShort-term borrowings, by original maturity: |  |  | \nMore than three months - proceeds | 559 |  |  | \u2014 | \nMore than three months - payments | \u2014 |  |  | (396) | \nThree months or less, net | 647 |  |  | 53 | \n |  |  | \nCash dividends paid | (1,505) |  |  | (1,429) | \nShare repurchases - common | (193) |  |  | (106) | \n |  |  | \nProceeds from exercises of stock options | 49 |  |  | 62 | \nWithholding tax payments on restricted stock units (RSUs) and performance stock units (PSUs) converted | (85) |  |  | (71) | \nOther financing | (1) |  |  | \u2014 | \nNet Cash Used for Financing Activities | (1,780) |  |  | (1,888) | \nEffect of exchange rate changes on cash and cash equivalents and restricted cash | (17) |  |  | (10) | \nNet Increase/(Decrease) in Cash and Cash Equivalents and Restricted Cash | 984 |  |  | (2,523) | \nCash and Cash Equivalents and Restricted Cash, Beginning of Year | 5,707 |  |  | 8,254 | \nCash and Cash Equivalents and Restricted Cash, End of Period | $ | 6,691 |  |  | $ | 5,731 | \n |  |  | \nSupplemental Non-Cash Activity |  |  | \nRight-of-use assets obtained in exchange for lease obligations | $ | 100 |  |  | $ | 167 |   |  | \n  |  |  |  |  |  |  |  |  |  |  | \n | (Unaudited) |  | \n | 3/19/2022 |  | 12/25/2021\nASSETS |  |  | \nCurrent Assets |  |  | \nCash and cash equivalents | $ | 6,561 |  |  | $ | 5,596 | \nShort-term investments | 343 |  |  | 392 | \n |  |  | \nAccounts and notes receivable, less allowance: 3/22 - $192and 12/21 - $147 | 9,424 |  |  | 8,680 | \nInventories: |  |  | \nRaw materials and packaging | 2,017 |  |  | 1,898 | \nWork-in-process | 154 |  |  | 151 | \nFinished goods | 2,591 |  |  | 2,298 | \n | 4,762 |  |  | 4,347 | \nPrepaid expenses and other current assets | 1,252 |  |  | 980 | \nAssets held for sale | \u2014 |  |  | 1,788 | \nTotal Current Assets | 22,342 |  |  | 21,783 | \nProperty, plant and equipment | 46,533 |  |  | 46,828 | \nAccumulated depreciation | (24,516) |  |  | (24,421) | \nProperty, Plant and Equipment, net | 22,017 |  |  | 22,407 | \nAmortizable Intangible Assets, net | 1,497 |  |  | 1,538 | \nGoodwill | 18,112 |  |  | 18,381 | \nOther Indefinite-Lived Intangible Assets | 16,603 |  |  | 17,127 | \n |  |  | \nInvestments in Noncontrolled Affiliates | 3,595 |  |  | 2,627 | \nDeferred Income Taxes | 4,301 |  |  | 4,310 | \nOther Assets | 4,495 |  |  | 4,204 | \nTotal Assets | $ | 92,962 |  |  | $ | 92,377 | \n |  |  | \nLIABILITIES AND EQUITY |  |  | \nCurrent Liabilities |  |  | \nShort-term debt obligations | $ | 5,459 |  |  | $ | 4,308 | \nAccounts payable and other current liabilities | 20,365 |  |  | 21,159 | \nLiabilities held for sale | \u2014 |  |  | 753 | \nTotal Current Liabilities | 25,824 |  |  | 26,220 | \nLong-Term Debt Obligations | 34,590 |  |  | 36,026 | \nDeferred Income Taxes | 5,072 |  |  | 4,826 | \nOther Liabilities | 9,156 |  |  | 9,154 | \nTotal Liabilities | 74,642 |  |  | 76,226 | \nCommitments and contingencies |  |  | \nPepsiCo Common Shareholders\u2019 Equity |  |  | \nCommon stock, par value 12/3\u00a2 per share (authorized3,600shares; issued, net of repurchased common stock at par value:1,384and1,383shares, respectively) | 23 |  |  | 23 | \nCapital in excess of par value | 3,893 |  |  | 4,001 | \nRetained earnings | 67,934 |  |  | 65,165 | \nAccumulated other comprehensive loss | (15,343) |  |  | (14,898) | \nRepurchased common stock, in excess of par value (483and484shares, respectively) | (38,305) |  |  | (38,248) | \nTotal PepsiCo Common Shareholders\u2019 Equity | 18,202 |  |  | 16,043 | \nNoncontrolling interests | 118 |  |  | 108 | \nTotal Equity | 18,320 |  |  | 16,151 | \nTotal Liabilities and Equity | $ | 92,962 |  |  | $ | 92,377 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended\n |  |  |  |  | 3/19/2022 |  | 3/20/2021\n |  |  |  |  |  |  |  |  | Shares |  | Amount |  | Shares |  | Amount\n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCommon Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  |  |  |  |  |  |  | 1,383 |  |  | $ | 23 |  |  | 1,380 |  |  | $ | 23 | \nChange in repurchased common stock |  |  |  |  |  |  |  |  | 1 |  |  | \u2014 |  |  | 2 |  |  | \u2014 | \nBalance, end of period |  |  |  |  |  |  |  |  | 1,384 |  |  | 23 |  |  | 1,382 |  |  | 23 | \nCapital in Excess of Par Value |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  |  |  |  |  |  |  |  |  | 4,001 |  |  |  |  | 3,910 | \nShare-based compensation expense |  |  |  |  |  |  |  |  |  |  | 83 |  |  |  |  | 80 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nStock option exercises, RSUs and PSUs converted |  |  |  |  |  |  |  |  |  |  | (106) |  |  |  |  | (119) | \nWithholding tax on RSUs and PSUs converted |  |  |  |  |  |  |  |  |  |  | (85) |  |  |  |  | (71) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, end of period |  |  |  |  |  |  |  |  |  |  | 3,893 |  |  |  |  | 3,800 | \nRetained Earnings |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  |  |  |  |  |  |  |  |  | 65,165 |  |  |  |  | 63,443 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nNet income attributable to PepsiCo |  |  |  |  |  |  |  |  |  |  | 4,261 |  |  |  |  | 1,714 | \nCash dividends declared \u2013 common(a) |  |  |  |  |  |  |  |  |  |  | (1,492) |  |  |  |  | (1,417) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, end of period |  |  |  |  |  |  |  |  |  |  | 67,934 |  |  |  |  | 63,740 | \nAccumulated Other Comprehensive Loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  |  |  |  |  |  |  |  |  | (14,898) |  |  |  |  | (15,476) | \nOther comprehensive (loss)/income attributable to PepsiCo |  |  |  |  |  |  |  |  |  |  | (445) |  |  |  |  | 230 | \nBalance, end of period |  |  |  |  |  |  |  |  |  |  | (15,343) |  |  |  |  | (15,246) | \nRepurchased Common Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  |  |  |  |  |  |  | (484) |  |  | (38,248) |  |  | (487) |  |  | (38,446) | \nShare repurchases |  |  |  |  |  |  |  |  | (1) |  |  | (213) |  |  | (1) |  |  | (106) | \nStock option exercises, RSUs and PSUs converted |  |  |  |  |  |  |  |  | 2 |  |  | 156 |  |  | 3 |  |  | 182 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, end of period |  |  |  |  |  |  |  |  | (483) |  |  | (38,305) |  |  | (485) |  |  | (38,370) | \nTotal PepsiCo Common Shareholders\u2019 Equity |  |  |  |  |  |  |  |  |  |  | 18,202 |  |  |  |  | 13,947 | \nNoncontrolling Interests |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  |  |  |  |  |  |  |  |  | 108 |  |  |  |  | 98 | \nNet income attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  |  | 12 |  |  |  |  | 9 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOther, net |  |  |  |  |  |  |  |  |  |  | (2) |  |  |  |  | (1) | \nBalance, end of period |  |  |  |  |  |  |  |  |  |  | 118 |  |  |  |  | 106 | \nTotal Equity |  |  |  |  |  |  |  |  |  |  | $ | 18,320 |  |  |  |  | $ | 14,053 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended\n |  |  |  |  | 3/19/2022 |  | 3/20/2021\nFLNA |  |  |  |  | $ | 4,839 |  |  | $ | 4,236 | \nQFNA |  |  |  |  | 713 |  |  | 646 | \nPBNA |  |  |  |  | 5,353 |  |  | 5,074 | \nLatAm |  |  |  |  | 1,474 |  |  | 1,242 | \nEurope |  |  |  |  | 1,797 |  |  | 1,795 | \nAMESA |  |  |  |  | 1,004 |  |  | 883 | \nAPAC |  |  |  |  | 1,020 |  |  | 944 | \nTotal |  |  |  |  | $ | 16,200 |  |  | $ | 14,820 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 3/19/2022 |  | 3/20/2021\n | Beverages(a) |  | Convenient Foods |  | Beverages(a) |  | Convenient Foods\nLatAm | 10 | % |  | 90 | % |  | 10 | % |  | 90 | %\nEurope | 50 | % |  | 50 | % |  | 50 | % |  | 50 | %\nAMESA | 30 | % |  | 70 | % |  | 30 | % |  | 70 | %\nAPAC | 15 | % |  | 85 | % |  | 15 | % |  | 85 | %\nPepsiCo(b) | 40 | % |  | 60 | % |  | 45 | % |  | 55 | %\n |  |  |  |  |  |  | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended\n |  |  |  |  | 3/19/2022 |  | 3/20/2021\nFLNA |  |  |  |  | $ | 1,296 |  |  | $ | 1,240 | \nQFNA |  |  |  |  | 159 |  |  | 150 | \nPBNA(a) |  |  |  |  | 3,434 |  |  | 366 | \nLatAm |  |  |  |  | 323 |  |  | 218 | \nEurope(a) (b) |  |  |  |  | (136) |  |  | 131 | \nAMESA |  |  |  |  | 180 |  |  | 138 | \nAPAC |  |  |  |  | 215 |  |  | 208 | \nTotal divisions |  |  |  |  | 5,471 |  |  | 2,451 | \nCorporate unallocated expenses(c) |  |  |  |  | (204) |  |  | (139) | \nTotal |  |  |  |  | $ | 5,267 |  |  | $ | 2,312 |   |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | \n |  |  |  |  | 12 Weeks Ended 3/19/2022 |  |  |  | \nImpairment charges related to property, plant and equipment |  |  |  |  | $ | 123 |  |  |  |  | \n |  |  |  |  |  |  |  |  | \nAllowance for expected credit losses |  |  |  |  | 37 |  |  |  |  | \nInventory write-downs |  |  |  |  | 33 |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \nOther |  |  |  |  | 48 |  |  |  |  | \nTotal(a) |  |  |  |  | $ | 241 |  |  |  |  | \nAfter-tax amount |  |  |  |  | $ | 241 |  |  |  |  | \nImpact on net income attributable to PepsiCo per common share |  |  |  |  | $ | (0.17) |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended\n |  |  |  |  | 3/19/2022 |  | 3/20/2021\nFLNA |  |  |  |  | $ | 14 |  |  | $ | 24 | \nQFNA |  |  |  |  | 1 |  |  | 2 | \nPBNA |  |  |  |  | 10 |  |  | 13 | \nLatAm |  |  |  |  | 6 |  |  | 15 | \nEurope |  |  |  |  | 1 |  |  | 6 | \nAMESA(a) |  |  |  |  | 2 |  |  | (1) | \nAPAC |  |  |  |  | 2 |  |  | 2 | \nTotal |  |  |  |  | $ | 36 |  |  | $ | 61 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | FLNA |  | QFNA |  | PBNA |  | LatAm |  | Europe |  | AMESA |  | APAC |  | Corporate\nExpected pre-tax charges | 15 | % |  | 1 | % |  | 25 | % |  | 10 | % |  | 25 | % |  | 5 | % |  | 4 | % |  | 15 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended\n |  |  |  |  | 3/19/2022 |  | 3/20/2021\nCost of sales |  |  |  |  | $ | 5 |  |  | $ | 2 | \nSelling, general and administrative expenses |  |  |  |  | 22 |  |  | 35 | \nOther pension and retiree medical benefits expense |  |  |  |  | \u2014 |  |  | 6 | \nTotal restructuring and impairment charges |  |  |  |  | $ | 27 |  |  | $ | 43 | \nAfter-tax amount |  |  |  |  | $ | 21 |  |  | $ | 35 | \nImpact on net income attributable to PepsiCo per common share |  |  |  |  | $ | (0.02) |  |  | $ | (0.03) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended |  | Plan to Date\n |  |  |  |  | 3/19/2022 |  | 3/20/2021 |  | through 3/19/2022\nFLNA |  |  |  |  | $ | 3 |  |  | $ | 15 |  |  | $ | 167 | \nQFNA |  |  |  |  | \u2014 |  |  | \u2014 |  |  | 12 | \nPBNA |  |  |  |  | 3 |  |  | 4 |  |  | 161 | \nLatAm |  |  |  |  | 6 |  |  | 2 |  |  | 145 | \nEurope |  |  |  |  | 7 |  |  | 11 |  |  | 241 | \nAMESA |  |  |  |  | 2 |  |  | 1 |  |  | 72 | \nAPAC |  |  |  |  | 1 |  |  | \u2014 |  |  | 62 | \nCorporate |  |  |  |  | 5 |  |  | 4 |  |  | 144 | \n |  |  |  |  | 27 |  |  | 37 |  |  | 1,004 | \nOther pension and retiree medical benefits expense |  |  |  |  | \u2014 |  |  | 6 |  |  | 67 | \nTotal |  |  |  |  | $ | 27 |  |  | $ | 43 |  |  | $ | 1,071 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended |  | Plan to Date\n |  |  |  |  | 3/19/2022 |  | 3/20/2021 |  | through 3/19/2022\nSeverance and\u00a0other employee costs |  |  |  |  | $ | 11 |  |  | $ | 34 |  |  | $ | 575 | \nAsset impairments |  |  |  |  | \u2014 |  |  | \u2014 |  |  | 157 | \nOther\u00a0costs |  |  |  |  | 16 |  |  | 9 |  |  | 339 | \nTotal |  |  |  |  | $ | 27 |  |  | $ | 43 |  |  | $ | 1,071 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Severance and\u00a0Other Employee Costs |  |  |  | Other\u00a0Costs |  | Total\nLiability as of December 25, 2021 | $ | 64 |  |  |  |  | $ | 7 |  |  | $ | 71 | \n2022 restructuring charges | 11 |  |  |  |  | 16 |  |  | 27 | \nCash payments | (16) |  |  |  |  | (16) |  |  | (32) | \n |  |  |  |  |  |  | \nLiability as of March 19, 2022 | $ | 59 |  |  |  |  | $ | 7 |  |  | $ | 66 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | 3/19/2022 |  | 12/25/2021\n |  | Gross |  | Accumulated Amortization |  | Net |  | Gross |  | Accumulated Amortization |  | Net\nAcquired franchise rights(a) |  | $ | 975 |  |  | $ | (189) |  |  | $ | 786 |  |  | $ | 976 |  |  | $ | (187) |  |  | $ | 789 | \nCustomer relationships |  | 608 |  |  | (222) |  |  | 386 |  |  | 623 |  |  | (227) |  |  | 396 | \nBrands |  | 1,120 |  |  | (984) |  |  | 136 |  |  | 1,151 |  |  | (989) |  |  | 162 | \nOther identifiable intangibles |  | 450 |  |  | (261) |  |  | 189 |  |  | 451 |  |  | (260) |  |  | 191 | \nTotal |  | $ | 3,153 |  |  | $ | (1,656) |  |  | $ | 1,497 |  |  | $ | 3,201 |  |  | $ | (1,663) |  |  | $ | 1,538 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Balance12/25/2021 |  |  |  | Translationand Other |  | Balance3/19/2022\n |  |  | \nFLNA |  |  |  |  |  |  | \nGoodwill | $ | 458 |  |  |  |  | $ | 2 |  |  | $ | 460 | \nBrands | 340 |  |  |  |  | \u2014 |  |  | 340 | \nTotal | 798 |  |  |  |  | 2 |  |  | 800 | \nQFNA |  |  |  |  |  |  | \nGoodwill | 189 |  |  |  |  | \u2014 |  |  | 189 | \nTotal | 189 |  |  |  |  | \u2014 |  |  | 189 | \nPBNA |  |  |  |  |  |  | \nGoodwill | 11,974 |  |  |  |  | 6 |  |  | 11,980 | \nReacquired franchise rights | 7,107 |  |  |  |  | 13 |  |  | 7,120 | \nAcquired franchise rights | 1,538 |  |  |  |  | 2 |  |  | 1,540 | \nBrands | 2,508 |  |  |  |  | \u2014 |  |  | 2,508 | \nTotal | 23,127 |  |  |  |  | 21 |  |  | 23,148 | \nLatAm |  |  |  |  |  |  | \nGoodwill | 433 |  |  |  |  | 15 |  |  | 448 | \nBrands | 100 |  |  |  |  | 5 |  |  | 105 | \nTotal | 533 |  |  |  |  | 20 |  |  | 553 | \nEurope(a) |  |  |  |  |  |  | \nGoodwill | 3,700 |  |  |  |  | (308) |  |  | 3,392 | \nReacquired franchise rights | 441 |  |  |  |  | (36) |  |  | 405 | \nAcquired franchise rights | 158 |  |  |  |  | (2) |  |  | 156 | \nBrands | 4,254 |  |  |  |  | (513) |  |  | 3,741 | \nTotal | 8,553 |  |  |  |  | (859) |  |  | 7,694 | \nAMESA |  |  |  |  |  |  | \nGoodwill | 1,063 |  |  |  |  | 16 |  |  | 1,079 | \nBrands | 205 |  |  |  |  | 6 |  |  | 211 | \nTotal | 1,268 |  |  |  |  | 22 |  |  | 1,290 | \nAPAC |  |  |  |  |  |  | \nGoodwill | 564 |  |  |  |  | \u2014 |  |  | 564 | \nBrands | 476 |  |  |  |  | 1 |  |  | 477 | \nTotal | 1,040 |  |  |  |  | 1 |  |  | 1,041 | \n |  |  |  |  |  |  | \nTotal goodwill | 18,381 |  |  |  |  | (269) |  |  | 18,112 | \nTotal reacquired franchise rights | 7,548 |  |  |  |  | (23) |  |  | 7,525 | \nTotal acquired franchise rights | 1,696 |  |  |  |  | \u2014 |  |  | 1,696 | \nTotal brands | 7,883 |  |  |  |  | (501) |  |  | 7,382 | \nTotal | $ | 35,508 |  |  |  |  | $ | (793) |  |  | $ | 34,715 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended\n |  |  |  |  | 3/19/2022 |  | 3/20/2021\nShare-based compensation expense \u2013 equity awards |  |  |  |  | $ | 81 |  |  | $ | 79 | \nShare-based compensation expense \u2013 liability awards |  |  |  |  | 5 |  |  | 4 | \nAcquisition and divestiture-related charges |  |  |  |  | 3 |  |  | \u2014 | \nRestructuring charges |  |  |  |  | (1) |  |  | 1 | \nTotal |  |  |  |  | $ | 88 |  |  | $ | 84 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 3/19/2022 |  | 3/20/2021\n | Granted(a) |  | Weighted-Average Grant Price |  | Granted(a) |  | Weighted-Average Grant Price\nStock options | 2.1 |  |  | $ | 163.00 |  |  | 1.8 |  |  | $ | 131.25 | \nRSUs and PSUs | 2.3 |  |  | $ | 163.00 |  |  | 2.6 |  |  | $ | 131.25 |   |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 3/19/2022 |  | 3/20/2021\nExpected life | 7years |  | 7years\nRisk-free interest rate | 1.7 | % |  | 1.1 | %\nExpected volatility | 16 | % |  | 14 | %\nExpected dividend yield | 2.5 | % |  | 3.1 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | Pension |  | Retiree Medical\n | U.S. |  | International |  | \n | 3/19/2022 |  | 3/20/2021 |  | 3/19/2022 |  | 3/20/2021 |  | 3/19/2022 |  | 3/20/2021\nService cost | $ | 114 |  |  | $ | 120 |  |  | $ | 17 |  |  | $ | 19 |  |  | $ | 8 |  |  | $ | 8 | \nOther pension and retiree medical benefits income: |  |  |  | \nInterest cost | 88 |  |  | 75 |  |  | 17 |  |  | 13 |  |  | 4 |  |  | 3 | \nExpected return on plan assets | (215) |  |  | (224) |  |  | (42) |  |  | (41) |  |  | (3) |  |  | (4) | \nAmortization of prior service credits | (6) |  |  | (7) |  |  | \u2014 |  |  | \u2014 |  |  | (2) |  |  | (2) | \nAmortization of net losses/(gains) | 33 |  |  | 51 |  |  | 5 |  |  | 13 |  |  | (3) |  |  | (3) | \nSettlement/curtailment gains | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (16) |  |  | \u2014 | \nSpecial termination benefits | 6 |  |  | 6 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nTotal other pension and retiree medical benefits income | (94) |  |  | (99) |  |  | (20) |  |  | (15) |  |  | (20) |  |  | (6) | \nTotal | $ | 20 |  |  | $ | 21 |  |  | $ | (3) |  |  | $ | 4 |  |  | $ | (12) |  |  | $ | 2 |   |  |  |  |  |  |  |  |  |  |  | \n | Notional Amounts(a)\n | 3/19/2022 |  | 12/25/2021\nCommodity | $ | 1.6 |  |  | $ | 1.6 | \nForeign exchange | $ | 2.6 |  |  | $ | 2.8 | \nInterest rate | $ | 2.1 |  |  | $ | 2.1 | \nNet investment(b) | $ | 2.1 |  |  | $ | 2.1 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 3/19/2022 |  | 12/25/2021\n | Fair Value Hierarchy Levels(a) |  | Assets(a) |  | Liabilities(a) |  | Assets(a) |  | Liabilities(a)\n |  |  |  |  |  |  |  |  | \nIndex funds(b) | 1 |  | $ | 297 |  |  | $ | \u2014 |  |  | $ | 337 |  |  | $ | \u2014 | \nPrepaid forward contracts(c) | 2 |  | $ | 20 |  |  | $ | \u2014 |  |  | $ | 21 |  |  | $ | \u2014 | \nDeferred compensation(d) | 2 |  | $ | \u2014 |  |  | $ | 480 |  |  | $ | \u2014 |  |  | $ | 505 | \n |  |  |  |  |  |  |  |  | \nDerivatives designated as cash flow hedging instruments: |  |  |  |  |  |  |  |  | \nForeign exchange(e) | 2 |  | $ | 43 |  |  | $ | 16 |  |  | $ | 29 |  |  | $ | 14 | \nInterest rate(e) | 2 |  | 28 |  |  | 275 |  |  | 14 |  |  | 264 | \nCommodity(f) | 2 |  | 119 |  |  | 1 |  |  | 70 |  |  | 5 | \n |  |  | $ | 190 |  |  | $ | 292 |  |  | $ | 113 |  |  | $ | 283 | \nDerivatives not designated as hedging instruments: |  |  |  |  |  |  |  |  | \nForeign exchange(e) | 2 |  | $ | 39 |  |  | $ | 22 |  |  | $ | 19 |  |  | $ | 7 | \nCommodity(f) | 2 |  | 56 |  |  | 12 |  |  | 35 |  |  | 22 | \n |  |  | $ | 95 |  |  | $ | 34 |  |  | $ | 54 |  |  | $ | 29 | \nTotal derivatives at fair value(g) |  |  | $ | 285 |  |  | $ | 326 |  |  | $ | 167 |  |  | $ | 312 | \nTotal |  |  | $ | 602 |  |  | $ | 806 |  |  | $ | 525 |  |  | $ | 817 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | Non-designated Hedges |  | Cash Flow and Net Investment Hedges\n | Losses/(Gains)Recognized inIncome\u00a0Statement(a) |  | Losses/(Gains)Recognized inAccumulated\u00a0OtherComprehensive\u00a0Loss |  | Losses/(Gains)Reclassified fromAccumulated\u00a0OtherComprehensive\u00a0Lossinto Income Statement(b)\n | 3/19/2022 |  | 3/20/2021 |  | 3/19/2022 |  | 3/20/2021 |  | 3/19/2022 |  | 3/20/2021\nForeign exchange | $ | (16) |  |  | $ | 4 |  |  | $ | (8) |  |  | $ | 11 |  |  | $ | (4) |  |  | $ | 13 | \nInterest rate | \u2014 |  |  | 1 |  |  | (3) |  |  | (18) |  |  | 20 |  |  | (4) | \nCommodity | (166) |  |  | (81) |  |  | (189) |  |  | (90) |  |  | (78) |  |  | (10) | \nNet investment | \u2014 |  |  | \u2014 |  |  | (51) |  |  | (63) |  |  | \u2014 |  |  | \u2014 | \nTotal | $ | (182) |  |  | $ | (76) |  |  | $ | (251) |  |  | $ | (160) |  |  | $ | (62) |  |  | $ | (1) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 3/19/2022 |  | 3/20/2021\n | Income |  | Shares(a) |  | Income |  | Shares(a)\n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nBasic net income attributable to PepsiCo per common share | $ | 3.08 |  |  |  |  | $ | 1.24 |  |  | \nNet income available for PepsiCo common shareholders | $ | 4,261 |  |  | 1,383 |  |  | $ | 1,714 |  |  | 1,380 | \nDilutive securities: |  |  |  |  |  |  | \nStock options, RSUs, PSUs and other(b) | \u2014 |  |  | 8 |  |  | \u2014 |  |  | 7 | \nDiluted | $ | 4,261 |  |  | 1,391 |  |  | $ | 1,714 |  |  | 1,387 | \nDiluted net income attributable to PepsiCo per common share | $ | 3.06 |  |  |  |  | $ | 1.24 |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Currency Translation Adjustment |  | Cash Flow Hedges |  | Pension and Retiree Medical |  |  |  | Other |  | Accumulated Other Comprehensive Loss Attributable to PepsiCo\nBalance as of December 25, 2021(a) | $ | (12,309) |  |  | $ | 159 |  |  | $ | (2,750) |  |  |  |  | $ | 2 |  |  | $ | (14,898) | \nOther comprehensive (loss)/income before reclassifications(b) | (549) |  |  | 200 |  |  | (8) |  |  |  |  | \u2014 |  |  | (357) | \nAmounts reclassified from accumulated other comprehensive loss | \u2014 |  |  | (62) |  |  | 25 |  |  |  |  | \u2014 |  |  | (37) | \nNet other comprehensive (loss)/income | (549) |  |  | 138 |  |  | 17 |  |  |  |  | \u2014 |  |  | (394) | \nTax amounts | (11) |  |  | (32) |  |  | (4) |  |  |  |  | (4) |  |  | (51) | \nBalance as of March 19, 2022(a) | $ | (12,869) |  |  | $ | 265 |  |  | $ | (2,737) |  |  |  |  | $ | (2) |  |  | $ | (15,343) | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Currency Translation Adjustment |  | Cash Flow Hedges |  | Pension and Retiree Medical |  |  |  | Other |  | Accumulated Other Comprehensive Loss Attributable to PepsiCo\nBalance as of December 26, 2020(a) | $ | (11,940) |  |  | $ | 4 |  |  | $ | (3,520) |  |  |  |  | $ | (20) |  |  | $ | (15,476) | \nOther comprehensive income/(loss) before reclassifications(b) | 128 |  |  | 97 |  |  | (20) |  |  |  |  | \u2014 |  |  | 205 | \nAmounts reclassified from accumulated other comprehensive loss | 18 |  |  | (1) |  |  | 52 |  |  |  |  | \u2014 |  |  | 69 | \nNet other comprehensive income | 146 |  |  | 96 |  |  | 32 |  |  |  |  | \u2014 |  |  | 274 | \nTax amounts | (15) |  |  | (24) |  |  | (5) |  |  |  |  | \u2014 |  |  | (44) | \nBalance as of March 20, 2021(a) | $ | (11,809) |  |  | $ | 76 |  |  | $ | (3,493) |  |  |  |  | $ | (20) |  |  | $ | (15,246) | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | 12 Weeks Ended |  | \n |  |  |  |  |  | 3/19/2022 |  | 3/20/2021 |  | Affected Line Item in the Income Statement\n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \nCurrency translation: |  |  |  |  |  |  |  |  |  | \nDivestiture |  |  |  |  |  | $ | \u2014 |  |  | $ | 18 |  |  | Selling, general and administrative expenses\n |  |  |  |  |  |  |  |  |  | \nCash flow hedges: |  |  |  |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  | $ | (2) |  |  | $ | 1 |  |  | Net revenue\nForeign exchange contracts |  |  |  |  |  | (2) |  |  | 12 |  |  | Cost of sales\nInterest rate derivatives |  |  |  |  |  | 20 |  |  | (4) |  |  | Selling, general and administrative expenses\nCommodity contracts |  |  |  |  |  | (76) |  |  | (11) |  |  | Cost of sales\nCommodity contracts |  |  |  |  |  | (2) |  |  | 1 |  |  | Selling, general and administrative expenses\nNet gains before tax |  |  |  |  |  | (62) |  |  | (1) |  |  | \nTax amounts |  |  |  |  |  | 10 |  |  | 1 |  |  | \nNet gains after tax |  |  |  |  |  | $ | (52) |  |  | $ | \u2014 |  |  | \n |  |  |  |  |  |  |  |  |  | \nPension and retiree medical items: |  |  |  |  |  |  |  |  |  | \nAmortization of prior service credits |  |  |  |  |  | $ | (8) |  |  | $ | (9) |  |  | Other pension and retiree medical benefits income\nAmortization of net losses |  |  |  |  |  | 35 |  |  | 61 |  |  | Other pension and retiree medical benefits income\nSettlement/curtailment gains |  |  |  |  |  | (2) |  |  | \u2014 |  |  | Other pension and retiree medical benefits income\nNet losses before tax |  |  |  |  |  | 25 |  |  | 52 |  |  | \nTax amounts |  |  |  |  |  | (6) |  |  | (11) |  |  | \nNet losses after tax |  |  |  |  |  | $ | 19 |  |  | $ | 41 |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \nTotal net (gains)/losses reclassified, net of tax |  |  |  |  |  | $ | (33) |  |  | $ | 59 |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | PBNA |  | Europe |  | Corporate |  | PepsiCo |  | Provision for income taxes(a) |  | Net income attributable to PepsiCo |  | Impact on net income attributable to PepsiCo per common share\nGain associated with the Juice Transaction | $ | (3,024) |  |  | $ | (298) |  |  | $ | \u2014 |  |  | $ | (3,322) |  |  | $ | 452 |  |  | $ | (2,870) |  |  | $ | 2.06 | \nAcquisition and divestiture-related charges | 37 |  |  | 10 |  |  | 3 |  |  | 50 |  |  | (8) |  |  | 42 |  |  | (0.03) | \nOperating profit | $ | (2,987) |  |  | $ | (288) |  |  | $ | 3 |  |  | (3,272) |  |  | 444 |  |  | (2,828) |  |  | 2.03 | \nOther pension and retiree medical benefits income(b) |  |  |  |  |  |  | (10) |  |  | 3 |  |  | (7) |  |  | 0.01 | \nTotal Juice Transaction |  |  |  |  |  |  | $ | (3,282) |  |  | $ | 447 |  |  | $ | (2,835) |  |  | $ | 2.04 | \n |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended |  | \n |  |  |  |  | 3/19/2022 |  | 3/20/2021 |  | Transaction\nFLNA |  |  |  |  | $ | \u2014 |  |  | $ | 2 |  |  | BFY Brands, Inc.\nPBNA |  |  |  |  | 37 |  |  | 1 |  |  | Juice Transaction, Rockstar\nEurope |  |  |  |  | 10 |  |  | \u2014 |  |  | Juice Transaction\nAMESA |  |  |  |  | \u2014 |  |  | 1 |  |  | Pioneer Foods\n |  |  |  |  |  |  |  |  | \nCorporate(a) |  |  |  |  | 3 |  |  | (14) |  |  | Juice Transaction, Rockstar\nTotal(b) |  |  |  |  | 50 |  |  | (10) |  |  | \nOther pension and retiree medical benefits expense |  |  |  |  | 6 |  |  | \u2014 |  |  | Juice Transaction\nTotal acquisition and divestiture-related charges |  |  |  |  | $ | 56 |  |  | $ | (10) |  |  | \nAfter-tax amount |  |  |  |  | $ | 47 |  |  | $ | (7) |  |  | \nImpact on net income attributable to PepsiCo per common share |  |  |  |  | $ | (0.03) |  |  | $ | 0.01 |  |  | \n |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended\n |  |  |  |  |  |  | 3/19/2022 |  | 3/20/2021 |  | Change\nNet revenue |  |  |  |  |  |  | $ | 16,200 |  |  | $ | 14,820 |  |  | 9 | %\nOperating profit |  |  |  |  |  |  | $ | 5,267 |  |  | $ | 2,312 |  |  | 128 | %\nOperating margin |  |  |  |  |  |  | 32.5 | % |  | 15.6 | % |  | 16.9 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 3/19/2022\n |  |  | Impact of |  |  |  |  |  |  |  | Impact of\n | Reported% Change, GAAP Measure |  | Foreign exchange translation |  | Acquisitions and divestitures |  |  |  | Organic% Change, Non-GAAP Measure(a) |  |  |  |  |  | Organic volume(b) |  | Effective net pricing\nFLNA | 14 | % |  | \u2014 |  |  | \u2014 |  |  |  |  | 14 | % |  |  |  |  |  | 2 |  |  | 12 | \nQFNA | 11 | % |  | \u2014 |  |  | \u2014 |  |  |  |  | 11 | % |  |  |  |  |  | (1.5) |  |  | 12 | \nPBNA | 5.5 | % |  | \u2014 |  |  | 7 |  |  |  |  | 13 | % |  |  |  |  |  | 4 |  |  | 8 | \nLatAm | 19 | % |  | 3 |  |  | 1 |  |  |  |  | 22 | % |  |  |  |  |  | 6 |  |  | 16 | \nEurope | \u2014 | % |  | 8 |  |  | 2 |  |  |  |  | 11 | % |  |  |  |  |  | \u2014 |  |  | 11 | \nAMESA | 14 | % |  | 2 |  |  | 2 |  |  |  |  | 18 | % |  |  |  |  |  | 11 |  |  | 7 | \nAPAC | 8 | % |  | 1 |  |  | 0.5 |  |  |  |  | 9 | % |  |  |  |  |  | 2 |  |  | 8 | \nTotal | 9 | % |  | 1 |  |  | 3 |  |  |  |  | 14 | % |  |  |  |  |  | 3 |  |  | 10 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 3/19/2022\n |  |  | Items Affecting Comparability(a) |  | \n | Reported, GAAP Measure(b) |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges |  | Gain associated with the Juice Transaction |  | Russia-Ukraine conflict charges |  | Brand Portfolio Impairment Charges |  | Core,Non-GAAP Measure(b)\nFLNA | $ | 1,296 |  |  | $ | \u2014 |  |  | $ | 3 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 1,299 | \nQFNA | 159 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 159 | \nPBNA | 3,434 |  |  | \u2014 |  |  | 3 |  |  | 37 |  |  | (3,024) |  |  | \u2014 |  |  | \u2014 |  |  | 450 | \nLatAm | 323 |  |  | \u2014 |  |  | 6 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 329 | \nEurope | (136) |  |  | \u2014 |  |  | 7 |  |  | 10 |  |  | (298) |  |  | 241 |  |  | 241 |  |  | 65 | \nAMESA | 180 |  |  | \u2014 |  |  | 2 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 182 | \nAPAC | 215 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 216 | \nCorporate unallocated expenses | (204) |  |  | (112) |  |  | 5 |  |  | 3 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (308) | \nTotal | $ | 5,267 |  |  | $ | (112) |  |  | $ | 27 |  |  | $ | 50 |  |  | $ | (3,322) |  |  | $ | 241 |  |  | $ | 241 |  |  | $ | 2,392 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 3/20/2021\n |  |  | Items Affecting Comparability(a) |  | \n | Reported,GAAP Measure(b) |  | Mark-to-market net impact |  | Restructuringand impairment charges |  | Acquisition and divestiture-related charges(c) |  | Core,Non-GAAP Measure(b)\nFLNA | $ | 1,240 |  |  | $ | \u2014 |  |  | $ | 15 |  |  | $ | 2 |  |  | $ | 1,257 | \nQFNA | 150 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 150 | \nPBNA | 366 |  |  | \u2014 |  |  | 4 |  |  | 1 |  |  | 371 | \nLatAm | 218 |  |  | \u2014 |  |  | 2 |  |  | \u2014 |  |  | 220 | \nEurope | 131 |  |  | \u2014 |  |  | 11 |  |  | \u2014 |  |  | 142 | \nAMESA | 138 |  |  | \u2014 |  |  | 1 |  |  | 1 |  |  | 140 | \nAPAC | 208 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 208 | \nCorporate unallocated expenses | (139) |  |  | (75) |  |  | 4 |  |  | (14) |  |  | (224) | \nTotal | $ | 2,312 |  |  | $ | (75) |  |  | $ | 37 |  |  | $ | (10) |  |  | $ | 2,264 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 3/19/2022\n |  |  | Impact of Items Affecting Comparability(a) |  |  |  |  |  | Impact of |  | \n | Reported % Change, GAAP Measure |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges |  | Gain associated with the Juice Transaction |  | Russia-Ukraine conflict charges |  | Brand Portfolio Impairment Charges |  |  |  | Core% Change, Non-GAAP Measure(b) |  | Foreign exchangetranslation |  | Core Constant Currency% Change, Non-GAAP Measure(b)\nFLNA | 4.5 | % |  | \u2014 |  |  | (1) |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 3 | % |  | \u2014 |  |  | 3 | %\nQFNA | 6 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 6 | % |  | \u2014 |  |  | 6 | %\nPBNA | 839 | % |  | \u2014 |  |  | (1) |  |  | 10 |  |  | (827) |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 21 | % |  | \u2014 |  |  | 21 | %\nLatAm | 48 | % |  | \u2014 |  |  | 2 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 50 | % |  | 3.5 |  |  | 53 | %\nEurope | (204) | % |  | \u2014 |  |  | (3) |  |  | 8 |  |  | (234) |  |  | 189 |  |  | 189 |  |  |  |  | (55) | % |  | 5 |  |  | (50) | %\nAMESA | 30 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 30 | % |  | 1.5 |  |  | 32 | %\nAPAC | 3 | % |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 4 | % |  | 1 |  |  | 5 | %\nCorporate unallocated expenses | 46 | % |  | (15) |  |  | \u2014 |  |  | 7 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 37 | % |  | \u2014 |  |  | 37 | %\nTotal | 128 | % |  | (2) |  |  | \u2014 |  |  | 3 |  |  | (144) |  |  | 10 |  |  | 10 |  |  |  |  | 6 | % |  | 1 |  |  | 6 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended | \n |  |  |  |  |  |  | 3/19/2022 |  | 3/20/2021 |  | Change | \nOther pension and retiree medical benefits income |  |  |  |  |  |  | $ | 134 |  |  | $ | 120 |  |  | $ | 14 |  | \nNet interest expense and other |  |  |  |  |  |  | $ | (240) |  |  | $ | (258) |  |  | $ | 18 |  | \nTax rate |  |  |  |  |  |  | 17.2 | % |  | 20.7 | % |  |  | \nNet income attributable to PepsiCo(a) |  |  |  |  |  |  | $ | 4,261 |  |  | $ | 1,714 |  |  | 149 | % | \nNet income attributable to PepsiCo per common share \u2013 diluted(a) |  |  |  |  |  |  | $ | 3.06 |  |  | $ | 1.24 |  |  | 148 | % | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 3/19/2022\n | Cost of sales |  | Gross profit |  | Selling, general and administrative expenses |  | Gain associated with the Juice Transaction |  | Operating profit |  | Other pension and retiree medical benefits income |  |  |  | Provision for income taxes(a) |  |  |  | Net income attributable to PepsiCo\nReported, GAAP Measure | $ | 7,433 |  |  | $ | 8,767 |  |  | $ | 6,822 |  |  | $ | (3,322) |  |  | $ | 5,267 |  |  | $ | 134 |  |  |  |  | $ | 888 |  |  |  |  | $ | 4,261 | \nItems Affecting Comparability |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMark-to-market net impact | 33 |  |  | (33) |  |  | 79 |  |  | \u2014 |  |  | (112) |  |  | \u2014 |  |  |  |  | (26) |  |  |  |  | (86) | \nRestructuring and impairment charges | (5) |  |  | 5 |  |  | (22) |  |  | \u2014 |  |  | 27 |  |  | \u2014 |  |  |  |  | 6 |  |  |  |  | 21 | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  | (50) |  |  | \u2014 |  |  | 50 |  |  | 6 |  |  |  |  | 9 |  |  |  |  | 47 | \nGain associated with the Juice Transaction | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 3,322 |  |  | (3,322) |  |  | \u2014 |  |  |  |  | (452) |  |  |  |  | (2,870) | \nRussia-Ukraine conflict charges | (140) |  |  | 140 |  |  | (101) |  |  | \u2014 |  |  | 241 |  |  | \u2014 |  |  |  |  | \u2014 |  |  |  |  | 241 | \nBrand Portfolio Impairment Charges | \u2014 |  |  | \u2014 |  |  | (241) |  |  | \u2014 |  |  | 241 |  |  | \u2014 |  |  |  |  | 48 |  |  |  |  | 193 | \nPension and retiree medical-related impact | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (16) |  |  |  |  | (4) |  |  |  |  | (12) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCore, Non-GAAP Measure | $ | 7,321 |  |  | $ | 8,879 |  |  | $ | 6,487 |  |  | $ | \u2014 |  |  | $ | 2,392 |  |  | $ | 124 |  |  |  |  | $ | 469 |  |  |  |  | $ | 1,795 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 3/20/2021\n | Cost of sales |  | Gross profit |  | Selling, general and administrative expenses |  | Operating profit |  | Other pension and retiree medical benefits income |  | Provision for income taxes(a) |  |  |  | Net income attributable to PepsiCo\nReported, GAAP Measure | $ | 6,671 |  |  | $ | 8,149 |  |  | $ | 5,837 |  |  | $ | 2,312 |  |  | $ | 120 |  |  | $ | 451 |  |  |  |  | $ | 1,714 | \nItems Affecting Comparability |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMark-to-market net impact | 36 |  |  | (36) |  |  | 39 |  |  | (75) |  |  | \u2014 |  |  | (17) |  |  |  |  | (58) | \nRestructuring and impairment charges | (2) |  |  | 2 |  |  | (35) |  |  | 37 |  |  | 6 |  |  | 8 |  |  |  |  | 35 | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  | 10 |  |  | (10) |  |  | \u2014 |  |  | (3) |  |  |  |  | (7) | \nCore, Non-GAAP Measure | $ | 6,705 |  |  | $ | 8,115 |  |  | $ | 5,851 |  |  | $ | 2,264 |  |  | $ | 126 |  |  | $ | 439 |  |  |  |  | $ | 1,684 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended | \n |  |  |  |  |  |  | 3/19/2022 |  | 3/20/2021 |  | Change | \nNet income attributable to PepsiCo per common share \u2013 diluted, GAAP measure |  |  |  |  |  |  | $ | 3.06 |  |  | $ | 1.24 |  |  | 148 | % | \nMark-to-market net impact |  |  |  |  |  |  | (0.06) |  |  | (0.04) |  |  |  | \nRestructuring and impairment charges |  |  |  |  |  |  | 0.02 |  |  | 0.03 |  |  |  | \nAcquisition and divestiture-related charges |  |  |  |  |  |  | 0.03 |  |  | (0.01) |  |  |  | \nGain associated with the Juice Transaction |  |  |  |  |  |  | (2.06) |  |  | \u2014 |  |  |  | \nRussia-Ukraine conflict charges |  |  |  |  |  |  | 0.17 |  |  | \u2014 |  |  |  | \nBrand Portfolio Impairment Charges |  |  |  |  |  |  | 0.14 |  |  | \u2014 |  |  |  | \nPension and retiree medical-related impact |  |  |  |  |  |  | (0.01) |  |  | \u2014 |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \nCore net income attributable to PepsiCo per common share \u2013 diluted, non-GAAP measure |  |  |  |  |  |  | $ | 1.29 |  |  | $ | 1.21 |  | (a) | 6 | % | \nImpact of foreign exchange translation |  |  |  |  |  |  |  |  |  |  | 1 |  | \nGrowth in core net income attributable to PepsiCo per common share \u2013 diluted, on a constant currency basis, non-GAAP measure |  |  |  |  |  |  |  |  |  |  | 7 | % |   |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | 3/19/2022 |  | 3/20/2021 |  | \nNet cash used for operating activities, GAAP measure | $ | (174) |  |  | $ | (719) |  |  | \nCapital spending | (522) |  |  | (471) |  |  | \nSales of property, plant and equipment | 3 |  |  | 5 |  |  | \nFree cash flow, non-GAAP measure | $ | (693) |  |  | $ | (1,185) |  |  | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | Change(a) |  | Reference\nCash and cash equivalents | $ | 1.0 |  |  | Condensed Consolidated Statement of Cash Flows\nAccounts and notes receivable, less allowance | $ | 0.7 |  |  | (b)\nAssets held for sale | $ | (1.8) |  |  | (c)\nOther indefinite-lived intangible assets | $ | (0.5) |  |  | Note 3\nInvestments in noncontrolled affiliates | $ | 1.0 |  |  | Note 11  |  |  |  |  |  |  |  |  |  |  | \n | Change(a) |  | Reference\nShort-term debt obligations | $ | 1.2 |  |  | (d)\nAccounts payable and other current liabilities | $ | (0.8) |  |  | (e)\nLiabilities held for sale | $ | (0.8) |  |  | (c)\nLong-term debt obligations | $ | (1.4) |  |  | Note 7  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod |  | TotalNumber ofSharesRepurchased(a) |  | Average\u00a0PricePaid\u00a0Per\u00a0Share |  | Total\u00a0Numberof SharesPurchased asPart\u00a0of\u00a0PubliclyAnnouncedPlans orPrograms |  | MaximumNumber (orApproximateDollar\u00a0Value)\u00a0ofShares That May Yet BePurchasedUnder\u00a0the\u00a0Plansor Programs\n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n12/26/2021 - 1/22/2022 |  | \u2014 |  |  | $ | \u2014 |  |  | \u2014 |  |  | $ | \u2014 | \n |  |  |  |  |  |  |  | 10,000 | \n1/23/2022 - 2/19/2022 |  | \u2014 |  |  | $ | \u2014 |  |  | \u2014 |  |  | \u2014 | \n |  |  |  |  |  |  |  | 10,000 | \n2/20/2022 - 3/19/2022 |  | 1.3 |  |  | $ | 161.08 |  |  | 1.3 |  |  | (213) | \nTotal |  | 1.3 |  |  | $ | 161.08 |  |  | 1.3 |  |  | $ | 9,787 |   |  | \nSee \u201cIndex to Exhibits\u201d on page47.  |  |  |  |  | \nEXHIBIT | \nExhibit 3.1 | Amended and Restated Articles of Incorporation of PepsiCo, Inc., effective as of May 1, 2019, which are incorporated herein by reference to Exhibit 3.1 to PepsiCo, Inc.\u2019s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 3, 2019.\nExhibit 3.2 | By-Laws of PepsiCo, Inc., as amended and restated, effective as of April 15, 2020, which are incorporated herein by reference to Exhibit 3.2 to PepsiCo, Inc.\u2019s Current Report on Form 8-K filed with the Securities and Exchange Commission on April 16, 2020.\nExhibit 10.1 | Form of Annual Long-Term Incentive Agreement.\nExhibit 15 | Letter re: Unaudited Interim Financial Information.\nExhibit 31 | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.\nExhibit 32 | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.\nExhibit 101 | The following materials from PepsiCo, Inc.\u2019s Quarterly Report on Form 10-Q for the quarter ended March 19, 2022 formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Statement of Income, (ii) the Condensed Consolidated Statement of Comprehensive Income, (iii) the Condensed Consolidated Statement of Cash Flows, (iv) the Condensed Consolidated Balance Sheet, (v) the Condensed Consolidated Statement of Equity, and (vi) Notes to the Condensed Consolidated Financial Statements.\nExhibit 104 | The cover page from the Company\u2019s Quarterly Report on Form 10-Q for the quarter ended March 19, 2022, formatted in iXBRL and contained in Exhibit 101.  |  |  |  |  |  |  |  |  |  |  | \n |  |  | \n |  | PepsiCo, Inc. | \n |  | (Registrant) | \n |  |  | \nDate: | April 25, 2022 | /s/ Marie T. Gallagher | \n |  | Marie T. Gallagher | \n |  | Senior Vice President and Controller | \n |  | (Principal Accounting Officer) | \n |  |  | \nDate: | April 25, 2022 | /s/ David Flavell | \n |  | David Flavell | \n |  | Executive Vice President, General Counsel and Corporate Secretary | \n |  | (Duly Authorized Officer) | "}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Pepsico, in 2022 Q2, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  | \n\u2612 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \n\u2610 | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  | \nPepsiCo, Inc.  |  |  |  |  |  |  |  | \n |  | \nNorth Carolina |  | 13-1584302\n(State or Other Jurisdiction ofIncorporation or Organization) |  | (I.R.S. EmployerIdentification No.)\n | \n |  | \n |  |   |  | \n(Address of principal executive offices and Zip Code)  |  | \nRegistrant's telephone number, including area code  |  | \n(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTitle of each class |  | Trading Symbols |  | Name of each exchange on which registered\nCommon Stock, par value 1-2/3 cents per share |  | PEP |  | The Nasdaq Stock Market LLC\n2.500% Senior Notes Due 2022 |  | PEP22a |  | The Nasdaq Stock Market LLC\n0.250% Senior Notes Due 2024 |  | PEP24 |  | The Nasdaq Stock Market LLC\n2.625% Senior Notes Due 2026 |  | PEP26 |  | The Nasdaq Stock Market LLC\n0.750% Senior Notes Due 2027 |  | PEP27 |  | The Nasdaq Stock Market LLC\n0.875% Senior Notes Due 2028 |  | PEP28 |  | The Nasdaq Stock Market LLC\n0.500% Senior Notes Due 2028 |  | PEP28a |  | The Nasdaq Stock Market LLC\n1.125% Senior Notes Due 2031 |  | PEP31 |  | The Nasdaq Stock Market LLC\n0.400% Senior Notes Due 2032 |  | PEP32 |  | The Nasdaq Stock Market LLC\n0.750% Senior Notes Due 2033 |  | PEP33 |  | The Nasdaq Stock Market LLC\n0.875% Senior Notes Due 2039 |  | PEP39 |  | The Nasdaq Stock Market LLC\n1.050% Senior Notes Due 2050 |  | PEP50 |  | The Nasdaq Stock Market LLC  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 | Accelerated filer | \u2610\nNon-accelerated filer | \u2610 | Smaller reporting company | \u2610\n |  | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \n |  | Page\u00a0No.\nPart I        Financial Information | \nItem 1. | Condensed Consolidated Financial Statements | 3\n | Condensed Consolidated Statement of Income \u201312and 24Weeks EndedJune 11, 2022andJune 12, 2021 | 3\n | Condensed Consolidated Statement of Comprehensive Income \u201312and 24Weeks EndedJune 11,2022 andJune 12, 2021 | 4\n | Condensed Consolidated Statement of Cash Flows \u201324Weeks EndedJune 11, 2022 and June 12, 2021 | 5\n | Condensed Consolidated Balance Sheet \u2013June 11, 2022 and December 25, 2021 | 7\n | Condensed Consolidated Statement of Equity \u201312 and 24Weeks EndedJune 11, 2022 andJune 12, 2021 | 8\n | Notes to the Condensed Consolidated Financial Statements | 9\nItem\u00a02. | Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations | 28\nReport of Independent Registered Public Accounting Firm | 54\nItem 3. | Quantitative and Qualitative Disclosures About Market Risk | 55\nItem 4. | Controls and Procedures | 55\nPart II      Other Information | \nItem 1. | Legal Proceedings | 56\nItem 1A. | Risk Factors | 56\nItem 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 57\nItem 6. | Exhibits | 57  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | 6/11/2022 |  | 6/12/2021 |  | 6/11/2022 |  | 6/12/2021\nNet Revenue | $ | 20,225 |  |  | $ | 19,217 |  |  | $ | 36,425 |  |  | $ | 34,037 | \nCost of sales | 9,415 |  |  | 8,880 |  |  | 16,848 |  |  | 15,551 | \nGross profit | 10,810 |  |  | 10,337 |  |  | 19,577 |  |  | 18,486 | \nSelling, general and administrative expenses | 7,387 |  |  | 7,208 |  |  | 13,967 |  |  | 13,045 | \nGain associated with the Juice Transaction(a) | (13) |  |  | \u2014 |  |  | (3,335) |  |  | \u2014 | \nImpairment of intangible assets (see Notes 1 and 3) | 1,359 |  |  | \u2014 |  |  | 1,601 |  |  | \u2014 | \nOperating Profit | 2,077 |  |  | 3,129 |  |  | 7,344 |  |  | 5,441 | \nOther pension and retiree medical benefits (expense)/income | (2) |  |  | 126 |  |  | 132 |  |  | 246 | \nNet interest expense and other | (236) |  |  | (241) |  |  | (476) |  |  | (499) | \nIncome before income taxes | 1,839 |  |  | 3,014 |  |  | 7,000 |  |  | 5,188 | \nProvision for income taxes | 393 |  |  | 642 |  |  | 1,281 |  |  | 1,093 | \nNet income | 1,446 |  |  | 2,372 |  |  | 5,719 |  |  | 4,095 | \nLess: Net income attributable to noncontrolling interests | 17 |  |  | 14 |  |  | 29 |  |  | 23 | \nNet Income Attributable to PepsiCo | $ | 1,429 |  |  | $ | 2,358 |  |  | $ | 5,690 |  |  | $ | 4,072 | \nNet Income Attributable to PepsiCo per Common Share |  |  |  |  |  |  | \nBasic | $ | 1.03 |  |  | $ | 1.71 |  |  | $ | 4.11 |  |  | $ | 2.95 | \nDiluted | $ | 1.03 |  |  | $ | 1.70 |  |  | $ | 4.09 |  |  | $ | 2.94 | \nWeighted-average common shares outstanding |  |  |  |  |  |  | \nBasic | 1,382 |  |  | 1,382 |  |  | 1,383 |  |  | 1,381 | \nDiluted | 1,389 |  |  | 1,388 |  |  | 1,390 |  |  | 1,387 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | 6/11/2022 |  | 6/12/2021 |  | 6/11/2022 |  | 6/12/2021\nNet income | $ | 1,446 |  |  | $ | 2,372 |  |  | $ | 5,719 |  |  | $ | 4,095 | \nOther comprehensive income, net of taxes: |  |  |  |  |  |  | \nNet currency translation adjustment | 1,274 |  |  | 268 |  |  | 714 |  |  | 399 | \nNet change on cash flow hedges | (102) |  |  | 93 |  |  | 4 |  |  | 165 | \nNet pension and retiree medical adjustments | (250) |  |  | 24 |  |  | (237) |  |  | 51 | \nOther | 5 |  |  | 2 |  |  | 1 |  |  | 2 | \n | 927 |  |  | 387 |  |  | 482 |  |  | 617 | \nComprehensive income | 2,373 |  |  | 2,759 |  |  | 6,201 |  |  | 4,712 | \nLess: Comprehensive income attributable tononcontrolling interests | 17 |  |  | 14 |  |  | 29 |  |  | 23 | \nComprehensive Income Attributable to PepsiCo | $ | 2,356 |  |  | $ | 2,745 |  |  | $ | 6,172 |  |  | $ | 4,689 |   |  | \n  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended\n | 6/11/2022 |  | 6/12/2021\nOperating Activities |  |  | \nNet income | $ | 5,719 |  |  | $ | 4,095 | \nDepreciation and amortization | 1,195 |  |  | 1,213 | \nGain associated with the Juice Transaction | (3,335) |  |  | \u2014 | \nBrand portfolio impairment charges | 465 |  |  | \u2014 | \nRussia-Ukraine conflict charges | 1,406 |  |  | \u2014 | \nOperating lease right-of-use asset amortization | 223 |  |  | 220 | \nShare-based compensation expense | 156 |  |  | 144 | \nRestructuring and impairment charges | 75 |  |  | 77 | \nCash payments for restructuring charges | (82) |  |  | (104) | \nAcquisition and divestiture-related charges | 64 |  |  | 15 | \nCash payments for acquisition and divestiture-related charges | (34) |  |  | (14) | \nPension and retiree medical plan expenses | 139 |  |  | 48 | \nPension and retiree medical plan contributions | (214) |  |  | (461) | \nDeferred income taxes and other tax charges and credits | 49 |  |  | 220 | \n |  |  | \nTax payments related to the Tax Cuts and Jobs Act (TCJ Act) | (309) |  |  | (309) | \nChange in assets and liabilities: |  |  | \nAccounts and notes receivable | (1,753) |  |  | (1,214) | \nInventories | (990) |  |  | (810) | \nPrepaid expenses and other current assets | (186) |  |  | (40) | \nAccounts payable and other current liabilities | (990) |  |  | (1,114) | \nIncome taxes payable | 608 |  |  | 516 | \nOther, net | (325) |  |  | (142) | \nNet Cash Provided by Operating Activities | 1,881 |  |  | 2,340 | \n |  |  | \nInvesting Activities |  |  | \nCapital spending | (1,499) |  |  | (1,305) | \nSales of property, plant and equipment | 222 |  |  | 22 | \nAcquisitions, net of cash acquired, and investments in noncontrolled affiliates | (29) |  |  | (22) | \nProceeds associated with the Juice Transaction | 3,456 |  |  | \u2014 | \nOther divestitures and sales of investments in noncontrolled affiliates | 15 |  |  | 120 | \nShort-term investments, by original maturity: |  |  | \n |  |  | \nMore than three months - maturities | \u2014 |  |  | 1,135 | \n |  |  | \nThree months or less, net | 8 |  |  | (67) | \nOther investing, net | (1) |  |  | 1 | \nNet Cash Provided by/(Used for) Investing Activities | 2,172 |  |  | (116) |   |  | \n  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended\n | 6/11/2022 |  | 6/12/2021\nFinancing Activities |  |  | \n |  |  | \nPayments of long-term debt | (1,652) |  |  | (1,696) | \nDebt redemptions | (1,550) |  |  | \u2014 | \nShort-term borrowings, by original maturity: |  |  | \nMore than three months - proceeds | 1,935 |  |  | \u2014 | \nMore than three months - payments | \u2014 |  |  | (397) | \nThree months or less, net | 844 |  |  | 89 | \n |  |  | \nCash dividends paid | (2,997) |  |  | (2,842) | \nShare repurchases - common | (699) |  |  | (106) | \n |  |  | \nProceeds from exercises of stock options | 89 |  |  | 100 | \nWithholding tax payments on restricted stock units (RSUs) and performance stock units (PSUs) converted | (87) |  |  | (73) | \nOther financing | (15) |  |  | (19) | \nNet Cash Used for Financing Activities | (4,132) |  |  | (4,944) | \nEffect of exchange rate changes on cash and cash equivalents and restricted cash | (83) |  |  | 12 | \nNet Decrease in Cash and Cash Equivalents and Restricted Cash | (162) |  |  | (2,708) | \nCash and Cash Equivalents and Restricted Cash, Beginning of Year | 5,707 |  |  | 8,254 | \nCash and Cash Equivalents and Restricted Cash, End of Period | $ | 5,545 |  |  | $ | 5,546 | \n |  |  | \nSupplemental Non-Cash Activity |  |  | \nRight-of-use assets obtained in exchange for lease obligations | $ | 428 |  |  | $ | 319 |   |  | \n  |  |  |  |  |  |  |  |  |  |  | \n | (Unaudited) |  | \n | 6/11/2022 |  | 12/25/2021\nASSETS |  |  | \nCurrent Assets |  |  | \nCash and cash equivalents | $ | 5,405 |  |  | $ | 5,596 | \nShort-term investments | 287 |  |  | 392 | \n |  |  | \nAccounts and notes receivable, less allowance: 6/22 - $185and 12/21 - $147 | 10,498 |  |  | 8,680 | \nInventories: |  |  | \nRaw materials and packaging | 2,403 |  |  | 1,898 | \nWork-in-process | 158 |  |  | 151 | \nFinished goods | 2,726 |  |  | 2,298 | \n | 5,287 |  |  | 4,347 | \nPrepaid expenses and other current assets | 1,156 |  |  | 980 | \nAssets held for sale | \u2014 |  |  | 1,788 | \nTotal Current Assets | 22,633 |  |  | 21,783 | \nProperty, plant and equipment | 47,902 |  |  | 46,828 | \nAccumulated depreciation | (25,208) |  |  | (24,421) | \nProperty, Plant and Equipment, net | 22,694 |  |  | 22,407 | \nAmortizable Intangible Assets, net | 1,348 |  |  | 1,538 | \nGoodwill | 18,547 |  |  | 18,381 | \nOther Indefinite-Lived Intangible Assets | 15,743 |  |  | 17,127 | \n |  |  | \nInvestments in Noncontrolled Affiliates | 3,519 |  |  | 2,627 | \nDeferred Income Taxes | 4,345 |  |  | 4,310 | \nOther Assets | 4,274 |  |  | 4,204 | \nTotal Assets | $ | 93,103 |  |  | $ | 92,377 | \n |  |  | \nLIABILITIES AND EQUITY |  |  | \nCurrent Liabilities |  |  | \nShort-term debt obligations | $ | 6,032 |  |  | $ | 4,308 | \nAccounts payable and other current liabilities | 21,191 |  |  | 21,159 | \nLiabilities held for sale | \u2014 |  |  | 753 | \nTotal Current Liabilities | 27,223 |  |  | 26,220 | \nLong-Term Debt Obligations | 33,247 |  |  | 36,026 | \nDeferred Income Taxes | 4,838 |  |  | 4,826 | \nOther Liabilities | 9,121 |  |  | 9,154 | \nTotal Liabilities | 74,429 |  |  | 76,226 | \nCommitments and contingencies |  |  | \nPepsiCo Common Shareholders\u2019 Equity |  |  | \nCommon stock, par value 12/3\u00a2 per share (authorized3,600shares; issued, net of repurchased common stock at par value:1,381and1,383shares, respectively) | 23 |  |  | 23 | \nCapital in excess of par value | 3,970 |  |  | 4,001 | \nRetained earnings | 67,763 |  |  | 65,165 | \nAccumulated other comprehensive loss | (14,416) |  |  | (14,898) | \nRepurchased common stock, in excess of par value (486and484shares, respectively) | (38,787) |  |  | (38,248) | \nTotal PepsiCo Common Shareholders\u2019 Equity | 18,553 |  |  | 16,043 | \nNoncontrolling interests | 121 |  |  | 108 | \nTotal Equity | 18,674 |  |  | 16,151 | \nTotal Liabilities and Equity | $ | 93,103 |  |  | $ | 92,377 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | 6/11/2022 |  | 6/12/2021 |  | 6/11/2022 |  | 6/12/2021\n | Shares |  | Amount |  | Shares |  | Amount |  | Shares |  | Amount |  | Shares |  | Amount\n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCommon Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period | 1,384 |  |  | $ | 23 |  |  | 1,382 |  |  | $ | 23 |  |  | 1,383 |  |  | $ | 23 |  |  | 1,380 |  |  | $ | 23 | \nChange in repurchased common stock | (3) |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (2) |  |  | \u2014 |  |  | 2 |  |  | \u2014 | \nBalance, end of period | 1,381 |  |  | 23 |  |  | 1,382 |  |  | 23 |  |  | 1,381 |  |  | 23 |  |  | 1,382 |  |  | 23 | \nCapital in Excess of Par Value |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  | 3,893 |  |  |  |  | 3,800 |  |  |  |  | 4,001 |  |  |  |  | 3,910 | \nShare-based compensation expense |  |  | 76 |  |  |  |  | 65 |  |  |  |  | 159 |  |  |  |  | 145 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nStock option exercises, RSUs and PSUs converted |  |  | 3 |  |  |  |  | \u2014 |  |  |  |  | (103) |  |  |  |  | (119) | \nWithholding tax on RSUs and PSUs converted |  |  | (2) |  |  |  |  | (2) |  |  |  |  | (87) |  |  |  |  | (73) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, end of period |  |  | 3,970 |  |  |  |  | 3,863 |  |  |  |  | 3,970 |  |  |  |  | 3,863 | \nRetained Earnings |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  | 67,934 |  |  |  |  | 63,740 |  |  |  |  | 65,165 |  |  |  |  | 63,443 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nNet income attributable to PepsiCo |  |  | 1,429 |  |  |  |  | 2,358 |  |  |  |  | 5,690 |  |  |  |  | 4,072 | \nCash dividends declared \u2013 common(a) |  |  | (1,600) |  |  |  |  | (1,493) |  |  |  |  | (3,092) |  |  |  |  | (2,910) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, end of period |  |  | 67,763 |  |  |  |  | 64,605 |  |  |  |  | 67,763 |  |  |  |  | 64,605 | \nAccumulated Other Comprehensive Loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  | (15,343) |  |  |  |  | (15,246) |  |  |  |  | (14,898) |  |  |  |  | (15,476) | \nOther comprehensive income attributable to PepsiCo |  |  | 927 |  |  |  |  | 387 |  |  |  |  | 482 |  |  |  |  | 617 | \nBalance, end of period |  |  | (14,416) |  |  |  |  | (14,859) |  |  |  |  | (14,416) |  |  |  |  | (14,859) | \nRepurchased Common Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period | (483) |  |  | (38,305) |  |  | (485) |  |  | (38,370) |  |  | (484) |  |  | (38,248) |  |  | (487) |  |  | (38,446) | \nShare repurchases | (3) |  |  | (518) |  |  | \u2014 |  |  | \u2014 |  |  | (4) |  |  | (731) |  |  | (1) |  |  | (106) | \nStock option exercises, RSUs and PSUs converted | \u2014 |  |  | 36 |  |  | \u2014 |  |  | 37 |  |  | 2 |  |  | 192 |  |  | 3 |  |  | 219 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, end of period | (486) |  |  | (38,787) |  |  | (485) |  |  | (38,333) |  |  | (486) |  |  | (38,787) |  |  | (485) |  |  | (38,333) | \nTotal PepsiCo Common Shareholders\u2019 Equity |  |  | 18,553 |  |  |  |  | 15,299 |  |  |  |  | 18,553 |  |  |  |  | 15,299 | \nNoncontrolling Interests |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  | 118 |  |  |  |  | 106 |  |  |  |  | 108 |  |  |  |  | 98 | \nNet income attributable to noncontrolling interest |  |  | 17 |  |  |  |  | 14 |  |  |  |  | 29 |  |  |  |  | 23 | \nDistributions to noncontrolling interests |  |  | (14) |  |  |  |  | (19) |  |  |  |  | (14) |  |  |  |  | (20) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOther, net |  |  | \u2014 |  |  |  |  | (2) |  |  |  |  | (2) |  |  |  |  | (2) | \nBalance, end of period |  |  | 121 |  |  |  |  | 99 |  |  |  |  | 121 |  |  |  |  | 99 | \nTotal Equity |  |  | $ | 18,674 |  |  |  |  | $ | 15,398 |  |  |  |  | $ | 18,674 |  |  |  |  | $ | 15,398 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | 6/11/2022 |  | 6/12/2021 |  | 6/11/2022 |  | 6/12/2021\nFLNA | $ | 5,181 |  |  | $ | 4,552 |  |  | $ | 10,020 |  |  | $ | 8,788 | \nQFNA | 675 |  |  | 575 |  |  | 1,388 |  |  | 1,221 | \nPBNA | 6,120 |  |  | 6,156 |  |  | 11,473 |  |  | 11,230 | \nLatAm | 2,415 |  |  | 1,967 |  |  | 3,889 |  |  | 3,209 | \nEurope | 3,023 |  |  | 3,286 |  |  | 4,820 |  |  | 5,081 | \nAMESA | 1,696 |  |  | 1,602 |  |  | 2,700 |  |  | 2,485 | \nAPAC | 1,115 |  |  | 1,079 |  |  | 2,135 |  |  | 2,023 | \nTotal | $ | 20,225 |  |  | $ | 19,217 |  |  | $ | 36,425 |  |  | $ | 34,037 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 6/11/2022 |  | 6/12/2021\n | Beverages(a) |  | Convenient Foods |  | Beverages(a) |  | Convenient Foods\nLatAm | 10 | % |  | 90 | % |  | 10 | % |  | 90 | %\nEurope | 50 | % |  | 50 | % |  | 55 | % |  | 45 | %\nAMESA | 35 | % |  | 65 | % |  | 35 | % |  | 65 | %\nAPAC | 25 | % |  | 75 | % |  | 25 | % |  | 75 | %\nPepsiCo | 45 | % |  | 55 | % |  | 45 | % |  | 55 | %\n |  |  |  |  |  |  | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended |  |  |  |  | \n | 6/11/2022 |  | 6/12/2021 |  |  |  |  | \n | Beverages(a) |  | Convenient Foods |  | Beverages(a) |  | Convenient Foods |  |  |  |  | \nLatAm | 10 | % |  | 90 | % |  | 10 | % |  | 90 | % |  |  |  |  | \nEurope | 50 | % |  | 50 | % |  | 55 | % |  | 45 | % |  |  |  |  | \nAMESA | 30 | % |  | 70 | % |  | 30 | % |  | 70 | % |  |  |  |  | \nAPAC | 20 | % |  | 80 | % |  | 20 | % |  | 80 | % |  |  |  |  | \nPepsiCo | 45 | % |  | 55 | % |  | 45 | % |  | 55 | % |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | 6/11/2022 |  | 6/12/2021 |  | 6/11/2022 |  | 6/12/2021\nFLNA | $ | 1,448 |  |  | $ | 1,382 |  |  | $ | 2,744 |  |  | $ | 2,622 | \nQFNA | 135 |  |  | 128 |  |  | 294 |  |  | 278 | \nPBNA(a) (b) | 651 |  |  | 809 |  |  | 4,085 |  |  | 1,175 | \nLatAm(c) | 420 |  |  | 356 |  |  | 743 |  |  | 574 | \nEurope(a) (d) | (797) |  |  | 405 |  |  | (933) |  |  | 536 | \nAMESA | 290 |  |  | 256 |  |  | 470 |  |  | 394 | \nAPAC | 206 |  |  | 192 |  |  | 421 |  |  | 400 | \nTotal divisions | 2,353 |  |  | 3,528 |  |  | 7,824 |  |  | 5,979 | \nCorporate unallocated expenses(e)(f) | (276) |  |  | (399) |  |  | (480) |  |  | (538) | \nTotal | $ | 2,077 |  |  | $ | 3,129 |  |  | $ | 7,344 |  |  | $ | 5,441 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | \n | 6/11/2022 |  |  |  | \n | 12 Weeks Ended |  |  |  | 24 Weeks Ended |  |  |  | \nImpairment charges related to intangible assets(a) | $ | 1,197 |  |  |  |  | $ | 1,198 |  |  |  |  | \nImpairment charges related to property, plant and equipment | \u2014 |  |  |  |  | 123 |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n(Recovery of)/allowance for expected credit losses(b) | (11) |  |  |  |  | 26 |  |  |  |  | \n(Recovery of)/allowance for inventory write-downs(b) | (8) |  |  |  |  | 25 |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \nOther(b) | (13) |  |  |  |  | 34 |  |  |  |  | \nTotal | $ | 1,165 |  |  |  |  | $ | 1,406 |  |  |  |  | \nAfter-tax amount | $ | 927 |  |  |  |  | $ | 1,168 |  |  |  |  | \nImpact on net income attributable to PepsiCo per common share | $ | (0.67) |  |  |  |  | $ | (0.84) |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | 6/11/2022\n | 12 Weeks Ended |  | 24 Weeks Ended\nCost of sales(b) | $ | (7) |  |  | $ | 133 | \nSelling, general and administrative expenses(b) | (25) |  |  | 75 | \nImpairment of intangible assets(a) | 1,197 |  |  | 1,198 | \nTotal | $ | 1,165 |  |  | $ | 1,406 |   |  |  |  |  |  |  |  |  |  |  | \n | 6/11/2022\n | 12 Weeks Ended |  | 24 Weeks Ended\nRussia-Ukraine conflict impairment charges | $ | 1,197 |  |  | $ | 1,198 | \nBrand Portfolio Impairment Charges | 162 |  |  | 403 | \nTotal | $ | 1,359 |  |  | $ | 1,601 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | 6/11/2022 |  | 6/12/2021 |  | 6/11/2022 |  | 6/12/2021\nFLNA | $ | 5 |  |  | $ | 14 |  |  | $ | 19 |  |  | $ | 38 | \nQFNA | \u2014 |  |  | 1 |  |  | 1 |  |  | 3 | \nPBNA(a) | 1 |  |  | (11) |  |  | 11 |  |  | 2 | \nLatAm | 4 |  |  | 17 |  |  | 10 |  |  | 32 | \nEurope | 2 |  |  | 9 |  |  | 3 |  |  | 15 | \nAMESA | 1 |  |  | 3 |  |  | 3 |  |  | 2 | \nAPAC | 11 |  |  | 2 |  |  | 13 |  |  | 4 | \nTotal | $ | 24 |  |  | $ | 35 |  |  | $ | 60 |  |  | $ | 96 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | FLNA |  | QFNA |  | PBNA |  | LatAm |  | Europe |  | AMESA |  | APAC |  | Corporate\nExpected pre-tax charges | 15 | % |  | 1 | % |  | 25 | % |  | 10 | % |  | 25 | % |  | 5 | % |  | 4 | % |  | 15 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | 6/11/2022 |  | 6/12/2021 |  | 6/11/2022 |  | 6/12/2021\nCost of sales | $ | \u2014 |  |  | $ | 2 |  |  | $ | 5 |  |  | $ | 4 | \nSelling, general and administrative expenses | 45 |  |  | 33 |  |  | 67 |  |  | 68 | \nOther pension and retiree medical benefits expense/(income) | 3 |  |  | (1) |  |  | 3 |  |  | 5 | \nTotal restructuring and impairment charges | $ | 48 |  |  | $ | 34 |  |  | $ | 75 |  |  | $ | 77 | \nAfter-tax amount | $ | 40 |  |  | $ | 29 |  |  | $ | 61 |  |  | $ | 64 | \nImpact on net income attributable to PepsiCo per common share | $ | (0.03) |  |  | $ | (0.02) |  |  | $ | (0.04) |  |  | $ | (0.05) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended |  | Plan to Date\n | 6/11/2022 |  | 6/12/2021 |  | 6/11/2022 |  | 6/12/2021 |  | through 6/11/2022\nFLNA | $ | 3 |  |  | $ | 3 |  |  | $ | 6 |  |  | $ | 18 |  |  | $ | 170 | \nQFNA | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 12 | \nPBNA | 2 |  |  | 1 |  |  | 5 |  |  | 5 |  |  | 163 | \nLatAm | 8 |  |  | 6 |  |  | 14 |  |  | 8 |  |  | 153 | \nEurope | 12 |  |  | 15 |  |  | 19 |  |  | 26 |  |  | 253 | \nAMESA | 3 |  |  | 3 |  |  | 5 |  |  | 4 |  |  | 75 | \nAPAC | 3 |  |  | 1 |  |  | 4 |  |  | 1 |  |  | 65 | \nCorporate | 14 |  |  | 6 |  |  | 19 |  |  | 10 |  |  | 158 | \n | 45 |  |  | 35 |  |  | 72 |  |  | 72 |  |  | 1,049 | \nOther pension and retiree medical benefits expense/(income) | 3 |  |  | (1) |  |  | 3 |  |  | 5 |  |  | 70 | \nTotal | $ | 48 |  |  | $ | 34 |  |  | $ | 75 |  |  | $ | 77 |  |  | $ | 1,119 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended |  | Plan to Date\n | 6/11/2022 |  | 6/12/2021 |  | 6/11/2022 |  | 6/12/2021 |  | through 6/11/2022\nSeverance and\u00a0other employee costs | $ | 20 |  |  | $ | 15 |  |  | $ | 31 |  |  | $ | 49 |  |  | $ | 595 | \nAsset impairments | \u2014 |  |  | 1 |  |  | \u2014 |  |  | 1 |  |  | 157 | \nOther\u00a0costs | 28 |  |  | 18 |  |  | 44 |  |  | 27 |  |  | 367 | \nTotal | $ | 48 |  |  | $ | 34 |  |  | $ | 75 |  |  | $ | 77 |  |  | $ | 1,119 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Severance and\u00a0Other Employee Costs |  |  |  | Other\u00a0Costs |  | Total\nLiability as of December 25, 2021 | $ | 64 |  |  |  |  | $ | 7 |  |  | $ | 71 | \n2022 restructuring charges | 31 |  |  |  |  | 44 |  |  | 75 | \nCash payments | (37) |  |  |  |  | (45) |  |  | (82) | \nNon-cash charges and translation | (3) |  |  |  |  | (1) |  |  | (4) | \nLiability as of June 11, 2022 | $ | 55 |  |  |  |  | $ | 5 |  |  | $ | 60 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | 6/11/2022 |  | 12/25/2021\n |  | Gross |  | Accumulated Amortization |  | Net |  | Gross |  | Accumulated Amortization |  | Net\nAcquired franchise rights(a) |  | $ | 851 |  |  | $ | (196) |  |  | $ | 655 |  |  | $ | 976 |  |  | $ | (187) |  |  | $ | 789 | \nCustomer relationships |  | 617 |  |  | (243) |  |  | 374 |  |  | 623 |  |  | (227) |  |  | 396 | \nBrands |  | 1,119 |  |  | (983) |  |  | 136 |  |  | 1,151 |  |  | (989) |  |  | 162 | \nOther identifiable intangibles |  | 444 |  |  | (261) |  |  | 183 |  |  | 451 |  |  | (260) |  |  | 191 | \nTotal |  | $ | 3,031 |  |  | $ | (1,683) |  |  | $ | 1,348 |  |  | $ | 3,201 |  |  | $ | (1,663) |  |  | $ | 1,538 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Balance12/25/2021 |  | Impairment |  | Translationand Other |  | Balance6/11/2022\n |  |  | \nFLNA |  |  |  |  |  |  | \nGoodwill | $ | 458 |  |  | $ | \u2014 |  |  | $ | 1 |  |  | $ | 459 | \nBrands | 340 |  |  | \u2014 |  |  | \u2014 |  |  | 340 | \nTotal | 798 |  |  | \u2014 |  |  | 1 |  |  | 799 | \nQFNA |  |  |  |  |  |  | \nGoodwill | 189 |  |  | \u2014 |  |  | \u2014 |  |  | 189 | \nTotal | 189 |  |  | \u2014 |  |  | \u2014 |  |  | 189 | \nPBNA |  |  |  |  |  |  | \nGoodwill | 11,974 |  |  | \u2014 |  |  | 1 |  |  | 11,975 | \nReacquired franchise rights | 7,107 |  |  | \u2014 |  |  | 6 |  |  | 7,113 | \nAcquired franchise rights | 1,538 |  |  | \u2014 |  |  | \u2014 |  |  | 1,538 | \nBrands | 2,508 |  |  | \u2014 |  |  | \u2014 |  |  | 2,508 | \nTotal | 23,127 |  |  | \u2014 |  |  | 7 |  |  | 23,134 | \nLatAm |  |  |  |  |  |  | \nGoodwill | 433 |  |  | \u2014 |  |  | 27 |  |  | 460 | \nBrands(a) | 100 |  |  | (29) |  |  | 10 |  |  | 81 | \nTotal | 533 |  |  | (29) |  |  | 37 |  |  | 541 | \nEurope(b) |  |  |  |  |  |  | \nGoodwill | 3,700 |  |  | \u2014 |  |  | 159 |  |  | 3,859 | \nReacquired franchise rights | 441 |  |  | \u2014 |  |  | 4 |  |  | 445 | \nAcquired franchise rights | 158 |  |  | \u2014 |  |  | (8) |  |  | 150 | \nBrands(c) | 4,254 |  |  | (1,420) |  |  | 67 |  |  | 2,901 | \nTotal | 8,553 |  |  | (1,420) |  |  | 222 |  |  | 7,355 | \nAMESA |  |  |  |  |  |  | \nGoodwill | 1,063 |  |  | \u2014 |  |  | 2 |  |  | 1,065 | \nBrands | 205 |  |  | \u2014 |  |  | 4 |  |  | 209 | \nTotal | 1,268 |  |  | \u2014 |  |  | 6 |  |  | 1,274 | \nAPAC |  |  |  |  |  |  | \nGoodwill | 564 |  |  | \u2014 |  |  | (24) |  |  | 540 | \nBrands | 476 |  |  | \u2014 |  |  | (18) |  |  | 458 | \nTotal | 1,040 |  |  | \u2014 |  |  | (42) |  |  | 998 | \n |  |  |  |  |  |  | \nTotal goodwill | 18,381 |  |  | \u2014 |  |  | 166 |  |  | 18,547 | \nTotal reacquired franchise rights | 7,548 |  |  | \u2014 |  |  | 10 |  |  | 7,558 | \nTotal acquired franchise rights | 1,696 |  |  | \u2014 |  |  | (8) |  |  | 1,688 | \nTotal brands | 7,883 |  |  | (1,449) |  |  | 63 |  |  | 6,497 | \nTotal | $ | 35,508 |  |  | $ | (1,449) |  |  | $ | 231 |  |  | $ | 34,290 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | 6/11/2022 |  | 6/12/2021 |  | 6/11/2022 |  | 6/12/2021\nShare-based compensation expense \u2013 equity awards | $ | 75 |  |  | $ | 65 |  |  | $ | 156 |  |  | $ | 144 | \nShare-based compensation expense \u2013 liability awards | 7 |  |  | \u2014 |  |  | 12 |  |  | 4 | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  | 3 |  |  | \u2014 | \nRestructuring charges | 1 |  |  | \u2014 |  |  | \u2014 |  |  | 1 | \nTotal | $ | 83 |  |  | $ | 65 |  |  | $ | 171 |  |  | $ | 149 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended\n | 6/11/2022 |  | 6/12/2021\n | Granted(a) |  | Weighted-Average Grant Price |  | Granted(a) |  | Weighted-Average Grant Price\nStock options | 2.1 |  |  | $ | 163.00 |  |  | 1.8 |  |  | $ | 131.25 | \nRSUs and PSUs | 2.3 |  |  | $ | 163.00 |  |  | 2.6 |  |  | $ | 131.27 |   |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended\n | 6/11/2022 |  | 6/12/2021\nExpected life | 7years |  | 7years\nRisk-free interest rate | 1.7 | % |  | 1.1 | %\nExpected volatility | 16 | % |  | 14 | %\nExpected dividend yield | 2.5 | % |  | 3.1 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | Pension |  | Retiree Medical\n | U.S. |  | International |  | \n | 6/11/2022 |  | 6/12/2021 |  | 6/11/2022 |  | 6/12/2021 |  | 6/11/2022 |  | 6/12/2021\nService cost | $ | 115 |  |  | $ | 120 |  |  | $ | 17 |  |  | $ | 25 |  |  | $ | 9 |  |  | $ | 7 | \nOther pension and retiree medical benefits expense/(income):\nInterest cost | 87 |  |  | 74 |  |  | 23 |  |  | 19 |  |  | 4 |  |  | 4 | \nExpected return on plan assets | (216) |  |  | (224) |  |  | (56) |  |  | (57) |  |  | (4) |  |  | (3) | \nAmortization of prior service credits | (7) |  |  | (7) |  |  | \u2014 |  |  | (1) |  |  | (2) |  |  | (3) | \nAmortization of net losses/(gains) | 35 |  |  | 52 |  |  | 7 |  |  | 19 |  |  | (3) |  |  | (3) | \nSettlement/curtailment losses | 131 |  |  | \u2014 |  |  | \u2014 |  |  | 5 |  |  | \u2014 |  |  | \u2014 | \nSpecial termination benefits | 3 |  |  | (1) |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nTotal other pension and retiree medical benefits expense/(income) | 33 |  |  | (106) |  |  | (26) |  |  | (15) |  |  | (5) |  |  | (5) | \nTotal | $ | 148 |  |  | $ | 14 |  |  | $ | (9) |  |  | $ | 10 |  |  | $ | 4 |  |  | $ | 2 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended\n | Pension |  | Retiree Medical\n | U.S. |  | International |  | \n | 6/11/2022 |  | 6/12/2021 |  | 6/11/2022 |  | 6/12/2021 |  | 6/11/2022 |  | 6/12/2021\nService cost | $ | 229 |  |  | $ | 240 |  |  | $ | 34 |  |  | $ | 44 |  |  | $ | 17 |  |  | $ | 15 | \nOther pension and retiree medical benefits income: |  |  |  | \nInterest cost | 175 |  |  | 149 |  |  | 40 |  |  | 32 |  |  | 8 |  |  | 7 | \nExpected return on plan assets | (431) |  |  | (448) |  |  | (98) |  |  | (98) |  |  | (7) |  |  | (7) | \nAmortization of prior service credits | (13) |  |  | (14) |  |  | \u2014 |  |  | (1) |  |  | (4) |  |  | (5) | \nAmortization of net losses/(gains) | 68 |  |  | 103 |  |  | 12 |  |  | 32 |  |  | (6) |  |  | (6) | \nSettlement/curtailment losses/(gains) | 131 |  |  | \u2014 |  |  | \u2014 |  |  | 5 |  |  | (16) |  |  | \u2014 | \nSpecial termination benefits | 9 |  |  | 5 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nTotal other pension and retiree medical benefits income | (61) |  |  | (205) |  |  | (46) |  |  | (30) |  |  | (25) |  |  | (11) | \nTotal | $ | 168 |  |  | $ | 35 |  |  | $ | (12) |  |  | $ | 14 |  |  | $ | (8) |  |  | $ | 4 |   |  |  |  |  |  |  |  |  |  |  | \n | Notional Amounts(a)\n | 6/11/2022 |  | 12/25/2021\nCommodity | $ | 1.7 |  |  | $ | 1.6 | \nForeign exchange | $ | 2.3 |  |  | $ | 2.8 | \nInterest rate | $ | 2.1 |  |  | $ | 2.1 | \nNet investment(b) | $ | 2.0 |  |  | $ | 2.1 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 6/11/2022 |  | 12/25/2021\n | Fair Value Hierarchy Levels(a) |  | Assets(a) |  | Liabilities(a) |  | Assets(a) |  | Liabilities(a)\n |  |  |  |  |  |  |  |  | \nIndex funds(b) | 1 |  | $ | 279 |  |  | $ | \u2014 |  |  | $ | 337 |  |  | $ | \u2014 | \nPrepaid forward contracts(c) | 2 |  | $ | 13 |  |  | $ | \u2014 |  |  | $ | 21 |  |  | $ | \u2014 | \nDeferred compensation(d) | 2 |  | $ | \u2014 |  |  | $ | 440 |  |  | $ | \u2014 |  |  | $ | 505 | \n |  |  |  |  |  |  |  |  | \nDerivatives designated as cash flow hedging instruments: |  |  |  |  |  |  |  |  | \nForeign exchange(e) | 2 |  | $ | 14 |  |  | $ | 42 |  |  | $ | 29 |  |  | $ | 14 | \nInterest rate(e) | 2 |  | 20 |  |  | 349 |  |  | 14 |  |  | 264 | \nCommodity(f) | 2 |  | 22 |  |  | 30 |  |  | 70 |  |  | 5 | \n |  |  | $ | 56 |  |  | $ | 421 |  |  | $ | 113 |  |  | $ | 283 | \nDerivatives not designated as hedging instruments: |  |  |  |  |  |  |  |  | \nForeign exchange(e) | 2 |  | $ | 6 |  |  | $ | 9 |  |  | $ | 19 |  |  | $ | 7 | \nCommodity(f) | 2 |  | 46 |  |  | 25 |  |  | 35 |  |  | 22 | \n |  |  | $ | 52 |  |  | $ | 34 |  |  | $ | 54 |  |  | $ | 29 | \nTotal derivatives at fair value(g) |  |  | $ | 108 |  |  | $ | 455 |  |  | $ | 167 |  |  | $ | 312 | \nTotal |  |  | $ | 400 |  |  | $ | 895 |  |  | $ | 525 |  |  | $ | 817 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | Fair Value/Non-designated Hedges |  | Cash Flow and Net Investment Hedges\n | Losses/(Gains)Recognized inIncome\u00a0Statement(a) |  | Losses/(Gains)Recognized inAccumulated\u00a0OtherComprehensive\u00a0Loss |  | Losses/(Gains)Reclassified fromAccumulated\u00a0OtherComprehensive\u00a0Lossinto Income Statement(b)\n | 6/11/2022 |  | 6/12/2021 |  | 6/11/2022 |  | 6/12/2021 |  | 6/11/2022 |  | 6/12/2021\nForeign exchange | $ | 21 |  |  | $ | 6 |  |  | $ | 26 |  |  | $ | 27 |  |  | $ | (17) |  |  | $ | 27 | \nInterest rate | \u2014 |  |  | \u2014 |  |  | 82 |  |  | (46) |  |  | 61 |  |  | (47) | \nCommodity | (181) |  |  | (70) |  |  | (1) |  |  | (156) |  |  | (74) |  |  | (33) | \nNet investment | \u2014 |  |  | \u2014 |  |  | (88) |  |  | 55 |  |  | \u2014 |  |  | \u2014 | \nTotal | $ | (160) |  |  | $ | (64) |  |  | $ | 19 |  |  | $ | (120) |  |  | $ | (30) |  |  | $ | (53) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended\n | Fair Value/Non-designated Hedges |  | Cash Flow and Net Investment Hedges\n | Losses/(Gains)Recognized inIncome\u00a0Statement(a) |  | Losses/(Gains)Recognized inAccumulated\u00a0OtherComprehensive\u00a0Loss |  | Losses/(Gains)Reclassified fromAccumulated\u00a0OtherComprehensive\u00a0Lossinto Income Statement(b)\n | 6/11/2022 |  | 6/12/2021 |  | 6/11/2022 |  | 6/12/2021 |  | 6/11/2022 |  | 6/12/2021\nForeign exchange | $ | 5 |  |  | $ | 10 |  |  | $ | 18 |  |  | $ | 38 |  |  | $ | (21) |  |  | $ | 40 | \nInterest rate | \u2014 |  |  | 1 |  |  | 79 |  |  | (64) |  |  | 81 |  |  | (51) | \nCommodity | (347) |  |  | (151) |  |  | (190) |  |  | (246) |  |  | (152) |  |  | (43) | \nNet investment | \u2014 |  |  | \u2014 |  |  | (139) |  |  | (8) |  |  | \u2014 |  |  | \u2014 | \nTotal | $ | (342) |  |  | $ | (140) |  |  | $ | (232) |  |  | $ | (280) |  |  | $ | (92) |  |  | $ | (54) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 6/11/2022 |  | 6/12/2021\n | Income |  | Shares(a) |  | Income |  | Shares(a)\n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nBasic net income attributable to PepsiCo per common share | $ | 1.03 |  |  |  |  | $ | 1.71 |  |  | \nNet income available for PepsiCo common shareholders | $ | 1,429 |  |  | 1,382 |  |  | $ | 2,358 |  |  | 1,382 | \nDilutive securities: |  |  |  |  |  |  | \nStock options, RSUs, PSUs and other(b) | \u2014 |  |  | 7 |  |  | \u2014 |  |  | 6 | \n |  |  |  |  |  |  | \nDiluted | $ | 1,429 |  |  | 1,389 |  |  | $ | 2,358 |  |  | 1,388 | \nDiluted net income attributable to PepsiCo per common share | $ | 1.03 |  |  |  |  | $ | 1.70 |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended\n | 6/11/2022 |  | 6/12/2021\n | Income |  | Shares(a) |  | Income |  | Shares(a)\n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nBasic net income attributable to PepsiCo per common share | $ | 4.11 |  |  |  |  | $ | 2.95 |  |  | \nNet income available for PepsiCo common shareholders | $ | 5,690 |  |  | 1,383 |  |  | $ | 4,072 |  |  | 1,381 | \nDilutive securities: |  |  |  |  |  |  | \nStock options, RSUs, PSUs and other(b) | \u2014 |  |  | 7 |  |  | \u2014 |  |  | 6 | \nDiluted | $ | 5,690 |  |  | 1,390 |  |  | $ | 4,072 |  |  | 1,387 | \nDiluted net income attributable to PepsiCo per common share | $ | 4.09 |  |  |  |  | $ | 2.94 |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Currency Translation Adjustment |  | Cash Flow Hedges |  | Pension and Retiree Medical |  |  |  | Other |  | Accumulated Other Comprehensive Loss Attributable to PepsiCo\nBalance as of December 25, 2021(a) | $ | (12,309) |  |  | $ | 159 |  |  | $ | (2,750) |  |  |  |  | $ | 2 |  |  | $ | (14,898) | \nOther comprehensive (loss)/income before reclassifications(b) | (549) |  |  | 200 |  |  | (8) |  |  |  |  | \u2014 |  |  | (357) | \nAmounts reclassified from accumulated other comprehensive loss | \u2014 |  |  | (62) |  |  | 25 |  |  |  |  | \u2014 |  |  | (37) | \nNet other comprehensive (loss)/income | (549) |  |  | 138 |  |  | 17 |  |  |  |  | \u2014 |  |  | (394) | \nTax amounts | (11) |  |  | (32) |  |  | (4) |  |  |  |  | (4) |  |  | (51) | \nBalance as of March 19, 2022(a) | $ | (12,869) |  |  | $ | 265 |  |  | $ | (2,737) |  |  |  |  | $ | (2) |  |  | $ | (15,343) | \nOther comprehensive income/(loss) before reclassifications(c) | 1,298 |  |  | (107) |  |  | (484) |  |  |  |  | 5 |  |  | 712 | \nAmounts reclassified from accumulated other comprehensive loss | \u2014 |  |  | (30) |  |  | 161 |  |  |  |  | \u2014 |  |  | 131 | \nNet other comprehensive income/(loss) | 1,298 |  |  | (137) |  |  | (323) |  |  |  |  | 5 |  |  | 843 | \nTax amounts | (24) |  |  | 35 |  |  | 73 |  |  |  |  | \u2014 |  |  | 84 | \nBalance as of June 11, 2022(a) | $ | (11,595) |  |  | $ | 163 |  |  | $ | (2,987) |  |  |  |  | $ | 3 |  |  | $ | (14,416) | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Currency Translation Adjustment |  | Cash Flow Hedges |  | Pension and Retiree Medical |  |  |  | Other |  | Accumulated Other Comprehensive Loss Attributable to PepsiCo\nBalance as of December 26, 2020(a) | $ | (11,940) |  |  | $ | 4 |  |  | $ | (3,520) |  |  |  |  | $ | (20) |  |  | $ | (15,476) | \nOther comprehensive income/(loss) before reclassifications(b) | 128 |  |  | 97 |  |  | (20) |  |  |  |  | \u2014 |  |  | 205 | \nAmounts reclassified from accumulated other comprehensive loss | 18 |  |  | (1) |  |  | 52 |  |  |  |  | \u2014 |  |  | 69 | \nNet other comprehensive income | 146 |  |  | 96 |  |  | 32 |  |  |  |  | \u2014 |  |  | 274 | \nTax amounts | (15) |  |  | (24) |  |  | (5) |  |  |  |  | \u2014 |  |  | (44) | \nBalance as of March 20, 2021(a) | $ | (11,809) |  |  | $ | 76 |  |  | $ | (3,493) |  |  |  |  | $ | (20) |  |  | $ | (15,246) | \nOther comprehensive income/(loss) before reclassifications(c) | 255 |  |  | 175 |  |  | (28) |  |  |  |  | 2 |  |  | 404 | \nAmounts reclassified from accumulated other comprehensive loss | \u2014 |  |  | (53) |  |  | 57 |  |  |  |  | \u2014 |  |  | 4 | \nNet other comprehensive income | 255 |  |  | 122 |  |  | 29 |  |  |  |  | 2 |  |  | 408 | \nTax amounts | 13 |  |  | (29) |  |  | (5) |  |  |  |  | \u2014 |  |  | (21) | \nBalance as of June 12, 2021(a) | $ | (11,541) |  |  | $ | 169 |  |  | $ | (3,469) |  |  |  |  | $ | (18) |  |  | $ | (14,859) | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | 12 Weeks Ended |  | 24 Weeks Ended |  | \n |  | 6/11/2022 |  | 6/12/2021 |  | 6/11/2022 |  | 6/12/2021 |  | Affected Line Item in the Income Statement\n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \nCurrency translation: |  |  |  |  |  |  |  |  |  | \nDivestiture |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 18 |  |  | Selling, general and administrative expenses\n |  |  |  |  |  |  |  |  |  | \nCash flow hedges: |  |  |  |  |  |  |  |  |  | \nForeign exchange contracts |  | $ | (2) |  |  | $ | 3 |  |  | $ | (4) |  |  | $ | 4 |  |  | Net revenue\nForeign exchange contracts |  | (15) |  |  | 24 |  |  | (17) |  |  | 36 |  |  | Cost of sales\nInterest rate derivatives |  | 61 |  |  | (47) |  |  | 81 |  |  | (51) |  |  | Selling, general and administrative expenses\nCommodity contracts |  | (70) |  |  | (32) |  |  | (146) |  |  | (43) |  |  | Cost of sales\nCommodity contracts |  | (4) |  |  | (1) |  |  | (6) |  |  | \u2014 |  |  | Selling, general and administrative expenses\nNet gains before tax |  | (30) |  |  | (53) |  |  | (92) |  |  | (54) |  |  | \nTax amounts |  | 7 |  |  | 12 |  |  | 17 |  |  | 13 |  |  | \nNet gains after tax |  | $ | (23) |  |  | $ | (41) |  |  | $ | (75) |  |  | $ | (41) |  |  | \n |  |  |  |  |  |  |  |  |  | \nPension and retiree medical items: |  |  |  |  |  |  |  |  |  | \nAmortization of prior service credits |  | $ | (9) |  |  | $ | (11) |  |  | $ | (17) |  |  | $ | (20) |  |  | Other pension and retiree medical benefits (expense)/income\nAmortization of net losses |  | 39 |  |  | 68 |  |  | 74 |  |  | 129 |  |  | Other pension and retiree medical benefits (expense)/income\nSettlement/curtailment losses |  | 131 |  |  | \u2014 |  |  | 129 |  |  | \u2014 |  |  | Other pension and retiree medical benefits (expense)/income\nNet losses before tax |  | 161 |  |  | 57 |  |  | 186 |  |  | 109 |  |  | \nTax amounts |  | (35) |  |  | (12) |  |  | (41) |  |  | (23) |  |  | \nNet losses after tax |  | $ | 126 |  |  | $ | 45 |  |  | $ | 145 |  |  | $ | 86 |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \nTotal net losses reclassified, net of tax |  | $ | 103 |  |  | $ | 4 |  |  | $ | 70 |  |  | $ | 63 |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | PBNA |  | Europe |  | Corporate |  | Total PepsiCo |  | Provision for income taxes(a) |  | Net income attributable to PepsiCo |  | Impact on net income attributable to PepsiCo per common share | \nGain associated with the Juice Transaction | $ | (3,037) |  |  | $ | (298) |  |  | $ | \u2014 |  |  | $ | (3,335) |  |  | $ | 455 |  |  | $ | (2,880) |  |  | $ | 2.07 |  | \nAcquisition and divestiture-related charges | 39 |  |  | 13 |  |  | 6 |  |  | 58 |  |  | (10) |  |  | 48 |  |  | (0.04) |  | \nOperating profit | $ | (2,998) |  |  | $ | (285) |  |  | $ | 6 |  |  | (3,277) |  |  | 445 |  |  | (2,832) |  |  | 2.04 |  | (c)\nOther pension and retiree medical benefits income(b) |  |  |  |  |  |  | (10) |  |  | 3 |  |  | (7) |  |  | 0.01 |  | \nTotal Juice Transaction |  |  |  |  |  |  | $ | (3,287) |  |  | $ | 448 |  |  | $ | (2,839) |  |  | $ | 2.04 |  | (c)\n |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended |  | \n | 6/11/2022 |  | 6/12/2021 |  | 6/11/2022 |  | 6/12/2021 |  | Transaction\nFLNA | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 2 |  |  | BFY Brands, Inc.\nPBNA | 2 |  |  | 1 |  |  | 39 |  |  | 2 |  |  | Juice Transaction, Rockstar\nEurope | 3 |  |  | \u2014 |  |  | 13 |  |  | \u2014 |  |  | Juice Transaction\nAMESA | \u2014 |  |  | 6 |  |  | \u2014 |  |  | 7 |  |  | Pioneer Foods\nAPAC | \u2014 |  |  | 3 |  |  | \u2014 |  |  | 3 |  |  | Be & Cheery\nCorporate | 3 |  |  | 15 |  |  | 6 |  |  | 1 |  |  | Juice Transaction, Rockstar\nTotal(a) | $ | 8 |  |  | $ | 25 |  |  | $ | 58 |  |  | $ | 15 |  |  | \nOther pension and retiree medical benefits expense | \u2014 |  |  | \u2014 |  |  | 6 |  |  | \u2014 |  |  | Juice Transaction\nTotal acquisition and divestiture-related charges | $ | 8 |  |  | $ | 25 |  |  | $ | 64 |  |  | $ | 15 |  |  | \nAfter-tax amount | $ | 7 |  |  | $ | 21 |  |  | $ | 54 |  |  | $ | 14 |  |  | \nImpact on net income attributable to PepsiCo per common share | $ | (0.01) |  |  | $ | (0.02) |  |  | $ | (0.04) |  |  | $ | (0.01) |  |  | \n |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | 6/11/2022 |  | 6/12/2021 |  | Change |  | 6/11/2022 |  | 6/12/2021 |  | Change\nNet revenue | $ | 20,225 |  |  | $ | 19,217 |  |  | 5 | % |  | $ | 36,425 |  |  | $ | 34,037 |  |  | 7 | %\nOperating profit | $ | 2,077 |  |  | $ | 3,129 |  |  | (34) | % |  | $ | 7,344 |  |  | $ | 5,441 |  |  | 35 | %\nOperating margin | 10.3 | % |  | 16.3 | % |  | (6.0) |  |  | 20.2 | % |  | 16.0 | % |  | 4.2 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 6/11/2022\n |  |  | Impact of |  |  |  | Impact of\n | Reported% Change, GAAP Measure |  | Foreign exchange translation |  | Acquisitions and divestitures |  |  |  | Organic% Change, Non-GAAP Measure(a) |  | Organic volume(b) |  | Effective net pricing\nFLNA | 14 | % |  | \u2014 |  |  | \u2014 |  |  |  |  | 14 | % |  | \u2014 |  |  | 14 | \nQFNA | 17 | % |  | \u2014 |  |  | \u2014 |  |  |  |  | 18 | % |  | 2 |  |  | 16 | \nPBNA | (1) | % |  | \u2014 |  |  | 9 |  |  |  |  | 9 | % |  | \u2014 |  |  | 9 | \nLatAm | 23 | % |  | (2) |  |  | 1 |  |  |  |  | 22 | % |  | 7 |  |  | 15 | \nEurope | (8) | % |  | 12 |  |  | 5 |  |  |  |  | 9 | % |  | (8) |  |  | 17 | \nAMESA | 6 | % |  | 7 |  |  | 10 |  |  |  |  | 23 | % |  | 14 |  |  | 9 | \nAPAC | 3 | % |  | 2 |  |  | 7 |  |  |  |  | 13 | % |  | 10 |  |  | 2.5 | \nTotal | 5 | % |  | 3 |  |  | 5 |  |  |  |  | 13 | % |  | 1 |  |  | 12 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended 6/11/2022\n |  |  | Impact of |  |  |  |  |  |  |  | Impact of\n | Reported% Change, GAAP Measure |  | Foreign exchange translation |  | Acquisitions and divestitures |  |  |  | Organic% Change, Non-GAAP Measure(a) |  |  |  |  |  | Organic volume(b) |  | Effective net pricing\nFLNA | 14 | % |  | \u2014 |  |  | \u2014 |  |  |  |  | 14 | % |  |  |  |  |  | 1 |  |  | 13 | \nQFNA | 14 | % |  | \u2014 |  |  | \u2014 |  |  |  |  | 14 | % |  |  |  |  |  | \u2014 |  |  | 14 | \nPBNA | 2 | % |  | \u2014 |  |  | 8 |  |  |  |  | 10 | % |  |  |  |  |  | 2 |  |  | 9 | \nLatAm | 21 | % |  | \u2014 |  |  | 1 |  |  |  |  | 22 | % |  |  |  |  |  | 12 |  |  | 10 | \nEurope | (5) | % |  | 11 |  |  | 4 |  |  |  |  | 9 | % |  |  |  |  |  | (5) |  |  | 15 | \nAMESA | 9 | % |  | 6 |  |  | 7 |  |  |  |  | 21 | % |  |  |  |  |  | 13 |  |  | 8 | \nAPAC | 5.5 | % |  | 2 |  |  | 4 |  |  |  |  | 11 | % |  |  |  |  |  | 6 |  |  | 5 | \nTotal | 7 | % |  | 2 |  |  | 4 |  |  |  |  | 13 | % |  |  |  |  |  | 2.5 |  |  | 11 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 6/11/2022\n |  |  | Items Affecting Comparability(a) |  | \n | Reported, GAAP Measure(b) |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges |  | Gain associated with the Juice Transaction |  | Russia-Ukraine conflict charges |  | Brand Portfolio Impairment Charges |  | Core,Non-GAAP Measure(b)\nFLNA | $ | 1,448 |  |  | $ | \u2014 |  |  | $ | 3 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 1,451 | \nQFNA | 135 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 135 | \nPBNA | 651 |  |  | \u2014 |  |  | 2 |  |  | 2 |  |  | (13) |  |  | \u2014 |  |  | 141 |  |  | 783 | \nLatAm | 420 |  |  | \u2014 |  |  | 8 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 83 |  |  | 511 | \nEurope | (797) |  |  | \u2014 |  |  | 12 |  |  | 3 |  |  | \u2014 |  |  | 1,165 |  |  | \u2014 |  |  | 383 | \nAMESA | 290 |  |  | \u2014 |  |  | 3 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 293 | \nAPAC | 206 |  |  | \u2014 |  |  | 3 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 209 | \nCorporate unallocated expenses | (276) |  |  | (98) |  |  | 14 |  |  | 3 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (357) | \nTotal | $ | 2,077 |  |  | $ | (98) |  |  | $ | 45 |  |  | $ | 8 |  |  | $ | (13) |  |  | $ | 1,165 |  |  | $ | 224 |  |  | $ | 3,408 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 6/12/2021\n |  |  | Items Affecting Comparability(a) |  |  |  |  |  | \n | Reported,GAAP Measure(b) |  | Mark-to-market net impact |  | Restructuringand impairment charges |  | Acquisition and divestiture-related charges |  |  |  |  |  | Core,Non-GAAP Measure(b)\nFLNA | $ | 1,382 |  |  | $ | \u2014 |  |  | $ | 3 |  |  | $ | \u2014 |  |  |  |  |  |  | $ | 1,385 | \nQFNA | 128 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  |  |  | 128 | \nPBNA | 809 |  |  | \u2014 |  |  | 1 |  |  | 1 |  |  |  |  |  |  | 811 | \nLatAm | 356 |  |  | \u2014 |  |  | 6 |  |  | \u2014 |  |  |  |  |  |  | 362 | \nEurope | 405 |  |  | \u2014 |  |  | 15 |  |  | \u2014 |  |  |  |  |  |  | 420 | \nAMESA | 256 |  |  | \u2014 |  |  | 3 |  |  | 6 |  |  |  |  |  |  | 265 | \nAPAC | 192 |  |  | \u2014 |  |  | 1 |  |  | 3 |  |  |  |  |  |  | 196 | \nCorporate unallocated expenses | (399) |  |  | (20) |  |  | 6 |  |  | 15 |  |  |  |  |  |  | (398) | \nTotal | $ | 3,129 |  |  | $ | (20) |  |  | $ | 35 |  |  | $ | 25 |  |  |  |  |  |  | $ | 3,169 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended 6/11/2022\n |  |  | Items Affecting Comparability(a) |  | \n | Reported, GAAP Measure(b) |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges |  | Gain associated with the Juice Transaction |  | Russia-Ukraine conflict charges |  | Brand Portfolio Impairment Charges |  | Core,Non-GAAP Measure(b)\nFLNA | $ | 2,744 |  |  | $ | \u2014 |  |  | $ | 6 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 2,750 | \nQFNA | 294 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 294 | \nPBNA | 4,085 |  |  | \u2014 |  |  | 5 |  |  | 39 |  |  | (3,037) |  |  | \u2014 |  |  | 141 |  |  | 1,233 | \nLatAm | 743 |  |  | \u2014 |  |  | 14 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 83 |  |  | 840 | \nEurope | (933) |  |  | \u2014 |  |  | 19 |  |  | 13 |  |  | (298) |  |  | 1,406 |  |  | 241 |  |  | 448 | \nAMESA | 470 |  |  | \u2014 |  |  | 5 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 475 | \nAPAC | 421 |  |  | \u2014 |  |  | 4 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 425 | \nCorporate unallocated expenses | (480) |  |  | (210) |  |  | 19 |  |  | 6 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (665) | \nTotal | $ | 7,344 |  |  | $ | (210) |  |  | $ | 72 |  |  | $ | 58 |  |  | $ | (3,335) |  |  | $ | 1,406 |  |  | $ | 465 |  |  | $ | 5,800 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended 6/12/2021\n |  |  | Items Affecting Comparability(a) |  | \n | Reported,GAAP Measure(b) |  | Mark-to-market net impact |  | Restructuringand impairment charges |  | Acquisition and divestiture-related charges |  | Core,Non-GAAP Measure(b)\nFLNA | $ | 2,622 |  |  | $ | \u2014 |  |  | $ | 18 |  |  | $ | 2 |  |  | $ | 2,642 | \nQFNA | 278 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 278 | \nPBNA | 1,175 |  |  | \u2014 |  |  | 5 |  |  | 2 |  |  | 1,182 | \nLatAm | 574 |  |  | \u2014 |  |  | 8 |  |  | \u2014 |  |  | 582 | \nEurope | 536 |  |  | \u2014 |  |  | 26 |  |  | \u2014 |  |  | 562 | \nAMESA | 394 |  |  | \u2014 |  |  | 4 |  |  | 7 |  |  | 405 | \nAPAC | 400 |  |  | \u2014 |  |  | 1 |  |  | 3 |  |  | 404 | \nCorporate unallocated expenses | (538) |  |  | (95) |  |  | 10 |  |  | 1 |  |  | (622) | \nTotal | $ | 5,441 |  |  | $ | (95) |  |  | $ | 72 |  |  | $ | 15 |  |  | $ | 5,433 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 6/11/2022\n |  |  | Impact of Items Affecting Comparability(a) |  |  |  | Impact of |  | \n | Reported % Change, GAAP Measure |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges |  | Gain associated with the Juice Transaction |  | Russia-Ukraine conflict charges |  | Brand Portfolio Impairment Charges |  | Core% Change, Non-GAAP Measure(b) |  | Foreign exchange translation |  | Core Constant Currency% Change, Non-GAAP Measure(b)\nFLNA | 5 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 5 | % |  | \u2014 |  |  | 5 | %\nQFNA | 5 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 5 | % |  | \u2014 |  |  | 6 | %\nPBNA | (20) | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (2) |  |  | \u2014 |  |  | 17 |  |  | (3) | % |  | \u2014 |  |  | (3) | %\nLatAm | 18 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 23 |  |  | 41 | % |  | (2) |  |  | 39 | %\nEurope | (297) | % |  | \u2014 |  |  | (1) |  |  | 1 |  |  | \u2014 |  |  | 288 |  |  | \u2014 |  |  | (9) | % |  | 11 |  |  | 2 | %\nAMESA | 14 | % |  | \u2014 |  |  | \u2014 |  |  | (3) |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 10 | % |  | 7 |  |  | 18 | %\nAPAC | 7 | % |  | \u2014 |  |  | 1 |  |  | (1) |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 7 | % |  | 4 |  |  | 10 | %\nCorporate unallocated expenses | (31) | % |  | 20 |  |  | (2.5) |  |  | 3 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (10) | % |  | \u2014 |  |  | (10) | %\nTotal | (34) | % |  | (2.5) |  |  | \u2014 |  |  | (0.5) |  |  | \u2014 |  |  | 37 |  |  | 7 |  |  | 8 | % |  | 2 |  |  | 10 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended 6/11/2022\n |  |  | Impact of Items Affecting Comparability(a) |  |  |  |  |  | Impact of |  | \n | Reported % Change, GAAP Measure |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges |  | Gain associated with the Juice Transaction |  | Russia-Ukraine conflict charges |  | Brand Portfolio Impairment Charges |  |  |  | Core% Change, Non-GAAP Measure(b) |  | Foreign exchangetranslation |  | Core Constant Currency% Change, Non-GAAP Measure(b)\nFLNA | 5 | % |  | \u2014 |  |  | (0.5) |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 4 | % |  | \u2014 |  |  | 4 | %\nQFNA | 6 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 6 | % |  | \u2014 |  |  | 6 | %\nPBNA | 248 | % |  | \u2014 |  |  | \u2014 |  |  | 3 |  |  | (259) |  |  | \u2014 |  |  | 12 |  |  |  |  | 4 | % |  | \u2014 |  |  | 4.5 | %\nLatAm | 29 | % |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 14 |  |  |  |  | 44 | % |  | \u2014 |  |  | 44 | %\nEurope | (274) | % |  | \u2014 |  |  | (1) |  |  | 2 |  |  | (56) |  |  | 263 |  |  | 45 |  |  |  |  | (20) | % |  | 9 |  |  | (11) | %\nAMESA | 19 | % |  | \u2014 |  |  | \u2014 |  |  | (2) |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 17 | % |  | 5 |  |  | 23 | %\nAPAC | 5 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 5 | % |  | 2 |  |  | 8 | %\nCorporate unallocated expenses | (11) | % |  | 20 |  |  | (2) |  |  | (1) |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 7 | % |  | \u2014 |  |  | 7 | %\nTotal | 35 | % |  | (2) |  |  | \u2014 |  |  | 1 |  |  | (61) |  |  | 26 |  |  | 9 |  |  |  |  | 7 | % |  | 2 |  |  | 8 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended | \n | 6/11/2022 |  | 6/12/2021 |  | Change |  | 6/11/2022 |  | 6/12/2021 |  | Change | \nOther pension and retiree medical benefits (expense)/income | $ | (2) |  |  | $ | 126 |  |  | $ | (128) |  |  | $ | 132 |  |  | $ | 246 |  |  | $ | (114) |  | \nNet interest expense and other | $ | (236) |  |  | $ | (241) |  |  | $ | 5 |  |  | $ | (476) |  |  | $ | (499) |  |  | $ | 23 |  | \nTax rate | 21.4 | % |  | 21.3 | % |  |  |  | 18.3 | % |  | 21.1 | % |  |  | \nNet income attributable to PepsiCo(a) | $ | 1,429 |  |  | $ | 2,358 |  |  | (39) | % |  | $ | 5,690 |  |  | $ | 4,072 |  |  | 40 | % | \nNet income attributable to PepsiCo per common share \u2013 diluted(a) | $ | 1.03 |  |  | $ | 1.70 |  |  | (39) | % |  | $ | 4.09 |  |  | $ | 2.94 |  |  | 39 | % | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 6/11/2022\n | Cost of sales |  | Gross profit |  | Selling, general and administrative expenses |  | Gain associated with the Juice Transaction |  | Impairment of intangible assets |  | Operating profit |  | Other pension and retiree medical benefits (expense)/income |  | Provision for income taxes(a) |  | Net income attributable to noncontrolling interests |  | Net income attributable to PepsiCo\nReported, GAAP Measure | $ | 9,415 |  |  | $ | 10,810 |  |  | $ | 7,387 |  |  | $ | (13) |  |  | $ | 1,359 |  |  | $ | 2,077 |  |  | $ | (2) |  |  | $ | 393 |  |  | $ | 17 |  |  | $ | 1,429 | \nItems Affecting Comparability |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMark-to-market net impact | 22 |  |  | (22) |  |  | 76 |  |  | \u2014 |  |  | \u2014 |  |  | (98) |  |  | \u2014 |  |  | (25) |  |  | \u2014 |  |  | (73) | \nRestructuring and impairment charges | \u2014 |  |  | \u2014 |  |  | (45) |  |  | \u2014 |  |  | \u2014 |  |  | 45 |  |  | 3 |  |  | 8 |  |  | 1 |  |  | 39 | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  | (8) |  |  | \u2014 |  |  | \u2014 |  |  | 8 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | 7 | \nGain associated with the Juice Transaction | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 13 |  |  | \u2014 |  |  | (13) |  |  | \u2014 |  |  | (3) |  |  | \u2014 |  |  | (10) | \nRussia-Ukraine conflict charges | 7 |  |  | (7) |  |  | 25 |  |  | \u2014 |  |  | (1,197) |  |  | 1,165 |  |  | \u2014 |  |  | 238 |  |  | \u2014 |  |  | 927 | \nBrand Portfolio Impairment Charges | (8) |  |  | 8 |  |  | (54) |  |  | \u2014 |  |  | (162) |  |  | 224 |  |  | \u2014 |  |  | 61 |  |  | \u2014 |  |  | 163 | \nPension and retiree medical-related impact | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 131 |  |  | 30 |  |  | \u2014 |  |  | 101 | \nCore, Non-GAAP Measure | $ | 9,436 |  |  | $ | 10,789 |  |  | $ | 7,381 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 3,408 |  |  | $ | 132 |  |  | $ | 703 |  |  | $ | 18 |  |  | $ | 2,583 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 6/12/2021\n | Cost of sales |  | Gross profit |  | Selling, general and administrative expenses |  | Operating profit |  | Other pension and retiree medical benefits income |  | Provision for incometaxes(a) |  |  |  | Net income attributable to PepsiCo\nReported, GAAP Measure | $ | 8,880 |  |  | $ | 10,337 |  |  | $ | 7,208 |  |  | $ | 3,129 |  |  | $ | 126 |  |  | $ | 642 |  |  |  |  | $ | 2,358 | \nItems Affecting Comparability |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMark-to-market net impact | \u2014 |  |  | \u2014 |  |  | 20 |  |  | (20) |  |  | \u2014 |  |  | (4) |  |  |  |  | (16) | \nRestructuring and impairment charges | (2) |  |  | 2 |  |  | (33) |  |  | 35 |  |  | (1) |  |  | 5 |  |  |  |  | 29 | \nAcquisition and divestiture-related charges | (1) |  |  | 1 |  |  | (24) |  |  | 25 |  |  | \u2014 |  |  | 4 |  |  |  |  | 21 | \nCore, Non-GAAP Measure | $ | 8,877 |  |  | $ | 10,340 |  |  | $ | 7,171 |  |  | $ | 3,169 |  |  | $ | 125 |  |  | $ | 647 |  |  |  |  | $ | 2,392 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended 6/11/2022\n | Cost of sales |  | Gross profit |  | Selling, general and administrative expenses |  | Gain associated with the Juice Transaction |  | Impairment of intangible assets |  | Operating profit |  | Other pension and retiree medical benefits income |  |  |  | Provision for income taxes(a) |  | Net income attributable to noncontrolling interests |  | Net income attributable to PepsiCo\nReported, GAAP Measure | $ | 16,848 |  |  | $ | 19,577 |  |  | $ | 13,967 |  |  | $ | (3,335) |  |  | $ | 1,601 |  |  | $ | 7,344 |  |  | $ | 132 |  |  |  |  | $ | 1,281 |  |  | $ | 29 |  |  | $ | 5,690 | \nItems Affecting Comparability |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMark-to-market net impact | 55 |  |  | (55) |  |  | 155 |  |  | \u2014 |  |  | \u2014 |  |  | (210) |  |  | \u2014 |  |  |  |  | (51) |  |  | \u2014 |  |  | (159) | \nRestructuring and impairment charges | (5) |  |  | 5 |  |  | (67) |  |  | \u2014 |  |  | \u2014 |  |  | 72 |  |  | 3 |  |  |  |  | 14 |  |  | 1 |  |  | 60 | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  | (58) |  |  | \u2014 |  |  | \u2014 |  |  | 58 |  |  | 6 |  |  |  |  | 10 |  |  | \u2014 |  |  | 54 | \nGain associated with the Juice Transaction | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 3,335 |  |  | \u2014 |  |  | (3,335) |  |  | \u2014 |  |  |  |  | (455) |  |  | \u2014 |  |  | (2,880) | \nRussia-Ukraine conflict charges | (133) |  |  | 133 |  |  | (75) |  |  | \u2014 |  |  | (1,198) |  |  | 1,406 |  |  | \u2014 |  |  |  |  | 238 |  |  | \u2014 |  |  | 1,168 | \nBrand Portfolio Impairment Charges | (8) |  |  | 8 |  |  | (54) |  |  | \u2014 |  |  | (403) |  |  | 465 |  |  | \u2014 |  |  |  |  | 109 |  |  | \u2014 |  |  | 356 | \nPension and retiree medical-related impact | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 115 |  |  |  |  | 26 |  |  | \u2014 |  |  | 89 | \nCore, Non-GAAP Measure | $ | 16,757 |  |  | $ | 19,668 |  |  | $ | 13,868 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 5,800 |  |  | $ | 256 |  |  |  |  | $ | 1,172 |  |  | $ | 30 |  |  | $ | 4,378 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended 6/12/2021\n | Cost of sales |  | Gross profit |  | Selling, general and administrative expenses |  | Operating profit |  | Other pension and retiree medical benefits income |  | Provision for income taxes(a) |  |  |  | Net income attributable to PepsiCo\nReported, GAAP Measure | $ | 15,551 |  |  | $ | 18,486 |  |  | $ | 13,045 |  |  | $ | 5,441 |  |  | $ | 246 |  |  | $ | 1,093 |  |  |  |  | $ | 4,072 | \nItems Affecting Comparability |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMark-to-market net impact | 36 |  |  | (36) |  |  | 59 |  |  | (95) |  |  | \u2014 |  |  | (21) |  |  |  |  | (74) | \nRestructuring and impairment charges | (4) |  |  | 4 |  |  | (68) |  |  | 72 |  |  | 5 |  |  | 13 |  |  |  |  | 64 | \nAcquisition and divestiture-related charges | (1) |  |  | 1 |  |  | (14) |  |  | 15 |  |  | \u2014 |  |  | 1 |  |  |  |  | 14 | \nCore, Non-GAAP Measure | $ | 15,582 |  |  | $ | 18,455 |  |  | $ | 13,022 |  |  | $ | 5,433 |  |  | $ | 251 |  |  | $ | 1,086 |  |  |  |  | $ | 4,076 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended | \n | 6/11/2022 |  | 6/12/2021 |  | Change |  | 6/11/2022 |  | 6/12/2021 |  | Change | \nNet income attributable to PepsiCo per common share \u2013 diluted, GAAP measure | $ | 1.03 |  |  | $ | 1.70 |  |  | (39) | % |  | $ | 4.09 |  |  | $ | 2.94 |  |  | 39 | % | \nMark-to-market net impact | (0.05) |  |  | (0.01) |  |  |  |  | (0.11) |  |  | (0.05) |  |  |  | \nRestructuring and impairment charges | 0.03 |  |  | 0.02 |  |  |  |  | 0.04 |  |  | 0.05 |  |  |  | \nAcquisition and divestiture-related charges | 0.01 |  |  | 0.02 |  |  |  |  | 0.04 |  |  | 0.01 |  |  |  | \nGain associated with the Juice Transaction | (0.01) |  |  | \u2014 |  |  |  |  | (2.07) |  |  | \u2014 |  |  |  | \nRussia-Ukraine conflict charges | 0.67 |  |  | \u2014 |  |  |  |  | 0.84 |  |  | \u2014 |  |  |  | \nBrand Portfolio Impairment Charges | 0.12 |  |  | \u2014 |  |  |  |  | 0.26 |  |  | \u2014 |  |  |  | \nPension and retiree medical-related impact | 0.07 |  |  | \u2014 |  |  |  |  | 0.06 |  |  | \u2014 |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \nCore net income attributable to PepsiCo per common share \u2013 diluted, non-GAAP measure | $ | 1.86 |  | (a) | $ | 1.72 |  | (a) | 8 | % |  | $ | 3.15 |  |  | $ | 2.94 |  | (a) | 7 | % | \nImpact of foreign exchange translation |  |  |  |  | 2 |  |  |  |  |  |  | 2 |  | \nGrowth in core net income attributable to PepsiCo per common share \u2013 diluted, on a constant currency basis, non-GAAP measure |  |  |  |  | 10 | % |  |  |  |  |  | 9 | % |   |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended |  | \n | 6/11/2022 |  | 6/12/2021 |  | \nNet cash provided by operating activities, GAAP measure | $ | 1,881 |  |  | $ | 2,340 |  |  | \nCapital spending | (1,499) |  |  | (1,305) |  |  | \nSales of property, plant and equipment | 222 |  |  | 22 |  |  | \nFree cash flow, non-GAAP measure | $ | 604 |  |  | $ | 1,057 |  |  | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | Change(a) |  | Reference\n |  |  | \nAccounts and notes receivable, less allowance | $ | 1.8 |  |  | (b)\nInventories | $ | 0.9 |  |  | (c)\nAssets held for sale | $ | (1.8) |  |  | (d)\nOther indefinite-lived intangible assets | $ | (1.4) |  |  | Note 3\nInvestments in noncontrolled affiliates | $ | 0.9 |  |  | Note 11  |  |  |  |  |  |  |  |  |  |  | \n | Change(a) |  | Reference\nShort-term debt obligations | $ | 1.7 |  |  | (e)\n |  |  | \nLiabilities held for sale | $ | (0.8) |  |  | (d)\nLong-term debt obligations | $ | (2.8) |  |  | Note 7  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod |  | TotalNumber ofSharesRepurchased(a) |  | Average\u00a0PricePaid\u00a0Per\u00a0Share |  | Total\u00a0Numberof SharesPurchased asPart\u00a0of\u00a0PubliclyAnnouncedPlans orPrograms |  | MaximumNumber (orApproximateDollar\u00a0Value)\u00a0ofShares That May Yet BePurchasedUnder\u00a0the\u00a0Plansor Programs\n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n3/19/2022 |  |  |  |  |  |  |  | $ | 9,787 | \n |  |  |  |  |  |  |  | \n3/20/2022 - 4/16/2022 |  | 1.1 |  |  | $ | 168.85 |  |  | 1.1 |  |  | (176) | \n |  |  |  |  |  |  |  | 9,611 | \n4/17/2022 - 5/14/2022 |  | 0.8 |  |  | $ | 172.40 |  |  | 0.8 |  |  | (136) | \n |  |  |  |  |  |  |  | 9,475 | \n5/15/2022 - 6/11/2022 |  | 1.2 |  |  | $ | 166.12 |  |  | 1.2 |  |  | (206) | \nTotal |  | 3.1 |  |  | $ | 168.66 |  |  | 3.1 |  |  | $ | 9,269 |   |  | \nSee \u201cIndex to Exhibits\u201d on page58.  |  |  |  |  | \nEXHIBIT | \nExhibit 3.1 | Amended and Restated Articles of Incorporation of PepsiCo, Inc., effective as of May 1, 2019, which are incorporated herein by reference to Exhibit 3.1 to PepsiCo, Inc.\u2019s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 3, 2019.\nExhibit 3.2 | By-Laws of PepsiCo, Inc., as amended and restated, effective as of April 15, 2020, which are incorporated herein by reference to Exhibit 3.2 to PepsiCo, Inc.\u2019s Current Report on Form 8-K filed with the Securities and Exchange Commission on April 16, 2020.\nExhibit 15 | Letter re: Unaudited Interim Financial Information.\nExhibit 31 | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.\nExhibit 32 | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.\nExhibit 99.1 | 364-Day Credit Agreement, dated as of May 27, 2022, among PepsiCo, as borrower, the lenders named therein, and Citibank, N.A., as administrative agent, which is incorporated by reference to Exhibit 99.1 to PepsiCo, Inc.\u2019s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 27, 2022.\nExhibit 99.2 | Five-Year Credit Agreement, dated as of May 27, 2022, among PepsiCo, as borrower, the lenders named therein, and Citibank, N.A., as administrative agent, which is incorporated by reference to Exhibit 99.2 to PepsiCo, Inc.\u2019s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 27, 2022.\nExhibit 101 | The following materials from PepsiCo, Inc.\u2019s Quarterly Report on Form 10-Q for the quarter ended June 11, 2022 formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Statement of Income, (ii) the Condensed Consolidated Statement of Comprehensive Income, (iii) the Condensed Consolidated Statement of Cash Flows, (iv) the Condensed Consolidated Balance Sheet, (v) the Condensed Consolidated Statement of Equity, and (vi) Notes to the Condensed Consolidated Financial Statements.\nExhibit 104 | The cover page from the Company\u2019s Quarterly Report on Form 10-Q for the quarter ended June 11, 2022, formatted in iXBRL and contained in Exhibit 101.  |  |  |  |  |  |  |  |  |  |  | \n |  |  | \n |  | PepsiCo, Inc. | \n |  | (Registrant) | \n |  |  | \nDate: | July 11, 2022 | /s/ Marie T. Gallagher | \n |  | Marie T. Gallagher | \n |  | Senior Vice President and Controller | \n |  | (Principal Accounting Officer) | \n |  |  | \nDate: | July 11, 2022 | /s/ David Flavell | \n |  | David Flavell | \n |  | Executive Vice President, General Counsel and Corporate Secretary | \n |  | (Duly Authorized Officer) | "}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Pepsico, in 2022 Q3, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  | \n\u2612 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \n\u2610 | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  | \nPepsiCo, Inc.  |  |  |  |  |  |  |  | \n |  | \nNorth Carolina |  | 13-1584302\n(State or Other Jurisdiction ofIncorporation or Organization) |  | (I.R.S. EmployerIdentification No.)\n | \n |  | \n |  |   |  | \n(Address of principal executive offices and Zip Code)  |  | \nRegistrant's telephone number, including area code  |  | \n(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTitle of each class |  | Trading Symbols |  | Name of each exchange on which registered\nCommon Stock, par value 1-2/3 cents per share |  | PEP |  | The Nasdaq Stock Market LLC\n2.500% Senior Notes Due 2022 |  | PEP22a |  | The Nasdaq Stock Market LLC\n0.250% Senior Notes Due 2024 |  | PEP24 |  | The Nasdaq Stock Market LLC\n2.625% Senior Notes Due 2026 |  | PEP26 |  | The Nasdaq Stock Market LLC\n0.750% Senior Notes Due 2027 |  | PEP27 |  | The Nasdaq Stock Market LLC\n0.875% Senior Notes Due 2028 |  | PEP28 |  | The Nasdaq Stock Market LLC\n0.500% Senior Notes Due 2028 |  | PEP28a |  | The Nasdaq Stock Market LLC\n3.200% Senior Notes Due 2029 |  | PEP29 |  | The Nasdaq Stock Market LLC\n1.125% Senior Notes Due 2031 |  | PEP31 |  | The Nasdaq Stock Market LLC\n0.400% Senior Notes Due 2032 |  | PEP32 |  | The Nasdaq Stock Market LLC\n0.750% Senior Notes Due 2033 |  | PEP33 |  | The Nasdaq Stock Market LLC\n3.550% Senior Notes Due 2034 |  | PEP34 |  | The Nasdaq Stock Market LLC\n0.875% Senior Notes Due 2039 |  | PEP39 |  | The Nasdaq Stock Market LLC\n1.050% Senior Notes Due 2050 |  | PEP50 |  | The Nasdaq Stock Market LLC  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 | Accelerated filer | \u2610\nNon-accelerated filer | \u2610 | Smaller reporting company | \u2610\n |  | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \n |  | Page\u00a0No.\nPart I        Financial Information | \nItem 1. | Condensed Consolidated Financial Statements | 3\n | Condensed Consolidated Statement of Income \u201312 and36Weeks EndedSeptember3, 2022 andSeptember 4, 2021 | 3\n | Condensed Consolidated Statement of Comprehensive Income \u201312 and36Weeks EndedSeptember3, 2022andSeptember4, 2021 | 4\n | Condensed Consolidated Statement of Cash Flows \u201336Weeks EndedSeptember 3, 2022 andSeptember 4, 2021 | 5\n | Condensed Consolidated Balance Sheet \u2013September 3,2022 and December 25, 2021 | 7\n | Condensed Consolidated Statement of Equity \u201312 and36Weeks EndedSeptember 3, 2022 andSeptember 4, 2021 | 8\n | Notes to the Condensed Consolidated Financial Statements | 9\nItem\u00a02. | Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations | 30\nReport of Independent Registered Public Accounting Firm | 56\nItem 3. | Quantitative and Qualitative Disclosures About Market Risk | 57\nItem 4. | Controls and Procedures | 57\nPart II      Other Information | \nItem 1. | Legal Proceedings | 58\nItem 1A. | Risk Factors | 58\nItem 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 59\nItem 6. | Exhibits | 59  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | 9/3/2022 |  | 9/4/2021 |  | 9/3/2022 |  | 9/4/2021\nNet Revenue | $ | 21,971 |  |  | $ | 20,189 |  |  | $ | 58,396 |  |  | $ | 54,226 | \nCost of sales | 10,308 |  |  | 9,394 |  |  | 27,156 |  |  | 24,945 | \nGross profit | 11,663 |  |  | 10,795 |  |  | 31,240 |  |  | 29,281 | \nSelling, general and administrative expenses | 8,295 |  |  | 7,636 |  |  | 22,262 |  |  | 20,681 | \nGain associated with the Juice Transaction(a) | 14 |  |  | \u2014 |  |  | (3,321) |  |  | \u2014 | \nImpairment of intangible assets (see Notes 1 and 3) | 1 |  |  | \u2014 |  |  | 1,602 |  |  | \u2014 | \nOperating Profit | 3,353 |  |  | 3,159 |  |  | 10,697 |  |  | 8,600 | \nOther pension and retiree medical benefits income | 36 |  |  | 118 |  |  | 168 |  |  | 364 | \nNet interest expense and other | (190) |  |  | (232) |  |  | (666) |  |  | (731) | \nIncome before income taxes | 3,199 |  |  | 3,045 |  |  | 10,199 |  |  | 8,233 | \nProvision for income taxes | 475 |  |  | 802 |  |  | 1,756 |  |  | 1,895 | \nNet income | 2,724 |  |  | 2,243 |  |  | 8,443 |  |  | 6,338 | \nLess: Net income attributable to noncontrolling interests | 22 |  |  | 19 |  |  | 51 |  |  | 42 | \nNet Income Attributable to PepsiCo | $ | 2,702 |  |  | $ | 2,224 |  |  | $ | 8,392 |  |  | $ | 6,296 | \nNet Income Attributable to PepsiCo per Common Share |  |  |  |  |  |  | \nBasic | $ | 1.96 |  |  | $ | 1.61 |  |  | $ | 6.07 |  |  | $ | 4.56 | \nDiluted | $ | 1.95 |  |  | $ | 1.60 |  |  | $ | 6.04 |  |  | $ | 4.54 | \nWeighted-average common shares outstanding |  |  |  |  |  |  | \nBasic | 1,380 |  |  | 1,382 |  |  | 1,382 |  |  | 1,381 | \nDiluted | 1,387 |  |  | 1,389 |  |  | 1,389 |  |  | 1,388 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | 9/3/2022 |  | 9/4/2021 |  | 9/3/2022 |  | 9/4/2021\nNet income | $ | 2,724 |  |  | $ | 2,243 |  |  | $ | 8,443 |  |  | $ | 6,338 | \nOther comprehensive (loss)/income, net of taxes: |  |  |  |  |  |  | \nNet currency translation adjustment | (324) |  |  | (335) |  |  | 390 |  |  | 64 | \nNet change on cash flow hedges | (113) |  |  | (21) |  |  | (109) |  |  | 144 | \nNet pension and retiree medical adjustments | 108 |  |  | 90 |  |  | (129) |  |  | 141 | \n |  |  |  |  |  |  | \nOther | 2 |  |  | \u2014 |  |  | 3 |  |  | 2 | \n | (327) |  |  | (266) |  |  | 155 |  |  | 351 | \nComprehensive income | 2,397 |  |  | 1,977 |  |  | 8,598 |  |  | 6,689 | \nLess: Comprehensive income attributable tononcontrolling interests | 22 |  |  | 19 |  |  | 51 |  |  | 42 | \nComprehensive Income Attributable to PepsiCo | $ | 2,375 |  |  | $ | 1,958 |  |  | $ | 8,547 |  |  | $ | 6,647 |   |  | \n  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended\n | 9/3/2022 |  | 9/4/2021\nOperating Activities |  |  | \nNet income | $ | 8,443 |  |  | $ | 6,338 | \nDepreciation and amortization | 1,854 |  |  | 1,863 | \nGain associated with the Juice Transaction | (3,321) |  |  | \u2014 | \nBrand portfolio impairment charges | 475 |  |  | \u2014 | \nRussia-Ukraine conflict charges | 1,402 |  |  | \u2014 | \nOperating lease right-of-use asset amortization | 346 |  |  | 340 | \nShare-based compensation expense | 233 |  |  | 215 | \nRestructuring and impairment charges | 126 |  |  | 129 | \nCash payments for restructuring charges | (134) |  |  | (165) | \nAcquisition and divestiture-related charges | 69 |  |  | 12 | \nCash payments for acquisition and divestiture-related charges | (41) |  |  | (25) | \nPension and retiree medical plan expenses | 235 |  |  | 81 | \nPension and retiree medical plan contributions | (335) |  |  | (715) | \nDeferred income taxes and other tax charges and credits | (322) |  |  | 261 | \nTax expense related to the Tax Cuts and Jobs Act (TCJ Act) | 86 |  |  | 190 | \nTax payments related to the TCJ Act | (309) |  |  | (309) | \nChange in assets and liabilities: |  |  | \nAccounts and notes receivable | (2,258) |  |  | (1,416) | \nInventories | (837) |  |  | (579) | \nPrepaid expenses and other current assets | (124) |  |  | (46) | \nAccounts payable and other current liabilities | 426 |  |  | 99 | \nIncome taxes payable | 718 |  |  | 645 | \nOther, net | (426) |  |  | (284) | \nNet Cash Provided by Operating Activities | 6,306 |  |  | 6,634 | \n |  |  | \nInvesting Activities |  |  | \nCapital spending | (2,556) |  |  | (2,276) | \nSales of property, plant and equipment | 228 |  |  | 40 | \nAcquisitions, net of cash acquired, investments in noncontrolled affiliates and purchases of intangible and other assets | (804) |  |  | (28) | \nProceeds associated with the Juice Transaction | 3,456 |  |  | \u2014 | \nOther divestitures, sales of investments in noncontrolled affiliates and other assets | 15 |  |  | 158 | \nShort-term investments, by original maturity: |  |  | \nMore than three months - purchases | (46) |  |  | \u2014 | \nMore than three months - maturities | \u2014 |  |  | 1,135 | \n |  |  | \nThree months or less, net | 9 |  |  | (65) | \nOther investing, net | 7 |  |  | 6 | \nNet Cash Provided by/(Used for) Investing Activities | 309 |  |  | (1,030) |   |  | \n  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended\n | 9/3/2022 |  | 9/4/2021\nFinancing Activities |  |  | \nProceeds from issuances of long-term debt | 3,377 |  |  | \u2014 | \nPayments of long-term debt | (1,653) |  |  | (2,454) | \nDebt redemptions | (1,550) |  |  | \u2014 | \nShort-term borrowings, by original maturity: |  |  | \nMore than three months - proceeds | 1,947 |  |  | \u2014 | \nMore than three months - payments | (1,932) |  |  | (397) | \nThree months or less, net | (45) |  |  | 19 | \n |  |  | \nCash dividends paid | (4,586) |  |  | (4,328) | \nShare repurchases - common | (1,156) |  |  | (106) | \n |  |  | \nProceeds from exercises of stock options | 113 |  |  | 146 | \nWithholding tax payments on restricted stock units (RSUs) and performance stock units (PSUs) converted | (97) |  |  | (82) | \nOther financing | (25) |  |  | (19) | \nNet Cash Used for Financing Activities | (5,607) |  |  | (7,221) | \nEffect of exchange rate changes on cash and cash equivalents and restricted cash | (197) |  |  | (30) | \nNet Increase/(Decrease) in Cash and Cash Equivalents and Restricted Cash | 811 |  |  | (1,647) | \nCash and Cash Equivalents and Restricted Cash, Beginning of Year | 5,707 |  |  | 8,254 | \nCash and Cash Equivalents and Restricted Cash, End of Period | $ | 6,518 |  |  | $ | 6,607 | \n |  |  | \nSupplemental Non-Cash Activity |  |  | \nRight-of-use assets obtained in exchange for lease obligations | $ | 560 |  |  | $ | 494 |   |  | \n  |  |  |  |  |  |  |  |  |  |  | \n | (Unaudited) |  | \n | 9/3/2022 |  | 12/25/2021\nASSETS |  |  | \nCurrent Assets |  |  | \nCash and cash equivalents | $ | 6,415 |  |  | $ | 5,596 | \nShort-term investments | 327 |  |  | 392 | \n |  |  | \nAccounts and notes receivable, less allowance: 9/22 - $165and 12/21 - $147 | 10,739 |  |  | 8,680 | \nInventories: |  |  | \nRaw materials and packaging | 2,303 |  |  | 1,898 | \nWork-in-process | 150 |  |  | 151 | \nFinished goods | 2,566 |  |  | 2,298 | \n | 5,019 |  |  | 4,347 | \nPrepaid expenses and other current assets | 1,043 |  |  | 980 | \nAssets held for sale | \u2014 |  |  | 1,788 | \nTotal Current Assets | 23,543 |  |  | 21,783 | \nProperty, plant and equipment | 48,100 |  |  | 46,828 | \nAccumulated depreciation | (25,300) |  |  | (24,421) | \nProperty, Plant and Equipment, net | 22,800 |  |  | 22,407 | \nAmortizable Intangible Assets, net | 1,314 |  |  | 1,538 | \nGoodwill | 18,388 |  |  | 18,381 | \nOther Indefinite-Lived Intangible Assets | 15,838 |  |  | 17,127 | \n |  |  | \nInvestments in Noncontrolled Affiliates | 3,224 |  |  | 2,350 | \nDeferred Income Taxes | 4,324 |  |  | 4,310 | \nOther Assets | 5,030 |  |  | 4,481 | \nTotal Assets | $ | 94,461 |  |  | $ | 92,377 | \n |  |  | \nLIABILITIES AND EQUITY |  |  | \nCurrent Liabilities |  |  | \nShort-term debt obligations | $ | 3,109 |  |  | $ | 4,308 | \nAccounts payable and other current liabilities | 22,544 |  |  | 21,159 | \nLiabilities held for sale | \u2014 |  |  | 753 | \nTotal Current Liabilities | 25,653 |  |  | 26,220 | \nLong-Term Debt Obligations | 36,136 |  |  | 36,026 | \nDeferred Income Taxes | 4,724 |  |  | 4,826 | \nOther Liabilities | 8,813 |  |  | 9,154 | \nTotal Liabilities | 75,326 |  |  | 76,226 | \nCommitments and contingencies |  |  | \nPepsiCo Common Shareholders\u2019 Equity |  |  | \nCommon stock, par value 12/3\u00a2 per share (authorized3,600shares; issued, net of repurchased common stock at par value:1,379and1,383shares, respectively) | 23 |  |  | 23 | \nCapital in excess of par value | 4,036 |  |  | 4,001 | \nRetained earnings | 68,872 |  |  | 65,165 | \nAccumulated other comprehensive loss | (14,743) |  |  | (14,898) | \nRepurchased common stock, in excess of par value (488and484shares, respectively) | (39,211) |  |  | (38,248) | \nTotal PepsiCo Common Shareholders\u2019 Equity | 18,977 |  |  | 16,043 | \nNoncontrolling interests | 158 |  |  | 108 | \nTotal Equity | 19,135 |  |  | 16,151 | \nTotal Liabilities and Equity | $ | 94,461 |  |  | $ | 92,377 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | 9/3/2022 |  | 9/4/2021 |  | 9/3/2022 |  | 9/4/2021\n | Shares |  | Amount |  | Shares |  | Amount |  | Shares |  | Amount |  | Shares |  | Amount\n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCommon Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period | 1,381 |  |  | $ | 23 |  |  | 1,382 |  |  | $ | 23 |  |  | 1,383 |  |  | $ | 23 |  |  | 1,380 |  |  | $ | 23 | \nChange in repurchased common stock | (2) |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | (4) |  |  | \u2014 |  |  | 3 |  |  | \u2014 | \nBalance, end of period | 1,379 |  |  | 23 |  |  | 1,383 |  |  | 23 |  |  | 1,379 |  |  | 23 |  |  | 1,383 |  |  | 23 | \nCapital in Excess of Par Value |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  | 3,970 |  |  |  |  | 3,863 |  |  |  |  | 4,001 |  |  |  |  | 3,910 | \nShare-based compensation expense |  |  | 77 |  |  |  |  | 70 |  |  |  |  | 236 |  |  |  |  | 215 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nStock option exercises, RSUs and PSUs converted |  |  | 1 |  |  |  |  | \u2014 |  |  |  |  | (102) |  |  |  |  | (119) | \nWithholding tax on RSUs and PSUs converted |  |  | (10) |  |  |  |  | (9) |  |  |  |  | (97) |  |  |  |  | (82) | \nOther |  |  | (2) |  |  |  |  | \u2014 |  |  |  |  | (2) |  |  |  |  | \u2014 | \nBalance, end of period |  |  | 4,036 |  |  |  |  | 3,924 |  |  |  |  | 4,036 |  |  |  |  | 3,924 | \nRetained Earnings |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  | 67,763 |  |  |  |  | 64,605 |  |  |  |  | 65,165 |  |  |  |  | 63,443 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nNet income attributable to PepsiCo |  |  | 2,702 |  |  |  |  | 2,224 |  |  |  |  | 8,392 |  |  |  |  | 6,296 | \nCash dividends declared \u2013 common(a) |  |  | (1,593) |  |  |  |  | (1,493) |  |  |  |  | (4,685) |  |  |  |  | (4,403) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, end of period |  |  | 68,872 |  |  |  |  | 65,336 |  |  |  |  | 68,872 |  |  |  |  | 65,336 | \nAccumulated Other Comprehensive Loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  | (14,416) |  |  |  |  | (14,859) |  |  |  |  | (14,898) |  |  |  |  | (15,476) | \nOther comprehensive (loss)/income attributable to PepsiCo |  |  | (327) |  |  |  |  | (266) |  |  |  |  | 155 |  |  |  |  | 351 | \nBalance, end of period |  |  | (14,743) |  |  |  |  | (15,125) |  |  |  |  | (14,743) |  |  |  |  | (15,125) | \nRepurchased Common Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period | (486) |  |  | (38,787) |  |  | (485) |  |  | (38,333) |  |  | (484) |  |  | (38,248) |  |  | (487) |  |  | (38,446) | \nShare repurchases | (3) |  |  | (448) |  |  | \u2014 |  |  | \u2014 |  |  | (7) |  |  | (1,179) |  |  | (1) |  |  | (106) | \nStock option exercises, RSUs and PSUs converted | 1 |  |  | 23 |  |  | 1 |  |  | 46 |  |  | 3 |  |  | 215 |  |  | 4 |  |  | 265 | \nOther | \u2014 |  |  | 1 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | 1 | \nBalance, end of period | (488) |  |  | (39,211) |  |  | (484) |  |  | (38,286) |  |  | (488) |  |  | (39,211) |  |  | (484) |  |  | (38,286) | \nTotal PepsiCo Common Shareholders\u2019 Equity |  |  | 18,977 |  |  |  |  | 15,872 |  |  |  |  | 18,977 |  |  |  |  | 15,872 | \nNoncontrolling Interests |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  | 121 |  |  |  |  | 99 |  |  |  |  | 108 |  |  |  |  | 98 | \nNet income attributable to noncontrolling interest |  |  | 22 |  |  |  |  | 19 |  |  |  |  | 51 |  |  |  |  | 42 | \nDistributions to noncontrolling interests |  |  | (6) |  |  |  |  | \u2014 |  |  |  |  | (20) |  |  |  |  | (20) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nAcquisitions |  |  | 21 |  |  |  |  | \u2014 |  |  |  |  | 21 |  |  |  |  | \u2014 | \nOther, net |  |  | \u2014 |  |  |  |  | \u2014 |  |  |  |  | (2) |  |  |  |  | (2) | \nBalance, end of period |  |  | 158 |  |  |  |  | 118 |  |  |  |  | 158 |  |  |  |  | 118 | \nTotal Equity |  |  | $ | 19,135 |  |  |  |  | $ | 15,990 |  |  |  |  | $ | 19,135 |  |  |  |  | $ | 15,990 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | 9/3/2022 |  | 9/4/2021 |  | 9/3/2022 |  | 9/4/2021\nFLNA | $ | 5,563 |  |  | $ | 4,653 |  |  | $ | 15,583 |  |  | $ | 13,441 | \nQFNA | 713 |  |  | 618 |  |  | 2,101 |  |  | 1,839 | \nPBNA | 6,635 |  |  | 6,402 |  |  | 18,108 |  |  | 17,632 | \nLatAm | 2,517 |  |  | 2,100 |  |  | 6,406 |  |  | 5,309 | \nEurope | 3,646 |  |  | 3,612 |  |  | 8,466 |  |  | 8,693 | \nAMESA | 1,726 |  |  | 1,665 |  |  | 4,426 |  |  | 4,150 | \nAPAC | 1,171 |  |  | 1,139 |  |  | 3,306 |  |  | 3,162 | \nTotal | $ | 21,971 |  |  | $ | 20,189 |  |  | $ | 58,396 |  |  | $ | 54,226 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 9/3/2022 |  | 9/4/2021\n | Beverages(a) |  | Convenient Foods |  | Beverages(a) |  | Convenient Foods\nLatAm | 10 | % |  | 90 | % |  | 10 | % |  | 90 | %\nEurope | 55 | % |  | 45 | % |  | 55 | % |  | 45 | %\nAMESA | 35 | % |  | 65 | % |  | 35 | % |  | 65 | %\nAPAC | 25 | % |  | 75 | % |  | 25 | % |  | 75 | %\nPepsiCo | 45 | % |  | 55 | % |  | 45 | % |  | 55 | %\n |  |  |  |  |  |  | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended |  |  |  |  | \n | 9/3/2022 |  | 9/4/2021 |  |  |  |  | \n | Beverages(a) |  | Convenient Foods |  | Beverages(a) |  | Convenient Foods |  |  |  |  | \nLatAm | 10 | % |  | 90 | % |  | 10 | % |  | 90 | % |  |  |  |  | \nEurope | 50 | % |  | 50 | % |  | 55 | % |  | 45 | % |  |  |  |  | \nAMESA | 35 | % |  | 65 | % |  | 35 | % |  | 65 | % |  |  |  |  | \nAPAC | 25 | % |  | 75 | % |  | 25 | % |  | 75 | % |  |  |  |  | \nPepsiCo | 45 | % |  | 55 | % |  | 45 | % |  | 55 | % |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | 9/3/2022 |  | 9/4/2021 |  | 9/3/2022 |  | 9/4/2021\nFLNA | $ | 1,588 |  |  | $ | 1,357 |  |  | $ | 4,332 |  |  | $ | 3,979 | \nQFNA | 122 |  |  | 106 |  |  | 416 |  |  | 384 | \nPBNA(a) (b) | 784 |  |  | 773 |  |  | 4,869 |  |  | 1,948 | \nLatAm(c) | 463 |  |  | 393 |  |  | 1,206 |  |  | 967 | \nEurope(a) (d) | 564 |  |  | 439 |  |  | (369) |  |  | 975 | \nAMESA | 268 |  |  | 312 |  |  | 738 |  |  | 706 | \nAPAC | 199 |  |  | 201 |  |  | 620 |  |  | 601 | \nTotal divisions | 3,988 |  |  | 3,581 |  |  | 11,812 |  |  | 9,560 | \nCorporate unallocated expenses(e)(f) | (635) |  |  | (422) |  |  | (1,115) |  |  | (960) | \nTotal | $ | 3,353 |  |  | $ | 3,159 |  |  | $ | 10,697 |  |  | $ | 8,600 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | \n | 9/3/2022 |  |  |  | \n | 12 Weeks Ended |  |  |  | 36 Weeks Ended |  |  |  | \nImpairment charges related to intangible assets(a) | $ | \u2014 |  |  |  |  | $ | 1,198 |  |  |  |  | \nImpairment charges related to property, plant and equipment | 2 |  |  |  |  | 125 |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n(Recovery of)/allowance for expected credit losses(b) | (9) |  |  |  |  | 17 |  |  |  |  | \nAllowance for inventory write-downs | 1 |  |  |  |  | 26 |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \nOther | 2 |  |  |  |  | 36 |  |  |  |  | \nTotal | $ | (4) |  |  |  |  | $ | 1,402 |  |  |  |  | \nAfter-tax amount | $ | (5) |  |  |  |  | $ | 1,163 |  |  |  |  | \nImpact on net income attributable to PepsiCo per common share | $ | \u2014 |  |  |  |  | $ | (0.84) |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | 9/3/2022\n | 12 Weeks Ended |  | 36 Weeks Ended\nCost of sales | $ | 1 |  |  | $ | 134 | \nSelling, general and administrative expenses(b) | (5) |  |  | 70 | \nImpairment of intangible assets(a) | \u2014 |  |  | 1,198 | \nTotal | $ | (4) |  |  | $ | 1,402 |   |  |  |  |  |  |  |  |  |  |  | \n | 9/3/2022\n | 12 Weeks Ended |  | 36 Weeks Ended\nRussia-Ukraine conflict impairment charges | $ | \u2014 |  |  | $ | 1,198 | \nBrand Portfolio Impairment Charges | 1 |  |  | 404 | \nTotal | $ | 1 |  |  | $ | 1,602 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | 9/3/2022 |  | 9/4/2021 |  | 9/3/2022 |  | 9/4/2021\nFLNA | $ | 5 |  |  | $ | 6 |  |  | $ | 24 |  |  | $ | 44 | \nQFNA(a) | \u2014 |  |  | (1) |  |  | 1 |  |  | 2 | \nPBNA(a) | 6 |  |  | (12) |  |  | 17 |  |  | (10) | \nLatAm | 3 |  |  | 17 |  |  | 13 |  |  | 49 | \nEurope | 1 |  |  | 3 |  |  | 4 |  |  | 18 | \nAMESA | 2 |  |  | 3 |  |  | 5 |  |  | 5 | \nAPAC | 3 |  |  | 2 |  |  | 16 |  |  | 6 | \nTotal | $ | 20 |  |  | $ | 18 |  |  | $ | 80 |  |  | $ | 114 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | FLNA |  | QFNA |  | PBNA |  | LatAm |  | Europe |  | AMESA |  | APAC |  | Corporate\nExpected pre-tax charges | 15 | % |  | 1 | % |  | 25 | % |  | 10 | % |  | 25 | % |  | 5 | % |  | 4 | % |  | 15 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | 9/3/2022 |  | 9/4/2021 |  | 9/3/2022 |  | 9/4/2021\nCost of sales | $ | 1 |  |  | $ | 9 |  |  | $ | 6 |  |  | $ | 13 | \nSelling, general and administrative expenses | 50 |  |  | 42 |  |  | 117 |  |  | 110 | \nOther pension and retiree medical benefits expense | \u2014 |  |  | 1 |  |  | 3 |  |  | 6 | \nTotal restructuring and impairment charges | $ | 51 |  |  | $ | 52 |  |  | $ | 126 |  |  | $ | 129 | \nAfter-tax amount | $ | 40 |  |  | $ | 45 |  |  | $ | 101 |  |  | $ | 109 | \nImpact on net income attributable to PepsiCo per common share | $ | (0.03) |  |  | $ | (0.03) |  |  | $ | (0.07) |  |  | $ | (0.08) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended |  | Plan to Date\n | 9/3/2022 |  | 9/4/2021 |  | 9/3/2022 |  | 9/4/2021 |  | through 9/3/2022\nFLNA | $ | 4 |  |  | $ | 2 |  |  | $ | 10 |  |  | $ | 20 |  |  | $ | 174 | \nQFNA | 1 |  |  | 1 |  |  | 1 |  |  | 1 |  |  | 13 | \nPBNA | 4 |  |  | 3 |  |  | 9 |  |  | 8 |  |  | 167 | \nLatAm | 3 |  |  | 14 |  |  | 17 |  |  | 22 |  |  | 156 | \nEurope | 21 |  |  | 20 |  |  | 40 |  |  | 46 |  |  | 274 | \nAMESA | \u2014 |  |  | 5 |  |  | 5 |  |  | 9 |  |  | 75 | \nAPAC | 4 |  |  | 1 |  |  | 8 |  |  | 2 |  |  | 69 | \nCorporate | 14 |  |  | 5 |  |  | 33 |  |  | 15 |  |  | 172 | \n | 51 |  |  | 51 |  |  | 123 |  |  | 123 |  |  | 1,100 | \nOther pension and retiree medical benefits expense | \u2014 |  |  | 1 |  |  | 3 |  |  | 6 |  |  | 70 | \nTotal | $ | 51 |  |  | $ | 52 |  |  | $ | 126 |  |  | $ | 129 |  |  | $ | 1,170 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended |  | Plan to Date\n | 9/3/2022 |  | 9/4/2021 |  | 9/3/2022 |  | 9/4/2021 |  | through 9/3/2022\nSeverance and\u00a0other employee costs | $ | 10 |  |  | $ | 28 |  |  | $ | 41 |  |  | $ | 77 |  |  | $ | 605 | \nAsset impairments | 7 |  |  | 3 |  |  | 7 |  |  | 4 |  |  | 164 | \nOther\u00a0costs | 34 |  |  | 21 |  |  | 78 |  |  | 48 |  |  | 401 | \nTotal | $ | 51 |  |  | $ | 52 |  |  | $ | 126 |  |  | $ | 129 |  |  | $ | 1,170 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Severance and\u00a0Other Employee Costs |  | AssetImpairments |  | Other\u00a0Costs |  | Total\nLiability as of December 25, 2021 | $ | 64 |  |  | $ | \u2014 |  |  | $ | 7 |  |  | $ | 71 | \n2022 restructuring charges | 41 |  |  | 7 |  |  | 78 |  |  | 126 | \nCash payments | (55) |  |  | \u2014 |  |  | (79) |  |  | (134) | \nNon-cash charges and translation | (6) |  |  | (7) |  |  | \u2014 |  |  | (13) | \nLiability as of September 3, 2022 | $ | 44 |  |  | $ | \u2014 |  |  | $ | 6 |  |  | $ | 50 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | 9/3/2022 |  | 12/25/2021\n |  | Gross |  | Accumulated Amortization |  | Net |  | Gross |  | Accumulated Amortization |  | Net\nAcquired franchise rights(a) |  | $ | 844 |  |  | $ | (197) |  |  | $ | 647 |  |  | $ | 976 |  |  | $ | (187) |  |  | $ | 789 | \nCustomer relationships |  | 596 |  |  | (243) |  |  | 353 |  |  | 623 |  |  | (227) |  |  | 396 | \nBrands |  | 1,102 |  |  | (971) |  |  | 131 |  |  | 1,151 |  |  | (989) |  |  | 162 | \nOther identifiable intangibles |  | 448 |  |  | (265) |  |  | 183 |  |  | 451 |  |  | (260) |  |  | 191 | \nTotal |  | $ | 2,990 |  |  | $ | (1,676) |  |  | $ | 1,314 |  |  | $ | 3,201 |  |  | $ | (1,663) |  |  | $ | 1,538 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Balance12/25/2021 |  | Acquisitions |  | Impairment |  | Translationand Other |  | Balance9/3/2022\n |  |  |  | \nFLNA |  |  |  |  |  |  |  |  | \nGoodwill | $ | 458 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | (3) |  |  | $ | 455 | \nBrands | 340 |  |  | \u2014 |  |  | \u2014 |  |  | (1) |  |  | 339 | \nTotal | 798 |  |  | \u2014 |  |  | \u2014 |  |  | (4) |  |  | 794 | \nQFNA |  |  |  |  |  |  |  |  | \nGoodwill | 189 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 189 | \nTotal | 189 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 189 | \nPBNA |  |  | \u2014 |  |  |  |  |  |  | \nGoodwill | 11,974 |  |  | \u2014 |  |  | \u2014 |  |  | (14) |  |  | 11,960 | \nReacquired franchise rights | 7,107 |  |  | \u2014 |  |  | \u2014 |  |  | (22) |  |  | 7,085 | \nAcquired franchise rights(a) | 1,538 |  |  | 177 |  |  | \u2014 |  |  | (5) |  |  | 1,710 | \nBrands | 2,508 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 2,508 | \nTotal | 23,127 |  |  | 177 |  |  | \u2014 |  |  | (41) |  |  | 23,263 | \nLatAm |  |  |  |  |  |  |  |  | \nGoodwill | 433 |  |  | \u2014 |  |  | \u2014 |  |  | 8 |  |  | 441 | \nBrands(b) | 100 |  |  | \u2014 |  |  | (29) |  |  | 6 |  |  | 77 | \nTotal | 533 |  |  | \u2014 |  |  | (29) |  |  | 14 |  |  | 518 | \nEurope(c) |  |  |  |  |  |  |  |  | \nGoodwill | 3,700 |  |  | \u2014 |  |  | \u2014 |  |  | 103 |  |  | 3,803 | \nReacquired franchise rights | 441 |  |  | \u2014 |  |  | \u2014 |  |  | (18) |  |  | 423 | \nAcquired franchise rights | 158 |  |  | \u2014 |  |  | (1) |  |  | (18) |  |  | 139 | \nBrands(d) | 4,254 |  |  | \u2014 |  |  | (1,420) |  |  | 90 |  |  | 2,924 | \nTotal | 8,553 |  |  | \u2014 |  |  | (1,421) |  |  | 157 |  |  | 7,289 | \nAMESA |  |  |  |  |  |  |  |  | \nGoodwill | 1,063 |  |  | 14 |  |  | \u2014 |  |  | (56) |  |  | 1,021 | \nBrands | 205 |  |  | \u2014 |  |  | \u2014 |  |  | (14) |  |  | 191 | \nTotal | 1,268 |  |  | 14 |  |  | \u2014 |  |  | (70) |  |  | 1,212 | \nAPAC |  |  |  |  |  |  |  |  | \nGoodwill | 564 |  |  | \u2014 |  |  | \u2014 |  |  | (45) |  |  | 519 | \nBrands | 476 |  |  | \u2014 |  |  | \u2014 |  |  | (34) |  |  | 442 | \nTotal | 1,040 |  |  | \u2014 |  |  | \u2014 |  |  | (79) |  |  | 961 | \n |  |  |  |  |  |  |  |  | \nTotal goodwill | 18,381 |  |  | 14 |  |  | \u2014 |  |  | (7) |  |  | 18,388 | \nTotal reacquired franchise rights | 7,548 |  |  | \u2014 |  |  | \u2014 |  |  | (40) |  |  | 7,508 | \nTotal acquired franchise rights | 1,696 |  |  | 177 |  |  | (1) |  |  | (23) |  |  | 1,849 | \nTotal brands | 7,883 |  |  | \u2014 |  |  | (1,449) |  |  | 47 |  |  | 6,481 | \nTotal | $ | 35,508 |  |  | $ | 191 |  |  | $ | (1,450) |  |  | $ | (23) |  |  | $ | 34,226 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | 9/3/2022 |  | 9/4/2021 |  | 9/3/2022 |  | 9/4/2021\nShare-based compensation expense \u2013 equity awards | $ | 77 |  |  | $ | 71 |  |  | $ | 233 |  |  | $ | 215 | \nShare-based compensation expense \u2013 liability awards | 4 |  |  | 3 |  |  | 16 |  |  | 7 | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  | 3 |  |  | \u2014 | \nRestructuring charges | \u2014 |  |  | (1) |  |  | \u2014 |  |  | \u2014 | \nTotal | $ | 81 |  |  | $ | 73 |  |  | $ | 252 |  |  | $ | 222 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended\n | 9/3/2022 |  | 9/4/2021\n | Granted(a) |  | Weighted-Average Grant Price |  | Granted(a) |  | Weighted-Average Grant Price\nStock options | 2.3 |  |  | $ | 163.46 |  |  | 2.0 |  |  | $ | 133.23 | \nRSUs and PSUs | 2.3 |  |  | $ | 163.01 |  |  | 2.6 |  |  | $ | 131.28 |   |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended\n | 9/3/2022 |  | 9/4/2021\nExpected life | 7years |  | 7years\nRisk-free interest rate | 1.8 | % |  | 1.1 | %\nExpected volatility | 16 | % |  | 14 | %\nExpected dividend yield | 2.5 | % |  | 3.1 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended | \n | Pension |  | Retiree Medical | \n | U.S. |  | International |  |  | \n | 9/3/2022 |  | 9/4/2021 |  | 9/3/2022 |  | 9/4/2021 |  | 9/3/2022 |  | 9/4/2021 | \nService cost | $ | 111 |  |  | $ | 119 |  |  | $ | 13 |  |  | $ | 25 |  |  | $ | 8 |  |  | $ | 8 |  | \nOther pension and retiree medical benefits income: | \nInterest cost | 111 |  |  | 75 |  |  | 23 |  |  | 17 |  |  | 5 |  |  | 3 |  | \nExpected return on plan assets | (206) |  |  | (223) |  |  | (55) |  |  | (55) |  |  | (4) |  |  | (3) |  | \nAmortization of prior service credits | (6) |  |  | (8) |  |  | (1) |  |  | \u2014 |  |  | (2) |  |  | (2) |  | \nAmortization of net losses/(gains) | 35 |  |  | 52 |  |  | 8 |  |  | 19 |  |  | (3) |  |  | (4) |  | \nSettlement/curtailment losses | 59 |  |  | 5 |  |  | \u2014 |  |  | 5 |  |  | \u2014 |  |  | \u2014 |  | \nSpecial termination benefits | \u2014 |  |  | 1 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  | \nTotal other pension and retiree medical benefits income | (7) |  |  | (98) |  |  | (25) |  |  | (14) |  |  | (4) |  |  | (6) |  | \nTotal | $ | 104 |  |  | $ | 21 |  |  | $ | (12) |  |  | $ | 11 |  |  | $ | 4 |  |  | $ | 2 |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended\n | Pension |  | Retiree Medical\n | U.S. |  | International |  | \n | 9/3/2022 |  | 9/4/2021 |  | 9/3/2022 |  | 9/4/2021 |  | 9/3/2022 |  | 9/4/2021\nService cost | $ | 340 |  |  | $ | 359 |  |  | $ | 47 |  |  | $ | 69 |  |  | $ | 25 |  |  | $ | 23 | \nOther pension and retiree medical benefits income: |  |  |  | \nInterest cost | 286 |  |  | 224 |  |  | 63 |  |  | 49 |  |  | 13 |  |  | 10 | \nExpected return on plan assets | (637) |  |  | (671) |  |  | (153) |  |  | (153) |  |  | (11) |  |  | (10) | \nAmortization of prior service credits | (19) |  |  | (22) |  |  | (1) |  |  | (1) |  |  | (6) |  |  | (7) | \nAmortization of net losses/(gains) | 103 |  |  | 155 |  |  | 20 |  |  | 51 |  |  | (9) |  |  | (10) | \nSettlement/curtailment losses/(gains) | 190 |  |  | 5 |  |  | \u2014 |  |  | 10 |  |  | (16) |  |  | \u2014 | \nSpecial termination benefits | 9 |  |  | 6 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nTotal other pension and retiree medical benefits income | (68) |  |  | (303) |  |  | (71) |  |  | (44) |  |  | (29) |  |  | (17) | \nTotal | $ | 272 |  |  | $ | 56 |  |  | $ | (24) |  |  | $ | 25 |  |  | $ | (4) |  |  | $ | 6 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nInterest Rate |  | Maturity Date |  | Principal Amount(a) | \n3.200 | % |  | July 2029 |  | \u00a3 | 300 |  | (b)\n3.550 | % |  | July 2034 |  | \u00a3 | 450 |  | (b)\n3.600 | % |  | February 2028 |  | $ | 750 |  | \n3.900 | % |  | July 2032 |  | $ | 1,250 |  | \n4.200 | % |  | July 2052 |  | $ | 500 |  |   |  |  |  |  |  |  |  |  |  |  | \n | Notional Amounts(a)\n | 9/3/2022 |  | 12/25/2021\nCommodity | $ | 1.9 |  |  | $ | 1.6 | \nForeign exchange | $ | 2.8 |  |  | $ | 2.8 | \nInterest rate | $ | 2.1 |  |  | $ | 2.1 | \nNet investment(b) | $ | 2.7 |  |  | $ | 2.1 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 9/3/2022 |  | 12/25/2021\n | Fair Value Hierarchy Levels(a) |  | Assets(a) |  | Liabilities(a) |  | Assets(a) |  | Liabilities(a)\n |  |  |  |  |  |  |  |  | \nAvailable-for-sale debt security(b) | 2 |  | $ | 555 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 | \nIndex funds(c) | 1 |  | $ | 278 |  |  | $ | \u2014 |  |  | $ | 337 |  |  | $ | \u2014 | \nPrepaid forward contracts(d) | 2 |  | $ | 13 |  |  | $ | \u2014 |  |  | $ | 21 |  |  | $ | \u2014 | \nDeferred compensation(e) | 2 |  | $ | \u2014 |  |  | $ | 436 |  |  | $ | \u2014 |  |  | $ | 505 | \n |  |  |  |  |  |  |  |  | \nDerivatives designated as cash flow hedging instruments: |  |  |  |  |  |  |  |  | \nForeign exchange(f) | 2 |  | $ | 29 |  |  | $ | 14 |  |  | $ | 29 |  |  | $ | 14 | \nInterest rate(f) | 2 |  | 6 |  |  | 416 |  |  | 14 |  |  | 264 | \nCommodity(g) | 2 |  | \u2014 |  |  | 77 |  |  | 70 |  |  | 5 | \n |  |  | $ | 35 |  |  | $ | 507 |  |  | $ | 113 |  |  | $ | 283 | \nDerivatives not designated as hedging instruments: |  |  |  |  |  |  |  |  | \nForeign exchange(f) | 2 |  | $ | 30 |  |  | $ | 9 |  |  | $ | 19 |  |  | $ | 7 | \nCommodity(g) | 2 |  | 64 |  |  | 27 |  |  | 35 |  |  | 22 | \n |  |  | $ | 94 |  |  | $ | 36 |  |  | $ | 54 |  |  | $ | 29 | \nTotal derivatives at fair value(h) |  |  | $ | 129 |  |  | $ | 543 |  |  | $ | 167 |  |  | $ | 312 | \nTotal |  |  | $ | 975 |  |  | $ | 979 |  |  | $ | 525 |  |  | $ | 817 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | Fair Value/Non-designated Hedges |  | Cash Flow and Net Investment Hedges\n | Losses/(Gains)Recognized inIncome\u00a0Statement(a) |  | Losses/(Gains)Recognized inAccumulated\u00a0OtherComprehensive\u00a0Loss |  | Losses/(Gains)Reclassified fromAccumulated\u00a0OtherComprehensive\u00a0Lossinto Income Statement(b)\n | 9/3/2022 |  | 9/4/2021 |  | 9/3/2022 |  | 9/4/2021 |  | 9/3/2022 |  | 9/4/2021\nForeign exchange | $ | (60) |  |  | $ | (5) |  |  | $ | (31) |  |  | $ | (18) |  |  | $ | 1 |  |  | $ | 27 | \nInterest rate | \u2014 |  |  | 1 |  |  | 81 |  |  | 52 |  |  | 94 |  |  | 53 | \nCommodity | 53 |  |  | (31) |  |  | 141 |  |  | 11 |  |  | (51) |  |  | (66) | \nNet investment | \u2014 |  |  | \u2014 |  |  | (144) |  |  | (63) |  |  | \u2014 |  |  | \u2014 | \nTotal | $ | (7) |  |  | $ | (35) |  |  | $ | 47 |  |  | $ | (18) |  |  | $ | 44 |  |  | $ | 14 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended\n | Fair Value/Non-designated Hedges |  | Cash Flow and Net Investment Hedges\n | Losses/(Gains)Recognized inIncome\u00a0Statement(a) |  | Losses/(Gains)Recognized inAccumulated\u00a0OtherComprehensive\u00a0Loss |  | Losses/(Gains)Reclassified fromAccumulated\u00a0OtherComprehensive\u00a0Lossinto Income Statement(b)\n | 9/3/2022 |  | 9/4/2021 |  | 9/3/2022 |  | 9/4/2021 |  | 9/3/2022 |  | 9/4/2021\nForeign exchange | $ | (55) |  |  | $ | 5 |  |  | $ | (13) |  |  | $ | 20 |  |  | $ | (20) |  |  | $ | 67 | \nInterest rate | \u2014 |  |  | 2 |  |  | 160 |  |  | (12) |  |  | 175 |  |  | 2 | \nCommodity | (294) |  |  | (182) |  |  | (49) |  |  | (235) |  |  | (203) |  |  | (109) | \nNet investment | \u2014 |  |  | \u2014 |  |  | (283) |  |  | (71) |  |  | \u2014 |  |  | \u2014 | \nTotal | $ | (349) |  |  | $ | (175) |  |  | $ | (185) |  |  | $ | (298) |  |  | $ | (48) |  |  | $ | (40) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 9/3/2022 |  | 9/4/2021\n | Income |  | Shares(a) |  | Income |  | Shares(a)\n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nBasic net income attributable to PepsiCo per common share | $ | 1.96 |  |  |  |  | $ | 1.61 |  |  | \nNet income available for PepsiCo common shareholders | $ | 2,702 |  |  | 1,380 |  |  | $ | 2,224 |  |  | 1,382 | \nDilutive securities: |  |  |  |  |  |  | \nStock options, RSUs, PSUs and other(b) | \u2014 |  |  | 7 |  |  | \u2014 |  |  | 7 | \n |  |  |  |  |  |  | \nDiluted | $ | 2,702 |  |  | 1,387 |  |  | $ | 2,224 |  |  | 1,389 | \nDiluted net income attributable to PepsiCo per common share | $ | 1.95 |  |  |  |  | $ | 1.60 |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended\n | 9/3/2022 |  | 9/4/2021\n | Income |  | Shares(a) |  | Income |  | Shares(a)\n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nBasic net income attributable to PepsiCo per common share | $ | 6.07 |  |  |  |  | $ | 4.56 |  |  | \nNet income available for PepsiCo common shareholders | $ | 8,392 |  |  | 1,382 |  |  | $ | 6,296 |  |  | 1,381 | \nDilutive securities: |  |  |  |  |  |  | \nStock options, RSUs, PSUs and other(b) | \u2014 |  |  | 7 |  |  | \u2014 |  |  | 7 | \nDiluted | $ | 8,392 |  |  | 1,389 |  |  | $ | 6,296 |  |  | 1,388 | \nDiluted net income attributable to PepsiCo per common share | $ | 6.04 |  |  |  |  | $ | 4.54 |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Currency Translation Adjustment |  | Cash Flow Hedges |  | Pension and Retiree Medical |  |  |  | Other |  | Accumulated Other Comprehensive Loss Attributable to PepsiCo\nBalance as of December 25, 2021(a) | $ | (12,309) |  |  | $ | 159 |  |  | $ | (2,750) |  |  |  |  | $ | 2 |  |  | $ | (14,898) | \nOther comprehensive (loss)/income before reclassifications(b) | (549) |  |  | 200 |  |  | (8) |  |  |  |  | \u2014 |  |  | (357) | \nAmounts reclassified from accumulated other comprehensive loss | \u2014 |  |  | (62) |  |  | 25 |  |  |  |  | \u2014 |  |  | (37) | \nNet other comprehensive (loss)/income | (549) |  |  | 138 |  |  | 17 |  |  |  |  | \u2014 |  |  | (394) | \nTax amounts | (11) |  |  | (32) |  |  | (4) |  |  |  |  | (4) |  |  | (51) | \nBalance as of March 19, 2022(a) | $ | (12,869) |  |  | $ | 265 |  |  | $ | (2,737) |  |  |  |  | $ | (2) |  |  | $ | (15,343) | \nOther comprehensive income/(loss) before reclassifications(c) | 1,298 |  |  | (107) |  |  | (484) |  |  |  |  | 5 |  |  | 712 | \nAmounts reclassified from accumulated other comprehensive loss | \u2014 |  |  | (30) |  |  | 161 |  |  |  |  | \u2014 |  |  | 131 | \nNet other comprehensive income/(loss) | 1,298 |  |  | (137) |  |  | (323) |  |  |  |  | 5 |  |  | 843 | \nTax amounts | (24) |  |  | 35 |  |  | 73 |  |  |  |  | \u2014 |  |  | 84 | \nBalance as of June 11, 2022(a) | $ | (11,595) |  |  | $ | 163 |  |  | $ | (2,987) |  |  |  |  | $ | 3 |  |  | $ | (14,416) | \nOther comprehensive (loss)/income before reclassifications(d) | (292) |  |  | (191) |  |  | 50 |  |  |  |  | 2 |  |  | (431) | \nAmounts reclassified from accumulated other comprehensive loss | \u2014 |  |  | 44 |  |  | 90 |  |  |  |  | \u2014 |  |  | 134 | \nNet other comprehensive (loss)/income | (292) |  |  | (147) |  |  | 140 |  |  |  |  | 2 |  |  | (297) | \nTax amounts | (32) |  |  | 34 |  |  | (32) |  |  |  |  | \u2014 |  |  | (30) | \nBalance as of September 3, 2022(a) | $ | (11,919) |  |  | $ | 50 |  |  | $ | (2,879) |  |  |  |  | $ | 5 |  |  | $ | (14,743) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Currency Translation Adjustment |  | Cash Flow Hedges |  | Pension and Retiree Medical |  |  |  | Other |  | Accumulated Other Comprehensive Loss Attributable to PepsiCo\nBalance as of December 26, 2020(a) | $ | (11,940) |  |  | $ | 4 |  |  | $ | (3,520) |  |  |  |  | $ | (20) |  |  | $ | (15,476) | \nOther comprehensive income/(loss) before reclassifications(b) | 128 |  |  | 97 |  |  | (20) |  |  |  |  | \u2014 |  |  | 205 | \nAmounts reclassified from accumulated other comprehensive loss | 18 |  |  | (1) |  |  | 52 |  |  |  |  | \u2014 |  |  | 69 | \nNet other comprehensive income | 146 |  |  | 96 |  |  | 32 |  |  |  |  | \u2014 |  |  | 274 | \nTax amounts | (15) |  |  | (24) |  |  | (5) |  |  |  |  | \u2014 |  |  | (44) | \nBalance as of March 20, 2021(a) | $ | (11,809) |  |  | $ | 76 |  |  | $ | (3,493) |  |  |  |  | $ | (20) |  |  | $ | (15,246) | \nOther comprehensive income/(loss) before reclassifications(c) | 255 |  |  | 175 |  |  | (28) |  |  |  |  | 2 |  |  | 404 | \nAmounts reclassified from accumulated other comprehensive loss | \u2014 |  |  | (53) |  |  | 57 |  |  |  |  | \u2014 |  |  | 4 | \nNet other comprehensive income | 255 |  |  | 122 |  |  | 29 |  |  |  |  | 2 |  |  | 408 | \nTax amounts | 13 |  |  | (29) |  |  | (5) |  |  |  |  | \u2014 |  |  | (21) | \nBalance as of June 12, 2021(a) | $ | (11,541) |  |  | $ | 169 |  |  | $ | (3,469) |  |  |  |  | $ | (18) |  |  | $ | (14,859) | \nOther comprehensive (loss)/income before reclassifications(d) | (319) |  |  | (45) |  |  | 49 |  |  |  |  | \u2014 |  |  | (315) | \nAmounts reclassified from accumulated other comprehensive loss | \u2014 |  |  | 14 |  |  | 67 |  |  |  |  | \u2014 |  |  | 81 | \nNet other comprehensive (loss)/income | (319) |  |  | (31) |  |  | 116 |  |  |  |  | \u2014 |  |  | (234) | \nTax amounts | (16) |  |  | 10 |  |  | (26) |  |  |  |  | \u2014 |  |  | (32) | \nBalance as of September 4, 2021(a) | $ | (11,876) |  |  | $ | 148 |  |  | $ | (3,379) |  |  |  |  | $ | (18) |  |  | $ | (15,125) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | 12 Weeks Ended |  | 36 Weeks Ended |  | \n |  | 9/3/2022 |  | 9/4/2021 |  | 9/3/2022 |  | 9/4/2021 |  | Affected Line Item in the Income Statement\n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \nCurrency translation: |  |  |  |  |  |  |  |  |  | \nDivestiture |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 18 |  |  | Selling, general and administrative expenses\n |  |  |  |  |  |  |  |  |  | \nCash flow hedges: |  |  |  |  |  |  |  |  |  | \nForeign exchange contracts |  | $ | (5) |  |  | $ | 2 |  |  | $ | (9) |  |  | $ | 6 |  |  | Net revenue\nForeign exchange contracts |  | 6 |  |  | 25 |  |  | (11) |  |  | 61 |  |  | Cost of sales\nInterest rate derivatives |  | 94 |  |  | 53 |  |  | 175 |  |  | 2 |  |  | Selling, general and administrative expenses\nCommodity contracts |  | (45) |  |  | (65) |  |  | (191) |  |  | (108) |  |  | Cost of sales\nCommodity contracts |  | (6) |  |  | (1) |  |  | (12) |  |  | (1) |  |  | Selling, general and administrative expenses\nNet losses/(gains) before tax |  | 44 |  |  | 14 |  |  | (48) |  |  | (40) |  |  | \nTax amounts |  | (12) |  |  | (3) |  |  | 5 |  |  | 10 |  |  | \nNet losses/(gains) after tax |  | $ | 32 |  |  | $ | 11 |  |  | $ | (43) |  |  | $ | (30) |  |  | \n |  |  |  |  |  |  |  |  |  | \nPension and retiree medical items: |  |  |  |  |  |  |  |  |  | \nAmortization of prior service credits |  | $ | (9) |  |  | $ | (10) |  |  | $ | (26) |  |  | $ | (30) |  |  | Other pension and retiree medical benefits income\nAmortization of net losses |  | 40 |  |  | 67 |  |  | 114 |  |  | 196 |  |  | Other pension and retiree medical benefits income\nSettlement/curtailment losses |  | 59 |  |  | 10 |  |  | 188 |  |  | 10 |  |  | Other pension and retiree medical benefits income\nNet losses before tax |  | 90 |  |  | 67 |  |  | 276 |  |  | 176 |  |  | \nTax amounts |  | (19) |  |  | (14) |  |  | (60) |  |  | (37) |  |  | \nNet losses after tax |  | $ | 71 |  |  | $ | 53 |  |  | $ | 216 |  |  | $ | 139 |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \nTotal net losses reclassified, net of tax |  | $ | 103 |  |  | $ | 64 |  |  | $ | 173 |  |  | $ | 127 |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | PBNA |  | Europe |  | Corporate |  | Total PepsiCo |  | Provision for income taxes(a) |  | Net income attributable to PepsiCo |  | Impact on net income attributable to PepsiCo per common share | \nGain associated with the Juice Transaction | $ | (3,029) |  |  | $ | (292) |  |  | $ | \u2014 |  |  | $ | (3,321) |  |  | $ | 452 |  |  | $ | (2,869) |  |  | $ | 2.07 |  | \nAcquisition and divestiture-related charges | 42 |  |  | 13 |  |  | 6 |  |  | 61 |  |  | (10) |  |  | 51 |  |  | (0.04) |  | \nOperating profit | $ | (2,987) |  |  | $ | (279) |  |  | $ | 6 |  |  | (3,260) |  |  | 442 |  |  | (2,818) |  |  | 2.03 |  | \nOther pension and retiree medical benefits income(b) |  |  |  |  |  |  | (10) |  |  | 3 |  |  | (7) |  |  | 0.01 |  | \nTotal Juice Transaction |  |  |  |  |  |  | $ | (3,270) |  |  | $ | 445 |  |  | $ | (2,825) |  |  | $ | 2.03 |  | (c)\n |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended |  | \n | 9/3/2022 |  | 9/4/2021 |  | 9/3/2022 |  | 9/4/2021 |  | Transaction\nFLNA | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 2 |  |  | BFY Brands, Inc.\nPBNA | 3 |  |  | \u2014 |  |  | 42 |  |  | 2 |  |  | Juice Transaction, Rockstar\nEurope | \u2014 |  |  | \u2014 |  |  | 13 |  |  | \u2014 |  |  | Juice Transaction\nAMESA | 2 |  |  | 1 |  |  | 2 |  |  | 8 |  |  | Pioneer Foods\nAPAC | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 3 |  |  | Be & Cheery\nCorporate(a) | \u2014 |  |  | (4) |  |  | 6 |  |  | (3) |  |  | Juice Transaction, Rockstar\nTotal(b) | 5 |  |  | (3) |  |  | 63 |  |  | 12 |  |  | \nOther pension and retiree medical benefits expense | \u2014 |  |  | \u2014 |  |  | 6 |  |  | \u2014 |  |  | Juice Transaction\nTotal acquisition and divestiture-related charges | $ | 5 |  |  | $ | (3) |  |  | $ | 69 |  |  | $ | 12 |  |  | \nAfter-tax amount | $ | 3 |  |  | $ | (2) |  |  | $ | 57 |  |  | $ | 12 |  |  | \nImpact on net income attributable to PepsiCo per common share | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | (0.04) |  |  | $ | (0.01) |  |  | \n |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | 9/3/2022 |  | 9/4/2021 |  | Change |  | 9/3/2022 |  | 9/4/2021 |  | Change\nNet revenue | $ | 21,971 |  |  | $ | 20,189 |  |  | 9 | % |  | $ | 58,396 |  |  | $ | 54,226 |  |  | 8 | %\nOperating profit | $ | 3,353 |  |  | $ | 3,159 |  |  | 6 | % |  | $ | 10,697 |  |  | $ | 8,600 |  |  | 24 | %\nOperating margin | 15.3 | % |  | 15.6 | % |  | (0.3) |  |  | 18.3 | % |  | 15.9 | % |  | 2.4 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 9/3/2022\n |  |  | Impact of |  |  |  | Impact of\n | Reported% Change, GAAP Measure |  | Foreign exchange translation |  | Acquisitions and divestitures |  |  |  | Organic% Change, Non-GAAP Measure(a) |  | Organic volume(b) |  | Effective net pricing\nFLNA | 20 | % |  | \u2014 |  |  | \u2014 |  |  |  |  | 20 | % |  | \u2014 |  |  | 20 | \nQFNA | 15 | % |  | \u2014 |  |  | \u2014 |  |  |  |  | 16 | % |  | (4) |  |  | 20 | \nPBNA | 4 | % |  | \u2014 |  |  | 9 |  |  |  |  | 13 | % |  | 1 |  |  | 12 | \nLatAm | 20 | % |  | 2 |  |  | 1 |  |  |  |  | 22 | % |  | 5 |  |  | 17 | \nEurope | 1 | % |  | 8 |  |  | 5.5 |  |  |  |  | 15 | % |  | (10) |  |  | 24 | \nAMESA | 4 | % |  | 14 |  |  | \u2014 |  |  |  |  | 17 | % |  | (1) |  |  | 19 | \nAPAC | 3 | % |  | 5 |  |  | \u2014 |  |  |  |  | 8 | % |  | 3 |  |  | 5 | \nTotal | 9 | % |  | 3 |  |  | 4 |  |  |  |  | 16 | % |  | (1) |  |  | 17 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended 9/3/2022\n |  |  | Impact of |  |  |  |  |  |  |  | Impact of\n | Reported% Change, GAAP Measure |  | Foreign exchange translation |  | Acquisitions and divestitures |  |  |  | Organic% Change, Non-GAAP Measure(a) |  |  |  |  |  | Organic volume(b) |  | Effective net pricing\nFLNA | 16 | % |  | \u2014 |  |  | \u2014 |  |  |  |  | 16 | % |  |  |  |  |  | 0.5 |  |  | 16 | \nQFNA | 14 | % |  | \u2014 |  |  | \u2014 |  |  |  |  | 15 | % |  |  |  |  |  | (1) |  |  | 16 | \nPBNA | 3 | % |  | \u2014 |  |  | 8 |  |  |  |  | 11 | % |  |  |  |  |  | 1.5 |  |  | 10 | \nLatAm | 21 | % |  | 1 |  |  | 1 |  |  |  |  | 22 | % |  |  |  |  |  | 3.5 |  |  | 19 | \nEurope | (3) | % |  | 10 |  |  | 4.5 |  |  |  |  | 12 | % |  |  |  |  |  | (7) |  |  | 18 | \nAMESA | 7 | % |  | 9 |  |  | 4 |  |  |  |  | 20 | % |  |  |  |  |  | 7 |  |  | 13 | \nAPAC | 5 | % |  | 3 |  |  | 2.5 |  |  |  |  | 10 | % |  |  |  |  |  | 5 |  |  | 5 | \nTotal | 8 | % |  | 3 |  |  | 4 |  |  |  |  | 14 | % |  |  |  |  |  | 1 |  |  | 14 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 9/3/2022\n |  |  | Items Affecting Comparability(a) |  | \n | Reported, GAAP Measure(b) |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges |  | Gain associated with the Juice Transaction |  | Russia-Ukraine conflict charges |  | Brand Portfolio Impairment Charges |  | Core,Non-GAAP Measure(b)\nFLNA | $ | 1,588 |  |  | $ | \u2014 |  |  | $ | 4 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 1,592 | \nQFNA | 122 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 123 | \nPBNA | 784 |  |  | \u2014 |  |  | 4 |  |  | 3 |  |  | 8 |  |  | \u2014 |  |  | 9 |  |  | 808 | \nLatAm | 463 |  |  | \u2014 |  |  | 3 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 466 | \nEurope | 564 |  |  | \u2014 |  |  | 21 |  |  | \u2014 |  |  | 6 |  |  | (4) |  |  | 1 |  |  | 588 | \nAMESA | 268 |  |  | \u2014 |  |  | \u2014 |  |  | 2 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 270 | \nAPAC | 199 |  |  | \u2014 |  |  | 4 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 203 | \nCorporate unallocated expenses | (635) |  |  | 166 |  |  | 14 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (455) | \nTotal | $ | 3,353 |  |  | $ | 166 |  |  | $ | 51 |  |  | $ | 5 |  |  | $ | 14 |  |  | $ | (4) |  |  | $ | 10 |  |  | $ | 3,595 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 9/4/2021\n |  |  | Items Affecting Comparability(a) |  |  |  |  |  | \n | Reported,GAAP Measure(b) |  | Mark-to-market net impact |  | Restructuringand impairment charges |  | Acquisition and divestiture-related charges(c) |  |  |  |  |  | Core,Non-GAAP Measure(b)\nFLNA | $ | 1,357 |  |  | $ | \u2014 |  |  | $ | 2 |  |  | $ | \u2014 |  |  |  |  |  |  | $ | 1,359 | \nQFNA | 106 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  |  |  |  |  | 107 | \nPBNA | 773 |  |  | \u2014 |  |  | 3 |  |  | \u2014 |  |  |  |  |  |  | 776 | \nLatAm | 393 |  |  | \u2014 |  |  | 14 |  |  | \u2014 |  |  |  |  |  |  | 407 | \nEurope | 439 |  |  | \u2014 |  |  | 20 |  |  | \u2014 |  |  |  |  |  |  | 459 | \nAMESA | 312 |  |  | \u2014 |  |  | 5 |  |  | 1 |  |  |  |  |  |  | 318 | \nAPAC | 201 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  |  |  |  |  | 202 | \nCorporate unallocated expenses | (422) |  |  | 34 |  |  | 5 |  |  | (4) |  |  |  |  |  |  | (387) | \nTotal | $ | 3,159 |  |  | $ | 34 |  |  | $ | 51 |  |  | $ | (3) |  |  |  |  |  |  | $ | 3,241 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended 9/3/2022\n |  |  | Items Affecting Comparability(a) |  | \n | Reported, GAAP Measure(b) |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges |  | Gain associated with the Juice Transaction |  | Russia-Ukraine conflict charges |  | Brand Portfolio Impairment Charges |  | Core,Non-GAAP Measure(b)\nFLNA | $ | 4,332 |  |  | $ | \u2014 |  |  | $ | 10 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 4,342 | \nQFNA | 416 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 417 | \nPBNA | 4,869 |  |  | \u2014 |  |  | 9 |  |  | 42 |  |  | (3,029) |  |  | \u2014 |  |  | 150 |  |  | 2,041 | \nLatAm | 1,206 |  |  | \u2014 |  |  | 17 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 83 |  |  | 1,306 | \nEurope | (369) |  |  | \u2014 |  |  | 40 |  |  | 13 |  |  | (292) |  |  | 1,402 |  |  | 242 |  |  | 1,036 | \nAMESA | 738 |  |  | \u2014 |  |  | 5 |  |  | 2 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 745 | \nAPAC | 620 |  |  | \u2014 |  |  | 8 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 628 | \nCorporate unallocated expenses | (1,115) |  |  | (44) |  |  | 33 |  |  | 6 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (1,120) | \nTotal | $ | 10,697 |  |  | $ | (44) |  |  | $ | 123 |  |  | $ | 63 |  |  | $ | (3,321) |  |  | $ | 1,402 |  |  | $ | 475 |  |  | $ | 9,395 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended 9/4/2021\n |  |  | Items Affecting Comparability(a) |  | \n | Reported,GAAP Measure(b) |  | Mark-to-market net impact |  | Restructuringand impairment charges |  | Acquisition and divestiture-related charges(c) |  | Core,Non-GAAP Measure(b)\nFLNA | $ | 3,979 |  |  | $ | \u2014 |  |  | $ | 20 |  |  | $ | 2 |  |  | $ | 4,001 | \nQFNA | 384 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | 385 | \nPBNA | 1,948 |  |  | \u2014 |  |  | 8 |  |  | 2 |  |  | 1,958 | \nLatAm | 967 |  |  | \u2014 |  |  | 22 |  |  | \u2014 |  |  | 989 | \nEurope | 975 |  |  | \u2014 |  |  | 46 |  |  | \u2014 |  |  | 1,021 | \nAMESA | 706 |  |  | \u2014 |  |  | 9 |  |  | 8 |  |  | 723 | \nAPAC | 601 |  |  | \u2014 |  |  | 2 |  |  | 3 |  |  | 606 | \nCorporate unallocated expenses | (960) |  |  | (61) |  |  | 15 |  |  | (3) |  |  | (1,009) | \nTotal | $ | 8,600 |  |  | $ | (61) |  |  | $ | 123 |  |  | $ | 12 |  |  | $ | 8,674 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 9/3/2022\n |  |  | Impact of Items Affecting Comparability(a) |  |  |  | Impact of |  | \n | Reported % Change, GAAP Measure |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges |  | Gain associated with the Juice Transaction |  | Russia-Ukraine conflict charges |  | Brand Portfolio Impairment Charges |  | Core% Change, Non-GAAP Measure(b) |  | Foreign exchange translation |  | Core Constant Currency% Change, Non-GAAP Measure(b)\nFLNA | 17 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 17 | % |  | \u2014 |  |  | 17 | %\nQFNA | 15 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 15 | % |  | \u2014 |  |  | 15 | %\nPBNA | 1 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | 1 |  |  | 4 | % |  | \u2014 |  |  | 4 | %\nLatAm | 18 | % |  | \u2014 |  |  | (3) |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 15 | % |  | 2 |  |  | 17 | %\nEurope | 28 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 28 | % |  | 10 |  |  | 38 | %\nAMESA | (14) | % |  | \u2014 |  |  | (1) |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (15) | % |  | 10 |  |  | (5) | %\nAPAC | (1) | % |  | \u2014 |  |  | 2 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 1 | % |  | 5 |  |  | 6 | %\nCorporate unallocated expenses | 50 | % |  | (30) |  |  | (2) |  |  | (1) |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 17 | % |  | \u2014 |  |  | 17 | %\nTotal | 6 | % |  | 4 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 11 | % |  | 3 |  |  | 14 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended 9/3/2022\n |  |  | Impact of Items Affecting Comparability(a) |  |  |  |  |  | Impact of |  | \n | Reported % Change, GAAP Measure |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges |  | Gain associated with the Juice Transaction |  | Russia-Ukraine conflict charges |  | Brand Portfolio Impairment Charges |  |  |  | Core% Change, Non-GAAP Measure(b) |  | Foreign exchangetranslation |  | Core Constant Currency% Change, Non-GAAP Measure(b)\nFLNA | 9 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 9 | % |  | \u2014 |  |  | 9 | %\nQFNA | 8 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 8 | % |  | \u2014 |  |  | 8 | %\nPBNA | 150 | % |  | \u2014 |  |  | \u2014 |  |  | 2 |  |  | (156) |  |  | \u2014 |  |  | 8 |  |  |  |  | 4 | % |  | \u2014 |  |  | 4.5 | %\nLatAm | 25 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 8 |  |  |  |  | 32 | % |  | 1 |  |  | 33 | %\nEurope | (138) | % |  | \u2014 |  |  | (1) |  |  | 1 |  |  | (30) |  |  | 144 |  |  | 25 |  |  |  |  | 1 | % |  | 10 |  |  | 11 | %\nAMESA | 5 | % |  | \u2014 |  |  | (1) |  |  | (1) |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 3 | % |  | 7 |  |  | 10 | %\nAPAC | 3 | % |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 4 | % |  | 3 |  |  | 7 | %\nCorporate unallocated expenses | 16 | % |  | (2) |  |  | (2) |  |  | (1) |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 11 | % |  | \u2014 |  |  | 11 | %\nTotal | 24 | % |  | \u2014 |  |  | \u2014 |  |  | 1 |  |  | (39) |  |  | 16 |  |  | 5.5 |  |  |  |  | 8 | % |  | 2 |  |  | 11 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended | \n | 9/3/2022 |  | 9/4/2021 |  | Change |  | 9/3/2022 |  | 9/4/2021 |  | Change | \nOther pension and retiree medical benefits income | $ | 36 |  |  | $ | 118 |  |  | $ | (82) |  |  | $ | 168 |  |  | $ | 364 |  |  | $ | (196) |  | \nNet interest expense and other | $ | (190) |  |  | $ | (232) |  |  | $ | 42 |  |  | $ | (666) |  |  | $ | (731) |  |  | $ | 65 |  | \nTax rate | 14.9 | % |  | 26.3 | % |  |  |  | 17.2 | % |  | 23.0 | % |  |  | \nNet income attributable to PepsiCo(a) | $ | 2,702 |  |  | $ | 2,224 |  |  | 21 | % |  | $ | 8,392 |  |  | $ | 6,296 |  |  | 33 | % | \nNet income attributable to PepsiCo per common share \u2013 diluted(a) | $ | 1.95 |  |  | $ | 1.60 |  |  | 22 | % |  | $ | 6.04 |  |  | $ | 4.54 |  |  | 33 | % | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 9/3/2022\n | Cost of sales |  | Gross profit |  | Selling, general and administrative expenses |  | Gain associated with the Juice Transaction |  | Impairment of intangible assets |  | Operating profit |  | Other pension and retiree medical benefits income |  | Provision for income taxes(a) |  |  |  | Net income attributable to PepsiCo\nReported, GAAP Measure | $ | 10,308 |  |  | $ | 11,663 |  |  | $ | 8,295 |  |  | $ | 14 |  |  | $ | 1 |  |  | $ | 3,353 |  |  | $ | 36 |  |  | $ | 475 |  |  |  |  | $ | 2,702 | \nItems Affecting Comparability |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMark-to-market net impact | (54) |  |  | 54 |  |  | (112) |  |  | \u2014 |  |  | \u2014 |  |  | 166 |  |  | \u2014 |  |  | 40 |  |  |  |  | 126 | \nRestructuring and impairment charges | (1) |  |  | 1 |  |  | (50) |  |  | \u2014 |  |  | \u2014 |  |  | 51 |  |  | \u2014 |  |  | 11 |  |  |  |  | 40 | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  | (5) |  |  | \u2014 |  |  | \u2014 |  |  | 5 |  |  | \u2014 |  |  | 2 |  |  |  |  | 3 | \nGain associated with the Juice Transaction | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (14) |  |  | \u2014 |  |  | 14 |  |  | \u2014 |  |  | 3 |  |  |  |  | 11 | \nRussia-Ukraine conflict charges | (1) |  |  | 1 |  |  | 5 |  |  | \u2014 |  |  | \u2014 |  |  | (4) |  |  | \u2014 |  |  | 1 |  |  |  |  | (5) | \nBrand Portfolio Impairment Charges | (10) |  |  | 10 |  |  | 1 |  |  | \u2014 |  |  | (1) |  |  | 10 |  |  | \u2014 |  |  | 2 |  |  |  |  | 8 | \nPension and retiree medical-related impact | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 59 |  |  | 13 |  |  |  |  | 46 | \nTax benefit related to the IRS audit | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 284 |  |  |  |  | (284) | \nTax expense related to the TCJ Act | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (86) |  |  |  |  | 86 | \nCore, Non-GAAP Measure | $ | 10,242 |  |  | $ | 11,729 |  |  | $ | 8,134 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 3,595 |  |  | $ | 95 |  |  | $ | 745 |  |  |  |  | $ | 2,733 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 9/4/2021\n | Cost of sales |  | Gross profit |  | Selling, general and administrative expenses |  | Operating profit |  | Other pension and retiree medical benefits income |  | Provision for incometaxes(a) |  |  |  | Net income attributable to PepsiCo\nReported, GAAP Measure | $ | 9,394 |  |  | $ | 10,795 |  |  | $ | 7,636 |  |  | $ | 3,159 |  |  | $ | 118 |  |  | $ | 802 |  |  |  |  | $ | 2,224 | \nItems Affecting Comparability |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMark-to-market net impact | (15) |  |  | 15 |  |  | (19) |  |  | 34 |  |  | \u2014 |  |  | 8 |  |  |  |  | 26 | \nRestructuring and impairment charges | (9) |  |  | 9 |  |  | (42) |  |  | 51 |  |  | 1 |  |  | 7 |  |  |  |  | 45 | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  | 3 |  |  | (3) |  |  | \u2014 |  |  | (1) |  |  |  |  | (2) | \nTax expense related to the TCJ Act | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (190) |  |  |  |  | 190 | \nCore, Non-GAAP Measure | $ | 9,370 |  |  | $ | 10,819 |  |  | $ | 7,578 |  |  | $ | 3,241 |  |  | $ | 119 |  |  | $ | 626 |  |  |  |  | $ | 2,483 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended 9/3/2022\n | Cost of sales |  | Gross profit |  | Selling, general and administrative expenses |  | Gain associated with the Juice Transaction |  | Impairment of intangible assets |  | Operating profit |  | Other pension and retiree medical benefits income |  |  |  | Provision for income taxes(a) |  | Net income attributable to noncontrolling interests |  | Net income attributable to PepsiCo\nReported, GAAP Measure | $ | 27,156 |  |  | $ | 31,240 |  |  | $ | 22,262 |  |  | $ | (3,321) |  |  | $ | 1,602 |  |  | $ | 10,697 |  |  | $ | 168 |  |  |  |  | $ | 1,756 |  |  | $ | 51 |  |  | $ | 8,392 | \nItems Affecting Comparability |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMark-to-market net impact | 1 |  |  | (1) |  |  | 43 |  |  | \u2014 |  |  | \u2014 |  |  | (44) |  |  | \u2014 |  |  |  |  | (11) |  |  | \u2014 |  |  | (33) | \nRestructuring and impairment charges | (6) |  |  | 6 |  |  | (117) |  |  | \u2014 |  |  | \u2014 |  |  | 123 |  |  | 3 |  |  |  |  | 25 |  |  | 1 |  |  | 100 | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  | (63) |  |  | \u2014 |  |  | \u2014 |  |  | 63 |  |  | 6 |  |  |  |  | 12 |  |  | \u2014 |  |  | 57 | \nGain associated with the Juice Transaction | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 3,321 |  |  | \u2014 |  |  | (3,321) |  |  | \u2014 |  |  |  |  | (452) |  |  | \u2014 |  |  | (2,869) | \nRussia-Ukraine conflict charges | (134) |  |  | 134 |  |  | (70) |  |  | \u2014 |  |  | (1,198) |  |  | 1,402 |  |  | \u2014 |  |  |  |  | 239 |  |  | \u2014 |  |  | 1,163 | \nBrand Portfolio Impairment Charges | (18) |  |  | 18 |  |  | (53) |  |  | \u2014 |  |  | (404) |  |  | 475 |  |  | \u2014 |  |  |  |  | 111 |  |  | \u2014 |  |  | 364 | \nPension and retiree medical-related impact | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 174 |  |  |  |  | 39 |  |  | \u2014 |  |  | 135 | \nTax benefit related to the IRS audit | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 284 |  |  | \u2014 |  |  | (284) | \nTax expense related to the TCJ Act | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | (86) |  |  | \u2014 |  |  | 86 | \nCore, Non-GAAP Measure | $ | 26,999 |  |  | $ | 31,397 |  |  | $ | 22,002 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 9,395 |  |  | $ | 351 |  |  |  |  | $ | 1,917 |  |  | $ | 52 |  |  | $ | 7,111 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended 9/4/2021\n | Cost of sales |  | Gross profit |  | Selling, general and administrative expenses |  | Operating profit |  | Other pension and retiree medical benefits income |  | Provision for income taxes(a) |  |  |  | Net income attributable to PepsiCo\nReported, GAAP Measure | $ | 24,945 |  |  | $ | 29,281 |  |  | $ | 20,681 |  |  | $ | 8,600 |  |  | $ | 364 |  |  | $ | 1,895 |  |  |  |  | $ | 6,296 | \nItems Affecting Comparability |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMark-to-market net impact | 21 |  |  | (21) |  |  | 40 |  |  | (61) |  |  | \u2014 |  |  | (13) |  |  |  |  | (48) | \nRestructuring and impairment charges | (13) |  |  | 13 |  |  | (110) |  |  | 123 |  |  | 6 |  |  | 20 |  |  |  |  | 109 | \nAcquisition and divestiture-related charges | (1) |  |  | 1 |  |  | (11) |  |  | 12 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 12 | \nTax expense related to the TCJ Act | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (190) |  |  |  |  | 190 | \nCore, Non-GAAP Measure | $ | 24,952 |  |  | $ | 29,274 |  |  | $ | 20,600 |  |  | $ | 8,674 |  |  | $ | 370 |  |  | $ | 1,712 |  |  |  |  | $ | 6,559 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended | \n | 9/3/2022 |  | 9/4/2021 |  | Change |  | 9/3/2022 |  | 9/4/2021 |  | Change | \nNet income attributable to PepsiCo per common share \u2013 diluted, GAAP measure | $ | 1.95 |  |  | $ | 1.60 |  |  | 22 | % |  | $ | 6.04 |  |  | $ | 4.54 |  |  | 33 | % | \nMark-to-market net impact | 0.09 |  |  | 0.02 |  |  |  |  | (0.02) |  |  | (0.03) |  |  |  | \nRestructuring and impairment charges | 0.03 |  |  | 0.03 |  |  |  |  | 0.07 |  |  | 0.08 |  |  |  | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  |  |  | 0.04 |  |  | 0.01 |  |  |  | \nGain associated with the Juice Transaction | 0.01 |  |  | \u2014 |  |  |  |  | (2.07) |  |  | \u2014 |  |  |  | \nRussia-Ukraine conflict charges | \u2014 |  |  | \u2014 |  |  |  |  | 0.84 |  |  | \u2014 |  |  |  | \nBrand Portfolio Impairment Charges | 0.01 |  |  | \u2014 |  |  |  |  | 0.26 |  |  | \u2014 |  |  |  | \nPension and retiree medical-related impact | 0.03 |  |  | \u2014 |  |  |  |  | 0.10 |  |  | \u2014 |  |  |  | \nTax benefit related to the IRS audit | (0.20) |  |  | \u2014 |  |  |  |  | (0.20) |  |  | \u2014 |  |  |  | \nTax expense related to the TCJ Act | 0.06 |  |  | 0.14 |  |  |  |  | 0.06 |  |  | 0.14 |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \nCore net income attributable to PepsiCo per common share \u2013 diluted, non-GAAP measure | $ | 1.97 |  | (a) | $ | 1.79 |  |  | 10 | % |  | $ | 5.12 |  |  | $ | 4.73 |  | (a) | 8 | % | \nImpact of foreign exchange translation |  |  |  |  | 3 |  |  |  |  |  |  | 2 |  | \nGrowth in core net income attributable to PepsiCo per common share \u2013 diluted, on a constant currency basis, non-GAAP measure |  |  |  |  | 14 | % | (a) |  |  |  |  | 11 | % | (a)  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended |  | \n | 9/3/2022 |  | 9/4/2021 |  | \nNet cash provided by operating activities, GAAP measure | $ | 6,306 |  |  | $ | 6,634 |  |  | \nCapital spending | (2,556) |  |  | (2,276) |  |  | \nSales of property, plant and equipment | 228 |  |  | 40 |  |  | \nFree cash flow, non-GAAP measure | $ | 3,978 |  |  | $ | 4,398 |  |  | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | Change(a) |  | Reference\n |  |  | \nCash and cash equivalents | $ | 0.8 |  |  | Statement of Cash Flows\nAccounts and notes receivable, less allowance | $ | 2.1 |  |  | (b)\nInventories | $ | 0.7 |  |  | (c)\nAssets held for sale | $ | (1.8) |  |  | (d)\nOther indefinite-lived intangible assets | $ | (1.3) |  |  | Note 3\nInvestments in noncontrolled affiliates | $ | 0.9 |  |  | Note 11\nOther assets | $ | 0.5 |  |  | (e)  |  |  |  |  |  |  |  |  |  |  | \n | Change(a) |  | Reference\nShort-term debt obligations | $ | (1.2) |  |  | (f)\nAccounts payable and other current liabilities | $ | 1.4 |  |  | (g)\nLiabilities held for sale | $ | (0.8) |  |  | (d)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod |  | TotalNumber ofSharesRepurchased(a) |  | Average\u00a0PricePaid\u00a0Per\u00a0Share |  | Total\u00a0Numberof SharesPurchased asPart\u00a0of\u00a0PubliclyAnnouncedPlans orPrograms |  | MaximumNumber (orApproximateDollar\u00a0Value)\u00a0ofShares That May Yet BePurchasedUnder\u00a0the\u00a0Plansor Programs\n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n6/11/2022 |  |  |  |  |  |  |  | $ | 9,269 | \n |  |  |  |  |  |  |  | \n6/12/2022 - 7/9/2022 |  | 1.1 |  |  | $ | 164.06 |  |  | 1.1 |  |  | (187) | \n |  |  |  |  |  |  |  | 9,082 | \n7/10/2022 - 8/6/2022 |  | 0.6 |  |  | $ | 172.85 |  |  | 0.6 |  |  | (98) | \n |  |  |  |  |  |  |  | 8,984 | \n8/7/2022 - 9/3/2022 |  | 0.9 |  |  | $ | 176.30 |  |  | 0.9 |  |  | (163) | \nTotal |  | 2.6 |  |  | $ | 170.25 |  |  | 2.6 |  |  | $ | 8,821 |   |  | \nSee \u201cIndex to Exhibits\u201d on page60.  |  |  |  |  | \nEXHIBIT | \nExhibit 3.1 | Amended and Restated Articles of Incorporation of PepsiCo, Inc., effective as of May 1, 2019, which are incorporated herein by reference to Exhibit 3.1 to PepsiCo, Inc.\u2019s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 3, 2019.\nExhibit 3.2 | By-Laws of PepsiCo, Inc., as amended and restated, effective as of April 15, 2020, which are incorporated herein by reference to Exhibit 3.2 to PepsiCo, Inc.\u2019s Current Report on Form 8-K filed with the Securities and Exchange Commission on April 16, 2020.\nExhibit 15 | Letter re: Unaudited Interim Financial Information.\nExhibit 31 | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.\nExhibit 32 | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.\nExhibit 101 | The following materials from PepsiCo, Inc.\u2019s Quarterly Report on Form 10-Q for the quarter ended September 3, 2022 formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Statement of Income, (ii) the Condensed Consolidated Statement of Comprehensive Income, (iii) the Condensed Consolidated Statement of Cash Flows, (iv) the Condensed Consolidated Balance Sheet, (v) the Condensed Consolidated Statement of Equity, and (vi) Notes to the Condensed Consolidated Financial Statements.\nExhibit 104 | The cover page from the Company\u2019s Quarterly Report on Form 10-Q for the quarter ended September 3, 2022, formatted in iXBRL and contained in Exhibit 101.  |  |  |  |  |  |  |  |  |  |  | \n |  |  | \n |  | PepsiCo, Inc. | \n |  | (Registrant) | \n |  |  | \nDate: | October 11, 2022 | /s/ Marie T. Gallagher | \n |  | Marie T. Gallagher | \n |  | Senior Vice President and Controller | \n |  | (Principal Accounting Officer) | \n |  |  | \nDate: | October 11, 2022 | /s/ David Flavell | \n |  | David Flavell | \n |  | Executive Vice President, General Counsel and Corporate Secretary | \n |  | (Duly Authorized Officer) | "}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Pepsico, in 2023 Q1, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  | \n\u2612 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \n\u2610 | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  | \nPepsiCo, Inc.  |  |  |  |  |  |  |  | \n |  | \nNorth Carolina |  | 13-1584302\n(State or Other Jurisdiction ofIncorporation or Organization) |  | (I.R.S. EmployerIdentification No.)\n | \n |  | \n |  |   |  | \n(Address of principal executive offices and Zip Code)  |  | \nRegistrant's telephone number, including area code  |  | \n(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTitle of each class |  | Trading Symbols |  | Name of each exchange on which registered\nCommon Stock, par value 1-2/3 cents per share |  | PEP |  | The Nasdaq Stock Market LLC\n0.250% Senior Notes Due 2024 |  | PEP24 |  | The Nasdaq Stock Market LLC\n2.625% Senior Notes Due 2026 |  | PEP26 |  | The Nasdaq Stock Market LLC\n0.750% Senior Notes Due 2027 |  | PEP27 |  | The Nasdaq Stock Market LLC\n0.875% Senior Notes Due 2028 |  | PEP28 |  | The Nasdaq Stock Market LLC\n0.500% Senior Notes Due 2028 |  | PEP28a |  | The Nasdaq Stock Market LLC\n3.200% Senior Notes Due 2029 |  | PEP29 |  | The Nasdaq Stock Market LLC\n1.125% Senior Notes Due 2031 |  | PEP31 |  | The Nasdaq Stock Market LLC\n0.400% Senior Notes Due 2032 |  | PEP32 |  | The Nasdaq Stock Market LLC\n0.750% Senior Notes Due 2033 |  | PEP33 |  | The Nasdaq Stock Market LLC\n3.550% Senior Notes Due 2034 |  | PEP34 |  | The Nasdaq Stock Market LLC\n0.875% Senior Notes Due 2039 |  | PEP39 |  | The Nasdaq Stock Market LLC\n1.050% Senior Notes Due 2050 |  | PEP50 |  | The Nasdaq Stock Market LLC  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 | Accelerated filer | \u2610\nNon-accelerated filer | \u2610 | Smaller reporting company | \u2610\n |  | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \n |  | Page\u00a0No.\nPart I        Financial Information | \nItem 1. | Condensed Consolidated Financial Statements | 2\n | Condensed Consolidated Statement of Income \u201312WeeksEndedMarch 25, 2023andMarch19, 2022 | 2\n | Condensed Consolidated Statement of Comprehensive Income \u201312Weeks EndedMarch25, 2023andMarch19, 2022 | 3\n | Condensed Consolidated Statement of Cash Flows \u201312Weeks EndedMarch25, 2023andMarch19, 2022 | 4\n | Condensed Consolidated Balance Sheet \u2013March25, 2023and December31, 2022 | 6\n | Condensed Consolidated Statement of Equity \u201312Weeks EndedMarch25, 2023andMarch19, 2022 | 7\n | Notes to the Condensed Consolidated Financial Statements | 8\nItem\u00a02. | Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations | 22\nReport of Independent Registered Public Accounting Firm | 40\nItem 3. | Quantitative and Qualitative Disclosures About Market Risk | 41\nItem 4. | Controls and Procedures | 41\nPart II      Other Information | \nItem 1. | Legal Proceedings | 42\nItem 1A. | Risk Factors | 42\nItem 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 42\nItem 6. | Exhibits | 42  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended\n |  |  |  |  | 3/25/2023 |  | 3/19/2022\nNet Revenue |  |  |  |  | $ | 17,846 |  |  | $ | 16,200 | \nCost of sales |  |  |  |  | 7,988 |  |  | 7,433 | \nGross profit |  |  |  |  | 9,858 |  |  | 8,767 | \nSelling, general and administrative expenses |  |  |  |  | 7,229 |  |  | 6,580 | \nGain associated with the Juice Transaction(a) |  |  |  |  | \u2014 |  |  | (3,322) | \nImpairment of intangible assets (see Notes 1 and 4) |  |  |  |  | \u2014 |  |  | 242 | \nOperating Profit |  |  |  |  | 2,629 |  |  | 5,267 | \nOther pension and retiree medical benefits income |  |  |  |  | 61 |  |  | 134 | \nNet interest expense and other |  |  |  |  | (200) |  |  | (240) | \nIncome before income taxes |  |  |  |  | 2,490 |  |  | 5,161 | \nProvision for income taxes |  |  |  |  | 546 |  |  | 888 | \nNet income |  |  |  |  | 1,944 |  |  | 4,273 | \nLess: Net income attributable to noncontrolling interests |  |  |  |  | 12 |  |  | 12 | \nNet Income Attributable to PepsiCo |  |  |  |  | $ | 1,932 |  |  | $ | 4,261 | \nNet Income Attributable to PepsiCo per Common Share |  |  |  |  |  |  | \nBasic |  |  |  |  | $ | 1.40 |  |  | $ | 3.08 | \nDiluted |  |  |  |  | $ | 1.40 |  |  | $ | 3.06 | \nWeighted-average common shares outstanding |  |  |  |  |  |  | \nBasic |  |  |  |  | 1,378 |  |  | 1,383 | \nDiluted |  |  |  |  | 1,384 |  |  | 1,391 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended\n |  |  |  |  | 3/25/2023 |  | 3/19/2022\nNet income |  |  |  |  | $ | 1,944 |  |  | $ | 4,273 | \nOther comprehensive loss, net of taxes: |  |  |  |  |  |  | \nNet currency translation adjustment |  |  |  |  | (235) |  |  | (560) | \nNet change on cash flow hedges |  |  |  |  | (59) |  |  | 106 | \nNet pension and retiree medical adjustments |  |  |  |  | (4) |  |  | 13 | \n |  |  |  |  |  |  | \nOther |  |  |  |  | (1) |  |  | (4) | \n |  |  |  |  | (299) |  |  | (445) | \nComprehensive income |  |  |  |  | 1,645 |  |  | 3,828 | \nLess: Comprehensive income attributable tononcontrolling interests |  |  |  |  | 12 |  |  | 12 | \nComprehensive Income Attributable to PepsiCo |  |  |  |  | $ | 1,633 |  |  | $ | 3,816 |   |  | \n  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 3/25/2023 |  | 3/19/2022\nOperating Activities |  |  | \nNet income | $ | 1,944 |  |  | $ | 4,273 | \nDepreciation and amortization | 590 |  |  | 555 | \nGain associated with the Juice Transaction | \u2014 |  |  | (3,322) | \n |  |  | \n |  |  | \nImpairment and other (credits)/charges | (13) |  |  | 482 | \nOperating lease right-of-use asset amortization | 116 |  |  | 103 | \nShare-based compensation expense | 93 |  |  | 81 | \nRestructuring and impairment charges | 112 |  |  | 27 | \nCash payments for restructuring charges | (64) |  |  | (32) | \nAcquisition and divestiture-related charges | 2 |  |  | 56 | \nCash payments for acquisition and divestiture-related charges | (4) |  |  | (17) | \nPension and retiree medical plan expense/(income) | 30 |  |  | (1) | \nPension and retiree medical plan contributions | (175) |  |  | (178) | \nDeferred income taxes and other tax charges and credits | 78 |  |  | 257 | \n |  |  | \n |  |  | \nChange in assets and liabilities: |  |  | \nAccounts and notes receivable | (348) |  |  | (837) | \nInventories | (542) |  |  | (549) | \nPrepaid expenses and other current assets | (288) |  |  | (190) | \nAccounts payable and other current liabilities | (2,259) |  |  | (1,238) | \nIncome taxes payable | 290 |  |  | 489 | \nOther, net | 46 |  |  | (133) | \nNet Cash Used for Operating Activities | (392) |  |  | (174) | \n |  |  | \nInvesting Activities |  |  | \nCapital spending | (581) |  |  | (522) | \nSales of property, plant and equipment | 19 |  |  | 3 | \nAcquisitions, net of cash acquired, investments in noncontrolled affiliates and purchases of intangible and other assets | (16) |  |  | (13) | \nProceeds associated with the Juice Transaction | \u2014 |  |  | 3,456 | \nOther divestitures, sales of investments in noncontrolled affiliates and other assets | 85 |  |  | 5 | \nShort-term investments, by original maturity: |  |  | \nMore than three months - purchases | (158) |  |  | \u2014 | \nMore than three months - maturities | 100 |  |  | \u2014 | \n |  |  | \nThree months or less, net | 19 |  |  | 22 | \nOther investing, net | \u2014 |  |  | 4 | \nNet Cash (Used for)/Provided by Investing Activities | (532) |  |  | 2,955 |   |  | \n  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 3/25/2023 |  | 3/19/2022\nFinancing Activities |  |  | \nProceeds from issuances of long-term debt | $ | 2,986 |  |  | $ | \u2014 | \nPayments of long-term debt | (1,251) |  |  | (1,251) | \n |  |  | \nShort-term borrowings, by original maturity: |  |  | \nMore than three months - proceeds | 393 |  |  | 559 | \nMore than three months - payments | (1) |  |  | \u2014 | \nThree months or less, net | 491 |  |  | 647 | \n |  |  | \nCash dividends paid | (1,608) |  |  | (1,505) | \nShare repurchases - common | (160) |  |  | (193) | \n |  |  | \nProceeds from exercises of stock options | 46 |  |  | 49 | \nWithholding tax payments on restricted stock units (RSUs) and performance stock units (PSUs) converted | (116) |  |  | (85) | \nOther financing | (3) |  |  | (1) | \nNet Cash Provided by/(Used for) Financing Activities | 777 |  |  | (1,780) | \nEffect of exchange rate changes on cash and cash equivalents and restricted cash | (116) |  |  | (17) | \nNet (Decrease)/Increase in Cash and Cash Equivalents and Restricted Cash | (263) |  |  | 984 | \nCash and Cash Equivalents and Restricted Cash, Beginning of Year | 5,100 |  |  | 5,707 | \nCash and Cash Equivalents and Restricted Cash, End of Period | $ | 4,837 |  |  | $ | 6,691 | \n |  |  | \nSupplemental Non-Cash Activity |  |  | \nRight-of-use assets obtained in exchange for lease obligations | $ | 213 |  |  | $ | 100 |   |  | \n  |  |  |  |  |  |  |  |  |  |  | \n | (Unaudited) |  | \n | 3/25/2023 |  | 12/31/2022\nASSETS |  |  | \nCurrent Assets |  |  | \nCash and cash equivalents | $ | 4,770 |  |  | $ | 4,954 | \nShort-term investments | 434 |  |  | 394 | \n |  |  | \nAccounts and notes receivable, less allowance ($184 and $150, respectively) | 10,469 |  |  | 10,163 | \nInventories: |  |  | \nRaw materials and packaging | 2,435 |  |  | 2,366 | \nWork-in-process | 115 |  |  | 114 | \nFinished goods | 3,147 |  |  | 2,742 | \n | 5,697 |  |  | 5,222 | \nPrepaid expenses and other current assets | 1,057 |  |  | 806 | \n |  |  | \nTotal Current Assets | 22,427 |  |  | 21,539 | \nProperty, plant and equipment | 50,022 |  |  | 49,784 | \nAccumulated depreciation | (25,794) |  |  | (25,493) | \nProperty, Plant and Equipment, net | 24,228 |  |  | 24,291 | \nAmortizable Intangible Assets, net | 1,250 |  |  | 1,277 | \nGoodwill | 18,089 |  |  | 18,202 | \nOther Indefinite-Lived Intangible Assets | 14,273 |  |  | 14,309 | \n |  |  | \nInvestments in Noncontrolled Affiliates | 3,123 |  |  | 3,073 | \nDeferred Income Taxes | 4,211 |  |  | 4,204 | \nOther Assets | 5,441 |  |  | 5,292 | \nTotal Assets | $ | 93,042 |  |  | $ | 92,187 | \n |  |  | \nLIABILITIES AND EQUITY |  |  | \nCurrent Liabilities |  |  | \nShort-term debt obligations | $ | 4,281 |  |  | $ | 3,414 | \nAccounts payable and other current liabilities | 21,556 |  |  | 23,371 | \n |  |  | \nTotal Current Liabilities | 25,837 |  |  | 26,785 | \nLong-Term Debt Obligations | 37,486 |  |  | 35,657 | \nDeferred Income Taxes | 4,039 |  |  | 4,133 | \nOther Liabilities | 8,505 |  |  | 8,339 | \nTotal Liabilities | 75,867 |  |  | 74,914 | \nCommitments and contingencies |  |  | \nPepsiCo Common Shareholders\u2019 Equity |  |  | \nCommon stock, par value 12/3\u00a2 per share (authorized3,600shares; issued, net of repurchased common stock at par value:1,378and1,377shares, respectively) | 23 |  |  | 23 | \nCapital in excess of par value | 3,996 |  |  | 4,134 | \nRetained earnings | 68,142 |  |  | 67,800 | \nAccumulated other comprehensive loss | (15,601) |  |  | (15,302) | \nRepurchased common stock, in excess of par value (489and490shares, respectively) | (39,518) |  |  | (39,506) | \nTotal PepsiCo Common Shareholders\u2019 Equity | 17,042 |  |  | 17,149 | \nNoncontrolling interests | 133 |  |  | 124 | \nTotal Equity | 17,175 |  |  | 17,273 | \nTotal Liabilities and Equity | $ | 93,042 |  |  | $ | 92,187 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended\n |  |  |  |  | 3/25/2023 |  | 3/19/2022\n |  |  |  |  |  |  |  |  | Shares |  | Amount |  | Shares |  | Amount\n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCommon Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  |  |  |  |  |  |  | 1,377 |  |  | $ | 23 |  |  | 1,383 |  |  | $ | 23 | \nChange in repurchased common stock |  |  |  |  |  |  |  |  | 1 |  |  | \u2014 |  |  | 1 |  |  | \u2014 | \nBalance, end of period |  |  |  |  |  |  |  |  | 1,378 |  |  | 23 |  |  | 1,384 |  |  | 23 | \nCapital in Excess of Par Value |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  |  |  |  |  |  |  |  |  | 4,134 |  |  |  |  | 4,001 | \nShare-based compensation expense |  |  |  |  |  |  |  |  |  |  | 94 |  |  |  |  | 83 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nStock option exercises, RSUs and PSUs converted |  |  |  |  |  |  |  |  |  |  | (116) |  |  |  |  | (106) | \nWithholding tax on RSUs and PSUs converted |  |  |  |  |  |  |  |  |  |  | (116) |  |  |  |  | (85) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, end of period |  |  |  |  |  |  |  |  |  |  | 3,996 |  |  |  |  | 3,893 | \nRetained Earnings |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  |  |  |  |  |  |  |  |  | 67,800 |  |  |  |  | 65,165 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nNet income attributable to PepsiCo |  |  |  |  |  |  |  |  |  |  | 1,932 |  |  |  |  | 4,261 | \nCash dividends declared \u2013 common(a) |  |  |  |  |  |  |  |  |  |  | (1,590) |  |  |  |  | (1,492) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, end of period |  |  |  |  |  |  |  |  |  |  | 68,142 |  |  |  |  | 67,934 | \nAccumulated Other Comprehensive Loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  |  |  |  |  |  |  |  |  | (15,302) |  |  |  |  | (14,898) | \nOther comprehensive loss attributable to PepsiCo |  |  |  |  |  |  |  |  |  |  | (299) |  |  |  |  | (445) | \nBalance, end of period |  |  |  |  |  |  |  |  |  |  | (15,601) |  |  |  |  | (15,343) | \nRepurchased Common Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  |  |  |  |  |  |  | (490) |  |  | (39,506) |  |  | (484) |  |  | (38,248) | \nShare repurchases |  |  |  |  |  |  |  |  | (1) |  |  | (174) |  |  | (1) |  |  | (213) | \nStock option exercises, RSUs and PSUs converted |  |  |  |  |  |  |  |  | 2 |  |  | 162 |  |  | 2 |  |  | 156 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, end of period |  |  |  |  |  |  |  |  | (489) |  |  | (39,518) |  |  | (483) |  |  | (38,305) | \nTotal PepsiCo Common Shareholders\u2019 Equity |  |  |  |  |  |  |  |  |  |  | 17,042 |  |  |  |  | 18,202 | \nNoncontrolling Interests |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  |  |  |  |  |  |  |  |  | 124 |  |  |  |  | 108 | \nNet income attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  |  | 12 |  |  |  |  | 12 | \nDistributions to noncontrolling interests |  |  |  |  |  |  |  |  |  |  | (1) |  |  |  |  | \u2014 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOther, net |  |  |  |  |  |  |  |  |  |  | (2) |  |  |  |  | (2) | \nBalance, end of period |  |  |  |  |  |  |  |  |  |  | 133 |  |  |  |  | 118 | \nTotal Equity |  |  |  |  |  |  |  |  |  |  | $ | 17,175 |  |  |  |  | $ | 18,320 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended\n |  |  |  |  | 3/25/2023 |  | 3/19/2022\nFLNA |  |  |  |  | $ | 5,583 |  |  | $ | 4,839 | \nQFNA |  |  |  |  | 777 |  |  | 713 | \nPBNA |  |  |  |  | 5,798 |  |  | 5,353 | \nLatAm |  |  |  |  | 1,777 |  |  | 1,474 | \nEurope |  |  |  |  | 1,886 |  |  | 1,797 | \nAMESA |  |  |  |  | 1,019 |  |  | 1,004 | \nAPAC |  |  |  |  | 1,006 |  |  | 1,020 | \nTotal |  |  |  |  | $ | 17,846 |  |  | $ | 16,200 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  |  |  |  | \n | 3/25/2023 |  | 3/19/2022 |  |  |  |  | \n | Beverages(a) |  | Convenient Foods |  | Beverages(a) |  | Convenient Foods |  |  |  |  | \nLatAm | 10 | % |  | 90 | % |  | 10 | % |  | 90 | % |  |  |  |  | \nEurope | 45 | % |  | 55 | % |  | 50 | % |  | 50 | % |  |  |  |  | \nAMESA | 30 | % |  | 70 | % |  | 30 | % |  | 70 | % |  |  |  |  | \nAPAC | 15 | % |  | 85 | % |  | 15 | % |  | 85 | % |  |  |  |  | \nPepsiCo | 40 | % |  | 60 | % |  | 40 | % |  | 60 | % |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended\n |  |  |  |  | 3/25/2023 |  | 3/19/2022\nFLNA |  |  |  |  | $ | 1,599 |  |  | $ | 1,296 | \nQFNA |  |  |  |  | 188 |  |  | 159 | \nPBNA(a) |  |  |  |  | 483 |  |  | 3,434 | \nLatAm |  |  |  |  | 364 |  |  | 323 | \nEurope(a) (b) |  |  |  |  | 71 |  |  | (136) | \nAMESA |  |  |  |  | 168 |  |  | 180 | \nAPAC |  |  |  |  | 227 |  |  | 215 | \nTotal divisions |  |  |  |  | 3,100 |  |  | 5,471 | \nCorporate unallocated expenses |  |  |  |  | (471) |  |  | (204) | \nTotal |  |  |  |  | $ | 2,629 |  |  | $ | 5,267 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | FLNA |  | QFNA |  | PBNA |  | LatAm |  | Europe |  | AMESA |  | APAC |  | Corporate\nExpected pre-tax charges | 15 | % |  | 1 | % |  | 25 | % |  | 10 | % |  | 25 | % |  | 5 | % |  | 4 | % |  | 15 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended\n |  |  |  |  | 3/25/2023 |  | 3/19/2022\nCost of sales |  |  |  |  | $ | 3 |  |  | $ | 5 | \nSelling, general and administrative expenses |  |  |  |  | 110 |  |  | 22 | \nOther pension and retiree medical benefits income(a) |  |  |  |  | (1) |  |  | \u2014 | \nTotal restructuring and impairment charges |  |  |  |  | $ | 112 |  |  | $ | 27 | \nAfter-tax amount |  |  |  |  | $ | 98 |  |  | $ | 21 | \nImpact on net income attributable to PepsiCo per common share |  |  |  |  | $ | (0.07) |  |  | $ | (0.02) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended |  | Plan to Date\n |  |  |  |  | 3/25/2023 |  | 3/19/2022 |  | through 3/25/2023\nFLNA |  |  |  |  | $ | 7 |  |  | $ | 3 |  |  | $ | 217 | \nQFNA |  |  |  |  | \u2014 |  |  | \u2014 |  |  | 19 | \nPBNA |  |  |  |  | 5 |  |  | 3 |  |  | 231 | \nLatAm |  |  |  |  | 5 |  |  | 6 |  |  | 176 | \nEurope |  |  |  |  | 89 |  |  | 7 |  |  | 432 | \nAMESA |  |  |  |  | 5 |  |  | 2 |  |  | 87 | \nAPAC |  |  |  |  | 1 |  |  | 1 |  |  | 78 | \nCorporate |  |  |  |  | 1 |  |  | 5 |  |  | 230 | \n |  |  |  |  | 113 |  |  | 27 |  |  | 1,470 | \nOther pension and retiree medical benefits (income)/expense(a) |  |  |  |  | (1) |  |  | \u2014 |  |  | 97 | \nTotal |  |  |  |  | $ | 112 |  |  | $ | 27 |  |  | $ | 1,567 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended |  | Plan to Date\n |  |  |  |  | 3/25/2023 |  | 3/19/2022 |  | through 3/25/2023\nSeverance and\u00a0other employee costs |  |  |  |  | $ | 92 |  |  | $ | 11 |  |  | $ | 899 | \nAsset impairments |  |  |  |  | \u2014 |  |  | \u2014 |  |  | 190 | \nOther\u00a0costs |  |  |  |  | 20 |  |  | 16 |  |  | 478 | \nTotal |  |  |  |  | $ | 112 |  |  | $ | 27 |  |  | $ | 1,567 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Severance and\u00a0Other Employee Costs |  |  |  | Other\u00a0Costs |  | Total\nLiability as of December 31, 2022 | $ | 188 |  |  |  |  | $ | 8 |  |  | $ | 196 | \n2023 restructuring charges | 92 |  |  |  |  | 20 |  |  | 112 | \nCash payments | (44) |  |  |  |  | (20) |  |  | (64) | \nNon-cash charges and translation | (4) |  |  |  |  | \u2014 |  |  | (4) | \nLiability as of March 25, 2023 | $ | 232 |  |  |  |  | $ | 8 |  |  | $ | 240 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | 3/25/2023 |  | 12/31/2022\n |  | Gross |  | Accumulated Amortization |  | Net |  | Gross |  | Accumulated Amortization |  | Net\nAcquired franchise rights |  | $ | 833 |  |  | $ | (202) |  |  | $ | 631 |  |  | $ | 837 |  |  | $ | (200) |  |  | $ | 637 | \nCustomer relationships |  | 563 |  |  | (240) |  |  | 323 |  |  | 571 |  |  | (237) |  |  | 334 | \nBrands |  | 1,085 |  |  | (969) |  |  | 116 |  |  | 1,097 |  |  | (973) |  |  | 124 | \nOther identifiable intangibles |  | 445 |  |  | (265) |  |  | 180 |  |  | 447 |  |  | (265) |  |  | 182 | \nTotal |  | $ | 2,926 |  |  | $ | (1,676) |  |  | $ | 1,250 |  |  | $ | 2,952 |  |  | $ | (1,675) |  |  | $ | 1,277 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Balance12/31/2022 |  |  |  |  |  | Translationand Other |  | Balance3/25/2023\n |  |  |  | \nFLNA |  |  |  |  |  |  |  |  | \nGoodwill | $ | 451 |  |  |  |  |  |  | $ | (2) |  |  | $ | 449 | \nBrands | 251 |  |  |  |  |  |  | \u2014 |  |  | 251 | \nTotal | 702 |  |  |  |  |  |  | (2) |  |  | 700 | \nQFNA |  |  |  |  |  |  |  |  | \nGoodwill | 189 |  |  |  |  |  |  | \u2014 |  |  | 189 | \nTotal | 189 |  |  |  |  |  |  | \u2014 |  |  | 189 | \nPBNA |  |  |  |  |  |  |  |  | \nGoodwill | 11,947 |  |  |  |  |  |  | (7) |  |  | 11,940 | \nReacquired franchise rights | 7,061 |  |  |  |  |  |  | (12) |  |  | 7,049 | \nAcquired franchise rights | 1,758 |  |  |  |  |  |  | (2) |  |  | 1,756 | \nBrands | 2,508 |  |  |  |  |  |  | 1 |  |  | 2,509 | \nTotal | 23,274 |  |  |  |  |  |  | (20) |  |  | 23,254 | \nLatAm |  |  |  |  |  |  |  |  | \nGoodwill | 436 |  |  |  |  |  |  | 7 |  |  | 443 | \nBrands | 75 |  |  |  |  |  |  | 2 |  |  | 77 | \nTotal | 511 |  |  |  |  |  |  | 9 |  |  | 520 | \nEurope |  |  |  |  |  |  |  |  | \nGoodwill | 3,646 |  |  |  |  |  |  | (56) |  |  | 3,590 | \nReacquired franchise rights | 421 |  |  |  |  |  |  | (8) |  |  | 413 | \nAcquired franchise rights | 148 |  |  |  |  |  |  | (1) |  |  | 147 | \nBrands | 1,664 |  |  |  |  |  |  | (1) |  |  | 1,663 | \nTotal | 5,879 |  |  |  |  |  |  | (66) |  |  | 5,813 | \nAMESA |  |  |  |  |  |  |  |  | \nGoodwill | 1,015 |  |  |  |  |  |  | (52) |  |  | 963 | \nBrands | 156 |  |  |  |  |  |  | (13) |  |  | 143 | \nTotal | 1,171 |  |  |  |  |  |  | (65) |  |  | 1,106 | \nAPAC |  |  |  |  |  |  |  |  | \nGoodwill | 518 |  |  |  |  |  |  | (3) |  |  | 515 | \nBrands | 267 |  |  |  |  |  |  | (2) |  |  | 265 | \nTotal | 785 |  |  |  |  |  |  | (5) |  |  | 780 | \n |  |  |  |  |  |  |  |  | \nTotal goodwill | 18,202 |  |  |  |  |  |  | (113) |  |  | 18,089 | \nTotal reacquired franchise rights | 7,482 |  |  |  |  |  |  | (20) |  |  | 7,462 | \nTotal acquired franchise rights | 1,906 |  |  |  |  |  |  | (3) |  |  | 1,903 | \nTotal brands | 4,921 |  |  |  |  |  |  | (13) |  |  | 4,908 | \nTotal | $ | 32,511 |  |  |  |  |  |  | $ | (149) |  |  | $ | 32,362 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended\n |  |  |  |  | 3/25/2023 |  | 3/19/2022\nShare-based compensation expense \u2013 equity awards |  |  |  |  | $ | 93 |  |  | $ | 81 | \nShare-based compensation expense \u2013 liability awards |  |  |  |  | 6 |  |  | 5 | \nAcquisition and divestiture-related charges |  |  |  |  | \u2014 |  |  | 3 | \nRestructuring charges |  |  |  |  | 1 |  |  | (1) | \nTotal |  |  |  |  | $ | 100 |  |  | $ | 88 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 3/25/2023 |  | 3/19/2022\n | Granted(a) |  | Weighted-Average Grant Price |  | Granted(a) |  | Weighted-Average Grant Price\nStock options | 2.0 |  |  | $ | 171.00 |  |  | 2.1 |  |  | $ | 163.00 | \nRSUs and PSUs | 2.1 |  |  | $ | 171.00 |  |  | 2.3 |  |  | $ | 163.00 |   |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 3/25/2023 |  | 3/19/2022\nExpected life | 7years |  | 7years\nRisk-free interest rate | 4.2 | % |  | 1.7 | %\nExpected volatility | 16 | % |  | 16 | %\nExpected dividend yield | 2.7 | % |  | 2.5 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | Pension |  | Retiree Medical\n | U.S. |  | International |  | \n | 3/25/2023 |  | 3/19/2022 |  | 3/25/2023 |  | 3/19/2022 |  | 3/25/2023 |  | 3/19/2022\nService cost | $ | 76 |  |  | $ | 114 |  |  | $ | 8 |  |  | $ | 17 |  |  | $ | 6 |  |  | $ | 8 | \nOther pension and retiree medical benefits income: |  |  |  | \nInterest cost | 137 |  |  | 88 |  |  | 25 |  |  | 17 |  |  | 8 |  |  | 4 | \nExpected return on plan assets | (197) |  |  | (215) |  |  | (35) |  |  | (42) |  |  | (3) |  |  | (3) | \nAmortization of prior service credits | (6) |  |  | (6) |  |  | \u2014 |  |  | \u2014 |  |  | (1) |  |  | (2) | \nAmortization of net losses/(gains) | 16 |  |  | 33 |  |  | 2 |  |  | 5 |  |  | (6) |  |  | (3) | \nSettlement/curtailment gains | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (16) | \nSpecial termination benefits | (1) |  |  | 6 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nTotal other pension and retiree medical benefits income | (51) |  |  | (94) |  |  | (8) |  |  | (20) |  |  | (2) |  |  | (20) | \nTotal | $ | 25 |  |  | $ | 20 |  |  | $ | \u2014 |  |  | $ | (3) |  |  | $ | 4 |  |  | $ | (12) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nInterest Rate |  | Maturity Date |  | Principal Amount(a) | \nFloating rate |  | February 2026 |  | $ | 350 |  | \n4.550 | % |  | February 2026 |  | $ | 500 |  | \n4.450 | % |  | May 2028 |  | $ | 650 |  | \n4.450 | % |  | February 2033 |  | $ | 1,000 |  | \n4.650 | % |  | February 2053 |  | $ | 500 |  |   |  |  |  |  |  |  |  |  |  |  | \n | Notional Amounts(a)\n | 3/25/2023 |  | 12/31/2022\nCommodity | $ | 1.8 |  |  | $ | 1.8 | \nForeign exchange | $ | 2.8 |  |  | $ | 3.0 | \nInterest rate | $ | 1.3 |  |  | $ | 1.3 | \nNet investment(b) | $ | 2.9 |  |  | $ | 2.9 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 3/25/2023 |  | 12/31/2022\n | Fair Value Hierarchy Levels(a) |  | Assets(a) |  | Liabilities(a) |  | Assets(a) |  | Liabilities(a)\n |  |  |  |  |  |  |  |  | \nAvailable-for-sale debt securities(b) | 2 |  | $ | 658 |  |  | $ | \u2014 |  |  | $ | 660 |  |  | $ | \u2014 | \nIndex funds(c) | 1 |  | $ | 250 |  |  | $ | \u2014 |  |  | $ | 257 |  |  | $ | \u2014 | \nPrepaid forward contracts(d) | 2 |  | $ | 14 |  |  | $ | \u2014 |  |  | $ | 14 |  |  | $ | \u2014 | \nDeferred compensation(e) | 2 |  | $ | \u2014 |  |  | $ | 432 |  |  | $ | \u2014 |  |  | $ | 434 | \n |  |  |  |  |  |  |  |  | \nDerivatives designated as cash flow hedging instruments: |  |  |  |  |  |  |  |  | \nForeign exchange(f) | 2 |  | $ | 23 |  |  | $ | 34 |  |  | $ | 24 |  |  | $ | 22 | \nInterest rate(f) | 2 |  | \u2014 |  |  | 175 |  |  | \u2014 |  |  | 164 | \nCommodity(g) | 2 |  | 2 |  |  | 50 |  |  | 2 |  |  | 60 | \n |  |  | $ | 25 |  |  | $ | 259 |  |  | $ | 26 |  |  | $ | 246 | \nDerivatives not designated as hedging instruments: |  |  |  |  |  |  |  |  | \nForeign exchange(f) | 2 |  | $ | 17 |  |  | $ | 17 |  |  | $ | 21 |  |  | $ | 21 | \nCommodity(g) | 2 |  | 9 |  |  | 45 |  |  | 11 |  |  | 51 | \n |  |  | $ | 26 |  |  | $ | 62 |  |  | $ | 32 |  |  | $ | 72 | \nTotal derivatives at fair value(h) |  |  | $ | 51 |  |  | $ | 321 |  |  | $ | 58 |  |  | $ | 318 | \nTotal |  |  | $ | 973 |  |  | $ | 753 |  |  | $ | 989 |  |  | $ | 752 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | 12 Weeks Ended\n |  |  | Losses/(Gains)Recognized inAccumulated\u00a0OtherComprehensive\u00a0Loss |  | Losses/(Gains)Reclassified fromAccumulated\u00a0OtherComprehensive\u00a0Lossinto Income Statement(a)\n |  |  |  |  | 3/25/2023 |  | 3/19/2022 |  | 3/25/2023 |  | 3/19/2022\nForeign exchange |  |  |  |  | $ | 16 |  |  | $ | (8) |  |  | $ | 1 |  |  | $ | (4) | \nInterest rate |  |  |  |  | 11 |  |  | (3) |  |  | 3 |  |  | 20 | \nCommodity |  |  |  |  | 65 |  |  | (189) |  |  | 9 |  |  | (78) | \nNet investment |  |  |  |  | 37 |  |  | (51) |  |  | \u2014 |  |  | \u2014 | \nTotal |  |  |  |  | $ | 129 |  |  | $ | (251) |  |  | $ | 13 |  |  | $ | (62) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 3/25/2023 |  | 3/19/2022\n | Cost of sales |  | Selling, general and administrative expenses |  | Total |  | Cost of sales |  | Selling, general and administrative expenses |  | Total\nForeign exchange | $ | (1) |  |  | $ | (5) |  |  | $ | (6) |  |  | $ | 11 |  |  | $ | (27) |  |  | $ | (16) | \nCommodity | 31 |  |  | 50 |  |  | 81 |  | (74) |  |  | (92) |  |  | (166) | \nTotal | $ | 30 |  |  | $ | 45 |  |  | $ | 75 |  |  | $ | (63) |  |  | $ | (119) |  |  | $ | (182) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 3/25/2023 |  | 3/19/2022\n | Income |  | Shares(a) |  | Income |  | Shares(a)\n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nBasic net income attributable to PepsiCo per common share | $ | 1.40 |  |  |  |  | $ | 3.08 |  |  | \nNet income available for PepsiCo common shareholders | $ | 1,932 |  |  | 1,378 |  |  | $ | 4,261 |  |  | 1,383 | \nDilutive securities: |  |  |  |  |  |  | \nStock options, RSUs, PSUs and other(b) | \u2014 |  |  | 6 |  |  | \u2014 |  |  | 8 | \nDiluted | $ | 1,932 |  |  | 1,384 |  |  | $ | 4,261 |  |  | 1,391 | \nDiluted net income attributable to PepsiCo per common share | $ | 1.40 |  |  |  |  | $ | 3.06 |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Currency Translation Adjustment |  | Cash Flow Hedges |  | Pension and Retiree Medical |  |  |  | Other |  | Accumulated Other Comprehensive Loss Attributable to PepsiCo\nBalance as of December 31, 2022(a) | $ | (12,948) |  |  | $ | 1 |  |  | $ | (2,361) |  |  |  |  | $ | 6 |  |  | $ | (15,302) | \nOther comprehensive (loss) before reclassifications(b) | (350) |  |  | (92) |  |  | (9) |  |  |  |  | (1) |  |  | (452) | \nAmounts reclassified from accumulated other comprehensive loss(c) | 108 |  |  | 13 |  |  | 5 |  |  |  |  | \u2014 |  |  | 126 | \nNet other comprehensive (loss) | (242) |  |  | (79) |  |  | (4) |  |  |  |  | (1) |  |  | (326) | \nTax amounts | 7 |  |  | 20 |  |  | \u2014 |  |  |  |  | \u2014 |  |  | 27 | \nBalance as of March 25, 2023(a) | $ | (13,183) |  |  | $ | (58) |  |  | $ | (2,365) |  |  |  |  | $ | 5 |  |  | $ | (15,601) | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Currency Translation Adjustment |  | Cash Flow Hedges |  | Pension and Retiree Medical |  |  |  | Other |  | Accumulated Other Comprehensive Loss Attributable to PepsiCo\nBalance as of December 25, 2021(a) | $ | (12,309) |  |  | $ | 159 |  |  | $ | (2,750) |  |  |  |  | $ | 2 |  |  | $ | (14,898) | \nOther comprehensive (loss)/income before reclassifications(b) | (549) |  |  | 200 |  |  | (8) |  |  |  |  | \u2014 |  |  | (357) | \nAmounts reclassified from accumulated other comprehensive loss | \u2014 |  |  | (62) |  |  | 25 |  |  |  |  | \u2014 |  |  | (37) | \nNet other comprehensive (loss)/income | (549) |  |  | 138 |  |  | 17 |  |  |  |  | \u2014 |  |  | (394) | \nTax amounts | (11) |  |  | (32) |  |  | (4) |  |  |  |  | (4) |  |  | (51) | \nBalance as of March 19, 2022(a) | $ | (12,869) |  |  | $ | 265 |  |  | $ | (2,737) |  |  |  |  | $ | (2) |  |  | $ | (15,343) | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | 12 Weeks Ended |  | \n |  |  |  |  |  | 3/25/2023 |  | 3/19/2022 |  | Affected Line Item in the Income Statement\n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \nCurrency translation: |  |  |  |  |  |  |  |  |  | \nDivestitures |  |  |  |  |  | $ | 108 |  |  | $ | \u2014 |  |  | Selling, general and administrative expenses\n |  |  |  |  |  |  |  |  |  | \nCash flow hedges: |  |  |  |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  | $ | (2) |  |  | $ | (2) |  |  | Net revenue\nForeign exchange contracts |  |  |  |  |  | 3 |  |  | (2) |  |  | Cost of sales\nInterest rate derivatives |  |  |  |  |  | 3 |  |  | 20 |  |  | Selling, general and administrative expenses\nCommodity contracts |  |  |  |  |  | 10 |  |  | (76) |  |  | Cost of sales\nCommodity contracts |  |  |  |  |  | (1) |  |  | (2) |  |  | Selling, general and administrative expenses\nNet losses/(gains) before tax |  |  |  |  |  | 13 |  |  | (62) |  |  | \nTax amounts |  |  |  |  |  | (4) |  |  | 10 |  |  | \nNet losses/(gains) after tax |  |  |  |  |  | $ | 9 |  |  | $ | (52) |  |  | \n |  |  |  |  |  |  |  |  |  | \nPension and retiree medical items: |  |  |  |  |  |  |  |  |  | \nAmortization of prior service credits |  |  |  |  |  | $ | (7) |  |  | $ | (8) |  |  | Other pension and retiree medical benefits income\nAmortization of net losses |  |  |  |  |  | 12 |  |  | 35 |  |  | Other pension and retiree medical benefits income\nSettlement/curtailment gains |  |  |  |  |  | \u2014 |  |  | (2) |  |  | Other pension and retiree medical benefits income\nNet losses before tax |  |  |  |  |  | 5 |  |  | 25 |  |  | \nTax amounts |  |  |  |  |  | (1) |  |  | (6) |  |  | \nNet losses after tax |  |  |  |  |  | $ | 4 |  |  | $ | 19 |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \nTotal net losses/(gains) reclassified, net of tax |  |  |  |  |  | $ | 121 |  |  | $ | (33) |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended |  | \n |  |  |  |  | 3/25/2023 |  | 3/19/2022 |  | \n |  |  |  |  |  |  |  |  | \nPBNA |  |  |  |  | $ | 2 |  |  | $ | 37 |  |  | \nEurope |  |  |  |  | \u2014 |  |  | 10 |  |  | \n |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \nCorporate |  |  |  |  | \u2014 |  |  | 3 |  |  | \n |  |  |  |  |  |  |  |  | \nTotal(a) |  |  |  |  | 2 |  |  | 50 |  |  | \nOther pension and retiree medical benefits expense |  |  |  |  | \u2014 |  |  | 6 |  |  | \nTotal acquisition and divestiture-related charges |  |  |  |  | $ | 2 |  |  | $ | 56 |  |  | \nAfter-tax amount |  |  |  |  | $ | 1 |  |  | $ | 47 |  |  | \nImpact on net income attributable to PepsiCo per common share |  |  |  |  | $ | \u2014 |  |  | $ | (0.03) |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended\n |  |  |  |  |  |  | 3/25/2023 |  | 3/19/2022 |  | Change\nNet revenue |  |  |  |  |  |  | $ | 17,846 |  |  | $ | 16,200 |  |  | 10 | %\nOperating profit |  |  |  |  |  |  | $ | 2,629 |  |  | $ | 5,267 |  |  | (50) | %\nOperating margin |  |  |  |  |  |  | 14.7 | % |  | 32.5 | % |  | (17.8) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended | \n |  |  |  |  |  |  | 3/25/2023 |  | 3/19/2022 |  | Change | \nOther pension and retiree medical benefits income |  |  |  |  |  |  | $ | 61 |  |  | $ | 134 |  |  | $ | (73) |  | \nNet interest expense and other |  |  |  |  |  |  | $ | (200) |  |  | $ | (240) |  |  | $ | 40 |  | \nTax rate |  |  |  |  |  |  | 21.9 | % |  | 17.2 | % |  |  | \nNet income attributable to PepsiCo(a) |  |  |  |  |  |  | $ | 1,932 |  |  | $ | 4,261 |  |  | (55) | % | \nNet income attributable to PepsiCo per common share \u2013 diluted(a) |  |  |  |  |  |  | $ | 1.40 |  |  | $ | 3.06 |  |  | (54) | % | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 3/25/2023\n |  |  | Impact of |  |  |  |  |  |  |  | Impact of\n | Reported% Change, GAAP Measure |  | Foreign exchange translation |  | Acquisitions and divestitures |  |  |  | Organic% Change, Non-GAAP Measure(a) |  |  |  |  |  | Organic volume(b) |  | Effective net pricing\nFLNA | 15 | % |  | \u2014 |  |  | \u2014 |  |  |  |  | 16 | % |  |  |  |  |  | \u2014 |  |  | 16 | \nQFNA | 9 | % |  | 1 |  |  | \u2014 |  |  |  |  | 10 | % |  |  |  |  |  | (5) |  |  | 15 | \nPBNA | 8 | % |  | \u2014 |  |  | 3 |  |  |  |  | 12 | % |  |  |  |  |  | (3) |  |  | 15 | \nLatAm | 21 | % |  | (6) |  |  | 1 |  |  |  |  | 16 | % |  |  |  |  |  | 1 |  |  | 15 | \nEurope | 5 | % |  | 5 |  |  | 4 |  |  |  |  | 14 | % |  |  |  |  |  | (9) |  |  | 23 | \nAMESA | 2 | % |  | 28 |  |  | \u2014 |  |  |  |  | 29 | % |  |  |  |  |  | (2) |  |  | 31 | \nAPAC | (1) | % |  | 6 |  |  | \u2014 |  |  |  |  | 4 | % |  |  |  |  |  | 2 |  |  | 2.5 | \nTotal | 10 | % |  | 2.5 |  |  | 2 |  |  |  |  | 14 | % |  |  |  |  |  | (2) |  |  | 16 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 3/25/2023\n |  |  | Items Affecting Comparability(a) |  | \n | Reported, GAAP Measure |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges |  |  |  | Impairment and other charges/credits(b) |  |  |  | Core,Non-GAAP Measure\nFLNA | $ | 1,599 |  |  | $ | \u2014 |  |  | $ | 7 |  |  | $ | \u2014 |  |  |  |  | $ | \u2014 |  |  |  |  | $ | 1,606 | \nQFNA | 188 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | \u2014 |  |  |  |  | 188 | \nPBNA | 483 |  |  | \u2014 |  |  | 5 |  |  | 2 |  |  |  |  | \u2014 |  |  |  |  | 490 | \nLatAm | 364 |  |  | \u2014 |  |  | 5 |  |  | \u2014 |  |  |  |  | \u2014 |  |  |  |  | 369 | \nEurope | 71 |  |  | \u2014 |  |  | 89 |  |  | \u2014 |  |  |  |  | \u2014 |  |  |  |  | 160 | \nAMESA | 168 |  |  | \u2014 |  |  | 5 |  |  | \u2014 |  |  |  |  | (13) |  |  |  |  | 160 | \nAPAC | 227 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  |  |  | \u2014 |  |  |  |  | 228 | \nCorporate unallocated expenses | (471) |  |  | 71 |  |  | 1 |  |  | \u2014 |  |  |  |  | \u2014 |  |  |  |  | (399) | \nTotal | $ | 2,629 |  |  | $ | 71 |  |  | $ | 113 |  |  | $ | 2 |  |  |  |  | $ | (13) |  |  |  |  | $ | 2,802 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 3/19/2022\n |  |  | Items Affecting Comparability(a) |  | \n | Reported,GAAP Measure |  | Mark-to-market net impact |  | Restructuringand impairment charges |  | Acquisition and divestiture-related charges |  | Gain associated with the Juice Transaction |  | Impairment and other charges/credits |  |  |  | Core,Non-GAAP Measure\nFLNA | $ | 1,296 |  |  | $ | \u2014 |  |  | $ | 3 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  |  |  | $ | 1,299 | \nQFNA | 159 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 159 | \nPBNA | 3,434 |  |  | \u2014 |  |  | 3 |  |  | 37 |  |  | (3,024) |  |  | \u2014 |  |  |  |  | 450 | \nLatAm | 323 |  |  | \u2014 |  |  | 6 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 329 | \nEurope | (136) |  |  | \u2014 |  |  | 7 |  |  | 10 |  |  | (298) |  |  | 482 |  |  |  |  | 65 | \nAMESA | 180 |  |  | \u2014 |  |  | 2 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 182 | \nAPAC | 215 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 216 | \nCorporate unallocated expenses | (204) |  |  | (112) |  |  | 5 |  |  | 3 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | (308) | \nTotal | $ | 5,267 |  |  | $ | (112) |  |  | $ | 27 |  |  | $ | 50 |  |  | $ | (3,322) |  |  | $ | 482 |  |  |  |  | $ | 2,392 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 3/25/2023\n |  |  | Impact of Items Affecting Comparability(a) |  |  |  |  |  |  |  | Impact of |  | \n | Reported % Change, GAAP Measure |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges |  | Gain associated with the Juice Transaction |  | Impairment and other charges/credits |  |  |  |  |  | Core% Change, Non-GAAP Measure(b) |  | Foreign exchangetranslation |  | Core Constant Currency% Change, Non-GAAP Measure(b)\nFLNA | 23 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  |  |  | 24 | % |  | \u2014 |  |  | 24 | %\nQFNA | 18 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  |  |  | 18 | % |  | \u2014 |  |  | 19 | %\nPBNA | (86) | % |  | \u2014 |  |  | \u2014 |  |  | (1) |  |  | 96 |  |  | \u2014 |  |  |  |  |  |  | 9 | % |  | 1 |  |  | 10 | %\nLatAm | 13 | % |  | \u2014 |  |  | (1) |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  |  |  | 12 | % |  | (6) |  |  | 6 | %\nEurope | n/m |  | \u2014 |  |  | n/m |  | n/m |  | n/m |  | n/m |  |  |  |  |  | 148 | % |  | 11 |  |  | 159 | %\nAMESA | (6) | % |  | \u2014 |  |  | 2 |  |  | \u2014 |  |  | \u2014 |  |  | (7) |  |  |  |  |  |  | (12) | % |  | 23 |  |  | 11 | %\nAPAC | 5.5 | % |  | \u2014 |  |  | 1 |  |  | (1) |  |  | \u2014 |  |  | \u2014 |  |  |  |  |  |  | 5.5 | % |  | 6 |  |  | 11 | %\nCorporate unallocated expenses | 132 | % |  | (105) |  |  | 3 |  |  | 1 |  |  | \u2014 |  |  | \u2014 |  |  |  |  |  |  | 30 | % |  | \u2014 |  |  | 30 | %\nTotal | (50) | % |  | 4 |  |  | 2 |  |  | (1) |  |  | 73 |  |  | (11) |  |  |  |  |  |  | 17 | % |  | 2 |  |  | 19 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 3/25/2023\n | Cost of sales |  | Gross profit |  | Selling, general and administrative expenses |  |  |  |  |  | Operating profit |  | Other pension and retiree medical benefits income |  |  |  | Provision for income taxes(a) |  | Net income attributable to noncontrolling interests |  | Net income attributable to PepsiCo\nReported, GAAP Measure | $ | 7,988 |  |  | $ | 9,858 |  |  | $ | 7,229 |  |  |  |  |  |  | $ | 2,629 |  |  | $ | 61 |  |  |  |  | $ | 546 |  |  | $ | 12 |  |  | $ | 1,932 | \nItems Affecting Comparability |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMark-to-market net impact | (14) |  |  | 14 |  |  | (57) |  |  |  |  |  |  | 71 |  |  | \u2014 |  |  |  |  | 17 |  |  | \u2014 |  |  | 54 | \nRestructuring and impairment charges | (3) |  |  | 3 |  |  | (110) |  |  |  |  |  |  | 113 |  |  | (1) |  |  |  |  | 14 |  |  | 1 |  |  | 97 | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  | (2) |  |  |  |  |  |  | 2 |  |  | \u2014 |  |  |  |  | 1 |  |  | \u2014 |  |  | 1 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nImpairment and other charges/credits | 4 |  |  | (4) |  |  | 9 |  |  |  |  |  |  | (13) |  |  | \u2014 |  |  |  |  | \u2014 |  |  | \u2014 |  |  | (13) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCore, Non-GAAP Measure | $ | 7,975 |  |  | $ | 9,871 |  |  | $ | 7,069 |  |  |  |  |  |  | $ | 2,802 |  |  | $ | 60 |  |  |  |  | $ | 578 |  |  | $ | 13 |  |  | $ | 2,071 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 3/19/2022\n | Cost of sales |  | Gross profit |  | Selling, general and administrative expenses |  | Gain associated with the Juice Transaction |  | Impairment of intangible assets |  | Operating profit |  | Other pension and retiree medical benefits income |  | Provision for income taxes(a) |  |  |  | Net income attributable to PepsiCo\nReported, GAAP Measure | $ | 7,433 |  |  | $ | 8,767 |  |  | $ | 6,580 |  |  | $ | (3,322) |  |  | $ | 242 |  |  | $ | 5,267 |  |  | $ | 134 |  |  | $ | 888 |  |  |  |  | $ | 4,261 | \nItems Affecting Comparability |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMark-to-market net impact | 33 |  |  | (33) |  |  | 79 |  |  | \u2014 |  |  | \u2014 |  |  | (112) |  |  | \u2014 |  |  | (26) |  |  |  |  | (86) | \nRestructuring and impairment charges | (5) |  |  | 5 |  |  | (22) |  |  | \u2014 |  |  | \u2014 |  |  | 27 |  |  | \u2014 |  |  | 6 |  |  |  |  | 21 | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  | (50) |  |  | \u2014 |  |  | \u2014 |  |  | 50 |  |  | 6 |  |  | 9 |  |  |  |  | 47 | \nGain associated with the Juice Transaction | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 3,322 |  |  | \u2014 |  |  | (3,322) |  |  | \u2014 |  |  | (452) |  |  |  |  | (2,870) | \nImpairment and other charges/credits | (140) |  |  | 140 |  |  | (100) |  |  | \u2014 |  |  | (242) |  |  | 482 |  |  | \u2014 |  |  | 48 |  |  |  |  | 434 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPension and retiree medical-related impact | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (16) |  |  | (4) |  |  |  |  | (12) | \nCore, Non-GAAP Measure | $ | 7,321 |  |  | $ | 8,879 |  |  | $ | 6,487 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 2,392 |  |  | $ | 124 |  |  | $ | 469 |  |  |  |  | $ | 1,795 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 12 Weeks Ended | \n |  |  |  |  |  |  | 3/25/2023 |  | 3/19/2022 |  | Change | \nNet income attributable to PepsiCo per common share \u2013 diluted, GAAP measure |  |  |  |  |  |  | $ | 1.40 |  |  | $ | 3.06 |  |  | (54) | % | \nMark-to-market net impact |  |  |  |  |  |  | 0.04 |  |  | (0.06) |  |  |  | \nRestructuring and impairment charges |  |  |  |  |  |  | 0.07 |  |  | 0.02 |  |  |  | \nAcquisition and divestiture-related charges |  |  |  |  |  |  | \u2014 |  |  | 0.03 |  |  |  | \nGain associated with the Juice Transaction |  |  |  |  |  |  | \u2014 |  |  | (2.06) |  |  |  | \nImpairment and other charges/credits |  |  |  |  |  |  | (0.01) |  |  | 0.31 |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \nPension and retiree medical-related impact |  |  |  |  |  |  | \u2014 |  |  | (0.01) |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \nCore net income attributable to PepsiCo per common share \u2013 diluted, non-GAAP measure |  |  |  |  |  |  | $ | 1.50 |  |  | $ | 1.29 |  |  | 16 | % | \nImpact of foreign exchange translation |  |  |  |  |  |  |  |  |  |  | 2 |  | \nGrowth in core net income attributable to PepsiCo per common share \u2013 diluted, on a constant currency basis, non-GAAP measure |  |  |  |  |  |  |  |  |  |  | 18 | % |   |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | 3/25/2023 |  | 3/19/2022 |  | \nNet cash used for operating activities, GAAP measure | $ | (392) |  |  | $ | (174) |  |  | \nCapital spending | (581) |  |  | (522) |  |  | \nSales of property, plant and equipment | 19 |  |  | 3 |  |  | \nFree cash flow, non-GAAP measure | $ | (954) |  |  | $ | (693) |  |  | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | Change(a) |  | Reference\nShort-term debt obligations | $ | 0.9 |  |  | (b)\nAccounts payable and other current liabilities | $ | (1.8) |  |  | (c)\nLong-term debt obligations | $ | 1.8 |  |  | (d)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod |  | TotalNumber ofSharesRepurchased(a) |  | Average\u00a0PricePaid\u00a0Per\u00a0Share |  | Total\u00a0Numberof SharesPurchased asPart\u00a0of\u00a0PubliclyAnnouncedPlans orPrograms |  | MaximumNumber (orApproximateDollar\u00a0Value)\u00a0ofShares That May Yet BePurchasedUnder\u00a0the\u00a0Plansor Programs\n12/31/2022 |  |  |  |  |  |  |  | $ | 8,500 | \n1/1/2023 - 1/28/2023 |  | \u2014 |  |  | $ | \u2014 |  |  | \u2014 |  |  | \u2014 | \n |  |  |  |  |  |  |  | 8,500 | \n1/29/2023 - 2/25/2023 |  | 0.2 |  |  | $ | 175.93 |  |  | 0.2 |  |  | (27) | \n |  |  |  |  |  |  |  | 8,473 | \n2/26/2023 - 3/25/2023 |  | 0.8 |  |  | $ | 174.40 |  |  | 0.8 |  |  | (147) | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nTotal |  | 1.0 |  |  | $ | 174.63 |  |  | 1.0 |  |  | $ | 8,326 |   |  | \nSee \u201cIndex to Exhibits\u201d on page43.  |  |  |  |  | \nEXHIBIT | \nExhibit 3.1 | Amended and Restated Articles of Incorporation of PepsiCo, Inc., effective as of May 1, 2019, which are incorporated herein by reference to Exhibit 3.1 to PepsiCo, Inc.\u2019s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 3, 2019.\nExhibit 3.2 | By-Laws of PepsiCo, Inc., as amended and restated, effective as of April 15, 2020, which are incorporated herein by reference to Exhibit 3.2 to PepsiCo, Inc.\u2019s Current Report on Form 8-K filed with the Securities and Exchange Commission on April 16, 2020.\nExhibit 10.1 | Form of Annual Long-Term Incentive Agreement.\nExhibit 15 | Letter re: Unaudited Interim Financial Information.\nExhibit 31 | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.\nExhibit 32 | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.\nExhibit 101 | The following materials from PepsiCo, Inc.\u2019s Quarterly Report on Form 10-Q for the quarter ended March 25, 2023 formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Statement of Income, (ii) the Condensed Consolidated Statement of Comprehensive Income, (iii) the Condensed Consolidated Statement of Cash Flows, (iv) the Condensed Consolidated Balance Sheet, (v) the Condensed Consolidated Statement of Equity, and (vi) Notes to the Condensed Consolidated Financial Statements.\nExhibit 104 | The cover page from the Company\u2019s Quarterly Report on Form 10-Q for the quarter ended March 25, 2023, formatted in iXBRL and contained in Exhibit 101.  |  |  |  |  |  |  |  |  |  |  | \n |  |  | \n |  | PepsiCo, Inc. | \n |  | (Registrant) | \n |  |  | \nDate: | April 24, 2023 | /s/ Marie T. Gallagher | \n |  | Marie T. Gallagher | \n |  | Senior Vice President and Controller | \n |  | (Principal Accounting Officer) | \n |  |  | \nDate: | April 24, 2023 | /s/ David Flavell | \n |  | David Flavell | \n |  | Executive Vice President, General Counsel and Corporate Secretary | \n |  | (Duly Authorized Officer) | "}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Pepsico, in 2023 Q2, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  | \n\u2612 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \n\u2610 | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  | \nPepsiCo, Inc.  |  |  |  |  |  |  |  | \n |  | \nNorth Carolina |  | 13-1584302\n(State or Other Jurisdiction ofIncorporation or Organization) |  | (I.R.S. EmployerIdentification No.)\n | \n |  | \n |  |   |  | \n(Address of principal executive offices and Zip Code)  |  | \nRegistrant's telephone number, including area code  |  | \n(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTitle of each class |  | Trading Symbols |  | Name of each exchange on which registered\nCommon Stock, par value 1-2/3 cents per share |  | PEP |  | The Nasdaq Stock Market LLC\n0.250% Senior Notes Due 2024 |  | PEP24 |  | The Nasdaq Stock Market LLC\n2.625% Senior Notes Due 2026 |  | PEP26 |  | The Nasdaq Stock Market LLC\n0.750% Senior Notes Due 2027 |  | PEP27 |  | The Nasdaq Stock Market LLC\n0.875% Senior Notes Due 2028 |  | PEP28 |  | The Nasdaq Stock Market LLC\n0.500% Senior Notes Due 2028 |  | PEP28a |  | The Nasdaq Stock Market LLC\n3.200% Senior Notes Due 2029 |  | PEP29 |  | The Nasdaq Stock Market LLC\n1.125% Senior Notes Due 2031 |  | PEP31 |  | The Nasdaq Stock Market LLC\n0.400% Senior Notes Due 2032 |  | PEP32 |  | The Nasdaq Stock Market LLC\n0.750% Senior Notes Due 2033 |  | PEP33 |  | The Nasdaq Stock Market LLC\n3.550% Senior Notes Due 2034 |  | PEP34 |  | The Nasdaq Stock Market LLC\n0.875% Senior Notes Due 2039 |  | PEP39 |  | The Nasdaq Stock Market LLC\n1.050% Senior Notes Due 2050 |  | PEP50 |  | The Nasdaq Stock Market LLC  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 | Accelerated filer | \u2610\nNon-accelerated filer | \u2610 | Smaller reporting company | \u2610\n |  | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \n |  | Page\u00a0No.\nPart I        Financial Information | \nItem 1. | Condensed Consolidated Financial Statements | 2\n | Condensed Consolidated Statement of Income \u201312and 24Weeks EndedJune17, 2023 andJune11, 2022 | 2\n | Condensed Consolidated Statement of Comprehensive Income \u201312and 24Weeks EndedJune17, 2023 andJune11, 2022 | 3\n | Condensed Consolidated Statement of Cash Flows \u201324Weeks EndedJune17, 2023 andJune11, 2022 | 4\n | Condensed Consolidated Balance Sheet \u2013June17, 2023 and December 31, 2022 | 6\n | Condensed Consolidated Statement of Equity \u201312 Weeksand 24 WeeksEndedJune17, 2023 andJune11, 2022 | 7\n | Notes to the Condensed Consolidated Financial Statements | 8\nItem\u00a02. | Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations | 26\nReport of Independent Registered Public Accounting Firm | 49\nItem 3. | Quantitative and Qualitative Disclosures About Market Risk | 50\nItem 4. | Controls and Procedures | 50\nPart II      Other Information | \nItem 1. | Legal Proceedings | 51\nItem 1A. | Risk Factors | 51\nItem 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 51\nItem 6. | Exhibits | 51  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | 6/17/2023 |  | 6/11/2022 |  | 6/17/2023 |  | 6/11/2022\nNet Revenue | $ | 22,322 |  |  | $ | 20,225 |  |  | $ | 40,168 |  |  | $ | 36,425 | \nCost of sales | 10,121 |  |  | 9,415 |  |  | 18,109 |  |  | 16,848 | \nGross profit | 12,201 |  |  | 10,810 |  |  | 22,059 |  |  | 19,577 | \nSelling, general and administrative expenses | 8,542 |  |  | 7,387 |  |  | 15,771 |  |  | 13,967 | \nGain associated with the Juice Transaction(a) | \u2014 |  |  | (13) |  |  | \u2014 |  |  | (3,335) | \nImpairment of intangible assets (see Notes 1 and 4) | \u2014 |  |  | 1,359 |  |  | \u2014 |  |  | 1,601 | \nOperating Profit | 3,659 |  |  | 2,077 |  |  | 6,288 |  |  | 7,344 | \nOther pension and retiree medical benefits income/(expense) | 60 |  |  | (2) |  |  | 121 |  |  | 132 | \nNet interest expense and other | (201) |  |  | (236) |  |  | (401) |  |  | (476) | \nIncome before income taxes | 3,518 |  |  | 1,839 |  |  | 6,008 |  |  | 7,000 | \nProvision for income taxes | 747 |  |  | 393 |  |  | 1,293 |  |  | 1,281 | \nNet income | 2,771 |  |  | 1,446 |  |  | 4,715 |  |  | 5,719 | \nLess: Net income attributable to noncontrolling interests | 23 |  |  | 17 |  |  | 35 |  |  | 29 | \nNet Income Attributable to PepsiCo | $ | 2,748 |  |  | $ | 1,429 |  |  | $ | 4,680 |  |  | $ | 5,690 | \nNet Income Attributable to PepsiCo per Common Share |  |  |  |  |  |  | \nBasic | $ | 1.99 |  |  | $ | 1.03 |  |  | $ | 3.40 |  |  | $ | 4.11 | \nDiluted | $ | 1.99 |  |  | $ | 1.03 |  |  | $ | 3.38 |  |  | $ | 4.09 | \nWeighted-average common shares outstanding |  |  |  |  |  |  | \nBasic | 1,378 |  |  | 1,382 |  |  | 1,378 |  |  | 1,383 | \nDiluted | 1,384 |  |  | 1,389 |  |  | 1,384 |  |  | 1,390 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | 6/17/2023 |  | 6/11/2022 |  | 6/17/2023 |  | 6/11/2022\nNet income | $ | 2,771 |  |  | $ | 1,446 |  |  | $ | 4,715 |  |  | $ | 5,719 | \nOther comprehensive (loss)/income, net of taxes: |  |  |  |  |  |  | \nNet currency translation adjustment | (198) |  |  | 1,274 |  |  | (433) |  |  | 714 | \nNet change on cash flow hedges | 24 |  |  | (102) |  |  | (35) |  |  | 4 | \nNet pension and retiree medical adjustments | (6) |  |  | (250) |  |  | (10) |  |  | (237) | \n |  |  |  |  |  |  | \nOther | 1 |  |  | 5 |  |  | \u2014 |  |  | 1 | \n | (179) |  |  | 927 |  |  | (478) |  |  | 482 | \nComprehensive income | 2,592 |  |  | 2,373 |  |  | 4,237 |  |  | 6,201 | \nLess: Comprehensive income attributable tononcontrolling interests | 23 |  |  | 17 |  |  | 35 |  |  | 29 | \nComprehensive Income Attributable to PepsiCo | $ | 2,569 |  |  | $ | 2,356 |  |  | $ | 4,202 |  |  | $ | 6,172 |   |  | \n  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended\n | 6/17/2023 |  | 6/11/2022\nOperating Activities |  |  | \nNet income | $ | 4,715 |  |  | $ | 5,719 | \nDepreciation and amortization | 1,268 |  |  | 1,195 | \nGain associated with the Juice Transaction | \u2014 |  |  | (3,335) | \nImpairment and other charges | 97 |  |  | 1,871 | \nOperating lease right-of-use asset amortization | 248 |  |  | 223 | \nShare-based compensation expense | 179 |  |  | 156 | \nRestructuring and impairment charges | 204 |  |  | 75 | \nCash payments for restructuring charges | (187) |  |  | (82) | \nAcquisition and divestiture-related charges | 9 |  |  | 64 | \nCash payments for acquisition and divestiture-related charges | (10) |  |  | (34) | \nPension and retiree medical plan expenses | 62 |  |  | 139 | \nPension and retiree medical plan contributions | (209) |  |  | (214) | \nDeferred income taxes and other tax charges and credits | 270 |  |  | 49 | \n |  |  | \nTax payments related to the Tax Cuts and Jobs Act (TCJ Act) | (309) |  |  | (309) | \nChange in assets and liabilities: |  |  | \nAccounts and notes receivable | (1,330) |  |  | (1,753) | \nInventories | (851) |  |  | (990) | \nPrepaid expenses and other current assets | (271) |  |  | (186) | \nAccounts payable and other current liabilities | (1,960) |  |  | (990) | \nIncome taxes payable | 100 |  |  | 608 | \nOther, net | (6) |  |  | (325) | \nNet Cash Provided by Operating Activities | 2,019 |  |  | 1,881 | \n |  |  | \nInvesting Activities |  |  | \nCapital spending | (1,513) |  |  | (1,499) | \nSales of property, plant and equipment | 122 |  |  | 222 | \nAcquisitions, net of cash acquired, investments in noncontrolled affiliates and purchases of intangible and other assets | (83) |  |  | (29) | \nProceeds associated with the Juice Transaction | \u2014 |  |  | 3,456 | \nOther divestitures, sales of investments in noncontrolled affiliates and other assets | 75 |  |  | 15 | \nShort-term investments, by original maturity: |  |  | \nMore than three months - purchases | (435) |  |  | \u2014 | \nMore than three months - maturities | 363 |  |  | \u2014 | \nThree months or less, net | 16 |  |  | 8 | \nOther investing, net | 32 |  |  | (1) | \nNet Cash (Used for)/Provided by Investing Activities | (1,423) |  |  | 2,172 |   |  | \n  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended\n | 6/17/2023 |  | 6/11/2022\nFinancing Activities |  |  | \nProceeds from issuances of long-term debt | $ | 2,986 |  |  | $ | \u2014 | \nPayments of long-term debt | (2,252) |  |  | (1,652) | \nDebt redemptions | \u2014 |  |  | (1,550) | \nShort-term borrowings, by original maturity: |  |  | \nMore than three months - proceeds | 1,660 |  |  | 1,935 | \nMore than three months - payments | (26) |  |  | \u2014 | \nThree months or less, net | 2,023 |  |  | 844 | \n |  |  | \nCash dividends paid | (3,199) |  |  | (2,997) | \nShare repurchases - common | (453) |  |  | (699) | \n |  |  | \nProceeds from exercises of stock options | 86 |  |  | 89 | \nWithholding tax payments on restricted stock units (RSUs) and performance stock units (PSUs) converted | (119) |  |  | (87) | \nOther financing | (16) |  |  | (15) | \nNet Cash Provided by/(Used for) Financing Activities | 690 |  |  | (4,132) | \nEffect of exchange rate changes on cash and cash equivalents and restricted cash | (144) |  |  | (83) | \nNet Increase/(Decrease) in Cash and Cash Equivalents and Restricted Cash | 1,142 |  |  | (162) | \nCash and Cash Equivalents and Restricted Cash, Beginning of Year | 5,100 |  |  | 5,707 | \nCash and Cash Equivalents and Restricted Cash, End of Period | $ | 6,242 |  |  | $ | 5,545 | \n |  |  | \nSupplemental Non-Cash Activity |  |  | \nRight-of-use assets obtained in exchange for lease obligations | $ | 439 |  |  | $ | 428 | \nDebt discharged via legal defeasance | $ | 94 |  |  | $ | \u2014 |   |  | \n  |  |  |  |  |  |  |  |  |  |  | \n | (Unaudited) |  | \n | 6/17/2023 |  | 12/31/2022\nASSETS |  |  | \nCurrent Assets |  |  | \nCash and cash equivalents | $ | 6,116 |  |  | $ | 4,954 | \nShort-term investments | 338 |  |  | 394 | \n |  |  | \nAccounts and notes receivable, less allowance ($193and $150, respectively) | 11,456 |  |  | 10,163 | \nInventories: |  |  | \nRaw materials and packaging | 2,638 |  |  | 2,366 | \nWork-in-process | 110 |  |  | 114 | \nFinished goods | 3,221 |  |  | 2,742 | \n | 5,969 |  |  | 5,222 | \nPrepaid expenses and other current assets | 1,075 |  |  | 806 | \n |  |  | \nTotal Current Assets | 24,954 |  |  | 21,539 | \nProperty, plant and equipment | 50,804 |  |  | 49,784 | \nAccumulated depreciation | (26,304) |  |  | (25,493) | \nProperty, Plant and Equipment, net | 24,500 |  |  | 24,291 | \nAmortizable Intangible Assets, net | 1,232 |  |  | 1,277 | \nGoodwill | 17,997 |  |  | 18,202 | \nOther Indefinite-Lived Intangible Assets | 14,330 |  |  | 14,309 | \n |  |  | \nInvestments in Noncontrolled Affiliates | 3,038 |  |  | 3,073 | \nDeferred Income Taxes | 4,186 |  |  | 4,204 | \nOther Assets | 5,669 |  |  | 5,292 | \nTotal Assets | $ | 95,906 |  |  | $ | 92,187 | \n |  |  | \nLIABILITIES AND EQUITY |  |  | \nCurrent Liabilities |  |  | \nShort-term debt obligations | $ | 7,613 |  |  | $ | 3,414 | \nAccounts payable and other current liabilities | 22,005 |  |  | 23,371 | \n |  |  | \nTotal Current Liabilities | 29,618 |  |  | 26,785 | \nLong-Term Debt Obligations | 36,008 |  |  | 35,657 | \nDeferred Income Taxes | 4,113 |  |  | 4,133 | \nOther Liabilities | 8,342 |  |  | 8,339 | \nTotal Liabilities | 78,081 |  |  | 74,914 | \nCommitments and contingencies |  |  | \nPepsiCo Common Shareholders\u2019 Equity |  |  | \nCommon stock, par value 12/3\u00a2 per share (authorized3,600shares; issued, net of repurchased common stock at par value:1,377shares) | 23 |  |  | 23 | \nCapital in excess of par value | 4,082 |  |  | 4,134 | \nRetained earnings | 69,135 |  |  | 67,800 | \nAccumulated other comprehensive loss | (15,780) |  |  | (15,302) | \nRepurchased common stock, in excess of par value (490shares) | (39,775) |  |  | (39,506) | \nTotal PepsiCo Common Shareholders\u2019 Equity | 17,685 |  |  | 17,149 | \nNoncontrolling interests | 140 |  |  | 124 | \nTotal Equity | 17,825 |  |  | 17,273 | \nTotal Liabilities and Equity | $ | 95,906 |  |  | $ | 92,187 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | 6/17/2023 |  | 6/11/2022 |  | 6/17/2023 |  | 6/11/2022\n | Shares |  | Amount |  | Shares |  | Amount |  | Shares |  | Amount |  | Shares |  | Amount\n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCommon Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period | 1,378 |  |  | $ | 23 |  |  | 1,384 |  |  | $ | 23 |  |  | 1,377 |  |  | $ | 23 |  |  | 1,383 |  |  | $ | 23 | \nChange in repurchased common stock | (1) |  |  | \u2014 |  |  | (3) |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (2) |  |  | \u2014 | \nBalance, end of period | 1,377 |  |  | 23 |  |  | 1,381 |  |  | 23 |  |  | 1,377 |  |  | 23 |  |  | 1,381 |  |  | 23 | \nCapital in Excess of Par Value |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  | 3,996 |  |  |  |  | 3,893 |  |  |  |  | 4,134 |  |  |  |  | 4,001 | \nShare-based compensation expense |  |  | 85 |  |  |  |  | 76 |  |  |  |  | 179 |  |  |  |  | 159 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nStock option exercises, RSUs and PSUs converted |  |  | 5 |  |  |  |  | 3 |  |  |  |  | (111) |  |  |  |  | (103) | \nWithholding tax on RSUs and PSUs converted |  |  | (3) |  |  |  |  | (2) |  |  |  |  | (119) |  |  |  |  | (87) | \nOther |  |  | (1) |  |  |  |  | \u2014 |  |  |  |  | (1) |  |  |  |  | \u2014 | \nBalance, end of period |  |  | 4,082 |  |  |  |  | 3,970 |  |  |  |  | 4,082 |  |  |  |  | 3,970 | \nRetained Earnings |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  | 68,142 |  |  |  |  | 67,934 |  |  |  |  | 67,800 |  |  |  |  | 65,165 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nNet income attributable to PepsiCo |  |  | 2,748 |  |  |  |  | 1,429 |  |  |  |  | 4,680 |  |  |  |  | 5,690 | \nCash dividends declared \u2013 common(a) |  |  | (1,755) |  |  |  |  | (1,600) |  |  |  |  | (3,345) |  |  |  |  | (3,092) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, end of period |  |  | 69,135 |  |  |  |  | 67,763 |  |  |  |  | 69,135 |  |  |  |  | 67,763 | \nAccumulated Other Comprehensive Loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  | (15,601) |  |  |  |  | (15,343) |  |  |  |  | (15,302) |  |  |  |  | (14,898) | \nOther comprehensive (loss)/income attributable to PepsiCo |  |  | (179) |  |  |  |  | 927 |  |  |  |  | (478) |  |  |  |  | 482 | \nBalance, end of period |  |  | (15,780) |  |  |  |  | (14,416) |  |  |  |  | (15,780) |  |  |  |  | (14,416) | \nRepurchased Common Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period | (489) |  |  | (39,518) |  |  | (483) |  |  | (38,305) |  |  | (490) |  |  | (39,506) |  |  | (484) |  |  | (38,248) | \nShare repurchases | (2) |  |  | (292) |  |  | (3) |  |  | (518) |  |  | (3) |  |  | (466) |  |  | (4) |  |  | (731) | \nStock option exercises, RSUs and PSUs converted | 1 |  |  | 35 |  |  | \u2014 |  |  | 36 |  |  | 3 |  |  | 197 |  |  | 2 |  |  | 192 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, end of period | (490) |  |  | (39,775) |  |  | (486) |  |  | (38,787) |  |  | (490) |  |  | (39,775) |  |  | (486) |  |  | (38,787) | \nTotal PepsiCo Common Shareholders\u2019 Equity |  |  | 17,685 |  |  |  |  | 18,553 |  |  |  |  | 17,685 |  |  |  |  | 18,553 | \nNoncontrolling Interests |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  | 133 |  |  |  |  | 118 |  |  |  |  | 124 |  |  |  |  | 108 | \nNet income attributable to noncontrolling interest |  |  | 23 |  |  |  |  | 17 |  |  |  |  | 35 |  |  |  |  | 29 | \nDistributions to noncontrolling interests |  |  | (14) |  |  |  |  | (14) |  |  |  |  | (15) |  |  |  |  | (14) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOther, net |  |  | (2) |  |  |  |  | \u2014 |  |  |  |  | (4) |  |  |  |  | (2) | \nBalance, end of period |  |  | 140 |  |  |  |  | 121 |  |  |  |  | 140 |  |  |  |  | 121 | \nTotal Equity |  |  | $ | 17,825 |  |  |  |  | $ | 18,674 |  |  |  |  | $ | 17,825 |  |  |  |  | $ | 18,674 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | 6/17/2023 |  | 6/11/2022 |  | 6/17/2023 |  | 6/11/2022\nFLNA | $ | 5,904 |  |  | $ | 5,181 |  |  | $ | 11,487 |  |  | $ | 10,020 | \nQFNA | 684 |  |  | 675 |  |  | 1,461 |  |  | 1,388 | \nPBNA | 6,755 |  |  | 6,120 |  |  | 12,553 |  |  | 11,473 | \nLatAm | 2,856 |  |  | 2,415 |  |  | 4,633 |  |  | 3,889 | \nEurope | 3,428 |  |  | 3,023 |  |  | 5,314 |  |  | 4,820 | \nAMESA | 1,568 |  |  | 1,696 |  |  | 2,587 |  |  | 2,700 | \nAPAC | 1,127 |  |  | 1,115 |  |  | 2,133 |  |  | 2,135 | \nTotal | $ | 22,322 |  |  | $ | 20,225 |  |  | $ | 40,168 |  |  | $ | 36,425 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 6/17/2023 |  | 6/11/2022\n | Beverages(a) |  | Convenient Foods |  | Beverages(a) |  | Convenient Foods\nLatAm | 10 | % |  | 90 | % |  | 10 | % |  | 90 | %\nEurope | 50 | % |  | 50 | % |  | 50 | % |  | 50 | %\nAMESA | 30 | % |  | 70 | % |  | 35 | % |  | 65 | %\nAPAC | 25 | % |  | 75 | % |  | 25 | % |  | 75 | %\nPepsiCo | 40 | % |  | 60 | % |  | 45 | % |  | 55 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended |  |  |  |  | \n | 6/17/2023 |  | 6/11/2022 |  |  |  |  | \n | Beverages(a) |  | Convenient Foods |  | Beverages(a) |  | Convenient Foods |  |  |  |  | \nLatAm | 10 | % |  | 90 | % |  | 10 | % |  | 90 | % |  |  |  |  | \nEurope | 50 | % |  | 50 | % |  | 50 | % |  | 50 | % |  |  |  |  | \nAMESA | 30 | % |  | 70 | % |  | 30 | % |  | 70 | % |  |  |  |  | \nAPAC | 20 | % |  | 80 | % |  | 20 | % |  | 80 | % |  |  |  |  | \nPepsiCo | 40 | % |  | 60 | % |  | 45 | % |  | 55 | % |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | 6/17/2023 |  | 6/11/2022 |  | 6/17/2023 |  | 6/11/2022\nFLNA | $ | 1,647 |  |  | $ | 1,448 |  |  | $ | 3,246 |  |  | $ | 2,744 | \nQFNA | 129 |  |  | 135 |  |  | 317 |  |  | 294 | \nPBNA(a) (b) (c) | 723 |  |  | 651 |  |  | 1,206 |  |  | 4,085 | \nLatAm(d) | 592 |  |  | 420 |  |  | 956 |  |  | 743 | \nEurope(a) (e) (f) | 476 |  |  | (797) |  |  | 547 |  |  | (933) | \nAMESA | 250 |  |  | 290 |  |  | 418 |  |  | 470 | \nAPAC | 223 |  |  | 206 |  |  | 450 |  |  | 421 | \nTotal divisions | 4,040 |  |  | 2,353 |  |  | 7,140 |  |  | 7,824 | \nCorporate unallocated expenses(g) (h) | (381) |  |  | (276) |  |  | (852) |  |  | (480) | \nTotal | $ | 3,659 |  |  | $ | 2,077 |  |  | $ | 6,288 |  |  | $ | 7,344 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  | 6/11/2022\n |  |  |  |  |  |  | 12 Weeks Ended |  |  |  |  |  |  |  | 24 Weeks Ended\n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nRussia-Ukraine conflict impairment charges |  |  |  |  |  |  | $ | 1,197 |  |  |  |  |  |  |  |  | $ | 1,198 | \nBrand portfolio impairment charges |  |  |  |  |  |  | 162 |  |  |  |  |  |  |  |  | 403 | \nTotal |  |  |  |  |  |  | $ | 1,359 |  |  |  |  |  |  |  |  | $ | 1,601 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | FLNA |  | QFNA |  | PBNA |  | LatAm |  | Europe |  | AMESA |  | APAC |  | Corporate\nExpected pre-tax charges | 15 | % |  | 1 | % |  | 25 | % |  | 10 | % |  | 25 | % |  | 5 | % |  | 4 | % |  | 15 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | 6/17/2023 |  | 6/11/2022 |  | 6/17/2023 |  | 6/11/2022\nCost of sales | $ | 3 |  |  | $ | \u2014 |  |  | $ | 6 |  |  | $ | 5 | \nSelling, general and administrative expenses | 89 |  |  | 45 |  |  | 199 |  |  | 67 | \nOther pension and retiree medical benefits expense/(income)(a) | \u2014 |  |  | 3 |  |  | (1) |  |  | 3 | \nTotal restructuring and impairment charges | $ | 92 |  |  | $ | 48 |  |  | $ | 204 |  |  | $ | 75 | \nAfter-tax amount | $ | 63 |  |  | $ | 40 |  |  | $ | 161 |  |  | $ | 61 | \nImpact on net income attributable to PepsiCo per common share | $ | (0.05) |  |  | $ | (0.03) |  |  | $ | (0.12) |  |  | $ | (0.04) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended |  | Plan to Date\n | 6/17/2023 |  | 6/11/2022 |  | 6/17/2023 |  | 6/11/2022 |  | through 6/17/2023\nFLNA | $ | 6 |  |  | $ | 3 |  |  | $ | 13 |  |  | $ | 6 |  |  | $ | 223 | \nQFNA | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 19 | \nPBNA | 5 |  |  | 2 |  |  | 10 |  |  | 5 |  |  | 236 | \nLatAm | 6 |  |  | 8 |  |  | 11 |  |  | 14 |  |  | 182 | \nEurope | 52 |  |  | 12 |  |  | 141 |  |  | 19 |  |  | 484 | \nAMESA | \u2014 |  |  | 3 |  |  | 5 |  |  | 5 |  |  | 87 | \nAPAC | 4 |  |  | 3 |  |  | 5 |  |  | 4 |  |  | 82 | \nCorporate | 19 |  |  | 14 |  |  | 20 |  |  | 19 |  |  | 249 | \n | 92 |  |  | 45 |  |  | 205 |  |  | 72 |  |  | 1,562 | \nOther pension and retiree medical benefits expense/(income)(a) | \u2014 |  |  | 3 |  |  | (1) |  |  | 3 |  |  | 97 | \nTotal | $ | 92 |  |  | $ | 48 |  |  | $ | 204 |  |  | $ | 75 |  |  | $ | 1,659 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended |  | Plan to Date\n | 6/17/2023 |  | 6/11/2022 |  | 6/17/2023 |  | 6/11/2022 |  | through 6/17/2023\nSeverance and\u00a0other employee costs | $ | 50 |  |  | $ | 20 |  |  | $ | 142 |  |  | $ | 31 |  |  | $ | 949 | \nAsset impairments | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 190 | \nOther\u00a0costs | 42 |  |  | 28 |  |  | 62 |  |  | 44 |  |  | 520 | \nTotal | $ | 92 |  |  | $ | 48 |  |  | $ | 204 |  |  | $ | 75 |  |  | $ | 1,659 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Severance and\u00a0Other Employee Costs |  |  |  | Other\u00a0Costs |  | Total\nLiability as of December 31, 2022 | $ | 188 |  |  |  |  | $ | 8 |  |  | $ | 196 | \n2023 restructuring charges | 142 |  |  |  |  | 62 |  |  | 204 | \nCash payments | (120) |  |  |  |  | (67) |  |  | (187) | \nNon-cash charges and translation | (7) |  |  |  |  | \u2014 |  |  | (7) | \nLiability as of June 17, 2023 | $ | 203 |  |  |  |  | $ | 3 |  |  | $ | 206 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | 6/17/2023 |  | 12/31/2022\n |  | Gross |  | Accumulated Amortization |  | Net |  | Gross |  | Accumulated Amortization |  | Net\nAcquired franchise rights |  | $ | 840 |  |  | $ | (206) |  |  | $ | 634 |  |  | $ | 837 |  |  | $ | (200) |  |  | $ | 637 | \nCustomer relationships |  | 555 |  |  | (245) |  |  | 310 |  |  | 571 |  |  | (237) |  |  | 334 | \nBrands |  | 1,085 |  |  | (974) |  |  | 111 |  |  | 1,097 |  |  | (973) |  |  | 124 | \nOther identifiable intangibles |  | 443 |  |  | (266) |  |  | 177 |  |  | 447 |  |  | (265) |  |  | 182 | \nTotal |  | $ | 2,923 |  |  | $ | (1,691) |  |  | $ | 1,232 |  |  | $ | 2,952 |  |  | $ | (1,675) |  |  | $ | 1,277 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Balance12/31/2022 |  | Acquisitions |  |  |  | Translationand Other |  | Balance6/17/2023\n |  |  |  | \nFLNA |  |  |  |  |  |  |  |  | \nGoodwill | $ | 451 |  |  | $ | \u2014 |  |  |  |  | $ | 3 |  |  | $ | 454 | \nBrands | 251 |  |  | \u2014 |  |  |  |  | \u2014 |  |  | 251 | \nTotal | 702 |  |  | \u2014 |  |  |  |  | 3 |  |  | 705 | \nQFNA |  |  |  |  |  |  |  |  | \nGoodwill | 189 |  |  | \u2014 |  |  |  |  | \u2014 |  |  | 189 | \nTotal | 189 |  |  | \u2014 |  |  |  |  | \u2014 |  |  | 189 | \nPBNA |  |  |  |  |  |  |  |  | \nGoodwill | 11,947 |  |  | 3 |  |  |  |  | 10 |  |  | 11,960 | \nReacquired franchise rights | 7,061 |  |  | 62 |  |  |  |  | 20 |  |  | 7,143 | \nAcquired franchise rights(a) | 1,758 |  |  | \u2014 |  |  |  |  | (34) |  |  | 1,724 | \nBrands | 2,508 |  |  | \u2014 |  |  |  |  | \u2014 |  |  | 2,508 | \nTotal | 23,274 |  |  | 65 |  |  |  |  | (4) |  |  | 23,335 | \nLatAm |  |  |  |  |  |  |  |  | \nGoodwill | 436 |  |  | \u2014 |  |  |  |  | 17 |  |  | 453 | \nBrands | 75 |  |  | \u2014 |  |  |  |  | 4 |  |  | 79 | \nTotal | 511 |  |  | \u2014 |  |  |  |  | 21 |  |  | 532 | \nEurope |  |  |  |  |  |  |  |  | \nGoodwill | 3,646 |  |  | \u2014 |  |  |  |  | (132) |  |  | 3,514 | \nReacquired franchise rights | 421 |  |  | \u2014 |  |  |  |  | (10) |  |  | 411 | \nAcquired franchise rights | 148 |  |  | \u2014 |  |  |  |  | \u2014 |  |  | 148 | \nBrands | 1,664 |  |  | \u2014 |  |  |  |  | 10 |  |  | 1,674 | \nTotal | 5,879 |  |  | \u2014 |  |  |  |  | (132) |  |  | 5,747 | \nAMESA |  |  |  |  |  |  |  |  | \nGoodwill | 1,015 |  |  | \u2014 |  |  |  |  | (91) |  |  | 924 | \nBrands | 156 |  |  | \u2014 |  |  |  |  | (23) |  |  | 133 | \nTotal | 1,171 |  |  | \u2014 |  |  |  |  | (114) |  |  | 1,057 | \nAPAC |  |  |  |  |  |  |  |  | \nGoodwill | 518 |  |  | \u2014 |  |  |  |  | (15) |  |  | 503 | \nBrands | 267 |  |  | \u2014 |  |  |  |  | (8) |  |  | 259 | \nTotal | 785 |  |  | \u2014 |  |  |  |  | (23) |  |  | 762 | \n |  |  |  |  |  |  |  |  | \nTotal goodwill | 18,202 |  |  | 3 |  |  |  |  | (208) |  |  | 17,997 | \nTotal reacquired franchise rights | 7,482 |  |  | 62 |  |  |  |  | 10 |  |  | 7,554 | \nTotal acquired franchise rights | 1,906 |  |  | \u2014 |  |  |  |  | (34) |  |  | 1,872 | \nTotal brands | 4,921 |  |  | \u2014 |  |  |  |  | (17) |  |  | 4,904 | \nTotal | $ | 32,511 |  |  | $ | 65 |  |  |  |  | $ | (249) |  |  | $ | 32,327 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | 6/17/2023 |  | 6/11/2022 |  | 6/17/2023 |  | 6/11/2022\nShare-based compensation expense \u2013 equity awards | $ | 86 |  |  | $ | 75 |  |  | $ | 179 |  |  | $ | 156 | \nShare-based compensation expense \u2013 liability awards | 6 |  |  | 7 |  |  | 12 |  |  | 12 | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 3 | \nRestructuring charges | (1) |  |  | 1 |  |  | \u2014 |  |  | \u2014 | \nTotal | $ | 91 |  |  | $ | 83 |  |  | $ | 191 |  |  | $ | 171 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended\n | 6/17/2023 |  | 6/11/2022\n | Granted(a) |  | Weighted-Average Grant Price |  | Granted(a) |  | Weighted-Average Grant Price\nStock options | 2.0 |  |  | $ | 171.00 |  |  | 2.1 |  |  | $ | 163.00 | \nRSUs and PSUs | 2.1 |  |  | $ | 171.11 |  |  | 2.3 |  |  | $ | 163.00 |   |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended\n | 6/17/2023 |  | 6/11/2022\nExpected life | 7years |  | 7years\nRisk-free interest rate | 4.2 | % |  | 1.7 | %\nExpected volatility | 16 | % |  | 16 | %\nExpected dividend yield | 2.7 | % |  | 2.5 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | Pension |  | Retiree Medical\n | U.S. |  | International |  | \n | 6/17/2023 |  | 6/11/2022 |  | 6/17/2023 |  | 6/11/2022 |  | 6/17/2023 |  | 6/11/2022\nService cost | $ | 75 |  |  | $ | 115 |  |  | $ | 10 |  |  | $ | 17 |  |  | $ | 7 |  |  | $ | 9 | \nOther pension and retiree medical benefits (income)/expense: |  |  |  | \nInterest cost | 137 |  |  | 87 |  |  | 34 |  |  | 23 |  |  | 9 |  |  | 4 | \nExpected return on plan assets | (196) |  |  | (216) |  |  | (46) |  |  | (56) |  |  | (3) |  |  | (4) | \nAmortization of prior service credits | (6) |  |  | (7) |  |  | \u2014 |  |  | \u2014 |  |  | (2) |  |  | (2) | \nAmortization of net losses/(gains) | 16 |  |  | 35 |  |  | 3 |  |  | 7 |  |  | (6) |  |  | (3) | \nSettlement/curtailment losses | \u2014 |  |  | 131 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nSpecial termination benefits | \u2014 |  |  | 3 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nTotal other pension and retiree medical benefits (income)/expense | (49) |  |  | 33 |  |  | (9) |  |  | (26) |  |  | (2) |  |  | (5) | \nTotal | $ | 26 |  |  | $ | 148 |  |  | $ | 1 |  |  | $ | (9) |  |  | $ | 5 |  |  | $ | 4 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended\n | Pension |  | Retiree Medical\n | U.S. |  | International |  | \n | 6/17/2023 |  | 6/11/2022 |  | 6/17/2023 |  | 6/11/2022 |  | 6/17/2023 |  | 6/11/2022\nService cost | $ | 151 |  |  | $ | 229 |  |  | $ | 18 |  |  | $ | 34 |  |  | $ | 13 |  |  | $ | 17 | \nOther pension and retiree medical benefits income: |  |  |  | \nInterest cost | 274 |  |  | 175 |  |  | 59 |  |  | 40 |  |  | 17 |  |  | 8 | \nExpected return on plan assets | (393) |  |  | (431) |  |  | (81) |  |  | (98) |  |  | (6) |  |  | (7) | \nAmortization of prior service credits | (12) |  |  | (13) |  |  | \u2014 |  |  | \u2014 |  |  | (3) |  |  | (4) | \nAmortization of net losses/(gains) | 32 |  |  | 68 |  |  | 5 |  |  | 12 |  |  | (12) |  |  | (6) | \nSettlement/curtailment losses | \u2014 |  |  | 131 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (16) | \nSpecial termination benefits | (1) |  |  | 9 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nTotal other pension and retiree medical benefits income | (100) |  |  | (61) |  |  | (17) |  |  | (46) |  |  | (4) |  |  | (25) | \nTotal | $ | 51 |  |  | $ | 168 |  |  | $ | 1 |  |  | $ | (12) |  |  | $ | 9 |  |  | $ | (8) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nInterest Rate |  | Maturity Date |  | Principal Amount(a) | \nFloating rate |  | February 2026 |  | $ | 350 |  | \n4.550 | % |  | February 2026 |  | $ | 500 |  | \n4.450 | % |  | May 2028 |  | $ | 650 |  | \n4.450 | % |  | February 2033 |  | $ | 1,000 |  | \n4.650 | % |  | February 2053 |  | $ | 500 |  |   |  |  |  |  |  |  |  |  |  |  | \n | Notional Amounts(a)\n | 6/17/2023 |  | 12/31/2022\nCommodity | $ | 1.7 |  |  | $ | 1.8 | \nForeign exchange | $ | 2.8 |  |  | $ | 3.0 | \nInterest rate | $ | 1.3 |  |  | $ | 1.3 | \nNet investment(b) | $ | 3.0 |  |  | $ | 2.9 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 6/17/2023 |  | 12/31/2022\n | Fair Value Hierarchy Levels(a) |  | Assets(a) |  | Liabilities(a) |  | Assets(a) |  | Liabilities(a)\n |  |  |  |  |  |  |  |  | \nAvailable-for-sale debt securities(b) | 2 |  | $ | 574 |  |  | $ | \u2014 |  |  | $ | 660 |  |  | $ | \u2014 | \nIndex funds(c) | 1 |  | $ | 273 |  |  | $ | \u2014 |  |  | $ | 257 |  |  | $ | \u2014 | \nPrepaid forward contracts(d) | 2 |  | $ | 14 |  |  | $ | \u2014 |  |  | $ | 14 |  |  | $ | \u2014 | \nDeferred compensation(e) | 2 |  | $ | \u2014 |  |  | $ | 447 |  |  | $ | \u2014 |  |  | $ | 434 | \n |  |  |  |  |  |  |  |  | \nDerivatives designated as cash flow hedging instruments: |  |  |  |  |  |  |  |  | \nForeign exchange(f) | 2 |  | $ | 5 |  |  | $ | 43 |  |  | $ | 24 |  |  | $ | 22 | \nInterest rate(f) | 2 |  | 6 |  |  | 144 |  |  | \u2014 |  |  | 164 | \nCommodity(g) | 2 |  | \u2014 |  |  | 58 |  |  | 2 |  |  | 60 | \n |  |  | $ | 11 |  |  | $ | 245 |  |  | $ | 26 |  |  | $ | 246 | \nDerivatives not designated as hedging instruments: |  |  |  |  |  |  |  |  | \nForeign exchange(f) | 2 |  | $ | 9 |  |  | $ | 37 |  |  | $ | 21 |  |  | $ | 21 | \nCommodity(g) | 2 |  | 7 |  |  | 33 |  |  | 11 |  |  | 51 | \n |  |  | $ | 16 |  |  | $ | 70 |  |  | $ | 32 |  |  | $ | 72 | \nTotal derivatives at fair value(h) |  |  | $ | 27 |  |  | $ | 315 |  |  | $ | 58 |  |  | $ | 318 | \nTotal |  |  | $ | 888 |  |  | $ | 762 |  |  | $ | 989 |  |  | $ | 752 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | Losses/(Gains)Recognized inAccumulated\u00a0OtherComprehensive\u00a0Loss |  | Losses/(Gains)Reclassified fromAccumulated\u00a0OtherComprehensive\u00a0Lossinto Income Statement(a)\n | 6/17/2023 |  | 6/11/2022 |  | 6/17/2023 |  | 6/11/2022\nForeign exchange | $ | 43 |  |  | $ | 26 |  |  | $ | 14 |  |  | $ | (17) | \nInterest rate | (37) |  |  | 82 |  |  | (30) |  |  | 61 | \nCommodity | (15) |  |  | (1) |  |  | 28 |  |  | (74) | \nNet investment | 71 |  |  | (88) |  |  | \u2014 |  |  | \u2014 | \nTotal | $ | 62 |  |  | $ | 19 |  |  | $ | 12 |  |  | $ | (30) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | 24 Weeks Ended\n |  |  | Losses/(Gains)Recognized inAccumulated\u00a0OtherComprehensive\u00a0Loss |  | Losses/(Gains)Reclassified fromAccumulated\u00a0OtherComprehensive\u00a0Lossinto Income Statement(a)\n |  |  |  |  | 6/17/2023 |  | 6/11/2022 |  | 6/17/2023 |  | 6/11/2022\nForeign exchange |  |  |  |  | $ | 59 |  |  | $ | 18 |  |  | $ | 15 |  |  | $ | (21) | \nInterest rate |  |  |  |  | (26) |  |  | 79 |  |  | (27) |  |  | 81 | \nCommodity |  |  |  |  | 50 |  |  | (190) |  |  | 37 |  |  | (152) | \nNet investment |  |  |  |  | 108 |  |  | (139) |  |  | \u2014 |  |  | \u2014 | \nTotal |  |  |  |  | $ | 191 |  |  | $ | (232) |  |  | $ | 25 |  |  | $ | (92) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 6/17/2023 |  | 6/11/2022\n | Cost of sales |  | Selling, general and administrative expenses |  | Total |  | Cost of sales |  | Selling, general and administrative expenses |  | Total\nForeign exchange | $ | \u2014 |  |  | $ | 44 |  |  | $ | 44 |  |  | $ | (14) |  |  | $ | 35 |  |  | $ | 21 | \nCommodity | 5 |  |  | 3 |  |  | 8 |  |  | (60) |  |  | (121) |  |  | (181) | \nTotal | $ | 5 |  |  | $ | 47 |  |  | $ | 52 |  |  | $ | (74) |  |  | $ | (86) |  |  | $ | (160) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended\n | 6/17/2023 |  | 6/11/2022\n | Cost of sales |  | Selling, general and administrative expenses |  | Total |  | Cost of sales |  | Selling, general and administrative expenses |  | Total\nForeign exchange | $ | (1) |  |  | $ | 39 |  |  | $ | 38 |  |  | $ | (3) |  |  | $ | 8 |  |  | $ | 5 | \nCommodity | 36 |  |  | 53 |  |  | 89 |  |  | (134) |  |  | (213) |  |  | (347) | \nTotal | $ | 35 |  |  | $ | 92 |  |  | $ | 127 |  |  | $ | (137) |  |  | $ | (205) |  |  | $ | (342) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 6/17/2023 |  | 6/11/2022\n | Income |  | Shares(a) |  | Income |  | Shares(a)\n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nBasic net income attributable to PepsiCo per common share | $ | 1.99 |  |  |  |  | $ | 1.03 |  |  | \nNet income available for PepsiCo common shareholders | $ | 2,748 |  |  | 1,378 |  |  | $ | 1,429 |  |  | 1,382 | \nDilutive securities: |  |  |  |  |  |  | \nStock options, RSUs, PSUs and other(b) | \u2014 |  |  | 6 |  |  | \u2014 |  |  | 7 | \nDiluted | $ | 2,748 |  |  | 1,384 |  |  | $ | 1,429 |  |  | 1,389 | \nDiluted net income attributable to PepsiCo per common share | $ | 1.99 |  |  |  |  | $ | 1.03 |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended\n | 6/17/2023 |  | 6/11/2022\n | Income |  | Shares(a) |  | Income |  | Shares(a)\n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nBasic net income attributable to PepsiCo per common share | $ | 3.40 |  |  |  |  | $ | 4.11 |  |  | \nNet income available for PepsiCo common shareholders | $ | 4,680 |  |  | 1,378 |  |  | $ | 5,690 |  |  | 1,383 | \nDilutive securities: |  |  |  |  |  |  | \nStock options, RSUs, PSUs and other(b) | \u2014 |  |  | 6 |  |  | \u2014 |  |  | 7 | \nDiluted | $ | 4,680 |  |  | 1,384 |  |  | $ | 5,690 |  |  | 1,390 | \nDiluted net income attributable to PepsiCo per common share | $ | 3.38 |  |  |  |  | $ | 4.09 |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Currency Translation Adjustment |  | Cash Flow Hedges |  | Pension and Retiree Medical |  |  |  | Other |  | Accumulated Other Comprehensive Loss Attributable to PepsiCo\nBalance as of December 31, 2022(a) | $ | (12,948) |  |  | $ | 1 |  |  | $ | (2,361) |  |  |  |  | $ | 6 |  |  | $ | (15,302) | \nOther comprehensive (loss) before reclassifications(b) | (350) |  |  | (92) |  |  | (9) |  |  |  |  | (1) |  |  | (452) | \nAmounts reclassified from accumulated other comprehensive loss(c) | 108 |  |  | 13 |  |  | 5 |  |  |  |  | \u2014 |  |  | 126 | \nNet other comprehensive (loss) | (242) |  |  | (79) |  |  | (4) |  |  |  |  | (1) |  |  | (326) | \nTax amounts | 7 |  |  | 20 |  |  | \u2014 |  |  |  |  | \u2014 |  |  | 27 | \nBalance as of March 25, 2023(a) | (13,183) |  |  | (58) |  |  | (2,365) |  |  |  |  | 5 |  |  | (15,601) | \nOther comprehensive (loss)/income before reclassifications(d) | (215) |  |  | 19 |  |  | (14) |  |  |  |  | 1 |  |  | (209) | \nAmounts reclassified from accumulated other comprehensive loss | \u2014 |  |  | 12 |  |  | 5 |  |  |  |  | \u2014 |  |  | 17 | \nNet other comprehensive (loss)/income | (215) |  |  | 31 |  |  | (9) |  |  |  |  | 1 |  |  | (192) | \nTax amounts | 17 |  |  | (7) |  |  | 3 |  |  |  |  | \u2014 |  |  | 13 | \nBalance as of June 17, 2023(a) | $ | (13,381) |  |  | $ | (34) |  |  | $ | (2,371) |  |  |  |  | $ | 6 |  |  | $ | (15,780) | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Currency Translation Adjustment |  | Cash Flow Hedges |  | Pension and Retiree Medical |  |  |  | Other |  | Accumulated Other Comprehensive Loss Attributable to PepsiCo\nBalance as of December 25, 2021(a) | $ | (12,309) |  |  | $ | 159 |  |  | $ | (2,750) |  |  |  |  | $ | 2 |  |  | $ | (14,898) | \nOther comprehensive (loss)/income before reclassifications(b) | (549) |  |  | 200 |  |  | (8) |  |  |  |  | \u2014 |  |  | (357) | \nAmounts reclassified from accumulated other comprehensive loss | \u2014 |  |  | (62) |  |  | 25 |  |  |  |  | \u2014 |  |  | (37) | \nNet other comprehensive (loss)/income | (549) |  |  | 138 |  |  | 17 |  |  |  |  | \u2014 |  |  | (394) | \nTax amounts | (11) |  |  | (32) |  |  | (4) |  |  |  |  | (4) |  |  | (51) | \nBalance as of March 19, 2022(a) | (12,869) |  |  | 265 |  |  | (2,737) |  |  |  |  | (2) |  |  | (15,343) | \nOther comprehensive income/(loss) before reclassifications(c) | 1,298 |  |  | (107) |  |  | (484) |  |  |  |  | 5 |  |  | 712 | \nAmounts reclassified from accumulated other comprehensive loss | \u2014 |  |  | (30) |  |  | 161 |  |  |  |  | \u2014 |  |  | 131 | \nNet other comprehensive income/(loss) | 1,298 |  |  | (137) |  |  | (323) |  |  |  |  | 5 |  |  | 843 | \nTax amounts | (24) |  |  | 35 |  |  | 73 |  |  |  |  | \u2014 |  |  | 84 | \nBalance as of June 11, 2022(a) | $ | (11,595) |  |  | $ | 163 |  |  | $ | (2,987) |  |  |  |  | $ | 3 |  |  | $ | (14,416) | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | 12 Weeks Ended |  | 24 Weeks Ended |  | \n |  | 6/17/2023 |  | 6/11/2022 |  | 6/17/2023 |  | 6/11/2022 |  | Affected Line Item in the Income Statement\n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \nCurrency translation: |  |  |  |  |  |  |  |  |  | \nDivestitures |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 108 |  |  | $ | \u2014 |  |  | Selling, general and administrative expenses\n |  |  |  |  |  |  |  |  |  | \nCash flow hedges: |  |  |  |  |  |  |  |  |  | \nForeign exchange contracts |  | $ | (1) |  |  | $ | (2) |  |  | $ | (3) |  |  | $ | (4) |  |  | Net revenue\nForeign exchange contracts |  | 15 |  |  | (15) |  |  | 18 |  |  | (17) |  |  | Cost of sales\nInterest rate derivatives |  | (30) |  |  | 61 |  |  | (27) |  |  | 81 |  |  | Selling, general and administrative expenses\nCommodity contracts |  | 28 |  |  | (70) |  |  | 38 |  |  | (146) |  |  | Cost of sales\nCommodity contracts |  | \u2014 |  |  | (4) |  |  | (1) |  |  | (6) |  |  | Selling, general and administrative expenses\nNet losses/(gains) before tax |  | 12 |  |  | (30) |  |  | 25 |  |  | (92) |  |  | \nTax amounts |  | (3) |  |  | 7 |  |  | (7) |  |  | 17 |  |  | \nNet losses/(gains) after tax |  | $ | 9 |  |  | $ | (23) |  |  | $ | 18 |  |  | $ | (75) |  |  | \n |  |  |  |  |  |  |  |  |  | \nPension and retiree medical items: |  |  |  |  |  |  |  |  |  | \nAmortization of prior service credits |  | $ | (8) |  |  | $ | (9) |  |  | $ | (15) |  |  | $ | (17) |  |  | Other pension and retiree medical benefits income/(expense)\nAmortization of net losses |  | 13 |  |  | 39 |  |  | 25 |  |  | 74 |  |  | Other pension and retiree medical benefits income/(expense)\nSettlement/curtailment losses |  | \u2014 |  |  | 131 |  |  | \u2014 |  |  | 129 |  |  | Other pension and retiree medical benefits income/(expense)\nNet losses before tax |  | 5 |  |  | 161 |  |  | 10 |  |  | 186 |  |  | \nTax amounts |  | (1) |  |  | (35) |  |  | (2) |  |  | (41) |  |  | \nNet losses after tax |  | $ | 4 |  |  | $ | 126 |  |  | $ | 8 |  |  | $ | 145 |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \nTotal net losses reclassified, net of tax |  | $ | 13 |  |  | $ | 103 |  |  | $ | 134 |  |  | $ | 70 |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended |  | \n | 6/17/2023 |  | 6/11/2022 |  | 6/17/2023 |  | 6/11/2022 |  | \n |  |  |  |  |  |  |  |  | \nPBNA | $ | 8 |  |  | $ | 2 |  |  | $ | 10 |  |  | $ | 39 |  |  | \nEurope(a) | (2) |  |  | 3 |  |  | (2) |  |  | 13 |  |  | \nAMESA | 1 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | \n |  |  |  |  |  |  |  |  | \nCorporate | \u2014 |  |  | 3 |  |  | \u2014 |  |  | 6 |  |  | \n |  |  |  |  |  |  |  |  | \nTotal(b) | 7 |  |  | 8 |  |  | 9 |  |  | 58 |  |  | \nOther pension and retiree medical benefits expense | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 6 |  |  | \nTotal acquisition and divestiture-related charges | $ | 7 |  |  | $ | 8 |  |  | $ | 9 |  |  | $ | 64 |  |  | \nAfter-tax amount | $ | 6 |  |  | $ | 7 |  |  | $ | 7 |  |  | $ | 54 |  |  | \nImpact on net income attributable to PepsiCo per common share | $ | \u2014 |  |  | $ | (0.01) |  |  | $ | \u2014 |  |  | $ | (0.04) |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | 6/17/2023 |  | 6/11/2022 |  | Change |  | 6/17/2023 |  | 6/11/2022 |  | Change\nNet revenue | $ | 22,322 |  |  | $ | 20,225 |  |  | 10 | % |  | $ | 40,168 |  |  | $ | 36,425 |  |  | 10 | %\nOperating profit | $ | 3,659 |  |  | $ | 2,077 |  |  | 76 | % |  | $ | 6,288 |  |  | $ | 7,344 |  |  | (14) | %\nOperating margin | 16.4 | % |  | 10.3 | % |  | 6.1 |  |  | 15.7 | % |  | 20.2 | % |  | (4.5) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended | \n | 6/17/2023 |  | 6/11/2022 |  | Change |  | 6/17/2023 |  | 6/11/2022 |  | Change | \nOther pension and retiree medical benefits income/(expense) | $ | 60 |  |  | $ | (2) |  |  | $ | 62 |  |  | $ | 121 |  |  | $ | 132 |  |  | $ | (11) |  | \nNet interest expense and other | $ | (201) |  |  | $ | (236) |  |  | $ | 35 |  |  | $ | (401) |  |  | $ | (476) |  |  | $ | 75 |  | \nTax rate | 21.3 | % |  | 21.4 | % |  |  |  | 21.5 | % |  | 18.3 | % |  |  | \nNet income attributable to PepsiCo(a) | $ | 2,748 |  |  | $ | 1,429 |  |  | 92 | % |  | $ | 4,680 |  |  | $ | 5,690 |  |  | (18) | % | \nNet income attributable to PepsiCo per common share \u2013 diluted(a) | $ | 1.99 |  |  | $ | 1.03 |  |  | 93 | % |  | $ | 3.38 |  |  | $ | 4.09 |  |  | (17) | % | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 6/17/2023\n |  |  | Impact of |  |  |  | Impact of\n | Reported% Change, GAAP Measure |  | Foreign exchange translation |  | Acquisitions and divestitures |  | Organic% Change, Non-GAAP Measure(a) |  | Organic volume(b) |  | Effective net pricing\nFLNA | 14 | % |  | \u2014 |  |  | \u2014 |  |  | 14 | % |  | 0.5 |  |  | 14 | \nQFNA | 1 | % |  | 1 |  |  | \u2014 |  |  | 2 | % |  | (5) |  |  | 7 | \nPBNA | 10 | % |  | 0.5 |  |  | (1) |  |  | 10 | % |  | (4) |  |  | 14 | \nLatAm | 18 | % |  | (6) |  |  | 1 |  |  | 13 | % |  | (3) |  |  | 16 | \nEurope | 13 | % |  | 4 |  |  | 2 |  |  | 19 | % |  | (1) |  |  | 20 | \nAMESA | (8) | % |  | 25 |  |  | 1 |  |  | 18 | % |  | (6) |  |  | 24 | \nAPAC | 1 | % |  | 6 |  |  | \u2014 |  |  | 7 | % |  | (2.5) |  |  | 9 | \nTotal | 10 | % |  | 2.5 |  |  | \u2014 |  |  | 13 | % |  | (2.5) |  |  | 15 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended 6/17/2023\n |  |  | Impact of |  |  |  |  |  |  |  | Impact of\n | Reported% Change, GAAP Measure |  | Foreign exchange translation |  | Acquisitions and divestitures |  |  |  | Organic% Change, Non-GAAP Measure(a) |  |  |  |  |  | Organic volume(b) |  | Effective net pricing\nFLNA | 15 | % |  | \u2014 |  |  | \u2014 |  |  |  |  | 15 | % |  |  |  |  |  | \u2014 |  |  | 15 | \nQFNA | 5 | % |  | 1 |  |  | \u2014 |  |  |  |  | 6 | % |  |  |  |  |  | (5) |  |  | 11 | \nPBNA | 9 | % |  | \u2014 |  |  | 1 |  |  |  |  | 11 | % |  |  |  |  |  | (3.5) |  |  | 14 | \nLatAm | 19 | % |  | (6) |  |  | 1 |  |  |  |  | 14 | % |  |  |  |  |  | (2.5) |  |  | 17 | \nEurope | 10 | % |  | 4 |  |  | 3 |  |  |  |  | 17 | % |  |  |  |  |  | (4) |  |  | 22 | \nAMESA | (4) | % |  | 26 |  |  | \u2014 |  |  |  |  | 22 | % |  |  |  |  |  | (4) |  |  | 26 | \nAPAC | \u2014 | % |  | 6 |  |  | \u2014 |  |  |  |  | 6 | % |  |  |  |  |  | (1) |  |  | 6 | \nTotal | 10 | % |  | 2.5 |  |  | 1 |  |  |  |  | 14 | % |  |  |  |  |  | (2) |  |  | 16 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 6/17/2023\n |  |  | Items Affecting Comparability(a) |  | \n | Reported, GAAP Measure |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges(b) |  | Impairment and other charges/credits(b) |  | Core,Non-GAAP Measure\nFLNA | $ | 1,647 |  |  | $ | \u2014 |  |  | $ | 6 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 1,653 | \nQFNA | 129 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 129 | \nPBNA | 723 |  |  | \u2014 |  |  | 5 |  |  | 8 |  |  | 113 |  |  | 849 | \nLatAm | 592 |  |  | \u2014 |  |  | 6 |  |  | \u2014 |  |  | 2 |  |  | 600 | \nEurope | 476 |  |  | \u2014 |  |  | 52 |  |  | (2) |  |  | (5) |  |  | 521 | \nAMESA | 250 |  |  | \u2014 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | 251 | \nAPAC | 223 |  |  | \u2014 |  |  | 4 |  |  | \u2014 |  |  | \u2014 |  |  | 227 | \nCorporate unallocated expenses | (381) |  |  | (9) |  |  | 19 |  |  | \u2014 |  |  | \u2014 |  |  | (371) | \nTotal | $ | 3,659 |  |  | $ | (9) |  |  | $ | 92 |  |  | $ | 7 |  |  | $ | 110 |  |  | $ | 3,859 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 6/11/2022\n |  |  | Items Affecting Comparability(a) |  | \n | Reported, GAAP Measure |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges |  | Gain associated with the Juice Transaction |  | Impairment and other charges/credits |  | Core,Non-GAAP Measure\nFLNA | $ | 1,448 |  |  | $ | \u2014 |  |  | $ | 3 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 1,451 | \nQFNA | 135 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 135 | \nPBNA | 651 |  |  | \u2014 |  |  | 2 |  |  | 2 |  |  | (13) |  |  | 141 |  |  | 783 | \nLatAm | 420 |  |  | \u2014 |  |  | 8 |  |  | \u2014 |  |  | \u2014 |  |  | 83 |  |  | 511 | \nEurope | (797) |  |  | \u2014 |  |  | 12 |  |  | 3 |  |  | \u2014 |  |  | 1,165 |  |  | 383 | \nAMESA | 290 |  |  | \u2014 |  |  | 3 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 293 | \nAPAC | 206 |  |  | \u2014 |  |  | 3 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 209 | \nCorporate unallocated expenses | (276) |  |  | (98) |  |  | 14 |  |  | 3 |  |  | \u2014 |  |  | \u2014 |  |  | (357) | \nTotal | $ | 2,077 |  |  | $ | (98) |  |  | $ | 45 |  |  | $ | 8 |  |  | $ | (13) |  |  | $ | 1,389 |  |  | $ | 3,408 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended 6/17/2023\n |  |  | Items Affecting Comparability(a) |  | \n | Reported, GAAP Measure |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges(b) |  |  |  | Impairment and other charges/credits(b) |  |  |  | Core,Non-GAAP Measure\nFLNA | $ | 3,246 |  |  | $ | \u2014 |  |  | $ | 13 |  |  | $ | \u2014 |  |  |  |  | $ | \u2014 |  |  |  |  | $ | 3,259 | \nQFNA | 317 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | \u2014 |  |  |  |  | 317 | \nPBNA | 1,206 |  |  | \u2014 |  |  | 10 |  |  | 10 |  |  |  |  | 113 |  |  |  |  | 1,339 | \nLatAm | 956 |  |  | \u2014 |  |  | 11 |  |  | \u2014 |  |  |  |  | 2 |  |  |  |  | 969 | \nEurope | 547 |  |  | \u2014 |  |  | 141 |  |  | (2) |  |  |  |  | (5) |  |  |  |  | 681 | \nAMESA | 418 |  |  | \u2014 |  |  | 5 |  |  | 1 |  |  |  |  | (13) |  |  |  |  | 411 | \nAPAC | 450 |  |  | \u2014 |  |  | 5 |  |  | \u2014 |  |  |  |  | \u2014 |  |  |  |  | 455 | \nCorporate unallocated expenses | (852) |  |  | 62 |  |  | 20 |  |  | \u2014 |  |  |  |  | \u2014 |  |  |  |  | (770) | \nTotal | $ | 6,288 |  |  | $ | 62 |  |  | $ | 205 |  |  | $ | 9 |  |  |  |  | $ | 97 |  |  |  |  | $ | 6,661 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended 6/11/2022\n |  |  | Items Affecting Comparability(a) |  | \n | Reported,GAAP Measure |  | Mark-to-market net impact |  | Restructuringand impairment charges |  | Acquisition and divestiture-related charges |  | Gain associated with the Juice Transaction |  | Impairment and other charges/credits |  |  |  | Core,Non-GAAP Measure\nFLNA | $ | 2,744 |  |  | $ | \u2014 |  |  | $ | 6 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  |  |  | $ | 2,750 | \nQFNA | 294 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 294 | \nPBNA | 4,085 |  |  | \u2014 |  |  | 5 |  |  | 39 |  |  | (3,037) |  |  | 141 |  |  |  |  | 1,233 | \nLatAm | 743 |  |  | \u2014 |  |  | 14 |  |  | \u2014 |  |  | \u2014 |  |  | 83 |  |  |  |  | 840 | \nEurope | (933) |  |  | \u2014 |  |  | 19 |  |  | 13 |  |  | (298) |  |  | 1,647 |  |  |  |  | 448 | \nAMESA | 470 |  |  | \u2014 |  |  | 5 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 475 | \nAPAC | 421 |  |  | \u2014 |  |  | 4 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 425 | \nCorporate unallocated expenses | (480) |  |  | (210) |  |  | 19 |  |  | 6 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | (665) | \nTotal | $ | 7,344 |  |  | $ | (210) |  |  | $ | 72 |  |  | $ | 58 |  |  | $ | (3,335) |  |  | $ | 1,871 |  |  |  |  | $ | 5,800 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 6/17/2023\n |  |  | Impact of Items Affecting Comparability(a) |  |  |  | Impact of |  | \n | Reported % Change, GAAP Measure |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges |  | Gain associated with the Juice Transaction |  | Impairment and other charges/credits |  | Core% Change, Non-GAAP Measure(b) |  | Foreign exchangetranslation |  | Core Constant Currency% Change, Non-GAAP Measure(b)\nFLNA | 14 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 14 | % |  | \u2014 |  |  | 14 | %\nQFNA | (5) | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (5) | % |  | \u2014 |  |  | (4.5) | %\nPBNA | 11 | % |  | \u2014 |  |  | \u2014 |  |  | 2 |  |  | 6 |  |  | (11) |  |  | 8 | % |  | 1 |  |  | 9 | %\nLatAm | 41 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (23) |  |  | 18 | % |  | (9) |  |  | 9 | %\nEurope | n/m |  | \u2014 |  |  | n/m |  | n/m |  | n/m |  | n/m |  | 36 | % |  | 10 |  |  | 46 | %\nAMESA | (14) | % |  | \u2014 |  |  | (0.5) |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (14) | % |  | 21 |  |  | 7 | %\nAPAC | 8 | % |  | \u2014 |  |  | 0.5 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 9 | % |  | 5 |  |  | 14 | %\nCorporate unallocated expenses | 37 | % |  | (34) |  |  | (1) |  |  | 1 |  |  | \u2014 |  |  | \u2014 |  |  | 4 | % |  | \u2014 |  |  | 4 | %\nTotal | 76 | % |  | 5 |  |  | 2.5 |  |  | \u2014 |  |  | 1 |  |  | (71) |  |  | 13 | % |  | 2 |  |  | 15 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended 6/17/2023\n |  |  | Impact of Items Affecting Comparability(a) |  |  |  |  |  |  |  | Impact of |  | \n | Reported % Change, GAAP Measure |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges |  | Gain associated with the Juice Transaction |  | Impairment and other charges/credits |  |  |  |  |  | Core% Change, Non-GAAP Measure(b) |  | Foreign exchangetranslation |  | Core Constant Currency% Change, Non-GAAP Measure(b)\nFLNA | 18 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  |  |  | 18 | % |  | \u2014 |  |  | 19 | %\nQFNA | 8 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  |  |  | 8 | % |  | \u2014 |  |  | 8 | %\nPBNA | (70) | % |  | \u2014 |  |  | \u2014 |  |  | (1) |  |  | 80 |  |  | (1) |  |  |  |  |  |  | 9 | % |  | 1 |  |  | 9 | %\nLatAm | 29 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (13) |  |  |  |  |  |  | 15 | % |  | (8) |  |  | 8 | %\nEurope | n/m |  | \u2014 |  |  | n/m |  | n/m |  | n/m |  | n/m |  |  |  |  |  | 52 | % |  | 10 |  |  | 62 | %\nAMESA | (11) | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (2.5) |  |  |  |  |  |  | (13) | % |  | 22 |  |  | 8 | %\nAPAC | 7 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  |  |  | 7 | % |  | 6 |  |  | 13 | %\nCorporate unallocated expenses | 77 | % |  | (63) |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | \u2014 |  |  |  |  |  |  | 16 | % |  | \u2014 |  |  | 16 | %\nTotal | (14) | % |  | 4 |  |  | 2 |  |  | (1) |  |  | 51 |  |  | (27) |  |  |  |  |  |  | 15 | % |  | 2 |  |  | 17 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 6/17/2023\n | Cost of sales |  | Gross profit |  | Selling, general and administrative expenses |  |  |  |  |  | Operating profit |  |  |  |  |  | Provision for income taxes(a) |  |  |  | Net income attributable to PepsiCo\nReported, GAAP Measure | $ | 10,121 |  |  | $ | 12,201 |  |  | $ | 8,542 |  |  |  |  |  |  | $ | 3,659 |  |  |  |  |  |  | $ | 747 |  |  |  |  | $ | 2,748 | \nItems Affecting Comparability |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMark-to-market net impact | 1 |  |  | (1) |  |  | 8 |  |  |  |  |  |  | (9) |  |  |  |  |  |  | (2) |  |  |  |  | (7) | \nRestructuring and impairment charges | (3) |  |  | 3 |  |  | (89) |  |  |  |  |  |  | 92 |  |  |  |  |  |  | 29 |  |  |  |  | 63 | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  | (7) |  |  |  |  |  |  | 7 |  |  |  |  |  |  | 1 |  |  |  |  | 6 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nImpairment and other charges/credits | 1 |  |  | (1) |  |  | (111) |  |  |  |  |  |  | 110 |  |  |  |  |  |  | 28 |  |  |  |  | 82 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCore, Non-GAAP Measure | $ | 10,120 |  |  | $ | 12,202 |  |  | $ | 8,343 |  |  |  |  |  |  | $ | 3,859 |  |  |  |  |  |  | $ | 803 |  |  |  |  | $ | 2,892 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 6/11/2022 |  |  |  |  |  |  |  |  |  |  |  | \n | Cost of sales |  | Gross profit |  | Selling, general and administrative expenses |  | Gain associated with the Juice Transaction |  | Impairment of intangible assets |  | Operating profit |  | Other pension and retiree medical benefits (expense)/income |  | Provision for income taxes(a) |  | Net income attributable to noncontrolling interests |  | Net income attributable to PepsiCo |  |  |  |  |  |  |  |  |  |  |  | \nReported, GAAP Measure | $ | 9,415 |  |  | $ | 10,810 |  |  | $ | 7,387 |  |  | $ | (13) |  |  | $ | 1,359 |  |  | $ | 2,077 |  |  | $ | (2) |  |  | $ | 393 |  |  | $ | 17 |  |  | $ | 1,429 |  |  |  |  |  |  |  |  |  |  |  |  | \nItems Affecting Comparability |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMark-to-market net impact | 22 |  |  | (22) |  |  | 76 |  |  | \u2014 |  |  | \u2014 |  |  | (98) |  |  | \u2014 |  |  | (25) |  |  | \u2014 |  |  | (73) |  |  |  |  |  |  |  |  |  |  |  |  | \nRestructuring and impairment charges | \u2014 |  |  | \u2014 |  |  | (45) |  |  | \u2014 |  |  | \u2014 |  |  | 45 |  |  | 3 |  |  | 8 |  |  | 1 |  |  | 39 |  |  |  |  |  |  |  |  |  |  |  |  | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  | (8) |  |  | \u2014 |  |  | \u2014 |  |  | 8 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | 7 |  |  |  |  |  |  |  |  |  |  |  |  | \nGain associated with the Juice Transaction | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 13 |  |  | \u2014 |  |  | (13) |  |  | \u2014 |  |  | (3) |  |  | \u2014 |  |  | (10) |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nImpairment and other charges/credits | (1) |  |  | 1 |  |  | (29) |  |  | \u2014 |  |  | (1,359) |  |  | 1,389 |  |  | \u2014 |  |  | 299 |  |  | \u2014 |  |  | 1,090 |  |  |  |  |  |  |  |  |  |  |  |  | \nPension and retiree medical-related impact | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 131 |  |  | 30 |  |  | \u2014 |  |  | 101 |  |  |  |  |  |  |  |  |  |  |  |  | \nCore, Non-GAAP Measure | $ | 9,436 |  |  | $ | 10,789 |  |  | $ | 7,381 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 3,408 |  |  | $ | 132 |  |  | $ | 703 |  |  | $ | 18 |  |  | $ | 2,583 |  |  |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended 6/17/2023\n | Cost of sales |  | Gross profit |  | Selling, general and administrative expenses |  |  |  |  |  | Operating profit |  | Other pension and retiree medical benefits income |  |  |  | Provision for income taxes(a) |  | Net income attributable to noncontrolling interests |  | Net income attributable to PepsiCo\nReported, GAAP Measure | $ | 18,109 |  |  | $ | 22,059 |  |  | $ | 15,771 |  |  |  |  |  |  | $ | 6,288 |  |  | $ | 121 |  |  |  |  | $ | 1,293 |  |  | $ | 35 |  |  | $ | 4,680 | \nItems Affecting Comparability |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMark-to-market net impact | (13) |  |  | 13 |  |  | (49) |  |  |  |  |  |  | 62 |  |  | \u2014 |  |  |  |  | 15 |  |  | \u2014 |  |  | 47 | \nRestructuring and impairment charges | (6) |  |  | 6 |  |  | (199) |  |  |  |  |  |  | 205 |  |  | (1) |  |  |  |  | 43 |  |  | 1 |  |  | 160 | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  | (9) |  |  |  |  |  |  | 9 |  |  | \u2014 |  |  |  |  | 2 |  |  | \u2014 |  |  | 7 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nImpairment and other charges/credits | 5 |  |  | (5) |  |  | (102) |  |  |  |  |  |  | 97 |  |  | \u2014 |  |  |  |  | 28 |  |  | \u2014 |  |  | 69 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCore, Non-GAAP Measure | $ | 18,095 |  |  | $ | 22,073 |  |  | $ | 15,412 |  |  |  |  |  |  | $ | 6,661 |  |  | $ | 120 |  |  |  |  | $ | 1,381 |  |  | $ | 36 |  |  | $ | 4,963 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended 6/11/2022\n | Cost of sales |  | Gross profit |  | Selling, general and administrative expenses |  | Gain associated with the Juice Transaction |  | Impairment of intangible assets |  | Operating profit |  | Other pension and retiree medical benefits income |  | Provision for income taxes(a) |  | Net income attributable to noncontrolling interests |  | Net income attributable to PepsiCo\nReported, GAAP Measure | $ | 16,848 |  |  | $ | 19,577 |  |  | $ | 13,967 |  |  | $ | (3,335) |  |  | $ | 1,601 |  |  | $ | 7,344 |  |  | $ | 132 |  |  | $ | 1,281 |  |  | $ | 29 |  |  | $ | 5,690 | \nItems Affecting Comparability |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMark-to-market net impact | 55 |  |  | (55) |  |  | 155 |  |  | \u2014 |  |  | \u2014 |  |  | (210) |  |  | \u2014 |  |  | (51) |  |  | \u2014 |  |  | (159) | \nRestructuring and impairment charges | (5) |  |  | 5 |  |  | (67) |  |  | \u2014 |  |  | \u2014 |  |  | 72 |  |  | 3 |  |  | 14 |  |  | 1 |  |  | 60 | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  | (58) |  |  | \u2014 |  |  | \u2014 |  |  | 58 |  |  | 6 |  |  | 10 |  |  | \u2014 |  |  | 54 | \nGain associated with the Juice Transaction | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 3,335 |  |  | \u2014 |  |  | (3,335) |  |  | \u2014 |  |  | (455) |  |  | \u2014 |  |  | (2,880) | \nImpairment and other charges/credits | (141) |  |  | 141 |  |  | (129) |  |  | \u2014 |  |  | (1,601) |  |  | 1,871 |  |  | \u2014 |  |  | 347 |  |  | \u2014 |  |  | 1,524 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPension and retiree medical-related impact | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 115 |  |  | 26 |  |  | \u2014 |  |  | 89 | \nCore, Non-GAAP Measure | $ | 16,757 |  |  | $ | 19,668 |  |  | $ | 13,868 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 5,800 |  |  | $ | 256 |  |  | $ | 1,172 |  |  | $ | 30 |  |  | $ | 4,378 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended | \n | 6/17/2023 |  | 6/11/2022 |  | Change |  | 6/17/2023 |  | 6/11/2022 |  | Change | \nNet income attributable to PepsiCo per common share \u2013 diluted, GAAP measure | $ | 1.99 |  |  | $ | 1.03 |  |  | 93 | % |  | $ | 3.38 |  |  | $ | 4.09 |  |  | (17) | % | \nMark-to-market net impact | \u2014 |  |  | (0.05) |  |  |  |  | 0.03 |  |  | (0.11) |  |  |  | \nRestructuring and impairment charges | 0.05 |  |  | 0.03 |  |  |  |  | 0.12 |  |  | 0.04 |  |  |  | \nAcquisition and divestiture-related charges | \u2014 |  |  | 0.01 |  |  |  |  | \u2014 |  |  | 0.04 |  |  |  | \nGain associated with the Juice Transaction | \u2014 |  |  | (0.01) |  |  |  |  | \u2014 |  |  | (2.07) |  |  |  | \nImpairment and other charges/credits | 0.06 |  |  | 0.79 |  |  |  |  | 0.05 |  |  | 1.10 |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \nPension and retiree medical-related impact | \u2014 |  |  | 0.07 |  |  |  |  | \u2014 |  |  | 0.06 |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \nCore net income attributable to PepsiCo per common share \u2013 diluted, non-GAAP measure | $ | 2.09 |  | (a) | $ | 1.86 |  | (a) | 12 | % |  | $ | 3.59 |  | (a) | $ | 3.15 |  |  | 14 | % | \nImpact of foreign exchange translation |  |  |  |  | 2 |  |  |  |  |  |  | 2 |  | \nGrowth in core net income attributable to PepsiCo per common share \u2013 diluted, on a constant currency basis, non-GAAP measure |  |  |  |  | 15 | % | (a) |  |  |  |  | 16 | % |   |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended |  | \n | 6/17/2023 |  | 6/11/2022 |  | \nNet cash provided by operating activities, GAAP measure | $ | 2,019 |  |  | $ | 1,881 |  |  | \nCapital spending | (1,513) |  |  | (1,499) |  |  | \nSales of property, plant and equipment | 122 |  |  | 222 |  |  | \nFree cash flow, non-GAAP measure | $ | 628 |  |  | $ | 604 |  |  | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | Change(a) |  | Reference\n |  |  | \nCash and cash equivalents | $ | 1.2 |  |  | Statement of Cash Flows\nAccounts and notes receivable, less allowance | $ | 1.3 |  |  | (b)\nInventories | $ | 0.7 |  |  | (c)  |  |  |  |  |  |  |  |  |  |  | \n | Change(a) |  | Reference\nShort-term debt obligations | $ | 4.2 |  |  | (d)\nAccounts payable and other current liabilities | $ | (1.4) |  |  | (e)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod |  | TotalNumber ofSharesRepurchased(a) |  | Average\u00a0PricePaid\u00a0Per\u00a0Share |  | Total\u00a0Numberof SharesPurchased asPart\u00a0of\u00a0PubliclyAnnouncedPlans orPrograms |  | MaximumNumber (orApproximateDollar\u00a0Value)\u00a0ofShares That May Yet BePurchasedUnder\u00a0the\u00a0Plansor Programs\n3/25/2023 |  |  |  |  |  |  |  | $ | 8,326 | \n |  |  |  |  |  |  |  | \n3/26/2023 - 4/22/2023 |  | 0.6 |  |  | $ | 183.00 |  |  | 0.6 |  |  | (110) | \n |  |  |  |  |  |  |  | 8,216 | \n4/23/2023 - 5/20/2023 |  | 0.4 |  |  | $ | 193.22 |  |  | 0.4 |  |  | (76) | \n |  |  |  |  |  |  |  | 8,140 | \n5/21/2023 - 6/17/2023 |  | 0.6 |  |  | $ | 183.37 |  |  | 0.6 |  |  | (106) | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nTotal |  | 1.6 |  |  | $ | 185.70 |  |  | 1.6 |  |  | $ | 8,034 |   |  | \nSee \u201cIndex to Exhibits\u201d on page52.  |  |  |  |  | \nEXHIBIT | \nExhibit 3.1 | Amended and Restated Articles of Incorporation of PepsiCo, Inc., effective as of May 1, 2019, which are incorporated herein by reference to Exhibit 3.1 to PepsiCo, Inc.\u2019s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 3, 2019.\nExhibit 3.2 | By-Laws of PepsiCo, Inc., as amended and restated, effective as of April 15, 2020, which are incorporated herein by reference to Exhibit 3.2 to PepsiCo, Inc.\u2019s Current Report on Form 8-K filed with the Securities and Exchange Commission on April 16, 2020.\nExhibit 15 | Letter re: Unaudited Interim Financial Information.\nExhibit 31 | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.\nExhibit 32 | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.\nExhibit 99.1 | 364 Day Credit Agreement, dated as of May 26, 2023, among PepsiCo, as borrower, the lenders named therein, and Citibank, N.A., as administrative agent, which is incorporated by reference to Exhibit 99.1 to PepsiCo, Inc.\u2019s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 30, 2023.\nExhibit 99.2 | Five Year Credit Agreement, dated as of May 26, 2023, among PepsiCo, as borrower, the lenders named therein, and Citibank, N.A., as administrative agent, which is incorporated by reference to Exhibit 99.2 to PepsiCo, Inc.\u2019s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 30, 2023.\nExhibit 101 | The following materials from PepsiCo, Inc.\u2019s Quarterly Report on Form 10-Q for the quarter ended June 17, 2023 formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Statement of Income, (ii) the Condensed Consolidated Statement of Comprehensive Income, (iii) the Condensed Consolidated Statement of Cash Flows, (iv) the Condensed Consolidated Balance Sheet, (v) the Condensed Consolidated Statement of Equity, and (vi) Notes to the Condensed Consolidated Financial Statements.\nExhibit 104 | The cover page from the Company\u2019s Quarterly Report on Form 10-Q for the quarter ended June 17, 2023, formatted in iXBRL and contained in Exhibit 101.  |  |  |  |  |  |  |  |  |  |  | \n |  |  | \n |  | PepsiCo, Inc. | \n |  | (Registrant) | \n |  |  | \nDate: | July 12, 2023 | /s/ Marie T. Gallagher | \n |  | Marie T. Gallagher | \n |  | Senior Vice President and Controller | \n |  | (Principal Accounting Officer) | \n |  |  | \nDate: | July 12, 2023 | /s/ David Flavell | \n |  | David Flavell | \n |  | Executive Vice President, General Counsel and Corporate Secretary | \n |  | (Duly Authorized Officer) | "}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Pepsico, in 2023 Q3, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  | \n\u2612 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \n\u2610 | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  | \nPepsiCo, Inc.  |  |  |  |  |  |  |  | \n |  | \nNorth Carolina |  | 13-1584302\n(State or Other Jurisdiction ofIncorporation or Organization) |  | (I.R.S. EmployerIdentification No.)\n | \n |  | \n |  |   |  | \n(Address of principal executive offices and Zip Code)  |  | \nRegistrant's telephone number, including area code  |  | \n(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTitle of each class |  | Trading Symbols |  | Name of each exchange on which registered\nCommon Stock, par value 1-2/3 cents per share |  | PEP |  | The Nasdaq Stock Market LLC\n0.250% Senior Notes Due 2024 |  | PEP24 |  | The Nasdaq Stock Market LLC\n2.625% Senior Notes Due 2026 |  | PEP26 |  | The Nasdaq Stock Market LLC\n0.750% Senior Notes Due 2027 |  | PEP27 |  | The Nasdaq Stock Market LLC\n0.875% Senior Notes Due 2028 |  | PEP28 |  | The Nasdaq Stock Market LLC\n0.500% Senior Notes Due 2028 |  | PEP28a |  | The Nasdaq Stock Market LLC\n3.200% Senior Notes Due 2029 |  | PEP29 |  | The Nasdaq Stock Market LLC\n1.125% Senior Notes Due 2031 |  | PEP31 |  | The Nasdaq Stock Market LLC\n0.400% Senior Notes Due 2032 |  | PEP32 |  | The Nasdaq Stock Market LLC\n0.750% Senior Notes Due 2033 |  | PEP33 |  | The Nasdaq Stock Market LLC\n3.550% Senior Notes Due 2034 |  | PEP34 |  | The Nasdaq Stock Market LLC\n0.875% Senior Notes Due 2039 |  | PEP39 |  | The Nasdaq Stock Market LLC\n1.050% Senior Notes Due 2050 |  | PEP50 |  | The Nasdaq Stock Market LLC  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 | Accelerated filer | \u2610\nNon-accelerated filer | \u2610 | Smaller reporting company | \u2610\n |  | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \n |  | Page\u00a0No.\nPart I        Financial Information | \nItem 1. | Condensed Consolidated Financial Statements | 2\n | Condensed Consolidated Statement of Income \u201312 and36Weeks EndedSeptember9, 2023 andSeptember3, 2022 | 2\n | Condensed Consolidated Statement of Comprehensive Income \u201312 and36Weeks EndedSeptember9, 2023 andSeptember3, 2022 | 3\n | Condensed Consolidated Statement of Cash Flows \u201336Weeks EndedSeptember9, 2023 andSeptember3, 2022 | 4\n | Condensed Consolidated Balance Sheet \u2013September9, 2023 and December 31, 2022 | 6\n | Condensed Consolidated Statement of Equity \u201312and36Weeks EndedSeptember9, 2023 andSeptember3, 2022 | 7\n | Notes to the Condensed Consolidated Financial Statements | 8\nItem\u00a02. | Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations | 26\nReport of Independent Registered Public Accounting Firm | 49\nItem 3. | Quantitative and Qualitative Disclosures About Market Risk | 50\nItem 4. | Controls and Procedures | 50\nPart II      Other Information | \nItem 1. | Legal Proceedings | 51\nItem 1A. | Risk Factors | 51\nItem 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 51\nItem 5. | Other Information | 51\nItem 6. | Exhibits | 52  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | 9/9/2023 |  | 9/3/2022 |  | 9/9/2023 |  | 9/3/2022\nNet Revenue | $ | 23,453 |  |  | $ | 21,971 |  |  | $ | 63,621 |  |  | $ | 58,396 | \nCost of sales | 10,675 |  |  | 10,308 |  |  | 28,784 |  |  | 27,156 | \nGross profit | 12,778 |  |  | 11,663 |  |  | 34,837 |  |  | 31,240 | \nSelling, general and administrative expenses | 8,757 |  |  | 8,295 |  |  | 24,528 |  |  | 22,262 | \nGain associated with the Juice Transaction(a) | \u2014 |  |  | 14 |  |  | \u2014 |  |  | (3,321) | \nImpairment of intangible assets (see Notes 1 and 4) | 6 |  |  | 1 |  |  | 6 |  |  | 1,602 | \nOperating Profit | 4,015 |  |  | 3,353 |  |  | 10,303 |  |  | 10,697 | \nOther pension and retiree medical benefits income | 62 |  |  | 36 |  |  | 183 |  |  | 168 | \nNet interest expense and other | (201) |  |  | (190) |  |  | (602) |  |  | (666) | \nIncome before income taxes | 3,876 |  |  | 3,199 |  |  | 9,884 |  |  | 10,199 | \nProvision for income taxes | 760 |  |  | 475 |  |  | 2,053 |  |  | 1,756 | \nNet income | 3,116 |  |  | 2,724 |  |  | 7,831 |  |  | 8,443 | \nLess: Net income attributable to noncontrolling interests | 24 |  |  | 22 |  |  | 59 |  |  | 51 | \nNet Income Attributable to PepsiCo | $ | 3,092 |  |  | $ | 2,702 |  |  | $ | 7,772 |  |  | $ | 8,392 | \nNet Income Attributable to PepsiCo per Common Share |  |  |  |  |  |  | \nBasic | $ | 2.25 |  |  | $ | 1.96 |  |  | $ | 5.64 |  |  | $ | 6.07 | \nDiluted | $ | 2.24 |  |  | $ | 1.95 |  |  | $ | 5.62 |  |  | $ | 6.04 | \nWeighted-average common shares outstanding |  |  |  |  |  |  | \nBasic | 1,376 |  |  | 1,380 |  |  | 1,377 |  |  | 1,382 | \nDiluted | 1,383 |  |  | 1,387 |  |  | 1,384 |  |  | 1,389 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | 9/9/2023 |  | 9/3/2022 |  | 9/9/2023 |  | 9/3/2022\nNet income | $ | 3,116 |  |  | $ | 2,724 |  |  | $ | 7,831 |  |  | $ | 8,443 | \nOther comprehensive (loss)/income, net of taxes: |  |  |  |  |  |  | \nNet currency translation adjustment | 2 |  |  | (324) |  |  | (431) |  |  | 390 | \nNet change on cash flow hedges | (11) |  |  | (113) |  |  | (46) |  |  | (109) | \nNet pension and retiree medical adjustments | (8) |  |  | 108 |  |  | (18) |  |  | (129) | \n |  |  |  |  |  |  | \nOther | 3 |  |  | 2 |  |  | 3 |  |  | 3 | \n | (14) |  |  | (327) |  |  | (492) |  |  | 155 | \nComprehensive income | 3,102 |  |  | 2,397 |  |  | 7,339 |  |  | 8,598 | \nLess: Comprehensive income attributable tononcontrolling interests | 24 |  |  | 22 |  |  | 59 |  |  | 51 | \nComprehensive Income Attributable to PepsiCo | $ | 3,078 |  |  | $ | 2,375 |  |  | $ | 7,280 |  |  | $ | 8,547 |   |  | \n  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended\n | 9/9/2023 |  | 9/3/2022\nOperating Activities |  |  | \nNet income | $ | 7,831 |  |  | $ | 8,443 | \nDepreciation and amortization | 1,973 |  |  | 1,854 | \nGain associated with the Juice Transaction | \u2014 |  |  | (3,321) | \nImpairment and other charges | 102 |  |  | 1,877 | \nOperating lease right-of-use asset amortization | 384 |  |  | 346 | \nShare-based compensation expense | 267 |  |  | 233 | \nRestructuring and impairment charges | 287 |  |  | 126 | \nCash payments for restructuring charges | (283) |  |  | (134) | \nAcquisition and divestiture-related charges | 20 |  |  | 69 | \nCash payments for acquisition and divestiture-related charges | (15) |  |  | (41) | \nPension and retiree medical plan expenses | 93 |  |  | 235 | \nPension and retiree medical plan contributions | (374) |  |  | (335) | \nDeferred income taxes and other tax charges and credits | 343 |  |  | (322) | \nTax expense related to the Tax Cuts and Jobs Act (TCJ Act) | \u2014 |  |  | 86 | \nTax payments related to the TCJ Act | (309) |  |  | (309) | \nChange in assets and liabilities: |  |  | \nAccounts and notes receivable | (1,699) |  |  | (2,258) | \nInventories | (473) |  |  | (837) | \nPrepaid expenses and other current assets | (242) |  |  | (124) | \nAccounts payable and other current liabilities | (859) |  |  | 426 | \nIncome taxes payable | 512 |  |  | 718 | \nOther, net | 72 |  |  | (426) | \nNet Cash Provided by Operating Activities | 7,630 |  |  | 6,306 | \n |  |  | \nInvesting Activities |  |  | \nCapital spending | (2,537) |  |  | (2,556) | \nSales of property, plant and equipment | 131 |  |  | 228 | \nAcquisitions, net of cash acquired, investments in noncontrolled affiliates and purchases of intangible and other assets | (132) |  |  | (804) | \nProceeds associated with the Juice Transaction | \u2014 |  |  | 3,456 | \nOther divestitures, sales of investments in noncontrolled affiliates and other assets | 75 |  |  | 15 | \nShort-term investments, by original maturity: |  |  | \nMore than three months - purchases | (555) |  |  | (46) | \nMore than three months - maturities | 554 |  |  | \u2014 | \nMore than three months - sales | 12 |  |  | \u2014 | \nThree months or less, net | 24 |  |  | 9 | \nOther investing, net | 49 |  |  | 7 | \nNet Cash (Used for)/Provided by Investing Activities | (2,379) |  |  | 309 |   |  | \n  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended\n | 9/9/2023 |  | 9/3/2022\nFinancing Activities |  |  | \nProceeds from issuances of long-term debt | $ | 2,986 |  |  | $ | 3,377 | \nPayments of long-term debt | (2,253) |  |  | (1,653) | \nDebt redemptions | \u2014 |  |  | (1,550) | \nShort-term borrowings, by original maturity: |  |  | \nMore than three months - proceeds | 4,688 |  |  | 1,947 | \nMore than three months - payments | (1,037) |  |  | (1,932) | \nThree months or less, net | 1,395 |  |  | (45) | \n |  |  | \nCash dividends paid | (4,941) |  |  | (4,586) | \nShare repurchases - common | (751) |  |  | (1,156) | \nProceeds from exercises of stock options | 100 |  |  | 113 | \nWithholding tax payments on restricted stock units (RSUs) and performance stock units (PSUs) converted | (135) |  |  | (97) | \nOther financing | (18) |  |  | (25) | \nNet Cash Provided by/(Used for) Financing Activities | 34 |  |  | (5,607) | \nEffect of exchange rate changes on cash and cash equivalents and restricted cash | (254) |  |  | (197) | \nNet Increase in Cash and Cash Equivalents and Restricted Cash | 5,031 |  |  | 811 | \nCash and Cash Equivalents and Restricted Cash, Beginning of Year | 5,100 |  |  | 5,707 | \nCash and Cash Equivalents and Restricted Cash, End of Period | $ | 10,131 |  |  | $ | 6,518 | \n |  |  | \nSupplemental Non-Cash Activity |  |  | \nRight-of-use assets obtained in exchange for lease obligations | $ | 705 |  |  | $ | 560 | \nDebt discharged via legal defeasance | $ | 94 |  |  | $ | \u2014 |   |  | \n  |  |  |  |  |  |  |  |  |  |  | \n | (Unaudited) |  | \n | 9/9/2023 |  | 12/31/2022\nASSETS |  |  | \nCurrent Assets |  |  | \nCash and cash equivalents | $ | 10,017 |  |  | $ | 4,954 | \nShort-term investments | 266 |  |  | 394 | \n |  |  | \nAccounts and notes receivable, less allowance ($188and $150, respectively) | 11,782 |  |  | 10,163 | \nInventories: |  |  | \nRaw materials and packaging | 2,456 |  |  | 2,366 | \nWork-in-process | 119 |  |  | 114 | \nFinished goods | 2,983 |  |  | 2,742 | \n | 5,558 |  |  | 5,222 | \nPrepaid expenses and other current assets | 1,026 |  |  | 806 | \n |  |  | \nTotal Current Assets | 28,649 |  |  | 21,539 | \nProperty, plant and equipment | 51,585 |  |  | 49,784 | \nAccumulated depreciation | (26,732) |  |  | (25,493) | \nProperty, Plant and Equipment, net | 24,853 |  |  | 24,291 | \nAmortizable Intangible Assets, net | 1,208 |  |  | 1,277 | \nGoodwill | 17,892 |  |  | 18,202 | \nOther Indefinite-Lived Intangible Assets | 14,293 |  |  | 14,309 | \n |  |  | \nInvestments in Noncontrolled Affiliates | 2,955 |  |  | 3,073 | \nDeferred Income Taxes | 4,165 |  |  | 4,204 | \nOther Assets | 5,938 |  |  | 5,292 | \nTotal Assets | $ | 99,953 |  |  | $ | 92,187 | \n |  |  | \nLIABILITIES AND EQUITY |  |  | \nCurrent Liabilities |  |  | \nShort-term debt obligations | $ | 8,937 |  |  | $ | 3,414 | \nAccounts payable and other current liabilities | 23,723 |  |  | 23,371 | \n |  |  | \nTotal Current Liabilities | 32,660 |  |  | 26,785 | \nLong-Term Debt Obligations | 35,837 |  |  | 35,657 | \nDeferred Income Taxes | 4,047 |  |  | 4,133 | \nOther Liabilities | 8,439 |  |  | 8,339 | \nTotal Liabilities | 80,983 |  |  | 74,914 | \nCommitments and contingencies |  |  | \nPepsiCo Common Shareholders\u2019 Equity |  |  | \nCommon stock, par value 12/3\u00a2 per share (authorized3,600shares; issued, net of repurchased common stock at par value:1,375and1,377shares, respectively) | 23 |  |  | 23 | \nCapital in excess of par value | 4,154 |  |  | 4,134 | \nRetained earnings | 70,479 |  |  | 67,800 | \nAccumulated other comprehensive loss | (15,794) |  |  | (15,302) | \nRepurchased common stock, in excess of par value (492and490shares, respectively) | (40,056) |  |  | (39,506) | \nTotal PepsiCo Common Shareholders\u2019 Equity | 18,806 |  |  | 17,149 | \nNoncontrolling interests | 164 |  |  | 124 | \nTotal Equity | 18,970 |  |  | 17,273 | \nTotal Liabilities and Equity | $ | 99,953 |  |  | $ | 92,187 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | 9/9/2023 |  | 9/3/2022 |  | 9/9/2023 |  | 9/3/2022\n | Shares |  | Amount |  | Shares |  | Amount |  | Shares |  | Amount |  | Shares |  | Amount\n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCommon Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period | 1,377 |  |  | $ | 23 |  |  | 1,381 |  |  | $ | 23 |  |  | 1,377 |  |  | $ | 23 |  |  | 1,383 |  |  | $ | 23 | \nChange in repurchased common stock | (2) |  |  | \u2014 |  |  | (2) |  |  | \u2014 |  |  | (2) |  |  | \u2014 |  |  | (4) |  |  | \u2014 | \nBalance, end of period | 1,375 |  |  | 23 |  |  | 1,379 |  |  | 23 |  |  | 1,375 |  |  | 23 |  |  | 1,379 |  |  | 23 | \nCapital in Excess of Par Value |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  | 4,082 |  |  |  |  | 3,970 |  |  |  |  | 4,134 |  |  |  |  | 4,001 | \nShare-based compensation expense |  |  | 88 |  |  |  |  | 77 |  |  |  |  | 267 |  |  |  |  | 236 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nStock option exercises, RSUs and PSUs converted |  |  | 3 |  |  |  |  | 1 |  |  |  |  | (108) |  |  |  |  | (102) | \nWithholding tax on RSUs and PSUs converted |  |  | (16) |  |  |  |  | (10) |  |  |  |  | (135) |  |  |  |  | (97) | \nOther |  |  | (3) |  |  |  |  | (2) |  |  |  |  | (4) |  |  |  |  | (2) | \nBalance, end of period |  |  | 4,154 |  |  |  |  | 4,036 |  |  |  |  | 4,154 |  |  |  |  | 4,036 | \nRetained Earnings |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  | 69,135 |  |  |  |  | 67,763 |  |  |  |  | 67,800 |  |  |  |  | 65,165 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nNet income attributable to PepsiCo |  |  | 3,092 |  |  |  |  | 2,702 |  |  |  |  | 7,772 |  |  |  |  | 8,392 | \nCash dividends declared \u2013 common(a) |  |  | (1,748) |  |  |  |  | (1,593) |  |  |  |  | (5,093) |  |  |  |  | (4,685) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, end of period |  |  | 70,479 |  |  |  |  | 68,872 |  |  |  |  | 70,479 |  |  |  |  | 68,872 | \nAccumulated Other Comprehensive Loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  | (15,780) |  |  |  |  | (14,416) |  |  |  |  | (15,302) |  |  |  |  | (14,898) | \nOther comprehensive (loss)/income attributable to PepsiCo |  |  | (14) |  |  |  |  | (327) |  |  |  |  | (492) |  |  |  |  | 155 | \nBalance, end of period |  |  | (15,794) |  |  |  |  | (14,743) |  |  |  |  | (15,794) |  |  |  |  | (14,743) | \nRepurchased Common Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period | (490) |  |  | (39,775) |  |  | (486) |  |  | (38,787) |  |  | (490) |  |  | (39,506) |  |  | (484) |  |  | (38,248) | \nShare repurchases | (2) |  |  | (293) |  |  | (3) |  |  | (448) |  |  | (5) |  |  | (759) |  |  | (7) |  |  | (1,179) | \nStock option exercises, RSUs and PSUs converted | \u2014 |  |  | 11 |  |  | 1 |  |  | 23 |  |  | 3 |  |  | 208 |  |  | 3 |  |  | 215 | \nOther | \u2014 |  |  | 1 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | 1 | \nBalance, end of period | (492) |  |  | (40,056) |  |  | (488) |  |  | (39,211) |  |  | (492) |  |  | (40,056) |  |  | (488) |  |  | (39,211) | \nTotal PepsiCo Common Shareholders\u2019 Equity |  |  | 18,806 |  |  |  |  | 18,977 |  |  |  |  | 18,806 |  |  |  |  | 18,977 | \nNoncontrolling Interests |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance, beginning of period |  |  | 140 |  |  |  |  | 121 |  |  |  |  | 124 |  |  |  |  | 108 | \nNet income attributable to noncontrolling interest |  |  | 24 |  |  |  |  | 22 |  |  |  |  | 59 |  |  |  |  | 51 | \nDistributions to noncontrolling interests |  |  | \u2014 |  |  |  |  | (6) |  |  |  |  | (15) |  |  |  |  | (20) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nAcquisitions |  |  | \u2014 |  |  |  |  | 21 |  |  |  |  | \u2014 |  |  |  |  | 21 | \nOther, net |  |  | \u2014 |  |  |  |  | \u2014 |  |  |  |  | (4) |  |  |  |  | (2) | \nBalance, end of period |  |  | 164 |  |  |  |  | 158 |  |  |  |  | 164 |  |  |  |  | 158 | \nTotal Equity |  |  | $ | 18,970 |  |  |  |  | $ | 19,135 |  |  |  |  | $ | 18,970 |  |  |  |  | $ | 19,135 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | 9/9/2023 |  | 9/3/2022 |  | 9/9/2023 |  | 9/3/2022\nFLNA | $ | 5,954 |  |  | $ | 5,563 |  |  | $ | 17,441 |  |  | $ | 15,583 | \nQFNA | 747 |  |  | 713 |  |  | 2,208 |  |  | 2,101 | \nPBNA | 7,161 |  |  | 6,635 |  |  | 19,714 |  |  | 18,108 | \nLatAm | 3,055 |  |  | 2,517 |  |  | 7,688 |  |  | 6,406 | \nEurope | 3,704 |  |  | 3,646 |  |  | 9,018 |  |  | 8,466 | \nAMESA | 1,615 |  |  | 1,726 |  |  | 4,202 |  |  | 4,426 | \nAPAC | 1,217 |  |  | 1,171 |  |  | 3,350 |  |  | 3,306 | \nTotal | $ | 23,453 |  |  | $ | 21,971 |  |  | $ | 63,621 |  |  | $ | 58,396 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 9/9/2023 |  | 9/3/2022\n | Beverages(a) |  | Convenient Foods |  | Beverages(a) |  | Convenient Foods\nLatAm | 10 | % |  | 90 | % |  | 10 | % |  | 90 | %\nEurope | 50 | % |  | 50 | % |  | 55 | % |  | 45 | %\nAMESA | 30 | % |  | 70 | % |  | 35 | % |  | 65 | %\nAPAC | 25 | % |  | 75 | % |  | 25 | % |  | 75 | %\nPepsiCo | 45 | % |  | 55 | % |  | 45 | % |  | 55 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended |  |  |  |  | \n | 9/9/2023 |  | 9/3/2022 |  |  |  |  | \n | Beverages(a) |  | Convenient Foods |  | Beverages(a) |  | Convenient Foods |  |  |  |  | \nLatAm | 10 | % |  | 90 | % |  | 10 | % |  | 90 | % |  |  |  |  | \nEurope | 50 | % |  | 50 | % |  | 50 | % |  | 50 | % |  |  |  |  | \nAMESA | 30 | % |  | 70 | % |  | 35 | % |  | 65 | % |  |  |  |  | \nAPAC | 25 | % |  | 75 | % |  | 25 | % |  | 75 | % |  |  |  |  | \nPepsiCo | 40 | % |  | 60 | % |  | 45 | % |  | 55 | % |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | 9/9/2023 |  | 9/3/2022 |  | 9/9/2023 |  | 9/3/2022\nFLNA | $ | 1,669 |  |  | $ | 1,588 |  |  | $ | 4,915 |  |  | $ | 4,332 | \nQFNA | 135 |  |  | 122 |  |  | 452 |  |  | 416 | \nPBNA(a) (b) (c) | 970 |  |  | 784 |  |  | 2,176 |  |  | 4,869 | \nLatAm(d) | 593 |  |  | 463 |  |  | 1,549 |  |  | 1,206 | \nEurope(a) (e) (f) | 659 |  |  | 564 |  |  | 1,206 |  |  | (369) | \nAMESA | 238 |  |  | 268 |  |  | 656 |  |  | 738 | \nAPAC | 239 |  |  | 199 |  |  | 689 |  |  | 620 | \nTotal divisions | 4,503 |  |  | 3,988 |  |  | 11,643 |  |  | 11,812 | \nCorporate unallocated expenses(g) (h) | (488) |  |  | (635) |  |  | (1,340) |  |  | (1,115) | \nTotal | $ | 4,015 |  |  | $ | 3,353 |  |  | $ | 10,303 |  |  | $ | 10,697 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | 9/9/2023 |  | 9/3/2022 |  | 9/9/2023 |  |  |  |  |  |  |  | 9/3/2022\n |  |  |  |  |  |  |  |  |  |  |  |  | \nRussia-Ukraine conflict impairment charges | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  |  |  |  |  |  |  | $ | 1,198 | \nBrand portfolio impairment charges | \u2014 |  |  | 1 |  |  | \u2014 |  |  |  |  |  |  |  |  | 404 | \nOther impairment charges | 6 |  |  | \u2014 |  |  | 6 |  |  |  |  |  |  |  |  | \u2014 | \nTotal | $ | 6 |  |  | $ | 1 |  |  | $ | 6 |  |  |  |  |  |  |  |  | $ | 1,602 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | FLNA |  | QFNA |  | PBNA |  | LatAm |  | Europe |  | AMESA |  | APAC |  | Corporate\nExpected pre-tax charges | 15 | % |  | 1 | % |  | 25 | % |  | 10 | % |  | 25 | % |  | 5 | % |  | 4 | % |  | 15 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | 9/9/2023 |  | 9/3/2022 |  | 9/9/2023 |  | 9/3/2022\nCost of sales | $ | 4 |  |  | $ | 1 |  |  | $ | 10 |  |  | $ | 6 | \nSelling, general and administrative expenses | 79 |  |  | 50 |  |  | 278 |  |  | 117 | \nOther pension and retiree medical benefits (income)/expense(a) | \u2014 |  |  | \u2014 |  |  | (1) |  |  | 3 | \nTotal restructuring and impairment charges | $ | 83 |  |  | $ | 51 |  |  | $ | 287 |  |  | $ | 126 | \nAfter-tax amount | $ | 67 |  |  | $ | 40 |  |  | $ | 228 |  |  | $ | 101 | \nImpact on net income attributable to PepsiCo per common share | $ | (0.05) |  |  | $ | (0.03) |  |  | $ | (0.16) |  |  | $ | (0.07) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended |  | Plan to Date\n | 9/9/2023 |  | 9/3/2022 |  | 9/9/2023 |  | 9/3/2022 |  | through 9/9/2023\nFLNA | $ | 6 |  |  | $ | 4 |  |  | $ | 19 |  |  | $ | 10 |  |  | $ | 229 | \nQFNA | \u2014 |  |  | 1 |  |  | \u2014 |  |  | 1 |  |  | 19 | \nPBNA | 8 |  |  | 4 |  |  | 18 |  |  | 9 |  |  | 244 | \nLatAm | 8 |  |  | 3 |  |  | 19 |  |  | 17 |  |  | 190 | \nEurope | 44 |  |  | 21 |  |  | 185 |  |  | 40 |  |  | 528 | \nAMESA | 5 |  |  | \u2014 |  |  | 10 |  |  | 5 |  |  | 92 | \nAPAC | 2 |  |  | 4 |  |  | 7 |  |  | 8 |  |  | 84 | \nCorporate | 10 |  |  | 14 |  |  | 30 |  |  | 33 |  |  | 259 | \n | 83 |  |  | 51 |  |  | 288 |  |  | 123 |  |  | 1,645 | \nOther pension and retiree medical benefits (income)/expense(a) | \u2014 |  |  | \u2014 |  |  | (1) |  |  | 3 |  |  | 97 | \nTotal | $ | 83 |  |  | $ | 51 |  |  | $ | 287 |  |  | $ | 126 |  |  | $ | 1,742 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended |  | Plan to Date\n | 9/9/2023 |  | 9/3/2022 |  | 9/9/2023 |  | 9/3/2022 |  | through 9/9/2023\nSeverance and\u00a0other employee costs | $ | 39 |  |  | $ | 10 |  |  | $ | 181 |  |  | $ | 41 |  |  | $ | 988 | \nAsset impairments | 1 |  |  | 7 |  |  | 1 |  |  | 7 |  |  | 191 | \nOther\u00a0costs | 43 |  |  | 34 |  |  | 105 |  |  | 78 |  |  | 563 | \nTotal | $ | 83 |  |  | $ | 51 |  |  | $ | 287 |  |  | $ | 126 |  |  | $ | 1,742 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Severance and\u00a0Other Employee Costs |  | AssetImpairments |  | Other\u00a0Costs |  | Total\nLiability as of December 31, 2022 | $ | 188 |  |  | $ | \u2014 |  |  | $ | 8 |  |  | $ | 196 | \n2023 restructuring charges | 181 |  |  | 1 |  |  | 105 |  |  | 287 | \nCash payments | (174) |  |  | \u2014 |  |  | (109) |  |  | (283) | \nNon-cash charges and translation | (8) |  |  | (1) |  |  | 1 |  |  | (8) | \nLiability as of September 9, 2023 | $ | 187 |  |  | $ | \u2014 |  |  | $ | 5 |  |  | $ | 192 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | 9/9/2023 |  | 12/31/2022\n |  | Gross |  | Accumulated Amortization |  | Net |  | Gross |  | Accumulated Amortization |  | Net\nAcquired franchise rights |  | $ | 833 |  |  | $ | (207) |  |  | $ | 626 |  |  | $ | 837 |  |  | $ | (200) |  |  | $ | 637 | \nCustomer relationships |  | 550 |  |  | (249) |  |  | 301 |  |  | 571 |  |  | (237) |  |  | 334 | \nBrands |  | 1,084 |  |  | (978) |  |  | 106 |  |  | 1,097 |  |  | (973) |  |  | 124 | \nOther identifiable intangibles |  | 444 |  |  | (269) |  |  | 175 |  |  | 447 |  |  | (265) |  |  | 182 | \nTotal |  | $ | 2,911 |  |  | $ | (1,703) |  |  | $ | 1,208 |  |  | $ | 2,952 |  |  | $ | (1,675) |  |  | $ | 1,277 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Balance12/31/2022 |  | Acquisitions |  |  |  | Translationand Other |  | Balance9/9/2023\n |  |  |  | \nFLNA |  |  |  |  |  |  |  |  | \nGoodwill | $ | 451 |  |  | $ | \u2014 |  |  |  |  | $ | (1) |  |  | $ | 450 | \nBrands | 251 |  |  | \u2014 |  |  |  |  | \u2014 |  |  | 251 | \nTotal | 702 |  |  | \u2014 |  |  |  |  | (1) |  |  | 701 | \nQFNA |  |  |  |  |  |  |  |  | \nGoodwill | 189 |  |  | \u2014 |  |  |  |  | \u2014 |  |  | 189 | \nTotal | 189 |  |  | \u2014 |  |  |  |  | \u2014 |  |  | 189 | \nPBNA |  |  |  |  |  |  |  |  | \nGoodwill | 11,947 |  |  | 4 |  |  |  |  | (4) |  |  | 11,947 | \nReacquired franchise rights | 7,061 |  |  | 36 |  |  |  |  | (8) |  |  | 7,089 | \nAcquired franchise rights(a) | 1,758 |  |  | 12 |  |  |  |  | (40) |  |  | 1,730 | \nBrands | 2,508 |  |  | \u2014 |  |  |  |  | \u2014 |  |  | 2,508 | \nTotal | 23,274 |  |  | 52 |  |  |  |  | (52) |  |  | 23,274 | \nLatAm |  |  |  |  |  |  |  |  | \nGoodwill | 436 |  |  | \u2014 |  |  |  |  | 23 |  |  | 459 | \nBrands | 75 |  |  | \u2014 |  |  |  |  | 7 |  |  | 82 | \nTotal | 511 |  |  | \u2014 |  |  |  |  | 30 |  |  | 541 | \nEurope |  |  |  |  |  |  |  |  | \nGoodwill(b) | 3,646 |  |  | \u2014 |  |  |  |  | (277) |  |  | 3,369 | \nReacquired franchise rights | 421 |  |  | \u2014 |  |  |  |  | (16) |  |  | 405 | \nAcquired franchise rights | 148 |  |  | \u2014 |  |  |  |  | 3 |  |  | 151 | \nBrands | 1,664 |  |  | \u2014 |  |  |  |  | 23 |  |  | 1,687 | \nTotal | 5,879 |  |  | \u2014 |  |  |  |  | (267) |  |  | 5,612 | \nAMESA |  |  |  |  |  |  |  |  | \nGoodwill | 1,015 |  |  | 34 |  |  |  |  | (63) |  |  | 986 | \nBrands | 156 |  |  | \u2014 |  |  |  |  | (21) |  |  | 135 | \nTotal | 1,171 |  |  | 34 |  |  |  |  | (84) |  |  | 1,121 | \nAPAC |  |  |  |  |  |  |  |  | \nGoodwill | 518 |  |  | \u2014 |  |  |  |  | (26) |  |  | 492 | \nBrands | 267 |  |  | \u2014 |  |  |  |  | (12) |  |  | 255 | \nTotal | 785 |  |  | \u2014 |  |  |  |  | (38) |  |  | 747 | \n |  |  |  |  |  |  |  |  | \nTotal goodwill | 18,202 |  |  | 38 |  |  |  |  | (348) |  |  | 17,892 | \nTotal reacquired franchise rights | 7,482 |  |  | 36 |  |  |  |  | (24) |  |  | 7,494 | \nTotal acquired franchise rights | 1,906 |  |  | 12 |  |  |  |  | (37) |  |  | 1,881 | \nTotal brands | 4,921 |  |  | \u2014 |  |  |  |  | (3) |  |  | 4,918 | \nTotal | $ | 32,511 |  |  | $ | 86 |  |  |  |  | $ | (412) |  |  | $ | 32,185 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | 9/9/2023 |  | 9/3/2022 |  | 9/9/2023 |  | 9/3/2022\nShare-based compensation expense \u2013 equity awards | $ | 88 |  |  | $ | 77 |  |  | $ | 267 |  |  | $ | 233 | \nShare-based compensation expense \u2013 liability awards | 7 |  |  | 4 |  |  | 19 |  |  | 16 | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 3 | \n |  |  |  |  |  |  | \nTotal | $ | 95 |  |  | $ | 81 |  |  | $ | 286 |  |  | $ | 252 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended\n | 9/9/2023 |  | 9/3/2022\n | Granted(a) |  | Weighted-Average Grant Price |  | Granted(a) |  | Weighted-Average Grant Price\nStock options | 2.1 |  |  | $ | 171.83 |  |  | 2.3 |  |  | $ | 163.46 | \nRSUs and PSUs | 2.1 |  |  | $ | 171.11 |  |  | 2.3 |  |  | $ | 163.01 |   |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended\n | 9/9/2023 |  | 9/3/2022\nExpected life | 7years |  | 7years\nRisk-free interest rate | 4.2 | % |  | 1.8 | %\nExpected volatility | 16 | % |  | 16 | %\nExpected dividend yield | 2.7 | % |  | 2.5 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | Pension |  | Retiree Medical\n | U.S. |  | International |  | \n | 9/9/2023 |  | 9/3/2022 |  | 9/9/2023 |  | 9/3/2022 |  | 9/9/2023 |  | 9/3/2022\nService cost | $ | 76 |  |  | $ | 111 |  |  | $ | 10 |  |  | $ | 13 |  |  | $ | 7 |  |  | $ | 8 | \nOther pension and retiree medical benefits income: |  |  |  | \nInterest cost | 137 |  |  | 111 |  |  | 34 |  |  | 23 |  |  | 7 |  |  | 5 | \nExpected return on plan assets | (197) |  |  | (206) |  |  | (45) |  |  | (55) |  |  | (3) |  |  | (4) | \nAmortization of prior service credits | (6) |  |  | (6) |  |  | (1) |  |  | (1) |  |  | (1) |  |  | (2) | \nAmortization of net losses/(gains) | 16 |  |  | 35 |  |  | 3 |  |  | 8 |  |  | (6) |  |  | (3) | \nSettlement/curtailment losses | \u2014 |  |  | 59 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \n |  |  |  |  |  |  |  |  |  |  | \nTotal other pension and retiree medical benefits income | (50) |  |  | (7) |  |  | (9) |  |  | (25) |  |  | (3) |  |  | (4) | \nTotal | $ | 26 |  |  | $ | 104 |  |  | $ | 1 |  |  | $ | (12) |  |  | $ | 4 |  |  | $ | 4 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended\n | Pension |  | Retiree Medical\n | U.S. |  | International |  | \n | 9/9/2023 |  | 9/3/2022 |  | 9/9/2023 |  | 9/3/2022 |  | 9/9/2023 |  | 9/3/2022\nService cost | $ | 227 |  |  | $ | 340 |  |  | $ | 28 |  |  | $ | 47 |  |  | $ | 20 |  |  | $ | 25 | \nOther pension and retiree medical benefits income: |  |  |  | \nInterest cost | 411 |  |  | 286 |  |  | 93 |  |  | 63 |  |  | 24 |  |  | 13 | \nExpected return on plan assets | (590) |  |  | (637) |  |  | (126) |  |  | (153) |  |  | (9) |  |  | (11) | \nAmortization of prior service credits | (18) |  |  | (19) |  |  | (1) |  |  | (1) |  |  | (4) |  |  | (6) | \nAmortization of net losses/(gains) | 48 |  |  | 103 |  |  | 8 |  |  | 20 |  |  | (18) |  |  | (9) | \nSettlement/curtailment losses/(gains) | \u2014 |  |  | 190 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (16) | \nSpecial termination benefits | (1) |  |  | 9 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nTotal other pension and retiree medical benefits income | (150) |  |  | (68) |  |  | (26) |  |  | (71) |  |  | (7) |  |  | (29) | \nTotal | $ | 77 |  |  | $ | 272 |  |  | $ | 2 |  |  | $ | (24) |  |  | $ | 13 |  |  | $ | (4) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nInterest Rate |  | Maturity Date |  | Principal Amount(a) | \nFloating rate |  | February 2026 |  | $ | 350 |  | \n4.550 | % |  | February 2026 |  | $ | 500 |  | \n4.450 | % |  | May 2028 |  | $ | 650 |  | \n4.450 | % |  | February 2033 |  | $ | 1,000 |  | \n4.650 | % |  | February 2053 |  | $ | 500 |  |   |  |  |  |  |  |  |  |  |  |  | \n | Notional Amounts(a)\n | 9/9/2023 |  | 12/31/2022\nCommodity | $ | 1.6 |  |  | $ | 1.8 | \nForeign exchange | $ | 2.9 |  |  | $ | 3.0 | \nInterest rate | $ | 1.3 |  |  | $ | 1.3 | \nNet investment(b) | $ | 2.9 |  |  | $ | 2.9 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | 9/9/2023 |  | 12/31/2022\n | Fair Value Hierarchy Levels(a) |  | Assets(a) |  | Liabilities(a) |  | Assets(a) |  | Liabilities(a)\n |  |  |  |  |  |  |  |  | \nAvailable-for-sale debt securities(b) | 2 |  | $ | 558 |  |  | $ | \u2014 |  |  | $ | 660 |  |  | $ | \u2014 | \nIndex funds(c) | 1 |  | $ | 265 |  |  | $ | \u2014 |  |  | $ | 257 |  |  | $ | \u2014 | \nPrepaid forward contracts(d) | 2 |  | $ | 14 |  |  | $ | \u2014 |  |  | $ | 14 |  |  | $ | \u2014 | \nDeferred compensation(e) | 2 |  | $ | \u2014 |  |  | $ | 439 |  |  | $ | \u2014 |  |  | $ | 434 | \n |  |  |  |  |  |  |  |  | \nDerivatives designated as cash flow hedging instruments: |  |  |  |  |  |  |  |  | \nForeign exchange(f) | 2 |  | $ | 11 |  |  | $ | 37 |  |  | $ | 24 |  |  | $ | 22 | \nInterest rate(f) | 2 |  | \u2014 |  |  | 161 |  |  | \u2014 |  |  | 164 | \nCommodity(g) | 2 |  | \u2014 |  |  | 49 |  |  | 2 |  |  | 60 | \n |  |  | $ | 11 |  |  | $ | 247 |  |  | $ | 26 |  |  | $ | 246 | \nDerivatives not designated as hedging instruments: |  |  |  |  |  |  |  |  | \nForeign exchange(f) | 2 |  | $ | 18 |  |  | $ | 18 |  |  | $ | 21 |  |  | $ | 21 | \nCommodity(g) | 2 |  | 10 |  |  | 17 |  |  | 11 |  |  | 51 | \n |  |  | $ | 28 |  |  | $ | 35 |  |  | $ | 32 |  |  | $ | 72 | \nTotal derivatives at fair value(h) |  |  | $ | 39 |  |  | $ | 282 |  |  | $ | 58 |  |  | $ | 318 | \nTotal |  |  | $ | 876 |  |  | $ | 721 |  |  | $ | 989 |  |  | $ | 752 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | Losses/(Gains)Recognized inAccumulated\u00a0OtherComprehensive\u00a0Loss |  | Losses/(Gains)Reclassified fromAccumulated\u00a0OtherComprehensive\u00a0Lossinto Income Statement(a)\n | 9/9/2023 |  | 9/3/2022 |  | 9/9/2023 |  | 9/3/2022\nForeign exchange | $ | 15 |  |  | $ | (31) |  |  | $ | 26 |  |  | $ | 1 | \nInterest rate | 23 |  |  | 81 |  |  | 31 |  |  | 94 | \nCommodity | 65 |  |  | 141 |  |  | 24 |  |  | (51) | \nNet investment | (68) |  |  | (144) |  |  | \u2014 |  |  | \u2014 | \nTotal | $ | 35 |  |  | $ | 47 |  |  | $ | 81 |  |  | $ | 44 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | 36 Weeks Ended\n |  |  | Losses/(Gains)Recognized inAccumulated\u00a0OtherComprehensive\u00a0Loss |  | Losses/(Gains)Reclassified fromAccumulated\u00a0OtherComprehensive\u00a0Lossinto Income Statement(a)\n |  |  |  |  | 9/9/2023 |  | 9/3/2022 |  | 9/9/2023 |  | 9/3/2022\nForeign exchange |  |  |  |  | $ | 74 |  |  | $ | (13) |  |  | $ | 41 |  |  | $ | (20) | \nInterest rate |  |  |  |  | (3) |  |  | 160 |  |  | 4 |  |  | 175 | \nCommodity |  |  |  |  | 115 |  |  | (49) |  |  | 61 |  |  | (203) | \nNet investment |  |  |  |  | 40 |  |  | (283) |  |  | \u2014 |  |  | \u2014 | \nTotal |  |  |  |  | $ | 226 |  |  | $ | (185) |  |  | $ | 106 |  |  | $ | (48) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 9/9/2023 |  | 9/3/2022\n | Cost of sales |  | Selling, general and administrative expenses |  | Total |  | Cost of sales |  | Selling, general and administrative expenses |  | Total\nForeign exchange | $ | \u2014 |  |  | $ | (7) |  |  | $ | (7) |  |  | $ | \u2014 |  |  | $ | (60) |  |  | $ | (60) | \nCommodity | (9) |  |  | (65) |  |  | (74) |  |  | (2) |  |  | 55 |  |  | 53 | \nTotal | $ | (9) |  |  | $ | (72) |  |  | $ | (81) |  |  | $ | (2) |  |  | $ | (5) |  |  | $ | (7) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended\n | 9/9/2023 |  | 9/3/2022\n | Cost of sales |  | Selling, general and administrative expenses |  | Total |  | Cost of sales |  | Selling, general and administrative expenses |  | Total\nForeign exchange | $ | (1) |  |  | $ | 32 |  |  | $ | 31 |  |  | $ | (3) |  |  | $ | (52) |  |  | $ | (55) | \nCommodity | 27 |  |  | (12) |  |  | 15 |  |  | (136) |  |  | (158) |  |  | (294) | \nTotal | $ | 26 |  |  | $ | 20 |  |  | $ | 46 |  |  | $ | (139) |  |  | $ | (210) |  |  | $ | (349) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | 9/9/2023 |  | 9/3/2022\n | Income |  | Shares(a) |  | Income |  | Shares(a)\n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nBasic net income attributable to PepsiCo per common share | $ | 2.25 |  |  |  |  | $ | 1.96 |  |  | \nNet income available for PepsiCo common shareholders | $ | 3,092 |  |  | 1,376 |  |  | $ | 2,702 |  |  | 1,380 | \nDilutive securities: |  |  |  |  |  |  | \nStock options, RSUs, PSUs and other(b) | \u2014 |  |  | 7 |  |  | \u2014 |  |  | 7 | \nDiluted | $ | 3,092 |  |  | 1,383 |  |  | $ | 2,702 |  |  | 1,387 | \nDiluted net income attributable to PepsiCo per common share | $ | 2.24 |  |  |  |  | $ | 1.95 |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended\n | 9/9/2023 |  | 9/3/2022\n | Income |  | Shares(a) |  | Income |  | Shares(a)\n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nBasic net income attributable to PepsiCo per common share | $ | 5.64 |  |  |  |  | $ | 6.07 |  |  | \nNet income available for PepsiCo common shareholders | $ | 7,772 |  |  | 1,377 |  |  | $ | 8,392 |  |  | 1,382 | \nDilutive securities: |  |  |  |  |  |  | \nStock options, RSUs, PSUs and other(b) | \u2014 |  |  | 7 |  |  | \u2014 |  |  | 7 | \nDiluted | $ | 7,772 |  |  | 1,384 |  |  | $ | 8,392 |  |  | 1,389 | \nDiluted net income attributable to PepsiCo per common share | $ | 5.62 |  |  |  |  | $ | 6.04 |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Currency Translation Adjustment |  | Cash Flow Hedges |  | Pension and Retiree Medical |  |  |  | Other |  | Accumulated Other Comprehensive Loss Attributable to PepsiCo\nBalance as of December 31, 2022(a) | $ | (12,948) |  |  | $ | 1 |  |  | $ | (2,361) |  |  |  |  | $ | 6 |  |  | $ | (15,302) | \nOther comprehensive (loss) before reclassifications(b) | (350) |  |  | (92) |  |  | (9) |  |  |  |  | (1) |  |  | (452) | \nAmounts reclassified from accumulated other comprehensive loss(c) | 108 |  |  | 13 |  |  | 5 |  |  |  |  | \u2014 |  |  | 126 | \nNet other comprehensive (loss) | (242) |  |  | (79) |  |  | (4) |  |  |  |  | (1) |  |  | (326) | \nTax amounts | 7 |  |  | 20 |  |  | \u2014 |  |  |  |  | \u2014 |  |  | 27 | \nBalance as of March 25, 2023(a) | (13,183) |  |  | (58) |  |  | (2,365) |  |  |  |  | 5 |  |  | (15,601) | \nOther comprehensive (loss)/income before reclassifications(d) | (215) |  |  | 19 |  |  | (14) |  |  |  |  | 1 |  |  | (209) | \nAmounts reclassified from accumulated other comprehensive loss | \u2014 |  |  | 12 |  |  | 5 |  |  |  |  | \u2014 |  |  | 17 | \nNet other comprehensive (loss)/income | (215) |  |  | 31 |  |  | (9) |  |  |  |  | 1 |  |  | (192) | \nTax amounts | 17 |  |  | (7) |  |  | 3 |  |  |  |  | \u2014 |  |  | 13 | \nBalance as of June 17, 2023(a) | (13,381) |  |  | (34) |  |  | (2,371) |  |  |  |  | 6 |  |  | (15,780) | \nOther comprehensive income/(loss) before reclassifications(e) | 19 |  |  | (96) |  |  | (15) |  |  |  |  | 3 |  |  | (89) | \nAmounts reclassified from accumulated other comprehensive loss | \u2014 |  |  | 81 |  |  | 5 |  |  |  |  | \u2014 |  |  | 86 | \nNet other comprehensive income/(loss) | 19 |  |  | (15) |  |  | (10) |  |  |  |  | 3 |  |  | (3) | \nTax amounts | (17) |  |  | 4 |  |  | 2 |  |  |  |  | \u2014 |  |  | (11) | \nBalance as of September 9, 2023(a) | $ | (13,379) |  |  | $ | (45) |  |  | $ | (2,379) |  |  |  |  | $ | 9 |  |  | $ | (15,794) | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Currency Translation Adjustment |  | Cash Flow Hedges |  | Pension and Retiree Medical |  |  |  | Other |  | Accumulated Other Comprehensive Loss Attributable to PepsiCo\nBalance as of December 25, 2021(a) | $ | (12,309) |  |  | $ | 159 |  |  | $ | (2,750) |  |  |  |  | $ | 2 |  |  | $ | (14,898) | \nOther comprehensive (loss)/income before reclassifications(b) | (549) |  |  | 200 |  |  | (8) |  |  |  |  | \u2014 |  |  | (357) | \nAmounts reclassified from accumulated other comprehensive loss | \u2014 |  |  | (62) |  |  | 25 |  |  |  |  | \u2014 |  |  | (37) | \nNet other comprehensive (loss)/income | (549) |  |  | 138 |  |  | 17 |  |  |  |  | \u2014 |  |  | (394) | \nTax amounts | (11) |  |  | (32) |  |  | (4) |  |  |  |  | (4) |  |  | (51) | \nBalance as of March 19, 2022(a) | (12,869) |  |  | 265 |  |  | (2,737) |  |  |  |  | (2) |  |  | (15,343) | \nOther comprehensive income/(loss) before reclassifications(c) | 1,298 |  |  | (107) |  |  | (484) |  |  |  |  | 5 |  |  | 712 | \nAmounts reclassified from accumulated other comprehensive loss | \u2014 |  |  | (30) |  |  | 161 |  |  |  |  | \u2014 |  |  | 131 | \nNet other comprehensive income/(loss) | 1,298 |  |  | (137) |  |  | (323) |  |  |  |  | 5 |  |  | 843 | \nTax amounts | (24) |  |  | 35 |  |  | 73 |  |  |  |  | \u2014 |  |  | 84 | \nBalance as of June 11, 2022(a) | (11,595) |  |  | 163 |  |  | (2,987) |  |  |  |  | 3 |  |  | (14,416) | \nOther comprehensive (loss)/income before reclassifications(d) | (292) |  |  | (191) |  |  | 50 |  |  |  |  | 2 |  |  | (431) | \nAmounts reclassified from accumulated other comprehensive loss | \u2014 |  |  | 44 |  |  | 90 |  |  |  |  | \u2014 |  |  | 134 | \nNet other comprehensive (loss)/income | (292) |  |  | (147) |  |  | 140 |  |  |  |  | 2 |  |  | (297) | \nTax amounts | (32) |  |  | 34 |  |  | (32) |  |  |  |  | \u2014 |  |  | (30) | \nBalance as of September 3, 2022(a) | $ | (11,919) |  |  | $ | 50 |  |  | $ | (2,879) |  |  |  |  | $ | 5 |  |  | $ | (14,743) | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | 12 Weeks Ended |  | 36 Weeks Ended |  | \n |  | 9/9/2023 |  | 9/3/2022 |  | 9/9/2023 |  | 9/3/2022 |  | Affected Line Item in the Income Statement\n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \nCurrency translation: |  |  |  |  |  |  |  |  |  | \nDivestitures |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 108 |  |  | $ | \u2014 |  |  | Selling, general and administrative expenses\n |  |  |  |  |  |  |  |  |  | \nCash flow hedges: |  |  |  |  |  |  |  |  |  | \nForeign exchange contracts |  | $ | \u2014 |  |  | $ | (5) |  |  | $ | (3) |  |  | $ | (9) |  |  | Net revenue\nForeign exchange contracts |  | 26 |  |  | 6 |  |  | 44 |  |  | (11) |  |  | Cost of sales\nInterest rate derivatives |  | 31 |  |  | 94 |  |  | 4 |  |  | 175 |  |  | Selling, general and administrative expenses\nCommodity contracts |  | 23 |  |  | (45) |  |  | 61 |  |  | (191) |  |  | Cost of sales\nCommodity contracts |  | 1 |  |  | (6) |  |  | \u2014 |  |  | (12) |  |  | Selling, general and administrative expenses\nNet losses/(gains) before tax |  | 81 |  |  | 44 |  |  | 106 |  |  | (48) |  |  | \nTax amounts |  | (20) |  |  | (12) |  |  | (27) |  |  | 5 |  |  | \nNet losses/(gains) after tax |  | $ | 61 |  |  | $ | 32 |  |  | $ | 79 |  |  | $ | (43) |  |  | \n |  |  |  |  |  |  |  |  |  | \nPension and retiree medical items: |  |  |  |  |  |  |  |  |  | \nAmortization of prior service credits |  | $ | (8) |  |  | $ | (9) |  |  | $ | (23) |  |  | $ | (26) |  |  | Other pension and retiree medical benefits income\nAmortization of net losses |  | 13 |  |  | 40 |  |  | 38 |  |  | 114 |  |  | Other pension and retiree medical benefits income\nSettlement/curtailment losses |  | \u2014 |  |  | 59 |  |  | \u2014 |  |  | 188 |  |  | Other pension and retiree medical benefits income\nNet losses before tax |  | 5 |  |  | 90 |  |  | 15 |  |  | 276 |  |  | \nTax amounts |  | (1) |  |  | (19) |  |  | (3) |  |  | (60) |  |  | \nNet losses after tax |  | $ | 4 |  |  | $ | 71 |  |  | $ | 12 |  |  | $ | 216 |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \nTotal net losses reclassified, net of tax |  | $ | 65 |  |  | $ | 103 |  |  | $ | 199 |  |  | $ | 173 |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended |  | \n | 9/9/2023 |  | 9/3/2022 |  | 9/9/2023 |  | 9/3/2022 |  | \n |  |  |  |  |  |  |  |  | \nPBNA | $ | 2 |  |  | $ | 3 |  |  | $ | 12 |  |  | $ | 42 |  |  | \nEurope(a) | \u2014 |  |  | \u2014 |  |  | (2) |  |  | 13 |  |  | \nAMESA | \u2014 |  |  | 2 |  |  | 1 |  |  | 2 |  |  | \n |  |  |  |  |  |  |  |  | \nCorporate | 9 |  |  | \u2014 |  |  | 9 |  |  | 6 |  |  | \n |  |  |  |  |  |  |  |  | \nTotal(b) | 11 |  |  | 5 |  |  | 20 |  |  | 63 |  |  | \nOther pension and retiree medical benefits expense | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 6 |  |  | \nTotal acquisition and divestiture-related charges | $ | 11 |  |  | $ | 5 |  |  | $ | 20 |  |  | $ | 69 |  |  | \nAfter-tax amount | $ | 9 |  |  | $ | 3 |  |  | $ | 16 |  |  | $ | 57 |  |  | \nImpact on net income attributable to PepsiCo per common share | $ | (0.01) |  |  | $ | \u2014 |  |  | $ | (0.01) |  |  | $ | (0.04) |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | 9/9/2023 |  | 9/3/2022 |  | Change |  | 9/9/2023 |  | 9/3/2022 |  | Change\nNet revenue | $ | 23,453 |  |  | $ | 21,971 |  |  | 7 | % |  | $ | 63,621 |  |  | $ | 58,396 |  |  | 9 | %\nOperating profit | $ | 4,015 |  |  | $ | 3,353 |  |  | 20 | % |  | $ | 10,303 |  |  | $ | 10,697 |  |  | (4) | %\nOperating margin | 17.1 | % |  | 15.3 | % |  | 1.8 |  |  | 16.2 | % |  | 18.3 | % |  | (2.1) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended | \n | 9/9/2023 |  | 9/3/2022 |  | Change |  | 9/9/2023 |  | 9/3/2022 |  | Change | \nOther pension and retiree medical benefits income | $ | 62 |  |  | $ | 36 |  |  | $ | 26 |  |  | $ | 183 |  |  | $ | 168 |  |  | $ | 15 |  | \nNet interest expense and other | $ | (201) |  |  | $ | (190) |  |  | $ | (11) |  |  | $ | (602) |  |  | $ | (666) |  |  | $ | 64 |  | \nTax rate | 19.6 | % |  | 14.9 | % |  |  |  | 20.8 | % |  | 17.2 | % |  |  | \nNet income attributable to PepsiCo(a) | $ | 3,092 |  |  | $ | 2,702 |  |  | 14 | % |  | $ | 7,772 |  |  | $ | 8,392 |  |  | (7) | % | \nNet income attributable to PepsiCo per common share \u2013 diluted(a) | $ | 2.24 |  |  | $ | 1.95 |  |  | 15 | % |  | $ | 5.62 |  |  | $ | 6.04 |  |  | (7) | % | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 9/9/2023\n |  |  | Impact of |  |  |  | Impact of\n | Reported% Change, GAAP Measure |  | Foreign exchange translation |  | Acquisitions and divestitures |  | Organic% Change, Non-GAAP Measure(a) |  | Organic volume(b) |  | Effective net pricing\nFLNA | 7 | % |  | \u2014 |  |  | \u2014 |  |  | 7 | % |  | (0.5) |  |  | 8 | \nQFNA | 5 | % |  | \u2014 |  |  | \u2014 |  |  | 5 | % |  | 1 |  |  | 4 | \nPBNA | 8 | % |  | \u2014 |  |  | (2) |  |  | 6 | % |  | (6) |  |  | 12 | \nLatAm | 21 | % |  | (13) |  |  | 1 |  |  | 9 | % |  | (5) |  |  | 14 | \nEurope | 2 | % |  | 10 |  |  | 1 |  |  | 13 | % |  | \u2014 |  |  | 13 | \nAMESA | (6) | % |  | 22 |  |  | 1 |  |  | 17 | % |  | (2) |  |  | 18 | \nAPAC | 4 | % |  | 5 |  |  | \u2014 |  |  | 9 | % |  | 1 |  |  | 7 | \nTotal | 7 | % |  | 2 |  |  | \u2014 |  |  | 9 | % |  | (2.5) |  |  | 11 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended 9/9/2023\n |  |  | Impact of |  |  |  |  |  |  |  | Impact of\n | Reported% Change, GAAP Measure |  | Foreign exchange translation |  | Acquisitions and divestitures |  |  |  | Organic% Change, Non-GAAP Measure(a) |  |  |  |  |  | Organic volume(b) |  | Effective net pricing\nFLNA | 12 | % |  | \u2014 |  |  | \u2014 |  |  |  |  | 12 | % |  |  |  |  |  | \u2014 |  |  | 12 | \nQFNA | 5 | % |  | 1 |  |  | \u2014 |  |  |  |  | 6 | % |  |  |  |  |  | (3) |  |  | 9 | \nPBNA | 9 | % |  | \u2014 |  |  | \u2014 |  |  |  |  | 9 | % |  |  |  |  |  | (4.5) |  |  | 14 | \nLatAm | 20 | % |  | (9) |  |  | 1 |  |  |  |  | 12 | % |  |  |  |  |  | (4) |  |  | 17 | \nEurope | 7 | % |  | 7 |  |  | 2 |  |  |  |  | 15 | % |  |  |  |  |  | (3) |  |  | 18 | \nAMESA | (5) | % |  | 25 |  |  | 0.5 |  |  |  |  | 20 | % |  |  |  |  |  | (3) |  |  | 23 | \nAPAC | 1 | % |  | 5 |  |  | \u2014 |  |  |  |  | 7 | % |  |  |  |  |  | \u2014 |  |  | 7 | \nTotal | 9 | % |  | 2 |  |  | \u2014 |  |  |  |  | 12 | % |  |  |  |  |  | (3) |  |  | 14 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 9/9/2023\n |  |  | Items Affecting Comparability(a) |  | \n | Reported, GAAP Measure |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges |  | Impairment and other charges/credits |  | Core,Non-GAAP Measure\nFLNA | $ | 1,669 |  |  | $ | \u2014 |  |  | $ | 6 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 1,675 | \nQFNA | 135 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 135 | \nPBNA | 970 |  |  | \u2014 |  |  | 8 |  |  | 2 |  |  | \u2014 |  |  | 980 | \nLatAm | 593 |  |  | \u2014 |  |  | 8 |  |  | \u2014 |  |  | \u2014 |  |  | 601 | \nEurope | 659 |  |  | \u2014 |  |  | 44 |  |  | \u2014 |  |  | (1) |  |  | 702 | \nAMESA | 238 |  |  | \u2014 |  |  | 5 |  |  | \u2014 |  |  | 6 |  |  | 249 | \nAPAC | 239 |  |  | \u2014 |  |  | 2 |  |  | \u2014 |  |  | \u2014 |  |  | 241 | \nCorporate unallocated expenses | (488) |  |  | (85) |  |  | 10 |  |  | 9 |  |  | \u2014 |  |  | (554) | \nTotal | $ | 4,015 |  |  | $ | (85) |  |  | $ | 83 |  |  | $ | 11 |  |  | $ | 5 |  |  | $ | 4,029 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 9/3/2022\n |  |  | Items Affecting Comparability(a) |  | \n | Reported, GAAP Measure |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges |  | Gain associated with the Juice Transaction |  | Impairment and other charges/credits(b) |  | Core,Non-GAAP Measure\nFLNA | $ | 1,588 |  |  | $ | \u2014 |  |  | $ | 4 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 1,592 | \nQFNA | 122 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 123 | \nPBNA | 784 |  |  | \u2014 |  |  | 4 |  |  | 3 |  |  | 8 |  |  | 9 |  |  | 808 | \nLatAm | 463 |  |  | \u2014 |  |  | 3 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 466 | \nEurope | 564 |  |  | \u2014 |  |  | 21 |  |  | \u2014 |  |  | 6 |  |  | (3) |  |  | 588 | \nAMESA | 268 |  |  | \u2014 |  |  | \u2014 |  |  | 2 |  |  | \u2014 |  |  | \u2014 |  |  | 270 | \nAPAC | 199 |  |  | \u2014 |  |  | 4 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 203 | \nCorporate unallocated expenses | (635) |  |  | 166 |  |  | 14 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (455) | \nTotal | $ | 3,353 |  |  | $ | 166 |  |  | $ | 51 |  |  | $ | 5 |  |  | $ | 14 |  |  | $ | 6 |  |  | $ | 3,595 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended 9/9/2023\n |  |  | Items Affecting Comparability(a) |  | \n | Reported, GAAP Measure |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges(b) |  |  |  | Impairment and other charges/credits(b) |  |  |  | Core,Non-GAAP Measure\nFLNA | $ | 4,915 |  |  | $ | \u2014 |  |  | $ | 19 |  |  | $ | \u2014 |  |  |  |  | $ | \u2014 |  |  |  |  | $ | 4,934 | \nQFNA | 452 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | \u2014 |  |  |  |  | 452 | \nPBNA | 2,176 |  |  | \u2014 |  |  | 18 |  |  | 12 |  |  |  |  | 113 |  |  |  |  | 2,319 | \nLatAm | 1,549 |  |  | \u2014 |  |  | 19 |  |  | \u2014 |  |  |  |  | 2 |  |  |  |  | 1,570 | \nEurope | 1,206 |  |  | \u2014 |  |  | 185 |  |  | (2) |  |  |  |  | (6) |  |  |  |  | 1,383 | \nAMESA | 656 |  |  | \u2014 |  |  | 10 |  |  | 1 |  |  |  |  | (7) |  |  |  |  | 660 | \nAPAC | 689 |  |  | \u2014 |  |  | 7 |  |  | \u2014 |  |  |  |  | \u2014 |  |  |  |  | 696 | \nCorporate unallocated expenses | (1,340) |  |  | (23) |  |  | 30 |  |  | 9 |  |  |  |  |  |  |  |  | (1,324) | \nTotal | $ | 10,303 |  |  | $ | (23) |  |  | $ | 288 |  |  | $ | 20 |  |  |  |  | $ | 102 |  |  |  |  | $ | 10,690 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended 9/3/2022\n |  |  | Items Affecting Comparability(a) |  | \n | Reported,GAAP Measure |  | Mark-to-market net impact |  | Restructuringand impairment charges |  | Acquisition and divestiture-related charges |  | Gain associated with the Juice Transaction |  | Impairment and other charges/credits |  |  |  | Core,Non-GAAP Measure\nFLNA | $ | 4,332 |  |  | $ | \u2014 |  |  | $ | 10 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  |  |  | $ | 4,342 | \nQFNA | 416 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 417 | \nPBNA | 4,869 |  |  | \u2014 |  |  | 9 |  |  | 42 |  |  | (3,029) |  |  | 150 |  |  |  |  | 2,041 | \nLatAm | 1,206 |  |  | \u2014 |  |  | 17 |  |  | \u2014 |  |  | \u2014 |  |  | 83 |  |  |  |  | 1,306 | \nEurope | (369) |  |  | \u2014 |  |  | 40 |  |  | 13 |  |  | (292) |  |  | 1,644 |  |  |  |  | 1,036 | \nAMESA | 738 |  |  | \u2014 |  |  | 5 |  |  | 2 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 745 | \nAPAC | 620 |  |  | \u2014 |  |  | 8 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | 628 | \nCorporate unallocated expenses | (1,115) |  |  | (44) |  |  | 33 |  |  | 6 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | (1,120) | \nTotal | $ | 10,697 |  |  | $ | (44) |  |  | $ | 123 |  |  | $ | 63 |  |  | $ | (3,321) |  |  | $ | 1,877 |  |  |  |  | $ | 9,395 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 9/9/2023\n |  |  | Impact of Items Affecting Comparability(a) |  |  |  | Impact of |  | \n | Reported % Change, GAAP Measure |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges |  | Gain associated with the Juice Transaction |  | Impairment and other charges/credits |  | Core% Change, Non-GAAP Measure(b) |  | Foreign exchangetranslation |  | Core Constant Currency% Change, Non-GAAP Measure(b)\nFLNA | 5 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 5 | % |  | \u2014 |  |  | 5.5 | %\nQFNA | 11 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 10 | % |  | \u2014 |  |  | 11 | %\nPBNA | 24 | % |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | (1.5) |  |  | (2) |  |  | 21 | % |  | \u2014 |  |  | 22 | %\nLatAm | 28 | % |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 29 | % |  | (17) |  |  | 12 | %\nEurope | 17 | % |  | \u2014 |  |  | 3 |  |  | \u2014 |  |  | (1) |  |  | \u2014 |  |  | 19 | % |  | 15 |  |  | 34 | %\nAMESA | (11) | % |  | \u2014 |  |  | 1 |  |  | \u2014 |  |  | \u2014 |  |  | 2 |  |  | (8) | % |  | 22 |  |  | 13 | %\nAPAC | 20 | % |  | \u2014 |  |  | (2) |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 18 | % |  | 4 |  |  | 23 | %\nCorporate unallocated expenses | (23) | % |  | 46 |  |  | 1 |  |  | (2) |  |  | \u2014 |  |  | \u2014 |  |  | 22 | % |  | \u2014 |  |  | 22 | %\nTotal | 20 | % |  | (8) |  |  | 1 |  |  | \u2014 |  |  | (0.5) |  |  | \u2014 |  |  | 12 | % |  | 2 |  |  | 14 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended 9/9/2023\n |  |  | Impact of Items Affecting Comparability(a) |  |  |  |  |  |  |  | Impact of |  | \n | Reported % Change, GAAP Measure |  | Mark-to-market net impact |  | Restructuring and impairment charges |  | Acquisition and divestiture-related charges |  | Gain associated with the Juice Transaction |  | Impairment and other charges/credits |  |  |  |  |  | Core% Change, Non-GAAP Measure(b) |  | Foreign exchangetranslation |  | Core Constant Currency% Change, Non-GAAP Measure(b)\nFLNA | 13 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  |  |  | 14 | % |  | \u2014 |  |  | 14 | %\nQFNA | 9 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  |  |  | 8 | % |  | \u2014 |  |  | 9 | %\nPBNA | (55) | % |  | \u2014 |  |  | \u2014 |  |  | (1) |  |  | 70 |  |  | (1) |  |  |  |  |  |  | 14 | % |  | 0.5 |  |  | 14 | %\nLatAm | 28 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (8) |  |  |  |  |  |  | 20 | % |  | (11) |  |  | 9 | %\nEurope | n/m |  | \u2014 |  |  | n/m |  | n/m |  | n/m |  | n/m |  |  |  |  |  | 33 | % |  | 13 |  |  | 46 | %\nAMESA | (11) | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (1) |  |  |  |  |  |  | (11) | % |  | 22 |  |  | 10 | %\nAPAC | 11 | % |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  |  |  | 11 | % |  | 5 |  |  | 16 | %\nCorporate unallocated expenses | 20 | % |  | (2) |  |  | 0.5 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  |  |  | 18 | % |  | \u2014 |  |  | 18 | %\nTotal | (4) | % |  | \u2014 |  |  | 2 |  |  | \u2014 |  |  | 34 |  |  | (18) |  |  |  |  |  |  | 14 | % |  | 2 |  |  | 16 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 9/9/2023\n | Cost of sales |  | Gross profit |  | Selling, general and administrative expenses |  |  |  | Impairment of intangible assets |  | Operating profit |  |  |  |  |  | Provision for income taxes(a) |  |  |  | Net income attributable to PepsiCo\nReported, GAAP Measure | $ | 10,675 |  |  | $ | 12,778 |  |  | $ | 8,757 |  |  |  |  | $ | 6 |  |  | $ | 4,015 |  |  |  |  |  |  | $ | 760 |  |  |  |  | $ | 3,092 | \nItems Affecting Comparability |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMark-to-market net impact | 16 |  |  | (16) |  |  | 69 |  |  |  |  | \u2014 |  |  | (85) |  |  |  |  |  |  | (21) |  |  |  |  | (64) | \nRestructuring and impairment charges | (4) |  |  | 4 |  |  | (79) |  |  |  |  | \u2014 |  |  | 83 |  |  |  |  |  |  | 17 |  |  |  |  | 66 | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  | (11) |  |  |  |  | \u2014 |  |  | 11 |  |  |  |  |  |  | 2 |  |  |  |  | 9 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nImpairment and other charges/credits | \u2014 |  |  | \u2014 |  |  | 1 |  |  |  |  | (6) |  |  | 5 |  |  |  |  |  |  | 1 |  |  |  |  | 4 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCore, Non-GAAP Measure | $ | 10,687 |  |  | $ | 12,766 |  |  | $ | 8,737 |  |  |  |  | $ | \u2014 |  |  | $ | 4,029 |  |  |  |  |  |  | $ | 759 |  |  |  |  | $ | 3,107 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended 9/3/2022 |  |  |  |  |  |  |  |  |  |  |  | \n | Cost of sales |  | Gross profit |  | Selling, general and administrative expenses |  | Gain associated with the Juice Transaction |  | Impairment of intangible assets |  | Operating profit |  | Other pension and retiree medical benefits income |  | Provision for income taxes(a) |  |  |  | Net income attributable to PepsiCo |  |  |  |  |  |  |  |  |  |  |  | \nReported, GAAP Measure | $ | 10,308 |  |  | $ | 11,663 |  |  | $ | 8,295 |  |  | $ | 14 |  |  | $ | 1 |  |  | $ | 3,353 |  |  | $ | 36 |  |  | $ | 475 |  |  |  |  | $ | 2,702 |  |  |  |  |  |  |  |  |  |  |  |  | \nItems Affecting Comparability |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMark-to-market net impact | (54) |  |  | 54 |  |  | (112) |  |  | \u2014 |  |  | \u2014 |  |  | 166 |  |  | \u2014 |  |  | 40 |  |  |  |  | 126 |  |  |  |  |  |  |  |  |  |  |  |  | \nRestructuring and impairment charges | (1) |  |  | 1 |  |  | (50) |  |  | \u2014 |  |  | \u2014 |  |  | 51 |  |  | \u2014 |  |  | 11 |  |  |  |  | 40 |  |  |  |  |  |  |  |  |  |  |  |  | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  | (5) |  |  | \u2014 |  |  | \u2014 |  |  | 5 |  |  | \u2014 |  |  | 2 |  |  |  |  | 3 |  |  |  |  |  |  |  |  |  |  |  |  | \nGain associated with the Juice Transaction | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (14) |  |  | \u2014 |  |  | 14 |  |  | \u2014 |  |  | 3 |  |  |  |  | 11 |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nImpairment and other charges/credits | (11) |  |  | 11 |  |  | 6 |  |  | \u2014 |  |  | (1) |  |  | 6 |  |  | \u2014 |  |  | 3 |  |  |  |  | 3 |  |  |  |  |  |  |  |  |  |  |  |  | \nPension and retiree medical-related impact | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 59 |  |  | 13 |  |  |  |  | 46 |  |  |  |  |  |  |  |  |  |  |  |  | \nTax benefit related to the IRS audit | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 284 |  |  |  |  | (284) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTax expense related to the TCJ Act | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (86) |  |  |  |  | 86 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCore, Non-GAAP Measure | $ | 10,242 |  |  | $ | 11,729 |  |  | $ | 8,134 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 3,595 |  |  | $ | 95 |  |  | $ | 745 |  |  |  |  | $ | 2,733 |  |  |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended 9/9/2023\n | Cost of sales |  | Gross profit |  | Selling, general and administrative expenses |  |  |  | Impairment of intangible assets |  | Operating profit |  | Other pension and retiree medical benefits income/(expense) |  |  |  | Provision for income taxes(a) |  | Net income attributable to noncontrolling interests |  | Net income attributable to PepsiCo\nReported, GAAP Measure | $ | 28,784 |  |  | $ | 34,837 |  |  | $ | 24,528 |  |  |  |  | $ | 6 |  |  | $ | 10,303 |  |  | $ | 183 |  |  |  |  | $ | 2,053 |  |  | $ | 59 |  |  | $ | 7,772 | \nItems Affecting Comparability |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMark-to-market net impact | 3 |  |  | (3) |  |  | 20 |  |  |  |  | \u2014 |  |  | (23) |  |  | \u2014 |  |  |  |  | (6) |  |  | \u2014 |  |  | (17) | \nRestructuring and impairment charges | (10) |  |  | 10 |  |  | (278) |  |  |  |  | \u2014 |  |  | 288 |  |  | (1) |  |  |  |  | 60 |  |  | 1 |  |  | 226 | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  | (20) |  |  |  |  | \u2014 |  |  | 20 |  |  | \u2014 |  |  |  |  | 4 |  |  | \u2014 |  |  | 16 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nImpairment and other charges/credits | 5 |  |  | (5) |  |  | (101) |  |  |  |  | (6) |  |  | 102 |  |  | \u2014 |  |  |  |  | 29 |  |  | \u2014 |  |  | 73 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCore, Non-GAAP Measure | $ | 28,782 |  |  | $ | 34,839 |  |  | $ | 24,149 |  |  |  |  | $ | \u2014 |  |  | $ | 10,690 |  |  | $ | 182 |  |  |  |  | $ | 2,140 |  |  | $ | 60 |  |  | $ | 8,070 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended 9/3/2022\n | Cost of sales |  | Gross profit |  | Selling, general and administrative expenses |  | Gain associated with the Juice Transaction |  | Impairment of intangible assets |  | Operating profit |  | Other pension and retiree medical benefits income |  | Provision for income taxes(a) |  | Net income attributable to noncontrolling interests |  | Net income attributable to PepsiCo\nReported, GAAP Measure | $ | 27,156 |  |  | $ | 31,240 |  |  | $ | 22,262 |  |  | $ | (3,321) |  |  | $ | 1,602 |  |  | $ | 10,697 |  |  | $ | 168 |  |  | $ | 1,756 |  |  | $ | 51 |  |  | $ | 8,392 | \nItems Affecting Comparability |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMark-to-market net impact | 1 |  |  | (1) |  |  | 43 |  |  | \u2014 |  |  | \u2014 |  |  | (44) |  |  | \u2014 |  |  | (11) |  |  | \u2014 |  |  | (33) | \nRestructuring and impairment charges | (6) |  |  | 6 |  |  | (117) |  |  | \u2014 |  |  | \u2014 |  |  | 123 |  |  | 3 |  |  | 25 |  |  | 1 |  |  | 100 | \nAcquisition and divestiture-related charges | \u2014 |  |  | \u2014 |  |  | (63) |  |  | \u2014 |  |  | \u2014 |  |  | 63 |  |  | 6 |  |  | 12 |  |  | \u2014 |  |  | 57 | \nGain associated with the Juice Transaction | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 3,321 |  |  | \u2014 |  |  | (3,321) |  |  | \u2014 |  |  | (452) |  |  | \u2014 |  |  | (2,869) | \nImpairment and other charges/credits | (152) |  |  | 152 |  |  | (123) |  |  | \u2014 |  |  | (1,602) |  |  | 1,877 |  |  | \u2014 |  |  | 350 |  |  | \u2014 |  |  | 1,527 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPension and retiree medical-related impact | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 174 |  |  | 39 |  |  | \u2014 |  |  | 135 | \nTax benefit related to the IRS audit | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 284 |  |  | \u2014 |  |  | (284) | \nTax expense related to the TCJ Act | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (86) |  |  | \u2014 |  |  | 86 | \nCore, Non-GAAP Measure | $ | 26,999 |  |  | $ | 31,397 |  |  | $ | 22,002 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 9,395 |  |  | $ | 351 |  |  | $ | 1,917 |  |  | $ | 52 |  |  | $ | 7,111 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended | \n | 9/9/2023 |  | 9/3/2022 |  | Change |  | 9/9/2023 |  | 9/3/2022 |  | Change | \nNet income attributable to PepsiCo per common share \u2013 diluted, GAAP measure | $ | 2.24 |  |  | $ | 1.95 |  |  | 15 | % |  | $ | 5.62 |  |  | $ | 6.04 |  |  | (7) | % | \nMark-to-market net impact | (0.05) |  |  | 0.09 |  |  |  |  | (0.01) |  |  | (0.02) |  |  |  | \nRestructuring and impairment charges | 0.05 |  |  | 0.03 |  |  |  |  | 0.16 |  |  | 0.07 |  |  |  | \nAcquisition and divestiture-related charges | 0.01 |  |  | \u2014 |  |  |  |  | 0.01 |  |  | 0.04 |  |  |  | \nGain associated with the Juice Transaction | \u2014 |  |  | 0.01 |  |  |  |  | \u2014 |  |  | (2.07) |  |  |  | \nImpairment and other charges/credits | \u2014 |  |  | 0.01 |  |  |  |  | 0.05 |  |  | 1.10 |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \nPension and retiree medical-related impact | \u2014 |  |  | 0.03 |  |  |  |  | \u2014 |  |  | 0.10 |  |  |  | \nTax benefit related to the IRS audit | \u2014 |  |  | (0.20) |  |  |  |  | \u2014 |  |  | (0.20) |  |  |  | \nTax expense related to the TCJ Act | \u2014 |  |  | 0.06 |  |  |  |  | \u2014 |  |  | 0.06 |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  | \nCore net income attributable to PepsiCo per common share \u2013 diluted, non-GAAP measure | $ | 2.25 |  |  | $ | 1.97 |  | (a) | 14 | % |  | $ | 5.83 |  |  | $ | 5.12 |  |  | 14 | % | \nImpact of foreign exchange translation |  |  |  |  | 2 |  |  |  |  |  |  | 2 |  | \nGrowth in core net income attributable to PepsiCo per common share \u2013 diluted, on a constant currency basis, non-GAAP measure |  |  |  |  | 16 | % |  |  |  |  |  | 16 | % |   |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended |  | \n | 9/9/2023 |  | 9/3/2022 |  | \nNet cash provided by operating activities, GAAP measure | $ | 7,630 |  |  | $ | 6,306 |  |  | \nCapital spending | (2,537) |  |  | (2,556) |  |  | \nSales of property, plant and equipment | 131 |  |  | 228 |  |  | \nFree cash flow, non-GAAP measure | $ | 5,224 |  |  | $ | 3,978 |  |  | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | Change(a) |  | Reference\n |  |  | \nCash and cash equivalents | $ | 5.1 |  |  | Statement of Cash Flows\nAccounts and notes receivable, less allowance | $ | 1.6 |  |  | (b)\nProperty, Plant and Equipment, net | $ | 0.6 |  |  | (c)\nOther Assets | $ | 0.6 |  |  | (d)  |  |  |  |  |  |  |  |  |  |  | \n | Change(a) |  | Reference\nShort-term debt obligations | $ | 5.5 |  |  | (e)\n |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod |  | TotalNumber ofSharesRepurchased(a) |  | Average\u00a0PricePaid\u00a0Per\u00a0Share |  | Total\u00a0Numberof SharesPurchased asPart\u00a0of\u00a0PubliclyAnnouncedPlans orPrograms |  | MaximumNumber (orApproximateDollar\u00a0Value)\u00a0ofShares That May Yet BePurchasedUnder\u00a0the\u00a0Plansor Programs\n6/17/2023 |  |  |  |  |  |  |  | $ | 8,034 | \n |  |  |  |  |  |  |  | \n6/18/2023 - 7/15/2023 |  | 0.5 |  |  | $ | 184.93 |  |  | 0.5 |  |  | (87) | \n |  |  |  |  |  |  |  | 7,947 | \n7/16/2023 - 8/12/2023 |  | 0.5 |  |  | $ | 187.63 |  |  | 0.5 |  |  | (100) | \n |  |  |  |  |  |  |  | 7,847 | \n8/13/2023 - 9/9/2023 |  | 0.6 |  |  | $ | 178.49 |  |  | 0.6 |  |  | (106) | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nTotal |  | 1.6 |  |  | $ | 183.44 |  |  | 1.6 |  |  | $ | 7,741 |   |  | \nSee \u201cIndex to Exhibits\u201d on page53.  |  |  |  |  | \nEXHIBIT | \nExhibit 3.1 | Amended and Restated Articles of Incorporation of PepsiCo, Inc., effective as of May 1, 2019, which are incorporated herein by reference to Exhibit 3.1 to PepsiCo, Inc.\u2019s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 3, 2019.\nExhibit 3.2 | By-Laws of PepsiCo, Inc., as amended and restated, effective as of April 15, 2020, which are incorporated herein by reference to Exhibit 3.2 to PepsiCo, Inc.\u2019s Current Report on Form 8-K filed with the Securities and Exchange Commission on April 16, 2020.\nExhibit 15 | Letter re: Unaudited Interim Financial Information.\nExhibit 31 | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.\nExhibit 32 | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.\nExhibit 101 | The following materials from PepsiCo, Inc.\u2019s Quarterly Report on Form 10-Q for the quarter ended September 9, 2023 formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Statement of Income, (ii) the Condensed Consolidated Statement of Comprehensive Income, (iii) the Condensed Consolidated Statement of Cash Flows, (iv) the Condensed Consolidated Balance Sheet, (v) the Condensed Consolidated Statement of Equity, and (vi) Notes to the Condensed Consolidated Financial Statements.\nExhibit 104 | The cover page from the Company\u2019s Quarterly Report on Form 10-Q for the quarter ended September 9, 2023, formatted in iXBRL and contained in Exhibit 101.  |  |  |  |  |  |  |  |  |  |  | \n |  |  | \n |  | PepsiCo, Inc. | \n |  | (Registrant) | \n |  |  | \nDate: | October 10, 2023 | /s/ Marie T. Gallagher | \n |  | Marie T. Gallagher | \n |  | Senior Vice President and Controller | \n |  | (Principal Accounting Officer) | \n |  |  | \nDate: | October 10, 2023 | /s/ David Flavell | \n |  | David Flavell | \n |  | Executive Vice President, General Counsel and Corporate Secretary | \n |  | (Duly Authorized Officer) | "}]}
